Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Melanoma in situ,A1BG,Alpha-1B-glycoprotein,15998,64,1.50 [0.35-6.45],0.5885484703375284
Chapter II Neoplasms,Melanoma in situ,AAMDC,Mth938 domain-containing protein,15528,62,0.94 [0.58-1.52],0.7975044559059815
Chapter II Neoplasms,Melanoma in situ,AARSD1,Alanyl-tRNA editing protein Aarsd1,18305,72,1.28 [0.88-1.86],0.1903511453972064
Chapter II Neoplasms,Melanoma in situ,ABCA2,ATP-binding cassette sub-family A member 2,15452,62,0.44 [0.21-0.90],0.0250815653155183
Chapter II Neoplasms,Melanoma in situ,ABHD14B,Protein ABHD14B,18185,69,1.12 [0.77-1.64],0.5463043326822541
Chapter II Neoplasms,Melanoma in situ,ABL1,Tyrosine-protein kinase ABL1,18305,72,1.15 [0.85-1.56],0.3538815173864224
Chapter II Neoplasms,Melanoma in situ,ABO,Histo-blood group ABO system transferase,15994,64,0.96 [0.82-1.14],0.653226565909344
Chapter II Neoplasms,Melanoma in situ,ABRAXAS2,BRISC complex subunit Abraxas 2,15452,62,1.15 [0.79-1.66],0.4686204455907924
Chapter II Neoplasms,Melanoma in situ,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",17977,71,1.11 [0.86-1.44],0.425111240779826
Chapter II Neoplasms,Melanoma in situ,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15697,63,0.97 [0.67-1.41],0.8875221424109824
Chapter II Neoplasms,Melanoma in situ,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",15975,64,1.06 [0.81-1.38],0.6763740944606589
Chapter II Neoplasms,Melanoma in situ,ACAN,Aggrecan core protein,18197,70,0.58 [0.26-1.27],0.170626847278019
Chapter II Neoplasms,Melanoma in situ,ACE,Angiotensin-converting enzyme,15994,64,1.08 [0.46-2.53],0.86244499736037
Chapter II Neoplasms,Melanoma in situ,ACE2,Angiotensin-converting enzyme 2,18071,70,0.70 [0.45-1.10],0.1196869806442117
Chapter II Neoplasms,Melanoma in situ,ACHE,Acetylcholinesterase,15623,63,0.89 [0.43-1.86],0.7620132320379398
Chapter II Neoplasms,Melanoma in situ,ACOT13,Acyl-coenzyme A thioesterase 13,15920,63,1.04 [0.84-1.29],0.6937391083288562
Chapter II Neoplasms,Melanoma in situ,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18395,74,0.92 [0.60-1.40],0.6918407503398446
Chapter II Neoplasms,Melanoma in situ,ACP1,Low molecular weight phosphotyrosine protein phosphatase,15491,59,1.30 [0.80-2.13],0.2862486714353444
Chapter II Neoplasms,Melanoma in situ,ACP5,Tartrate-resistant acid phosphatase type 5,18474,74,0.77 [0.41-1.43],0.4008390203837219
Chapter II Neoplasms,Melanoma in situ,ACP6,Lysophosphatidic acid phosphatase type 6,18546,74,1.06 [0.78-1.44],0.7175145759328664
Chapter II Neoplasms,Melanoma in situ,ACRBP,Acrosin-binding protein,15917,63,0.98 [0.54-1.79],0.9572324976433008
Chapter II Neoplasms,Melanoma in situ,ACRV1,Acrosomal protein SP-10,15491,59,1.07 [0.85-1.34],0.5519817848621005
Chapter II Neoplasms,Melanoma in situ,ACSL1,Long-chain-fatty-acid--CoA ligase 1,15452,62,0.31 [0.12-0.76],0.0107794663524703
Chapter II Neoplasms,Melanoma in situ,ACTA2,"Actin, aortic smooth muscle",18071,70,0.79 [0.46-1.38],0.4095233925733678
Chapter II Neoplasms,Melanoma in situ,ACTN2,Alpha-actinin-2,15452,62,1.02 [0.68-1.52],0.925338190388967
Chapter II Neoplasms,Melanoma in situ,ACTN4,Alpha-actinin-4,18088,71,1.10 [0.60-2.00],0.7671717032190448
Chapter II Neoplasms,Melanoma in situ,ACVRL1,Serine/threonine-protein kinase receptor R3,18208,69,0.79 [0.32-1.94],0.6070907714026716
Chapter II Neoplasms,Melanoma in situ,ACY1,Aminoacylase-1,18395,74,1.21 [0.87-1.69],0.2600290553494365
Chapter II Neoplasms,Melanoma in situ,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15452,62,1.17 [0.76-1.81],0.4852200663716669
Chapter II Neoplasms,Melanoma in situ,ACYP1,Acylphosphatase-1,15575,63,1.15 [0.79-1.66],0.467387021078456
Chapter II Neoplasms,Melanoma in situ,ADA,Adenosine deaminase,18615,74,0.82 [0.45-1.49],0.5140011179181061
Chapter II Neoplasms,Melanoma in situ,ADA2,Adenosine deaminase 2,18315,74,0.61 [0.37-1.00],0.0512591615077326
Chapter II Neoplasms,Melanoma in situ,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15491,59,1.06 [0.49-2.30],0.8783832084211467
Chapter II Neoplasms,Melanoma in situ,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18071,70,0.58 [0.29-1.15],0.1164160287498447
Chapter II Neoplasms,Melanoma in situ,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18242,69,0.73 [0.40-1.33],0.3041400739343123
Chapter II Neoplasms,Melanoma in situ,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18615,74,1.07 [0.59-1.94],0.8148095358779294
Chapter II Neoplasms,Melanoma in situ,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18531,75,1.25 [0.61-2.57],0.538432669336002
Chapter II Neoplasms,Melanoma in situ,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15920,63,0.77 [0.34-1.71],0.5161192850357404
Chapter II Neoplasms,Melanoma in situ,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15491,59,0.92 [0.40-2.09],0.8360429772193083
Chapter II Neoplasms,Melanoma in situ,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18626,75,1.59 [0.66-3.85],0.3037851885886629
Chapter II Neoplasms,Melanoma in situ,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18305,72,0.89 [0.53-1.49],0.6494839172917541
Chapter II Neoplasms,Melanoma in situ,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18071,70,0.69 [0.32-1.49],0.3457310518910237
Chapter II Neoplasms,Melanoma in situ,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15491,59,1.13 [0.56-2.26],0.737416950718458
Chapter II Neoplasms,Melanoma in situ,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18439,74,1.00 [0.64-1.58],0.9845488338856164
Chapter II Neoplasms,Melanoma in situ,ADAMTSL2,ADAMTS-like protein 2,15983,64,0.67 [0.31-1.43],0.2986958151467983
Chapter II Neoplasms,Melanoma in situ,ADAMTSL4,ADAMTS-like protein 4,15528,62,1.37 [0.50-3.76],0.539800907797064
Chapter II Neoplasms,Melanoma in situ,ADAMTSL5,ADAMTS-like protein 5,15975,64,0.65 [0.35-1.18],0.1556183278430697
Chapter II Neoplasms,Melanoma in situ,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,17977,71,1.04 [0.58-1.85],0.9049409761212702
Chapter II Neoplasms,Melanoma in situ,ADD1,Alpha-adducin,15623,63,1.11 [0.79-1.56],0.5536946354979393
Chapter II Neoplasms,Melanoma in situ,ADGRB3,Adhesion G protein-coupled receptor B3,18208,69,0.82 [0.43-1.57],0.5481661726279818
Chapter II Neoplasms,Melanoma in situ,ADGRD1,Adhesion G-protein coupled receptor D1,15623,63,1.38 [0.76-2.51],0.2966034233981743
Chapter II Neoplasms,Melanoma in situ,ADGRE1,Adhesion G protein-coupled receptor E1,15920,63,1.06 [0.68-1.66],0.7934082318007648
Chapter II Neoplasms,Melanoma in situ,ADGRE2,Adhesion G protein-coupled receptor E2,18455,74,0.52 [0.25-1.10],0.0884694663292753
Chapter II Neoplasms,Melanoma in situ,ADGRE5,Adhesion G protein-coupled receptor E5,18535,74,0.63 [0.31-1.27],0.1945387796597359
Chapter II Neoplasms,Melanoma in situ,ADGRF5,Adhesion G protein-coupled receptor F5,15975,64,0.72 [0.29-1.80],0.4821129872411395
Chapter II Neoplasms,Melanoma in situ,ADGRG1,Adhesion G-protein coupled receptor G1,18305,72,0.95 [0.73-1.22],0.6671499978508153
Chapter II Neoplasms,Melanoma in situ,ADGRG2,Adhesion G-protein coupled receptor G2,18395,74,1.03 [0.48-2.25],0.931189819789548
Chapter II Neoplasms,Melanoma in situ,ADGRV1,Adhesion G-protein coupled receptor V1,15489,61,0.85 [0.56-1.27],0.4158498196731853
Chapter II Neoplasms,Melanoma in situ,ADH1B,All-trans-retinol dehydrogenase,15623,63,0.82 [0.58-1.15],0.2462590836295008
Chapter II Neoplasms,Melanoma in situ,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18071,70,0.93 [0.71-1.21],0.5737988365865686
Chapter II Neoplasms,Melanoma in situ,ADIPOQ,Adiponectin,15998,64,1.14 [0.81-1.61],0.4642690609102181
Chapter II Neoplasms,Melanoma in situ,ADM,Pro-adrenomedullin,18569,74,1.09 [0.48-2.49],0.832750242869543
Chapter II Neoplasms,Melanoma in situ,ADRA2A,Alpha-2A adrenergic receptor,15452,62,1.32 [1.02-1.71],0.0321096156758426
Chapter II Neoplasms,Melanoma in situ,AFAP1,Actin filament-associated protein 1,15623,63,0.87 [0.63-1.18],0.3711469624790319
Chapter II Neoplasms,Melanoma in situ,AFM,Afamin,15998,64,0.63 [0.19-2.04],0.4400743048239199
Chapter II Neoplasms,Melanoma in situ,AFP,Alpha-fetoprotein,18174,68,1.28 [0.93-1.78],0.1336208304362213
Chapter II Neoplasms,Melanoma in situ,AGBL2,Cytosolic carboxypeptidase 2,15489,61,0.88 [0.69-1.11],0.2820458904139127
Chapter II Neoplasms,Melanoma in situ,AGER,Advanced glycosylation end product-specific receptor,18335,73,1.10 [0.66-1.84],0.7208005243278646
Chapter II Neoplasms,Melanoma in situ,AGR2,Anterior gradient protein 2 homolog,17871,69,0.99 [0.79-1.24],0.9391033050327467
Chapter II Neoplasms,Melanoma in situ,AGR3,Anterior gradient protein 3,17951,71,1.40 [1.02-1.93],0.0363055933488741
Chapter II Neoplasms,Melanoma in situ,AGRN,Agrin,18455,74,1.36 [0.76-2.45],0.3045164812558184
Chapter II Neoplasms,Melanoma in situ,AGRP,Agouti-related protein,18615,74,1.34 [0.89-2.04],0.1626596310403567
Chapter II Neoplasms,Melanoma in situ,AGT,Angiotensinogen,15994,64,0.94 [0.30-2.96],0.911490171341752
Chapter II Neoplasms,Melanoma in situ,AGXT,Serine--pyruvate aminotransferase,18395,74,0.93 [0.70-1.24],0.6403067750871396
Chapter II Neoplasms,Melanoma in situ,AHCY,Adenosylhomocysteinase,18395,74,1.08 [0.79-1.47],0.6234398512485031
Chapter II Neoplasms,Melanoma in situ,AHNAK,Neuroblast differentiation-associated protein AHNAK,15528,62,0.68 [0.30-1.55],0.3571034080743486
Chapter II Neoplasms,Melanoma in situ,AHNAK2,Protein AHNAK2,15528,62,0.56 [0.23-1.36],0.2012821961109585
Chapter II Neoplasms,Melanoma in situ,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,15917,63,1.21 [0.88-1.65],0.2359196594638365
Chapter II Neoplasms,Melanoma in situ,AHSG,Alpha-2-HS-glycoprotein,15994,64,2.14 [0.92-4.96],0.0778446437725926
Chapter II Neoplasms,Melanoma in situ,AHSP,Alpha-hemoglobin-stabilizing protein,18358,74,1.09 [0.85-1.41],0.5044701232217876
Chapter II Neoplasms,Melanoma in situ,AIDA,"Axin interactor, dorsalization-associated protein",15567,63,0.86 [0.62-1.18],0.3501208180256755
Chapter II Neoplasms,Melanoma in situ,AIF1,Allograft inflammatory factor 1,17977,71,1.07 [0.72-1.61],0.7254608175591359
Chapter II Neoplasms,Melanoma in situ,AIF1L,Allograft inflammatory factor 1-like,15528,62,0.71 [0.41-1.25],0.2396630798362006
Chapter II Neoplasms,Melanoma in situ,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18282,71,1.08 [0.88-1.31],0.4657453427097561
Chapter II Neoplasms,Melanoma in situ,AK1,Adenylate kinase isoenzyme 1,18395,74,1.15 [0.84-1.58],0.3903891441923657
Chapter II Neoplasms,Melanoma in situ,AK2,"Adenylate kinase 2, mitochondrial",15944,63,1.07 [0.85-1.34],0.5518989494490932
Chapter II Neoplasms,Melanoma in situ,AKAP12,A-kinase anchor protein 12,15623,63,1.39 [0.47-4.12],0.5576764286800737
Chapter II Neoplasms,Melanoma in situ,AKR1B1,Aldo-keto reductase family 1 member B1,17977,71,1.26 [0.96-1.65],0.0971623861429842
Chapter II Neoplasms,Melanoma in situ,AKR1B10,Aldo-keto reductase family 1 member B10,15567,63,0.98 [0.67-1.45],0.9293380570039615
Chapter II Neoplasms,Melanoma in situ,AKR1C4,Aldo-keto reductase family 1 member C4,18071,70,1.04 [0.68-1.59],0.8532578774064523
Chapter II Neoplasms,Melanoma in situ,AKR7L,Aflatoxin B1 aldehyde reductase member 4,15491,59,0.89 [0.60-1.32],0.5619781877223946
Chapter II Neoplasms,Melanoma in situ,AKT1S1,Proline-rich AKT1 substrate 1,18002,70,1.08 [0.78-1.49],0.6519094299899109
Chapter II Neoplasms,Melanoma in situ,AKT2,RAC-beta serine/threonine-protein kinase,15952,63,1.06 [0.88-1.29],0.5298077611495662
Chapter II Neoplasms,Melanoma in situ,AKT3,RAC-gamma serine/threonine-protein kinase,17891,71,1.18 [0.82-1.71],0.3694024203794064
Chapter II Neoplasms,Melanoma in situ,ALCAM,CD166 antigen,18626,75,0.56 [0.19-1.64],0.2886756310891111
Chapter II Neoplasms,Melanoma in situ,ALDH1A1,Retinal dehydrogenase 1,18396,74,0.98 [0.67-1.46],0.9387272627803324
Chapter II Neoplasms,Melanoma in situ,ALDH2,"Aldehyde dehydrogenase, mitochondrial",15917,63,0.81 [0.46-1.42],0.4613702293829631
Chapter II Neoplasms,Melanoma in situ,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18358,73,0.83 [0.59-1.16],0.2719736129797564
Chapter II Neoplasms,Melanoma in situ,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",15952,63,0.69 [0.39-1.21],0.1955560437394104
Chapter II Neoplasms,Melanoma in situ,ALMS1,Alstrom syndrome protein 1,15697,63,0.44 [0.22-0.85],0.0148982528037975
Chapter II Neoplasms,Melanoma in situ,ALPI,Intestinal-type alkaline phosphatase,15491,59,1.20 [0.99-1.46],0.0633735463423794
Chapter II Neoplasms,Melanoma in situ,ALPP,"Alkaline phosphatase, placental type",18305,72,1.02 [0.83-1.25],0.872581046315047
Chapter II Neoplasms,Melanoma in situ,AMBN,Ameloblastin,18088,71,0.82 [0.35-1.93],0.6467701418799017
Chapter II Neoplasms,Melanoma in situ,AMBP,Protein AMBP,18543,74,1.16 [0.41-3.29],0.7787187993162757
Chapter II Neoplasms,Melanoma in situ,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,15983,64,0.61 [0.25-1.48],0.2768743701403139
Chapter II Neoplasms,Melanoma in situ,AMFR,E3 ubiquitin-protein ligase AMFR,18002,70,0.84 [0.58-1.20],0.3403257570595996
Chapter II Neoplasms,Melanoma in situ,AMIGO1,Amphoterin-induced protein 1,15567,63,0.48 [0.25-0.92],0.027133051353493
Chapter II Neoplasms,Melanoma in situ,AMIGO2,Amphoterin-induced protein 2,18305,72,1.36 [0.56-3.28],0.4930793582491929
Chapter II Neoplasms,Melanoma in situ,AMN,Protein amnionless,18088,71,1.36 [0.89-2.09],0.1519730639115184
Chapter II Neoplasms,Melanoma in situ,AMOT,Angiomotin,15623,63,1.45 [0.77-2.70],0.2474010391103587
Chapter II Neoplasms,Melanoma in situ,AMOTL2,Angiomotin-like protein 2,15850,62,1.21 [0.78-1.87],0.3883226874986749
Chapter II Neoplasms,Melanoma in situ,AMPD3,AMP deaminase 3,15944,63,1.29 [0.92-1.79],0.1389256438775009
Chapter II Neoplasms,Melanoma in situ,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,14974,60,1.03 [0.63-1.70],0.9002224165955554
Chapter II Neoplasms,Melanoma in situ,AMY2A,Pancreatic alpha-amylase,17728,70,0.88 [0.57-1.37],0.5774312767120294
Chapter II Neoplasms,Melanoma in situ,AMY2B,Alpha-amylase 2B,17175,68,0.84 [0.54-1.32],0.4511185384141651
Chapter II Neoplasms,Melanoma in situ,ANG,Angiogenin,18372,74,0.65 [0.34-1.24],0.189833410615213
Chapter II Neoplasms,Melanoma in situ,ANGPT1,Angiopoietin-1,18319,73,1.31 [1.01-1.69],0.0402136050678771
Chapter II Neoplasms,Melanoma in situ,ANGPT2,Angiopoietin-2,18569,74,1.01 [0.58-1.76],0.979835661546513
Chapter II Neoplasms,Melanoma in situ,ANGPTL1,Angiopoietin-related protein 1,18117,73,0.86 [0.41-1.79],0.6782667861573085
Chapter II Neoplasms,Melanoma in situ,ANGPTL2,Angiopoietin-related protein 2,18387,74,0.86 [0.51-1.45],0.5676556022454158
Chapter II Neoplasms,Melanoma in situ,ANGPTL3,Angiopoietin-related protein 3,18431,74,0.74 [0.41-1.34],0.319169543887398
Chapter II Neoplasms,Melanoma in situ,ANGPTL4,Angiopoietin-related protein 4,18434,74,0.79 [0.49-1.27],0.3368860989554779
Chapter II Neoplasms,Melanoma in situ,ANGPTL7,Angiopoietin-related protein 7,18569,74,0.65 [0.37-1.14],0.1336015206946085
Chapter II Neoplasms,Melanoma in situ,ANK2,Ankyrin-2,15452,62,1.20 [0.89-1.63],0.2387601868255394
Chapter II Neoplasms,Melanoma in situ,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15491,59,1.31 [0.97-1.77],0.0769716561987785
Chapter II Neoplasms,Melanoma in situ,ANKRA2,Ankyrin repeat family A protein 2,15421,61,0.96 [0.61-1.51],0.8690644079508382
Chapter II Neoplasms,Melanoma in situ,ANKRD54,Ankyrin repeat domain-containing protein 54,17977,71,0.94 [0.65-1.38],0.7649818081163794
Chapter II Neoplasms,Melanoma in situ,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15528,62,0.66 [0.30-1.47],0.3089895215076686
Chapter II Neoplasms,Melanoma in situ,ANPEP,Aminopeptidase N,18460,74,0.66 [0.30-1.46],0.3020461454809341
Chapter II Neoplasms,Melanoma in situ,ANXA1,Annexin A1,15544,63,0.52 [0.27-1.00],0.0507774390680254
Chapter II Neoplasms,Melanoma in situ,ANXA10,Annexin A10,18002,70,0.98 [0.75-1.28],0.878938832418342
Chapter II Neoplasms,Melanoma in situ,ANXA11,Annexin A11,18352,73,1.15 [0.83-1.59],0.3977518058700103
Chapter II Neoplasms,Melanoma in situ,ANXA2,Annexin A2,15305,62,1.02 [0.72-1.45],0.912288617956046
Chapter II Neoplasms,Melanoma in situ,ANXA3,Annexin A3,18531,75,0.97 [0.72-1.29],0.8170283296719459
Chapter II Neoplasms,Melanoma in situ,ANXA4,Annexin A4,18315,73,1.03 [0.77-1.37],0.8620739507346263
Chapter II Neoplasms,Melanoma in situ,ANXA5,Annexin A5,17939,70,0.78 [0.38-1.62],0.5116188244942466
Chapter II Neoplasms,Melanoma in situ,AOC1,Amiloride-sensitive amine oxidase [copper-containing],18088,71,1.15 [0.82-1.61],0.4056735000216241
Chapter II Neoplasms,Melanoma in situ,AOC3,Membrane primary amine oxidase,18485,74,0.83 [0.41-1.68],0.610797630520672
Chapter II Neoplasms,Melanoma in situ,AP1G2,AP-1 complex subunit gamma-like 2,15917,63,1.34 [1.00-1.78],0.0465579910048126
Chapter II Neoplasms,Melanoma in situ,AP2B1,AP-2 complex subunit beta,15567,63,1.06 [0.64-1.75],0.8156069256205102
Chapter II Neoplasms,Melanoma in situ,AP3B1,AP-3 complex subunit beta-1,15920,63,1.07 [0.78-1.47],0.6634628728700345
Chapter II Neoplasms,Melanoma in situ,AP3S2,AP-3 complex subunit sigma-2,15944,63,1.13 [0.69-1.85],0.6150744941977135
Chapter II Neoplasms,Melanoma in situ,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18305,72,0.91 [0.57-1.47],0.7032267272680328
Chapter II Neoplasms,Melanoma in situ,APCS,Serum amyloid P-component,15854,64,0.85 [0.41-1.76],0.6580116516894748
Chapter II Neoplasms,Melanoma in situ,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18518,73,0.94 [0.66-1.35],0.7509183299971346
Chapter II Neoplasms,Melanoma in situ,APLP1,Amyloid-like protein 1,18395,74,0.74 [0.49-1.12],0.1513895917443495
Chapter II Neoplasms,Melanoma in situ,APOA1,Apolipoprotein A-I,15998,64,0.99 [0.40-2.45],0.9859655884607998
Chapter II Neoplasms,Melanoma in situ,APOA2,Apolipoprotein A-II,15994,64,0.95 [0.58-1.54],0.8329193245296975
Chapter II Neoplasms,Melanoma in situ,APOA4,Apolipoprotein A-IV,15998,64,1.32 [0.69-2.55],0.4048042736373327
Chapter II Neoplasms,Melanoma in situ,APOB,Apolipoprotein B-100,15994,64,0.50 [0.19-1.30],0.1536154975129282
Chapter II Neoplasms,Melanoma in situ,APOBR,Apolipoprotein B receptor,15528,62,0.76 [0.44-1.32],0.3333516545994168
Chapter II Neoplasms,Melanoma in situ,APOC1,Apolipoprotein C-I,15973,64,1.18 [0.64-2.17],0.5889280087853014
Chapter II Neoplasms,Melanoma in situ,APOD,Apolipoprotein D,15287,62,1.25 [0.75-2.07],0.3938291091927898
Chapter II Neoplasms,Melanoma in situ,APOE,Apolipoprotein E,15998,64,1.19 [0.91-1.55],0.2010250105658103
Chapter II Neoplasms,Melanoma in situ,APOF,Apolipoprotein F,15994,64,2.19 [0.71-6.74],0.1734666164785303
Chapter II Neoplasms,Melanoma in situ,APOH,Beta-2-glycoprotein 1,18396,74,0.99 [0.57-1.74],0.9733946476532912
Chapter II Neoplasms,Melanoma in situ,APOL1,Apolipoprotein L1,15994,64,0.83 [0.50-1.37],0.4655300465973609
Chapter II Neoplasms,Melanoma in situ,APOM,Apolipoprotein M,18463,74,1.17 [0.57-2.40],0.6602448600906117
Chapter II Neoplasms,Melanoma in situ,APP,Amyloid-beta precursor protein,18372,74,1.34 [0.99-1.81],0.0589114003715316
Chapter II Neoplasms,Melanoma in situ,APPL2,DCC-interacting protein 13-beta,15623,63,1.10 [0.89-1.37],0.3835944266116525
Chapter II Neoplasms,Melanoma in situ,APRT,Adenine phosphoribosyltransferase,18211,68,1.20 [0.75-1.91],0.4465474131182951
Chapter II Neoplasms,Melanoma in situ,ARAF,Serine/threonine-protein kinase A-Raf,15697,63,1.17 [0.87-1.59],0.3022880663357611
Chapter II Neoplasms,Melanoma in situ,AREG,Amphiregulin,18305,72,0.97 [0.55-1.70],0.9126329617568965
Chapter II Neoplasms,Melanoma in situ,ARF6,ADP-ribosylation factor 6,15920,63,1.10 [0.88-1.38],0.4030615676979143
Chapter II Neoplasms,Melanoma in situ,ARFIP1,Arfaptin-1,15952,63,1.06 [0.74-1.51],0.7529641441665299
Chapter II Neoplasms,Melanoma in situ,ARG1,Arginase-1,18294,72,0.96 [0.64-1.44],0.8536885859887674
Chapter II Neoplasms,Melanoma in situ,ARG2,"Arginase-2, mitochondrial",15917,63,0.77 [0.41-1.47],0.4303464705428989
Chapter II Neoplasms,Melanoma in situ,ARHGAP1,Rho GTPase-activating protein 1,17977,71,0.95 [0.60-1.50],0.8336328019134154
Chapter II Neoplasms,Melanoma in situ,ARHGAP25,Rho GTPase-activating protein 25,17977,71,1.27 [0.93-1.73],0.1373085144119698
Chapter II Neoplasms,Melanoma in situ,ARHGAP30,Rho GTPase-activating protein 30,15697,63,0.58 [0.26-1.29],0.1779637219650153
Chapter II Neoplasms,Melanoma in situ,ARHGAP45,Rho GTPase-activating protein 45,15623,63,1.11 [0.83-1.50],0.4774628951479562
Chapter II Neoplasms,Melanoma in situ,ARHGAP5,Rho GTPase-activating protein 5,15421,61,0.87 [0.61-1.23],0.4236841305577475
Chapter II Neoplasms,Melanoma in situ,ARHGEF1,Rho guanine nucleotide exchange factor 1,15944,63,1.21 [0.92-1.58],0.175751705016624
Chapter II Neoplasms,Melanoma in situ,ARHGEF10,Rho guanine nucleotide exchange factor 10,15952,63,1.27 [0.99-1.62],0.0560975156461166
Chapter II Neoplasms,Melanoma in situ,ARHGEF12,Rho guanine nucleotide exchange factor 12,18389,73,1.26 [1.03-1.54],0.024153225927833
Chapter II Neoplasms,Melanoma in situ,ARHGEF5,Rho guanine nucleotide exchange factor 5,15489,61,0.95 [0.67-1.35],0.7753315802488954
Chapter II Neoplasms,Melanoma in situ,ARID3A,AT-rich interactive domain-containing protein 3A,15489,61,0.63 [0.32-1.25],0.1858994563247301
Chapter II Neoplasms,Melanoma in situ,ARID4B,AT-rich interactive domain-containing protein 4B,18002,70,0.68 [0.36-1.28],0.2327104299529518
Chapter II Neoplasms,Melanoma in situ,ARL13B,ADP-ribosylation factor-like protein 13B,15452,62,1.14 [0.81-1.60],0.4515263594307515
Chapter II Neoplasms,Melanoma in situ,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15452,62,1.02 [0.55-1.88],0.956325130987144
Chapter II Neoplasms,Melanoma in situ,ARMCX2,Armadillo repeat-containing X-linked protein 2,15489,61,1.02 [0.68-1.52],0.9336455631327636
Chapter II Neoplasms,Melanoma in situ,ARNT,Aryl hydrocarbon receptor nuclear translocator,18088,71,0.67 [0.35-1.28],0.2250152901413044
Chapter II Neoplasms,Melanoma in situ,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15452,62,0.97 [0.60-1.56],0.8861693827295981
Chapter II Neoplasms,Melanoma in situ,ARSA,Arylsulfatase A,18396,74,0.84 [0.52-1.36],0.4802674782058237
Chapter II Neoplasms,Melanoma in situ,ARSB,Arylsulfatase B,18305,72,1.00 [0.69-1.46],0.9927417879725792
Chapter II Neoplasms,Melanoma in situ,ART3,Ecto-ADP-ribosyltransferase 3,18485,74,0.43 [0.26-0.70],0.0007011759999281
Chapter II Neoplasms,Melanoma in situ,ART5,Ecto-ADP-ribosyltransferase 5,15489,61,0.79 [0.48-1.28],0.3376951742715547
Chapter II Neoplasms,Melanoma in situ,ARTN,Artemin,18088,71,1.19 [0.80-1.79],0.3929420900463327
Chapter II Neoplasms,Melanoma in situ,ASAH1,Acid ceramidase,15842,64,1.02 [0.61-1.72],0.937257952872314
Chapter II Neoplasms,Melanoma in situ,ASAH2,Neutral ceramidase,18242,69,0.76 [0.54-1.08],0.1227758360311832
Chapter II Neoplasms,Melanoma in situ,ASGR1,Asialoglycoprotein receptor 1,18242,69,1.09 [0.53-2.24],0.81763898321528
Chapter II Neoplasms,Melanoma in situ,ASGR2,Asialoglycoprotein receptor 2,15994,64,1.57 [0.65-3.79],0.3208488514897806
Chapter II Neoplasms,Melanoma in situ,ASPN,Asporin,15975,64,0.60 [0.24-1.51],0.2779039026155777
Chapter II Neoplasms,Melanoma in situ,ASPSCR1,Tether containing UBX domain for GLUT4,15952,63,1.26 [0.88-1.80],0.2129363333770914
Chapter II Neoplasms,Melanoma in situ,ASRGL1,Isoaspartyl peptidase/L-asparaginase,15528,62,1.11 [0.87-1.42],0.4076663919193902
Chapter II Neoplasms,Melanoma in situ,ASS1,Argininosuccinate synthase,15452,62,0.83 [0.60-1.16],0.2871110249592128
Chapter II Neoplasms,Melanoma in situ,ATF2,Cyclic AMP-dependent transcription factor ATF-2,18002,70,0.78 [0.51-1.20],0.2592320978367221
Chapter II Neoplasms,Melanoma in situ,ATF4,Cyclic AMP-dependent transcription factor ATF-4,15421,61,0.77 [0.36-1.67],0.5121987759960424
Chapter II Neoplasms,Melanoma in situ,ATG16L1,Autophagy-related protein 16-1,15920,63,1.20 [0.90-1.58],0.2130674471045243
Chapter II Neoplasms,Melanoma in situ,ATG4A,Cysteine protease ATG4A,17977,71,1.14 [0.80-1.61],0.464727002138343
Chapter II Neoplasms,Melanoma in situ,ATOX1,Copper transport protein ATOX1,18439,74,1.14 [0.85-1.52],0.3907029869687742
Chapter II Neoplasms,Melanoma in situ,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15452,62,0.92 [0.53-1.59],0.7583940949144274
Chapter II Neoplasms,Melanoma in situ,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15452,62,0.37 [0.15-0.89],0.0256553574826978
Chapter II Neoplasms,Melanoma in situ,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15452,62,0.38 [0.17-0.87],0.0223045428208989
Chapter II Neoplasms,Melanoma in situ,ATP1B4,Protein ATP1B4,15421,61,0.62 [0.32-1.22],0.1698741931152094
Chapter II Neoplasms,Melanoma in situ,ATP2B4,Plasma membrane calcium-transporting ATPase 4,15452,62,0.75 [0.46-1.23],0.2590354061925415
Chapter II Neoplasms,Melanoma in situ,ATP5F1D,"ATP synthase subunit delta, mitochondrial",15452,62,0.96 [0.59-1.58],0.871829598253278
Chapter II Neoplasms,Melanoma in situ,ATP5IF1,"ATPase inhibitor, mitochondrial",18455,74,1.07 [0.89-1.29],0.4713014495240366
Chapter II Neoplasms,Melanoma in situ,ATP5PO,"ATP synthase subunit O, mitochondrial",18002,70,0.94 [0.55-1.60],0.8152626950172043
Chapter II Neoplasms,Melanoma in situ,ATP6AP2,Renin receptor,17977,71,0.88 [0.50-1.56],0.670163438472725
Chapter II Neoplasms,Melanoma in situ,ATP6V1D,V-type proton ATPase subunit D,18305,72,0.80 [0.34-1.91],0.6162583575817107
Chapter II Neoplasms,Melanoma in situ,ATP6V1F,V-type proton ATPase subunit F,17974,70,1.09 [0.79-1.49],0.5993688228725
Chapter II Neoplasms,Melanoma in situ,ATP6V1G1,V-type proton ATPase subunit G 1,15528,62,1.20 [0.87-1.66],0.2587378317140419
Chapter II Neoplasms,Melanoma in situ,ATP6V1G2,V-type proton ATPase subunit G 2,15452,62,1.20 [0.97-1.49],0.0962762183488515
Chapter II Neoplasms,Melanoma in situ,ATRAID,All-trans retinoic acid-induced differentiation factor,15920,63,1.12 [0.51-2.48],0.7761050605826174
Chapter II Neoplasms,Melanoma in situ,ATRN,"Attractin, Isoform 2",15998,64,0.87 [0.21-3.67],0.8490258229969014
Chapter II Neoplasms,Melanoma in situ,ATXN10,Ataxin-10,18002,70,1.32 [0.98-1.78],0.0681931130101959
Chapter II Neoplasms,Melanoma in situ,ATXN2,Ataxin-2,15489,61,1.03 [0.83-1.29],0.7889510547132479
Chapter II Neoplasms,Melanoma in situ,ATXN2L,Ataxin-2-like protein,15952,63,1.15 [0.72-1.83],0.5642956535701279
Chapter II Neoplasms,Melanoma in situ,ATXN3,Ataxin-3,15944,63,1.23 [0.84-1.79],0.29370302251468
Chapter II Neoplasms,Melanoma in situ,AXIN1,Axin-1,18389,73,1.23 [0.99-1.52],0.0648723509331493
Chapter II Neoplasms,Melanoma in situ,AXL,Tyrosine-protein kinase receptor UFO,18485,74,1.42 [0.67-3.00],0.3574422413529305
Chapter II Neoplasms,Melanoma in situ,AZI2,5-azacytidine-induced protein 2,15952,63,1.37 [0.91-2.05],0.1294499229709663
Chapter II Neoplasms,Melanoma in situ,AZU1,Azurocidin,17858,71,0.74 [0.54-1.03],0.0760491069871353
Chapter II Neoplasms,Melanoma in situ,B2M,Beta-2-microglobulin,15998,64,1.32 [0.75-2.34],0.3329079024508878
Chapter II Neoplasms,Melanoma in situ,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15452,62,0.36 [0.10-1.25],0.1061820218850099
Chapter II Neoplasms,Melanoma in situ,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15528,62,1.24 [0.64-2.41],0.5243997624478136
Chapter II Neoplasms,Melanoma in situ,B4GALT1,"Beta-1,4-galactosyltransferase 1",18455,74,0.99 [0.46-2.11],0.9745253480927656
Chapter II Neoplasms,Melanoma in situ,B4GAT1,"Beta-1,4-glucuronyltransferase 1",18396,74,0.78 [0.33-1.84],0.5702763036343399
Chapter II Neoplasms,Melanoma in situ,BABAM1,BRISC and BRCA1-A complex member 1,15491,59,1.03 [0.45-2.38],0.9451140061187197
Chapter II Neoplasms,Melanoma in situ,BACH1,Transcription regulator protein BACH1,18389,73,1.26 [0.96-1.66],0.0965298908356904
Chapter II Neoplasms,Melanoma in situ,BAG3,BAG family molecular chaperone regulator 3,18208,69,1.05 [0.61-1.81],0.8567382209884115
Chapter II Neoplasms,Melanoma in situ,BAG4,BAG family molecular chaperone regulator 4,15491,59,1.44 [0.94-2.22],0.0962283760715073
Chapter II Neoplasms,Melanoma in situ,BAG6,Large proline-rich protein BAG6,18071,70,1.39 [0.78-2.46],0.2639466876487675
Chapter II Neoplasms,Melanoma in situ,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,17977,71,1.05 [0.76-1.46],0.7746731020361952
Chapter II Neoplasms,Melanoma in situ,BAMBI,BMP and activin membrane-bound inhibitor homolog,17977,71,0.70 [0.32-1.53],0.3738294157262638
Chapter II Neoplasms,Melanoma in situ,BANK1,B-cell scaffold protein with ankyrin repeats,18389,73,1.21 [0.99-1.48],0.0662652150538967
Chapter II Neoplasms,Melanoma in situ,BAP18,Chromatin complexes subunit BAP18,15944,63,0.96 [0.67-1.37],0.814961780009093
Chapter II Neoplasms,Melanoma in situ,BATF,Basic leucine zipper transcriptional factor ATF-like,15567,63,0.92 [0.67-1.26],0.6086163911884648
Chapter II Neoplasms,Melanoma in situ,BAX,Apoptosis regulator BAX,17972,70,1.09 [0.87-1.38],0.4523940742871205
Chapter II Neoplasms,Melanoma in situ,BCAM,Basal cell adhesion molecule,18396,74,0.45 [0.18-1.08],0.0745131257214189
Chapter II Neoplasms,Melanoma in situ,BCAN,Brevican core protein,18242,69,0.99 [0.53-1.85],0.981912630817594
Chapter II Neoplasms,Melanoma in situ,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",15975,64,0.71 [0.30-1.64],0.4196576053770792
Chapter II Neoplasms,Melanoma in situ,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15489,61,0.82 [0.48-1.40],0.4693360580225667
Chapter II Neoplasms,Melanoma in situ,BCHE,Cholinesterase,15697,61,2.64 [1.01-6.92],0.0478225946705279
Chapter II Neoplasms,Melanoma in situ,BCL2,Apoptosis regulator Bcl-2,15920,63,0.82 [0.49-1.37],0.4430987786633136
Chapter II Neoplasms,Melanoma in situ,BCL2L1,Bcl-2-like protein 1,15944,63,1.11 [0.87-1.42],0.3992326059191654
Chapter II Neoplasms,Melanoma in situ,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18389,73,1.66 [0.95-2.90],0.0739918454544518
Chapter II Neoplasms,Melanoma in situ,BCL2L15,Bcl-2-like protein 15,15491,59,1.11 [0.74-1.65],0.6245265468948751
Chapter II Neoplasms,Melanoma in situ,BCL7A,B-cell CLL/lymphoma 7 protein family member A,15421,61,1.00 [0.68-1.47],0.9922650320689832
Chapter II Neoplasms,Melanoma in situ,BCL7B,B-cell CLL/lymphoma 7 protein family member B,15917,63,0.52 [0.26-1.02],0.0567508118164361
Chapter II Neoplasms,Melanoma in situ,BCR,Breakpoint cluster region protein,18389,73,1.20 [0.96-1.51],0.1099184609440317
Chapter II Neoplasms,Melanoma in situ,BDNF,Brain-derived neurotrophic factor,15983,64,1.11 [0.83-1.49],0.4779932443421221
Chapter II Neoplasms,Melanoma in situ,BECN1,Beclin-1,15528,62,1.15 [0.76-1.74],0.4971198405777506
Chapter II Neoplasms,Melanoma in situ,BEX3,Protein BEX3,15421,61,0.55 [0.28-1.07],0.079786192953239
Chapter II Neoplasms,Melanoma in situ,BGLAP,Osteocalcin,15983,64,0.98 [0.73-1.31],0.896664558278755
Chapter II Neoplasms,Melanoma in situ,BGN,Biglycan,17951,71,0.87 [0.72-1.05],0.1387251561225181
Chapter II Neoplasms,Melanoma in situ,BHLHE40,Class E basic helix-loop-helix protein 40,15489,61,0.74 [0.49-1.10],0.1360404095773611
Chapter II Neoplasms,Melanoma in situ,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15452,62,0.40 [0.16-0.98],0.04528034398993
Chapter II Neoplasms,Melanoma in situ,BID,BH3-interacting domain death agonist,18389,73,1.05 [0.77-1.43],0.7540553854455359
Chapter II Neoplasms,Melanoma in situ,BIN2,Bridging integrator 2,18396,74,1.09 [0.87-1.38],0.4470808083213469
Chapter II Neoplasms,Melanoma in situ,BIRC2,Baculoviral IAP repeat-containing protein 2,17977,71,1.10 [0.79-1.53],0.561726206993294
Chapter II Neoplasms,Melanoma in situ,BLMH,Bleomycin hydrolase,18626,75,1.05 [0.53-2.08],0.8813130728823565
Chapter II Neoplasms,Melanoma in situ,BLNK,B-cell linker protein,15491,59,1.12 [0.59-2.12],0.7233424226884355
Chapter II Neoplasms,Melanoma in situ,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15489,61,1.16 [0.88-1.54],0.297220602855985
Chapter II Neoplasms,Melanoma in situ,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,15944,63,1.40 [0.80-2.45],0.2362252643609276
Chapter II Neoplasms,Melanoma in situ,BLVRB,Flavin reductase,18396,74,1.02 [0.75-1.39],0.8862848895810091
Chapter II Neoplasms,Melanoma in situ,BMP10,Bone morphogenetic protein 10,15623,63,0.83 [0.36-1.91],0.6542843943624885
Chapter II Neoplasms,Melanoma in situ,BMP4,Bone morphogenetic protein 4,18208,69,1.15 [0.73-1.80],0.5476244238199393
Chapter II Neoplasms,Melanoma in situ,BMP6,Bone morphogenetic protein 6,18041,70,1.12 [0.66-1.92],0.6736197384762382
Chapter II Neoplasms,Melanoma in situ,BMPER,BMP-binding endothelial regulator protein,15623,63,0.54 [0.18-1.63],0.2761413907811388
Chapter II Neoplasms,Melanoma in situ,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,15975,64,1.09 [0.55-2.18],0.8085248510089895
Chapter II Neoplasms,Melanoma in situ,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15491,59,1.74 [1.08-2.80],0.0230224234978062
Chapter II Neoplasms,Melanoma in situ,BOC,Brother of CDO,18071,70,0.81 [0.32-2.04],0.6506087803438354
Chapter II Neoplasms,Melanoma in situ,BOLA1,BolA-like protein 1,15489,61,1.33 [0.87-2.02],0.1855223609727176
Chapter II Neoplasms,Melanoma in situ,BOLA2_BOLA2B,BolA-like protein 2,15528,62,1.26 [0.79-2.00],0.3300820197283026
Chapter II Neoplasms,Melanoma in situ,BPIFA2,BPI fold-containing family A member 2,14988,60,0.95 [0.75-1.21],0.6906952023812902
Chapter II Neoplasms,Melanoma in situ,BPIFB1,BPI fold-containing family B member 1,18369,74,0.97 [0.70-1.34],0.8466605037423849
Chapter II Neoplasms,Melanoma in situ,BPIFB2,BPI fold-containing family B member 2,15947,63,1.06 [0.72-1.55],0.764651452477872
Chapter II Neoplasms,Melanoma in situ,BRAP,BRCA1-associated protein,15757,62,1.07 [0.85-1.34],0.5755298890522644
Chapter II Neoplasms,Melanoma in situ,BRD1,Bromodomain-containing protein 1,15697,63,0.50 [0.20-1.26],0.1424340999453185
Chapter II Neoplasms,Melanoma in situ,BRD2,Bromodomain-containing protein 2,15489,61,0.40 [0.17-0.96],0.0411546136135623
Chapter II Neoplasms,Melanoma in situ,BRD3,Bromodomain-containing protein 3,15452,62,1.08 [0.70-1.67],0.712184119607676
Chapter II Neoplasms,Melanoma in situ,BRDT,Bromodomain testis-specific protein,15452,62,1.35 [0.73-2.52],0.3406989056815095
Chapter II Neoplasms,Melanoma in situ,BRK1,Protein BRICK1,18002,70,1.25 [0.78-2.00],0.3469353638227649
Chapter II Neoplasms,Melanoma in situ,BRME1,Break repair meiotic recombinase recruitment factor 1,15489,61,0.86 [0.43-1.70],0.657850728925305
Chapter II Neoplasms,Melanoma in situ,BRSK2,Serine/threonine-protein kinase BRSK2,15952,63,1.23 [0.65-2.31],0.5262787584933042
Chapter II Neoplasms,Melanoma in situ,BSG,Basigin,18582,74,0.67 [0.25-1.76],0.4130995852670261
Chapter II Neoplasms,Melanoma in situ,BSND,Barttin,15421,61,0.94 [0.44-1.99],0.8719304585022641
Chapter II Neoplasms,Melanoma in situ,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18561,75,1.26 [0.76-2.08],0.3720317218829435
Chapter II Neoplasms,Melanoma in situ,BST2,Bone marrow stromal antigen 2,18561,75,0.79 [0.50-1.26],0.327488626866341
Chapter II Neoplasms,Melanoma in situ,BTC,Probetacellulin,17977,71,1.04 [0.78-1.38],0.7911330623969883
Chapter II Neoplasms,Melanoma in situ,BTD,Biotinidase,15998,64,1.43 [0.43-4.75],0.5605223554119314
Chapter II Neoplasms,Melanoma in situ,BTLA,B- and T-lymphocyte attenuator,15421,61,0.60 [0.39-0.92],0.0193272240092852
Chapter II Neoplasms,Melanoma in situ,BTN1A1,Butyrophilin subfamily 1 member A1,15883,62,0.83 [0.40-1.69],0.6001498881027283
Chapter II Neoplasms,Melanoma in situ,BTN2A1,Butyrophilin subfamily 2 member A1,18455,74,1.52 [0.71-3.26],0.2767126123015794
Chapter II Neoplasms,Melanoma in situ,BTN3A2,Butyrophilin subfamily 3 member A2,18389,73,0.86 [0.49-1.50],0.5858710401841187
Chapter II Neoplasms,Melanoma in situ,BTNL10,Butyrophilin-like protein 10,15421,61,0.95 [0.50-1.81],0.8842511238458859
Chapter II Neoplasms,Melanoma in situ,C19orf12,Protein C19orf12,18002,70,0.77 [0.53-1.13],0.1839070500462265
Chapter II Neoplasms,Melanoma in situ,C1GALT1C1,C1GALT1-specific chaperone 1,15452,62,0.62 [0.27-1.43],0.2605999046174085
Chapter II Neoplasms,Melanoma in situ,C1QA,Complement C1q subcomponent subunit A,18523,72,0.88 [0.34-2.28],0.7920313891904105
Chapter II Neoplasms,Melanoma in situ,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",15952,63,0.75 [0.47-1.22],0.2475961612735856
Chapter II Neoplasms,Melanoma in situ,C1QL2,Complement C1q-like protein 2,15491,59,1.51 [0.90-2.55],0.1220446698351443
Chapter II Neoplasms,Melanoma in situ,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18485,74,0.64 [0.39-1.04],0.0725967409214734
Chapter II Neoplasms,Melanoma in situ,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15623,63,1.23 [0.62-2.45],0.5600580441379279
Chapter II Neoplasms,Melanoma in situ,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,15952,63,0.79 [0.35-1.77],0.5681582723536691
Chapter II Neoplasms,Melanoma in situ,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15599,63,0.76 [0.48-1.20],0.240005383831698
Chapter II Neoplasms,Melanoma in situ,C1R,Complement C1r subcomponent,15998,64,1.13 [0.31-4.12],0.8565515203866192
Chapter II Neoplasms,Melanoma in situ,C1RL,Complement C1r subcomponent-like protein,15963,64,6.15 [1.74-21.77],0.0048925862408849
Chapter II Neoplasms,Melanoma in situ,C1S,Complement C1s subcomponent,15998,64,0.58 [0.19-1.81],0.3494326581603123
Chapter II Neoplasms,Melanoma in situ,C2,Complement C2,18463,74,0.60 [0.31-1.16],0.1290225749185155
Chapter II Neoplasms,Melanoma in situ,C2CD2L,Phospholipid transfer protein C2CD2L,17974,70,1.02 [0.61-1.69],0.9523277512672668
Chapter II Neoplasms,Melanoma in situ,C2orf69,UPF0565 protein C2orf69,15567,63,1.32 [1.04-1.69],0.0227171685993572
Chapter II Neoplasms,Melanoma in situ,C3,Complement C3,15184,59,1.05 [0.60-1.82],0.8649702325637162
Chapter II Neoplasms,Melanoma in situ,C4BPB,C4b-binding protein beta chain,18439,74,1.09 [0.63-1.87],0.762567496311834
Chapter II Neoplasms,Melanoma in situ,C5,Complement C5,15998,64,0.75 [0.15-3.87],0.7357924434068285
Chapter II Neoplasms,Melanoma in situ,C7,Complement component C7,15618,62,0.63 [0.30-1.34],0.230349264997458
Chapter II Neoplasms,Melanoma in situ,C7orf50,Uncharacterized protein C7orf50,15944,63,1.01 [0.36-2.87],0.982064279437153
Chapter II Neoplasms,Melanoma in situ,C8B,Complement component C8 beta chain,15998,64,0.79 [0.36-1.74],0.5518385166765263
Chapter II Neoplasms,Melanoma in situ,C9,Complement component C9,15994,64,1.00 [0.65-1.52],0.9841485750789294
Chapter II Neoplasms,Melanoma in situ,C9orf40,Uncharacterized protein C9orf40,15920,63,1.07 [0.79-1.44],0.6754618627064661
Chapter II Neoplasms,Melanoma in situ,CA1,Carbonic anhydrase 1,18037,74,1.02 [0.71-1.46],0.9296460234390064
Chapter II Neoplasms,Melanoma in situ,CA11,Carbonic anhydrase-related protein 11,17977,71,0.50 [0.19-1.29],0.1529379756425843
Chapter II Neoplasms,Melanoma in situ,CA12,Carbonic anhydrase 12,18305,72,0.88 [0.45-1.71],0.7000705805674561
Chapter II Neoplasms,Melanoma in situ,CA13,Carbonic anhydrase 13,18173,74,1.09 [0.89-1.33],0.4063113180462095
Chapter II Neoplasms,Melanoma in situ,CA14,Carbonic anhydrase 14,18569,74,1.01 [0.57-1.80],0.9605452982583346
Chapter II Neoplasms,Melanoma in situ,CA2,Carbonic anhydrase 2,18338,74,1.10 [0.82-1.48],0.5205466580073639
Chapter II Neoplasms,Melanoma in situ,CA3,Carbonic anhydrase 3,18601,75,0.89 [0.62-1.26],0.5066346658706656
Chapter II Neoplasms,Melanoma in situ,CA4,Carbonic anhydrase 4,18626,75,0.56 [0.24-1.30],0.1751515171213675
Chapter II Neoplasms,Melanoma in situ,CA5A,"Carbonic anhydrase 5A, mitochondrial",18071,70,0.98 [0.77-1.24],0.8465471974882188
Chapter II Neoplasms,Melanoma in situ,CA6,Carbonic anhydrase 6,18338,74,0.79 [0.57-1.10],0.1637948278076089
Chapter II Neoplasms,Melanoma in situ,CA7,Carbonic anhydrase 7,15697,63,0.38 [0.16-0.88],0.0232230769050131
Chapter II Neoplasms,Melanoma in situ,CA8,Carbonic anhydrase-related protein,15491,59,0.46 [0.13-1.65],0.2335291338645263
Chapter II Neoplasms,Melanoma in situ,CA9,Carbonic anhydrase 9,18569,74,0.87 [0.55-1.36],0.5394594916141393
Chapter II Neoplasms,Melanoma in situ,CABP2,Calcium-binding protein 2,15567,63,1.03 [0.72-1.48],0.8706372462030383
Chapter II Neoplasms,Melanoma in situ,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15489,61,0.55 [0.23-1.34],0.1871671409468654
Chapter II Neoplasms,Melanoma in situ,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15452,62,0.37 [0.18-0.76],0.0065720549285523
Chapter II Neoplasms,Melanoma in situ,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15489,61,1.22 [0.85-1.74],0.2825460882969698
Chapter II Neoplasms,Melanoma in situ,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,15952,63,1.10 [0.83-1.47],0.5009959906542639
Chapter II Neoplasms,Melanoma in situ,CACYBP,Calcyclin-binding protein,15596,63,1.11 [0.87-1.41],0.4085183223773551
Chapter II Neoplasms,Melanoma in situ,CADPS,Calcium-dependent secretion activator 1,15567,63,1.08 [0.60-1.95],0.7898834654186155
Chapter II Neoplasms,Melanoma in situ,CALB1,Calbindin,18305,72,1.00 [0.62-1.60],0.9891738120274104
Chapter II Neoplasms,Melanoma in situ,CALB2,Calretinin,18002,70,0.83 [0.38-1.82],0.648174296435446
Chapter II Neoplasms,Melanoma in situ,CALCA,Calcitonin,18214,69,0.63 [0.44-0.89],0.0089093506796517
Chapter II Neoplasms,Melanoma in situ,CALCB,Calcitonin gene-related peptide 2,15944,63,0.55 [0.26-1.14],0.1056856757451862
Chapter II Neoplasms,Melanoma in situ,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18515,73,1.28 [1.04-1.56],0.0170347933937442
Chapter II Neoplasms,Melanoma in situ,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15528,62,1.25 [0.91-1.72],0.1715006042324756
Chapter II Neoplasms,Melanoma in situ,CALY,Neuron-specific vesicular protein calcyon,15452,62,0.75 [0.35-1.60],0.4594781819342064
Chapter II Neoplasms,Melanoma in situ,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,17977,71,0.98 [0.60-1.59],0.9345982681595671
Chapter II Neoplasms,Melanoma in situ,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15567,63,1.38 [0.95-2.00],0.0941818005723789
Chapter II Neoplasms,Melanoma in situ,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,15952,63,1.16 [0.93-1.45],0.1848081568564671
Chapter II Neoplasms,Melanoma in situ,CANT1,Soluble calcium-activated nucleotidase 1,18332,72,3.17 [1.13-8.92],0.0285083554108566
Chapter II Neoplasms,Melanoma in situ,CAPG,Macrophage-capping protein,18283,72,0.94 [0.66-1.35],0.734156435601846
Chapter II Neoplasms,Melanoma in situ,CAPN3,Calpain-3,15917,63,0.55 [0.26-1.19],0.1297222432727866
Chapter II Neoplasms,Melanoma in situ,CAPS,Calcyphosin,15944,63,1.08 [0.88-1.33],0.4482167938933038
Chapter II Neoplasms,Melanoma in situ,CARHSP1,Calcium-regulated heat-stable protein 1,18002,70,1.15 [0.77-1.72],0.4984918320133382
Chapter II Neoplasms,Melanoma in situ,CASC3,Protein CASC3,15567,63,1.14 [0.64-2.01],0.6631036719833827
Chapter II Neoplasms,Melanoma in situ,CASP1,Caspase-1,18002,70,1.02 [0.76-1.38],0.8923531524879248
Chapter II Neoplasms,Melanoma in situ,CASP10,Caspase-10,18002,70,0.92 [0.68-1.24],0.5709949091974295
Chapter II Neoplasms,Melanoma in situ,CASP2,Caspase-2,18389,73,1.28 [0.96-1.72],0.0977840286423866
Chapter II Neoplasms,Melanoma in situ,CASP3,Caspase-3,18626,75,1.13 [0.89-1.42],0.3203778967854602
Chapter II Neoplasms,Melanoma in situ,CASP4,Caspase-4,15697,63,1.07 [0.93-1.22],0.3489169677994151
Chapter II Neoplasms,Melanoma in situ,CASP7,Caspase-7,15944,63,1.18 [0.89-1.57],0.2573674995512348
Chapter II Neoplasms,Melanoma in situ,CASP8,Caspase-8,18520,74,1.12 [0.81-1.54],0.500905106176221
Chapter II Neoplasms,Melanoma in situ,CASP9,Caspase-9,15491,59,1.29 [0.90-1.85],0.1643078886790465
Chapter II Neoplasms,Melanoma in situ,CASQ2,Calsequestrin-2,15452,62,0.64 [0.33-1.26],0.1994094700391038
Chapter II Neoplasms,Melanoma in situ,CAT,Catalase,15761,63,0.99 [0.63-1.55],0.9608257482110598
Chapter II Neoplasms,Melanoma in situ,CBLIF,Cobalamin binding intrinsic factor,18375,74,0.97 [0.75-1.26],0.8092853941354349
Chapter II Neoplasms,Melanoma in situ,CBLN1,Cerebellin-1,15489,61,0.86 [0.62-1.19],0.3558750722624897
Chapter II Neoplasms,Melanoma in situ,CBLN4,Cerebellin-4,18569,74,0.46 [0.25-0.85],0.0131392235789735
Chapter II Neoplasms,Melanoma in situ,CBS,Cystathionine beta-synthase,15528,62,0.79 [0.46-1.35],0.3810956761447945
Chapter II Neoplasms,Melanoma in situ,CBX2,Chromobox protein homolog 2,15452,62,0.99 [0.53-1.86],0.976592986070914
Chapter II Neoplasms,Melanoma in situ,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18242,69,1.27 [0.96-1.67],0.0953614308228788
Chapter II Neoplasms,Melanoma in situ,CCAR2,Cell cycle and apoptosis regulator protein 2,15944,63,1.07 [0.71-1.61],0.757641912685901
Chapter II Neoplasms,Melanoma in situ,CCDC134,Coiled-coil domain-containing protein 134,15917,63,1.20 [0.75-1.91],0.4399105900349478
Chapter II Neoplasms,Melanoma in situ,CCDC28A,Coiled-coil domain-containing protein 28A,15567,63,0.42 [0.19-0.94],0.0349747405114397
Chapter II Neoplasms,Melanoma in situ,CCDC50,Coiled-coil domain-containing protein 50,15952,63,0.71 [0.47-1.06],0.0953106503335413
Chapter II Neoplasms,Melanoma in situ,CCDC80,Coiled-coil domain-containing protein 80,18395,74,1.11 [0.62-1.97],0.7342824186287343
Chapter II Neoplasms,Melanoma in situ,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15528,62,1.11 [0.75-1.63],0.6145736031140332
Chapter II Neoplasms,Melanoma in situ,CCL11,Eotaxin,18615,74,1.26 [0.73-2.18],0.4083387917195887
Chapter II Neoplasms,Melanoma in situ,CCL13,C-C motif chemokine 13,18587,73,1.25 [0.93-1.67],0.1431374640012867
Chapter II Neoplasms,Melanoma in situ,CCL14,C-C motif chemokine 14,18372,74,1.31 [0.82-2.11],0.2631569513314299
Chapter II Neoplasms,Melanoma in situ,CCL15,C-C motif chemokine 15,18626,75,0.91 [0.56-1.48],0.7097825410348657
Chapter II Neoplasms,Melanoma in situ,CCL16,C-C motif chemokine 16,18626,75,0.81 [0.56-1.18],0.2807459182891975
Chapter II Neoplasms,Melanoma in situ,CCL17,C-C motif chemokine 17,18337,74,1.09 [0.87-1.36],0.4651029024734534
Chapter II Neoplasms,Melanoma in situ,CCL18,C-C motif chemokine 18,18173,74,0.87 [0.63-1.20],0.3890617437725594
Chapter II Neoplasms,Melanoma in situ,CCL19,C-C motif chemokine 19,18561,75,0.95 [0.78-1.14],0.5721670522641599
Chapter II Neoplasms,Melanoma in situ,CCL2,C-C motif chemokine 2,18208,69,1.13 [0.76-1.68],0.5584083320651558
Chapter II Neoplasms,Melanoma in situ,CCL20,C-C motif chemokine 20,18615,74,1.01 [0.80-1.28],0.926802854960744
Chapter II Neoplasms,Melanoma in situ,CCL21,C-C motif chemokine 21,18455,74,0.96 [0.55-1.67],0.8809479747365595
Chapter II Neoplasms,Melanoma in situ,CCL22,C-C motif chemokine 22,18178,73,1.23 [0.83-1.82],0.3023661525657392
Chapter II Neoplasms,Melanoma in situ,CCL23,C-C motif chemokine 23,18455,74,1.82 [1.12-2.96],0.0154472762785078
Chapter II Neoplasms,Melanoma in situ,CCL24,C-C motif chemokine 24,18434,74,1.19 [0.93-1.52],0.160486445807012
Chapter II Neoplasms,Melanoma in situ,CCL25,C-C motif chemokine 25,18615,74,1.53 [1.01-2.31],0.0433794511278682
Chapter II Neoplasms,Melanoma in situ,CCL26,C-C motif chemokine 26,18389,73,1.18 [0.98-1.43],0.0890386603048431
Chapter II Neoplasms,Melanoma in situ,CCL27,C-C motif chemokine 27,18395,74,1.14 [0.81-1.61],0.4442730033121393
Chapter II Neoplasms,Melanoma in situ,CCL28,C-C motif chemokine 28,18326,73,1.20 [0.86-1.68],0.2746130003678578
Chapter II Neoplasms,Melanoma in situ,CCL3,C-C motif chemokine 3,18389,73,1.16 [0.81-1.65],0.4278577890043212
Chapter II Neoplasms,Melanoma in situ,CCL4,C-C motif chemokine 4,18397,74,1.18 [0.90-1.55],0.2392152582086167
Chapter II Neoplasms,Melanoma in situ,CCL5,C-C motif chemokine 5,18485,74,1.06 [0.87-1.30],0.5551471382968689
Chapter II Neoplasms,Melanoma in situ,CCL7,C-C motif chemokine 7,18389,73,1.36 [1.02-1.82],0.0371228290375279
Chapter II Neoplasms,Melanoma in situ,CCL8,C-C motif chemokine 8,18543,74,1.39 [0.99-1.96],0.058158282698504
Chapter II Neoplasms,Melanoma in situ,CCN1,CCN family member 1,18279,72,1.03 [0.77-1.38],0.8420008355856495
Chapter II Neoplasms,Melanoma in situ,CCN2,CCN family member 2,18381,74,1.44 [1.00-2.06],0.0499628384295945
Chapter II Neoplasms,Melanoma in situ,CCN3,CCN family member 3,18589,75,0.97 [0.51-1.83],0.9224073690815258
Chapter II Neoplasms,Melanoma in situ,CCN4,CCN family member 4,18569,74,1.71 [1.04-2.82],0.0344957619491955
Chapter II Neoplasms,Melanoma in situ,CCN5,CCN family member 5,18396,74,0.82 [0.47-1.42],0.4721311051380912
Chapter II Neoplasms,Melanoma in situ,CCND2,G1/S-specific cyclin-D2,15697,63,0.50 [0.27-0.92],0.0257838062639583
Chapter II Neoplasms,Melanoma in situ,CCNE1,G1/S-specific cyclin-E1,15491,59,0.94 [0.70-1.27],0.705286090987931
Chapter II Neoplasms,Melanoma in situ,CCS,Copper chaperone for superoxide dismutase,18242,69,1.58 [1.03-2.43],0.0379560245728948
Chapter II Neoplasms,Melanoma in situ,CCT5,T-complex protein 1 subunit epsilon,17977,71,1.21 [0.77-1.89],0.4128446308105441
Chapter II Neoplasms,Melanoma in situ,CD101,Immunoglobulin superfamily member 2,15920,63,0.65 [0.40-1.05],0.0781341409924401
Chapter II Neoplasms,Melanoma in situ,CD109,CD109 antigen,18396,74,0.76 [0.41-1.42],0.3899268661493609
Chapter II Neoplasms,Melanoma in situ,CD14,Monocyte differentiation antigen CD14,18061,74,0.92 [0.55-1.54],0.7601226778802651
Chapter II Neoplasms,Melanoma in situ,CD160,CD160 antigen,18615,74,1.40 [0.92-2.12],0.1197747405606046
Chapter II Neoplasms,Melanoma in situ,CD163,Scavenger receptor cysteine-rich type 1 protein M130,18485,74,0.67 [0.41-1.11],0.1179316530870955
Chapter II Neoplasms,Melanoma in situ,CD164,Sialomucin core protein 24,18396,74,1.06 [0.49-2.29],0.8847809601856753
Chapter II Neoplasms,Melanoma in situ,CD164L2,CD164 sialomucin-like 2 protein,15567,63,1.46 [0.83-2.56],0.1849488605487791
Chapter II Neoplasms,Melanoma in situ,CD177,CD177 antigen,18364,74,1.03 [0.88-1.20],0.7374906680330734
Chapter II Neoplasms,Melanoma in situ,CD1C,T-cell surface glycoprotein CD1c,18439,74,0.88 [0.38-2.07],0.7756802217743355
Chapter II Neoplasms,Melanoma in situ,CD2,T-cell surface antigen CD2,15452,62,0.83 [0.41-1.67],0.5942074999499576
Chapter II Neoplasms,Melanoma in situ,CD200,OX-2 membrane glycoprotein,18389,73,0.86 [0.39-1.93],0.7183616598331635
Chapter II Neoplasms,Melanoma in situ,CD200R1,Cell surface glycoprotein CD200 receptor 1,18322,72,1.32 [0.74-2.34],0.3459278485635426
Chapter II Neoplasms,Melanoma in situ,CD207,C-type lectin domain family 4 member K,17967,70,1.00 [0.57-1.73],0.9878472351862888
Chapter II Neoplasms,Melanoma in situ,CD209,CD209 antigen,18445,75,1.16 [0.68-1.97],0.5883297264229532
Chapter II Neoplasms,Melanoma in situ,CD22,B-cell receptor CD22,18615,74,0.72 [0.43-1.19],0.1983840635213716
Chapter II Neoplasms,Melanoma in situ,CD226,CD226 antigen,15491,59,1.76 [1.00-3.09],0.0513627304530196
Chapter II Neoplasms,Melanoma in situ,CD244,Natural killer cell receptor 2B4,18615,74,1.71 [0.83-3.51],0.1462048175202967
Chapter II Neoplasms,Melanoma in situ,CD248,Endosialin,15983,64,1.32 [0.73-2.37],0.3626423937928458
Chapter II Neoplasms,Melanoma in situ,CD27,CD27 antigen,18439,74,0.89 [0.53-1.50],0.6643841450481631
Chapter II Neoplasms,Melanoma in situ,CD274,Programmed cell death 1 ligand 1,18242,69,1.19 [0.64-2.24],0.5801582447224545
Chapter II Neoplasms,Melanoma in situ,CD276,CD276 antigen,18365,74,0.80 [0.45-1.39],0.4242668947018501
Chapter II Neoplasms,Melanoma in situ,CD28,T-cell-specific surface glycoprotein CD28,17977,71,0.68 [0.37-1.27],0.2253469764010026
Chapter II Neoplasms,Melanoma in situ,CD2AP,CD2-associated protein,18395,74,1.36 [0.99-1.86],0.0582990461256206
Chapter II Neoplasms,Melanoma in situ,CD300A,CMRF35-like molecule 8,15623,63,1.34 [0.61-2.95],0.4654575242536828
Chapter II Neoplasms,Melanoma in situ,CD300C,CMRF35-like molecule 6,18561,75,1.35 [0.75-2.42],0.3171399655489075
Chapter II Neoplasms,Melanoma in situ,CD300E,CMRF35-like molecule 2,18515,74,0.79 [0.47-1.34],0.3819912960622225
Chapter II Neoplasms,Melanoma in situ,CD300LF,CMRF35-like molecule 1,18569,74,1.24 [0.85-1.80],0.2708222898224746
Chapter II Neoplasms,Melanoma in situ,CD300LG,CMRF35-like molecule 9,18396,74,0.62 [0.35-1.08],0.0889342767891417
Chapter II Neoplasms,Melanoma in situ,CD302,CD302 antigen,18305,72,1.25 [0.63-2.48],0.5306719403171558
Chapter II Neoplasms,Melanoma in situ,CD33,Myeloid cell surface antigen CD33,18439,74,0.82 [0.65-1.05],0.1173601491437241
Chapter II Neoplasms,Melanoma in situ,CD34,Hematopoietic progenitor cell antigen CD34,18501,75,0.61 [0.26-1.45],0.2659264357201125
Chapter II Neoplasms,Melanoma in situ,CD36,Platelet glycoprotein 4,15491,59,1.38 [0.82-2.34],0.2279665244892068
Chapter II Neoplasms,Melanoma in situ,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18305,72,0.61 [0.32-1.18],0.1443604884726279
Chapter II Neoplasms,Melanoma in situ,CD3D,T-cell surface glycoprotein CD3 delta chain,15489,61,0.62 [0.26-1.48],0.2846974162186999
Chapter II Neoplasms,Melanoma in situ,CD3E,T-cell surface glycoprotein CD3 epsilon chain,15697,63,1.09 [0.59-2.01],0.786266710909982
Chapter II Neoplasms,Melanoma in situ,CD3G,T-cell surface glycoprotein CD3 gamma chain,15491,59,1.00 [0.75-1.33],0.9880067327454124
Chapter II Neoplasms,Melanoma in situ,CD4,T-cell surface glycoprotein CD4,18357,73,1.34 [0.73-2.46],0.339402382147587
Chapter II Neoplasms,Melanoma in situ,CD40,Tumor necrosis factor receptor superfamily member 5,18376,74,1.22 [0.81-1.82],0.3450696112226259
Chapter II Neoplasms,Melanoma in situ,CD40LG,CD40 ligand,18615,74,1.27 [0.98-1.64],0.076015167787032
Chapter II Neoplasms,Melanoma in situ,CD46,Membrane cofactor protein,18318,74,0.97 [0.47-2.03],0.9422122002402652
Chapter II Neoplasms,Melanoma in situ,CD48,CD48 antigen,18434,74,1.13 [0.56-2.28],0.7256664616960289
Chapter II Neoplasms,Melanoma in situ,CD5,T-cell surface glycoprotein CD5,18543,74,1.10 [0.60-2.04],0.7556195143207463
Chapter II Neoplasms,Melanoma in situ,CD55,Complement decay-accelerating factor,17776,71,0.42 [0.18-0.98],0.0445817968361193
Chapter II Neoplasms,Melanoma in situ,CD58,Lymphocyte function-associated antigen 3,18331,74,0.39 [0.13-1.21],0.1038628159203922
Chapter II Neoplasms,Melanoma in situ,CD59,CD59 glycoprotein,17757,71,0.57 [0.20-1.58],0.2796141197394446
Chapter II Neoplasms,Melanoma in situ,CD5L,CD5 antigen-like,15930,64,1.87 [1.15-3.05],0.0122280768420286
Chapter II Neoplasms,Melanoma in situ,CD6,T-cell differentiation antigen CD6,18582,74,0.69 [0.46-1.02],0.0622936819702658
Chapter II Neoplasms,Melanoma in situ,CD63,CD63 antigen,18208,69,1.42 [0.92-2.17],0.1114848506443819
Chapter II Neoplasms,Melanoma in situ,CD69,Early activation antigen CD69,18303,74,1.11 [0.87-1.40],0.3962895247128277
Chapter II Neoplasms,Melanoma in situ,CD7,T-cell antigen CD7,15464,59,1.27 [0.73-2.21],0.3885599430784425
Chapter II Neoplasms,Melanoma in situ,CD70,CD70 antigen,18389,73,1.11 [0.69-1.79],0.6667553939778541
Chapter II Neoplasms,Melanoma in situ,CD72,B-cell differentiation antigen CD72,15623,63,0.93 [0.51-1.70],0.8140378833648656
Chapter II Neoplasms,Melanoma in situ,CD74,HLA class II histocompatibility antigen gamma chain,18561,75,1.35 [0.74-2.45],0.3308897447043201
Chapter II Neoplasms,Melanoma in situ,CD79B,B-cell antigen receptor complex-associated protein beta chain,18615,74,0.61 [0.37-1.02],0.0575680589045695
Chapter II Neoplasms,Melanoma in situ,CD80,T-lymphocyte activation antigen CD80,15975,64,0.63 [0.29-1.35],0.2363658348581002
Chapter II Neoplasms,Melanoma in situ,CD82,CD82 antigen,15697,63,0.37 [0.16-0.85],0.0197355880750729
Chapter II Neoplasms,Melanoma in situ,CD83,CD83 antigen,18389,73,0.91 [0.48-1.74],0.7818983183368813
Chapter II Neoplasms,Melanoma in situ,CD84,SLAM family member 5,18389,73,1.91 [0.99-3.68],0.054172116440182
Chapter II Neoplasms,Melanoma in situ,CD86,T-lymphocyte activation antigen CD86,15920,63,0.70 [0.34-1.44],0.330096504948522
Chapter II Neoplasms,Melanoma in situ,CD8A,T-cell surface glycoprotein CD8 alpha chain,18561,75,1.12 [0.75-1.66],0.5755038378364936
Chapter II Neoplasms,Melanoma in situ,CD93,Complement component C1q receptor,17727,72,0.66 [0.33-1.34],0.2495978656240369
Chapter II Neoplasms,Melanoma in situ,CD99,CD99 antigen,18396,74,1.12 [0.39-3.27],0.8291264531696496
Chapter II Neoplasms,Melanoma in situ,CD99L2,CD99 antigen-like protein 2,18396,74,1.12 [0.48-2.61],0.7985613507566289
Chapter II Neoplasms,Melanoma in situ,CDA,Cytidine deaminase,15954,64,1.02 [0.62-1.67],0.9467298333872332
Chapter II Neoplasms,Melanoma in situ,CDAN1,Codanin-1,15944,63,0.46 [0.14-1.51],0.2029668768005208
Chapter II Neoplasms,Melanoma in situ,CDC123,Cell division cycle protein 123 homolog,15421,61,0.94 [0.62-1.42],0.75858073420178
Chapter II Neoplasms,Melanoma in situ,CDC25A,M-phase inducer phosphatase 1,15421,61,1.01 [0.53-1.93],0.9767683075037364
Chapter II Neoplasms,Melanoma in situ,CDC26,Anaphase-promoting complex subunit CDC26,15881,62,1.24 [0.88-1.75],0.2114538878463452
Chapter II Neoplasms,Melanoma in situ,CDC27,Cell division cycle protein 27 homolog,17977,71,1.24 [0.89-1.72],0.211440008697655
Chapter II Neoplasms,Melanoma in situ,CDC37,Hsp90 co-chaperone Cdc37,18439,74,1.12 [0.87-1.43],0.3718427413649422
Chapter II Neoplasms,Melanoma in situ,CDC42BPB,Serine/threonine-protein kinase MRCK beta,15920,63,1.15 [0.91-1.45],0.2505386274658147
Chapter II Neoplasms,Melanoma in situ,CDCP1,CUB domain-containing protein 1,18242,69,0.92 [0.62-1.37],0.6879763532537642
Chapter II Neoplasms,Melanoma in situ,CDH1,Cadherin-1,17800,72,1.05 [0.62-1.79],0.8591427870305679
Chapter II Neoplasms,Melanoma in situ,CDH15,Cadherin-15,18533,75,0.83 [0.61-1.13],0.237416026864856
Chapter II Neoplasms,Melanoma in situ,CDH17,Cadherin-17,18395,74,1.09 [0.81-1.47],0.5510966382594217
Chapter II Neoplasms,Melanoma in situ,CDH2,Cadherin-2,18395,74,1.53 [0.85-2.76],0.156601130005866
Chapter II Neoplasms,Melanoma in situ,CDH22,Cadherin-22,15697,63,0.40 [0.15-1.08],0.0700270592908235
Chapter II Neoplasms,Melanoma in situ,CDH23,Cadherin-23,15944,63,0.49 [0.19-1.26],0.1401020927074872
Chapter II Neoplasms,Melanoma in situ,CDH3,Cadherin-3,18561,75,1.45 [0.83-2.52],0.1934338535739237
Chapter II Neoplasms,Melanoma in situ,CDH4,Cadherin-4,15489,61,0.81 [0.46-1.42],0.4580739387202748
Chapter II Neoplasms,Melanoma in situ,CDH5,Cadherin-5,18626,75,0.67 [0.33-1.34],0.2552909103088844
Chapter II Neoplasms,Melanoma in situ,CDH6,Cadherin-6,18395,74,0.99 [0.58-1.71],0.9825469960845512
Chapter II Neoplasms,Melanoma in situ,CDHR1,Cadherin-related family member 1,18002,70,0.94 [0.55-1.59],0.808588712195419
Chapter II Neoplasms,Melanoma in situ,CDHR2,Cadherin-related family member 2,18305,72,0.89 [0.64-1.22],0.4698528009448491
Chapter II Neoplasms,Melanoma in situ,CDHR5,Cadherin-related family member 5,18395,74,1.35 [0.77-2.34],0.291549636471725
Chapter II Neoplasms,Melanoma in situ,CDK1,Cyclin-dependent kinase 1,15421,61,0.79 [0.40-1.54],0.48469429043854
Chapter II Neoplasms,Melanoma in situ,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,15952,63,0.98 [0.65-1.47],0.9233997359007988
Chapter II Neoplasms,Melanoma in situ,CDKL5,Cyclin-dependent kinase-like 5,15489,61,1.03 [0.64-1.64],0.9067159771205864
Chapter II Neoplasms,Melanoma in situ,CDKN1A,Cyclin-dependent kinase inhibitor 1,18305,72,1.14 [0.94-1.38],0.1988609702140746
Chapter II Neoplasms,Melanoma in situ,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18305,72,1.12 [0.89-1.41],0.324986332510375
Chapter II Neoplasms,Melanoma in situ,CDNF,Cerebral dopamine neurotrophic factor,18305,72,0.79 [0.41-1.54],0.4948681123275013
Chapter II Neoplasms,Melanoma in situ,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18395,74,1.50 [0.66-3.41],0.3297002325677911
Chapter II Neoplasms,Melanoma in situ,CDSN,Corneodesmosin,18564,74,1.51 [0.94-2.43],0.0855027899183656
Chapter II Neoplasms,Melanoma in situ,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18412,74,0.69 [0.25-1.88],0.4637713140953889
Chapter II Neoplasms,Melanoma in situ,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,15920,63,1.16 [0.86-1.57],0.3290445088459858
Chapter II Neoplasms,Melanoma in situ,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15697,63,1.25 [0.97-1.61],0.0818724466975413
Chapter II Neoplasms,Melanoma in situ,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,15920,63,0.98 [0.54-1.79],0.9510075896291128
Chapter II Neoplasms,Melanoma in situ,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15697,63,0.58 [0.30-1.13],0.1081495147343778
Chapter II Neoplasms,Melanoma in situ,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18389,73,0.96 [0.75-1.23],0.7526115545883266
Chapter II Neoplasms,Melanoma in situ,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,17977,71,0.85 [0.53-1.37],0.5092796973069551
Chapter II Neoplasms,Melanoma in situ,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17742,71,1.14 [0.81-1.60],0.4642022478837133
Chapter II Neoplasms,Melanoma in situ,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,15983,64,0.85 [0.45-1.60],0.6187374085961472
Chapter II Neoplasms,Melanoma in situ,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18071,70,0.94 [0.60-1.45],0.7681991633074999
Chapter II Neoplasms,Melanoma in situ,CEBPA,CCAAT/enhancer-binding protein alpha,15491,59,0.72 [0.31-1.67],0.4406667260984702
Chapter II Neoplasms,Melanoma in situ,CEBPB,CCAAT/enhancer-binding protein beta,18071,70,0.91 [0.51-1.64],0.7625097628143772
Chapter II Neoplasms,Melanoma in situ,CELA2A,Chymotrypsin-like elastase family member 2A,15983,64,0.87 [0.60-1.27],0.4753357372981882
Chapter II Neoplasms,Melanoma in situ,CELA3A,Chymotrypsin-like elastase family member 3A,18595,75,0.91 [0.64-1.28],0.5829113956257304
Chapter II Neoplasms,Melanoma in situ,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15623,63,0.44 [0.19-1.03],0.057208282196615
Chapter II Neoplasms,Melanoma in situ,CEMIP2,Cell surface hyaluronidase,15491,59,1.06 [0.47-2.37],0.8897134717443708
Chapter II Neoplasms,Melanoma in situ,CEND1,Cell cycle exit and neuronal differentiation protein 1,15489,61,0.87 [0.54-1.40],0.5595403531221259
Chapter II Neoplasms,Melanoma in situ,CENPF,Centromere protein F,15697,63,1.25 [0.82-1.90],0.3088384705368434
Chapter II Neoplasms,Melanoma in situ,CENPJ,Centromere protein J,15697,63,1.05 [0.75-1.47],0.7612320788067037
Chapter II Neoplasms,Melanoma in situ,CEP112,Centrosomal protein of 112 kDa,15452,62,1.09 [0.66-1.79],0.7327711476616516
Chapter II Neoplasms,Melanoma in situ,CEP152,Centrosomal protein of 152 kDa,15421,61,1.09 [0.63-1.88],0.7542192438958709
Chapter II Neoplasms,Melanoma in situ,CEP164,Centrosomal protein of 164 kDa,18088,71,1.05 [0.76-1.45],0.7582189206075112
Chapter II Neoplasms,Melanoma in situ,CEP170,Centrosomal protein of 170 kDa,15528,62,1.15 [0.86-1.56],0.347488303489267
Chapter II Neoplasms,Melanoma in situ,CEP20,Centrosomal protein 20,17977,71,1.10 [0.83-1.45],0.5094794137181347
Chapter II Neoplasms,Melanoma in situ,CEP290,Centrosomal protein of 290 kDa,15697,63,0.85 [0.52-1.40],0.5232415250953274
Chapter II Neoplasms,Melanoma in situ,CEP350,Centrosome-associated protein 350,15421,61,0.96 [0.49-1.86],0.899095134811791
Chapter II Neoplasms,Melanoma in situ,CEP43,Centrosomal protein 43,17930,69,1.08 [0.79-1.47],0.6391311856165924
Chapter II Neoplasms,Melanoma in situ,CEP85,Centrosomal protein of 85 kDa,17977,71,1.29 [0.94-1.77],0.1143650107732708
Chapter II Neoplasms,Melanoma in situ,CERT,Ceramide transfer protein,18002,70,1.20 [0.85-1.70],0.2909757239223196
Chapter II Neoplasms,Melanoma in situ,CES1,Liver carboxylesterase 1,18440,74,1.12 [0.88-1.42],0.3584636668254214
Chapter II Neoplasms,Melanoma in situ,CES2,Cocaine esterase,18305,72,1.00 [0.69-1.45],0.992589522856946
Chapter II Neoplasms,Melanoma in situ,CES3,Carboxylesterase 3,18305,72,1.30 [1.01-1.68],0.0450719985399921
Chapter II Neoplasms,Melanoma in situ,CETN2,Centrin-2,18002,70,1.21 [0.89-1.63],0.2252326029085951
Chapter II Neoplasms,Melanoma in situ,CETN3,Centrin-3,15920,63,1.32 [0.98-1.79],0.0716127060277079
Chapter II Neoplasms,Melanoma in situ,CFB,Complement factor B,15727,63,1.50 [0.71-3.18],0.293196540074404
Chapter II Neoplasms,Melanoma in situ,CFC1,Cryptic protein,17977,71,0.54 [0.32-0.91],0.0201107242896462
Chapter II Neoplasms,Melanoma in situ,CFD,Complement factor D,15998,64,0.71 [0.21-2.40],0.5769581929351255
Chapter II Neoplasms,Melanoma in situ,CFH,Complement factor H,15094,58,0.69 [0.23-2.06],0.5019230685628008
Chapter II Neoplasms,Melanoma in situ,CFHR2,Complement factor H-related protein 2,15883,63,1.01 [0.66-1.56],0.951604639466441
Chapter II Neoplasms,Melanoma in situ,CFHR4,Complement factor H-related protein 4,15964,64,0.94 [0.68-1.30],0.7058928768063342
Chapter II Neoplasms,Melanoma in situ,CFHR5,Complement factor H-related protein 5,15794,62,1.36 [0.73-2.53],0.334126575662124
Chapter II Neoplasms,Melanoma in situ,CFI,Complement factor I,15998,64,1.21 [0.35-4.18],0.763645236414805
Chapter II Neoplasms,Melanoma in situ,CFP,Properdin,15998,64,0.59 [0.18-1.93],0.3828206789858527
Chapter II Neoplasms,Melanoma in situ,CGA,Glycoprotein hormones alpha chain,18396,74,0.88 [0.63-1.24],0.4727825236639679
Chapter II Neoplasms,Melanoma in situ,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,15994,64,0.82 [0.43-1.55],0.5333134152688139
Chapter II Neoplasms,Melanoma in situ,CGN,Cingulin,15567,63,0.95 [0.50-1.83],0.8835758166443063
Chapter II Neoplasms,Melanoma in situ,CGREF1,Cell growth regulator with EF hand domain protein 1,18395,74,1.35 [0.84-2.16],0.2184985105643504
Chapter II Neoplasms,Melanoma in situ,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,17977,71,1.19 [0.85-1.68],0.3126927455554334
Chapter II Neoplasms,Melanoma in situ,CHAD,Chondroadherin,15623,63,0.69 [0.41-1.15],0.1541324596246355
Chapter II Neoplasms,Melanoma in situ,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15944,63,0.88 [0.47-1.63],0.6763259890299445
Chapter II Neoplasms,Melanoma in situ,CHCHD6,MICOS complex subunit MIC25,15917,63,0.69 [0.38-1.25],0.2216751235619101
Chapter II Neoplasms,Melanoma in situ,CHEK2,Serine/threonine-protein kinase Chk2,18071,70,1.18 [0.62-2.25],0.6202726541643672
Chapter II Neoplasms,Melanoma in situ,CHGA,Chromogranin-A,15983,64,1.01 [0.77-1.32],0.9673700896432444
Chapter II Neoplasms,Melanoma in situ,CHGB,Secretogranin-1,18511,75,0.76 [0.46-1.25],0.2745525760757132
Chapter II Neoplasms,Melanoma in situ,CHI3L1,Chitinase-3-like protein 1,18023,72,0.83 [0.63-1.09],0.1785142578531581
Chapter II Neoplasms,Melanoma in situ,CHIT1,Chitotriosidase-1,18483,74,1.15 [0.96-1.37],0.1236752453515869
Chapter II Neoplasms,Melanoma in situ,CHL1,Neural cell adhesion molecule L1-like protein,18458,74,0.57 [0.28-1.18],0.1280162194462848
Chapter II Neoplasms,Melanoma in situ,CHM,Rab proteins geranylgeranyltransferase component A 1,15567,63,0.98 [0.65-1.46],0.9054418735474012
Chapter II Neoplasms,Melanoma in situ,CHMP1A,Charged multivesicular body protein 1a,18242,69,1.16 [0.88-1.52],0.2963453844754353
Chapter II Neoplasms,Melanoma in situ,CHMP6,Charged multivesicular body protein 6,15975,64,1.14 [0.75-1.73],0.5449637475620881
Chapter II Neoplasms,Melanoma in situ,CHP1,Calcineurin B homologous protein 1,15489,61,0.75 [0.51-1.12],0.1576653467152304
Chapter II Neoplasms,Melanoma in situ,CHRDL1,Chordin-like protein 1,18434,74,0.77 [0.40-1.47],0.4198715440621144
Chapter II Neoplasms,Melanoma in situ,CHRDL2,Chordin-like protein 2,18395,74,0.65 [0.42-1.02],0.0620436256316551
Chapter II Neoplasms,Melanoma in situ,CHRM1,Muscarinic acetylcholine receptor M1,15567,63,0.61 [0.27-1.35],0.2199741934834347
Chapter II Neoplasms,Melanoma in situ,CIAPIN1,Anamorsin,18439,74,1.28 [0.91-1.78],0.1518097478264668
Chapter II Neoplasms,Melanoma in situ,CILP,Cartilage intermediate layer protein 1,15983,64,0.81 [0.54-1.23],0.326981986027734
Chapter II Neoplasms,Melanoma in situ,CINP,Cyclin-dependent kinase 2-interacting protein,15697,63,1.02 [0.60-1.74],0.9373811670170766
Chapter II Neoplasms,Melanoma in situ,CIRBP,Cold-inducible RNA-binding protein,15920,63,1.15 [0.89-1.48],0.2892652839762735
Chapter II Neoplasms,Melanoma in situ,CIT,Citron Rho-interacting kinase,15567,63,1.75 [1.23-2.50],0.001872732289295
Chapter II Neoplasms,Melanoma in situ,CKAP4,Cytoskeleton-associated protein 4,18524,74,0.80 [0.36-1.75],0.5778950622396686
Chapter II Neoplasms,Melanoma in situ,CKB,Creatine kinase B-type,15983,64,1.01 [0.66-1.55],0.9646381381171304
Chapter II Neoplasms,Melanoma in situ,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18312,74,1.09 [0.79-1.52],0.58820822228841
Chapter II Neoplasms,Melanoma in situ,CLASP1,CLIP-associating protein 1,15421,61,0.80 [0.55-1.17],0.2509496210851888
Chapter II Neoplasms,Melanoma in situ,CLC,Galectin-10,18366,74,1.06 [0.78-1.44],0.6969930751793587
Chapter II Neoplasms,Melanoma in situ,CLEC10A,C-type lectin domain family 10 member A,18242,69,0.71 [0.39-1.29],0.2567620172855316
Chapter II Neoplasms,Melanoma in situ,CLEC11A,C-type lectin domain family 11 member A,18368,74,1.18 [0.76-1.81],0.4582254782014444
Chapter II Neoplasms,Melanoma in situ,CLEC12A,C-type lectin domain family 12 member A,15491,59,2.18 [0.79-5.99],0.1301016718943269
Chapter II Neoplasms,Melanoma in situ,CLEC14A,C-type lectin domain family 14 member A,18396,74,0.66 [0.34-1.30],0.2324125807274596
Chapter II Neoplasms,Melanoma in situ,CLEC1A,C-type lectin domain family 1 member A,18071,70,0.96 [0.51-1.83],0.9094438793409312
Chapter II Neoplasms,Melanoma in situ,CLEC1B,C-type lectin domain family 1 member B,18561,75,1.14 [0.92-1.40],0.2380962064749206
Chapter II Neoplasms,Melanoma in situ,CLEC2L,C-type lectin domain family 2 member L,15567,63,0.80 [0.46-1.39],0.4344093078403791
Chapter II Neoplasms,Melanoma in situ,CLEC3B,Tetranectin,15639,63,0.93 [0.29-2.96],0.8999818611097875
Chapter II Neoplasms,Melanoma in situ,CLEC4A,C-type lectin domain family 4 member A,18389,73,1.27 [0.70-2.32],0.4280748490716742
Chapter II Neoplasms,Melanoma in situ,CLEC4C,C-type lectin domain family 4 member C,18389,73,1.87 [1.24-2.82],0.0026398875299734
Chapter II Neoplasms,Melanoma in situ,CLEC4D,C-type lectin domain family 4 member D,18389,73,1.26 [0.90-1.75],0.1778678256645052
Chapter II Neoplasms,Melanoma in situ,CLEC4G,C-type lectin domain family 4 member G,18389,73,1.49 [0.80-2.76],0.2087315214256407
Chapter II Neoplasms,Melanoma in situ,CLEC4M,C-type lectin domain family 4 member M,15961,64,1.02 [0.62-1.66],0.9401173762404872
Chapter II Neoplasms,Melanoma in situ,CLEC5A,C-type lectin domain family 5 member A,18335,74,0.84 [0.42-1.70],0.6301553571397378
Chapter II Neoplasms,Melanoma in situ,CLEC6A,C-type lectin domain family 6 member A,17977,71,1.30 [0.84-2.00],0.2368016727781839
Chapter II Neoplasms,Melanoma in situ,CLEC7A,C-type lectin domain family 7 member A,18615,74,1.11 [0.76-1.62],0.5820604633210188
Chapter II Neoplasms,Melanoma in situ,CLGN,Calmegin,15567,63,0.97 [0.57-1.67],0.9238728420854414
Chapter II Neoplasms,Melanoma in situ,CLIC5,Chloride intracellular channel protein 5,15567,63,0.39 [0.15-1.00],0.0504936138929267
Chapter II Neoplasms,Melanoma in situ,CLINT1,Clathrin interactor 1,15421,61,1.42 [1.03-1.95],0.0321362792625584
Chapter II Neoplasms,Melanoma in situ,CLIP2,CAP-Gly domain-containing linker protein 2,18389,73,1.15 [0.96-1.39],0.1329803290202653
Chapter II Neoplasms,Melanoma in situ,CLMP,CXADR-like membrane protein,18569,74,0.71 [0.27-1.89],0.4963840534394063
Chapter II Neoplasms,Melanoma in situ,CLNS1A,Methylosome subunit pICln,15567,63,0.98 [0.48-2.01],0.9656925192320154
Chapter II Neoplasms,Melanoma in situ,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18214,69,1.09 [0.88-1.37],0.423990163949934
Chapter II Neoplasms,Melanoma in situ,CLPS,Colipase,18358,74,0.80 [0.60-1.06],0.1246820544625742
Chapter II Neoplasms,Melanoma in situ,CLSPN,Claspin,17974,70,1.27 [0.83-1.94],0.2655264774857235
Chapter II Neoplasms,Melanoma in situ,CLSTN1,Calsyntenin-1,18002,70,0.91 [0.59-1.40],0.666562550250852
Chapter II Neoplasms,Melanoma in situ,CLSTN2,Calsyntenin-2,18615,74,0.72 [0.41-1.28],0.2620464713518191
Chapter II Neoplasms,Melanoma in situ,CLSTN3,Calsyntenin-3,15944,63,1.01 [0.46-2.26],0.9716187753550364
Chapter II Neoplasms,Melanoma in situ,CLTA,Clathrin light chain A,18071,70,0.87 [0.53-1.41],0.5740019161345824
Chapter II Neoplasms,Melanoma in situ,CLU,Clusterin,15998,64,1.45 [0.84-2.49],0.1816317741125829
Chapter II Neoplasms,Melanoma in situ,CLUL1,Clusterin-like protein 1,18361,74,1.21 [0.76-1.91],0.4170261283264053
Chapter II Neoplasms,Melanoma in situ,CMC1,COX assembly mitochondrial protein homolog,15975,64,1.06 [0.81-1.38],0.671484766557451
Chapter II Neoplasms,Melanoma in situ,CMIP,C-Maf-inducing protein,15917,63,1.14 [0.85-1.51],0.3857709994473102
Chapter II Neoplasms,Melanoma in situ,CNDP1,Beta-Ala-His dipeptidase,18485,74,1.16 [0.72-1.86],0.535917795715771
Chapter II Neoplasms,Melanoma in situ,CNGB3,Cyclic nucleotide-gated cation channel beta-3,15489,61,0.36 [0.17-0.74],0.0055768884672972
Chapter II Neoplasms,Melanoma in situ,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15500,62,1.21 [0.89-1.65],0.2264532907198451
Chapter II Neoplasms,Melanoma in situ,CNPY2,Protein canopy homolog 2,18071,70,0.87 [0.58-1.30],0.4960284928280034
Chapter II Neoplasms,Melanoma in situ,CNPY4,Protein canopy homolog 4,18305,72,1.16 [0.88-1.53],0.2900608303674326
Chapter II Neoplasms,Melanoma in situ,CNST,Consortin,18395,74,1.09 [0.90-1.32],0.3650509415684302
Chapter II Neoplasms,Melanoma in situ,CNTF,Ciliary neurotrophic factor,15489,61,0.70 [0.34-1.42],0.3227115058489936
Chapter II Neoplasms,Melanoma in situ,CNTN1,Contactin-1,18626,75,0.86 [0.41-1.82],0.699579450422956
Chapter II Neoplasms,Melanoma in situ,CNTN2,Contactin-2,18569,74,0.88 [0.55-1.40],0.5819502701124082
Chapter II Neoplasms,Melanoma in situ,CNTN3,Contactin-3,18396,74,1.47 [0.69-3.14],0.319872432453697
Chapter II Neoplasms,Melanoma in situ,CNTN4,Contactin-4,18396,74,0.92 [0.38-2.21],0.8543126462849829
Chapter II Neoplasms,Melanoma in situ,CNTN5,Contactin-5,18446,75,0.91 [0.52-1.60],0.7392017566466849
Chapter II Neoplasms,Melanoma in situ,CNTNAP2,Contactin-associated protein-like 2,18389,73,0.87 [0.52-1.43],0.5797406115058642
Chapter II Neoplasms,Melanoma in situ,CNTNAP4,Contactin-associated protein-like 4,15567,63,0.88 [0.67-1.15],0.3448896166043149
Chapter II Neoplasms,Melanoma in situ,COCH,Cochlin,15975,64,1.21 [0.72-2.03],0.4675234437966933
Chapter II Neoplasms,Melanoma in situ,COL15A1,Collagen alpha-1(XV) chain,15983,64,0.52 [0.22-1.25],0.144775385267824
Chapter II Neoplasms,Melanoma in situ,COL18A1,Collagen alpha-1(XVIII) chain,18470,74,1.46 [0.60-3.53],0.4049870290729752
Chapter II Neoplasms,Melanoma in situ,COL1A1,Collagen alpha-1(I) chain,18626,75,1.04 [0.43-2.48],0.9352025790298956
Chapter II Neoplasms,Melanoma in situ,COL24A1,Collagen alpha-1(XXIV) chain,15920,63,1.03 [0.67-1.58],0.9044924215962972
Chapter II Neoplasms,Melanoma in situ,COL28A1,Collagen alpha-1(XXVIII) chain,15567,63,0.69 [0.50-0.96],0.0299549386857495
Chapter II Neoplasms,Melanoma in situ,COL2A1,Collagen alpha-1(II) chain,15528,62,1.03 [0.75-1.41],0.8564496766604919
Chapter II Neoplasms,Melanoma in situ,COL3A1,Collagen alpha-1(III) chain,15983,64,0.57 [0.21-1.59],0.284819812884558
Chapter II Neoplasms,Melanoma in situ,COL4A1,Collagen alpha-1(IV) chain,18395,74,1.07 [0.63-1.83],0.8016259934869197
Chapter II Neoplasms,Melanoma in situ,COL4A4,Collagen alpha-4(IV) chain,15668,63,1.24 [0.77-1.99],0.3734953007163464
Chapter II Neoplasms,Melanoma in situ,COL5A1,Collagen alpha-1(V) chain,15623,63,1.36 [0.75-2.45],0.3109405890201622
Chapter II Neoplasms,Melanoma in situ,COL6A3,Collagen alpha-3(VI) chain,18626,75,0.94 [0.52-1.72],0.8455385357247754
Chapter II Neoplasms,Melanoma in situ,COL9A1,Collagen alpha-1(IX) chain,18389,73,0.94 [0.59-1.51],0.810981336266053
Chapter II Neoplasms,Melanoma in situ,COL9A2,Collagen alpha-2(IX) chain,15697,63,0.88 [0.49-1.59],0.6691783442313392
Chapter II Neoplasms,Melanoma in situ,COLEC12,Collectin-12,18365,74,1.20 [0.55-2.61],0.6521653460995287
Chapter II Neoplasms,Melanoma in situ,COMMD1,COMM domain-containing protein 1,15528,62,1.18 [0.79-1.77],0.4112650043558407
Chapter II Neoplasms,Melanoma in situ,COMMD9,COMM domain-containing protein 9,15917,63,0.76 [0.39-1.47],0.4147644856321433
Chapter II Neoplasms,Melanoma in situ,COMP,Cartilage oligomeric matrix protein,18225,74,0.70 [0.37-1.31],0.2625050417226469
Chapter II Neoplasms,Melanoma in situ,COMT,Catechol O-methyltransferase,17874,70,1.03 [0.80-1.34],0.7996657230566913
Chapter II Neoplasms,Melanoma in situ,COPB2,Coatomer subunit beta',15452,62,0.84 [0.47-1.50],0.5649903746845667
Chapter II Neoplasms,Melanoma in situ,COPE,Coatomer subunit epsilon,18002,70,0.94 [0.59-1.49],0.7813316032260336
Chapter II Neoplasms,Melanoma in situ,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15528,62,0.64 [0.32-1.27],0.1981366790420591
Chapter II Neoplasms,Melanoma in situ,CORO1A,Coronin-1A,18033,73,1.01 [0.79-1.27],0.9597150176591764
Chapter II Neoplasms,Melanoma in situ,CORO6,Coronin-6,15489,61,0.51 [0.23-1.10],0.0860608477122237
Chapter II Neoplasms,Melanoma in situ,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18305,72,1.08 [0.81-1.46],0.5965858726463471
Chapter II Neoplasms,Melanoma in situ,COX6B1,Cytochrome c oxidase subunit 6B1,15975,64,0.84 [0.40-1.78],0.6547757417041729
Chapter II Neoplasms,Melanoma in situ,CPA1,Carboxypeptidase A1,18626,75,0.93 [0.68-1.29],0.6758177964319714
Chapter II Neoplasms,Melanoma in situ,CPA2,Carboxypeptidase A2,18507,74,1.10 [0.81-1.49],0.5449791967442197
Chapter II Neoplasms,Melanoma in situ,CPA4,Carboxypeptidase A4,15323,63,1.11 [0.63-1.98],0.7181033475171876
Chapter II Neoplasms,Melanoma in situ,CPB1,Carboxypeptidase B,18626,75,1.03 [0.74-1.44],0.8622178260846427
Chapter II Neoplasms,Melanoma in situ,CPB2,Carboxypeptidase B2,15973,64,1.04 [0.36-3.03],0.9470043758376556
Chapter II Neoplasms,Melanoma in situ,CPE,Carboxypeptidase E,18409,74,0.71 [0.45-1.13],0.1515790900754152
Chapter II Neoplasms,Melanoma in situ,CPLX2,Complexin-2,15421,61,0.73 [0.32-1.70],0.4700865547710541
Chapter II Neoplasms,Melanoma in situ,CPM,Carboxypeptidase M,18474,74,0.70 [0.38-1.31],0.2632473820464139
Chapter II Neoplasms,Melanoma in situ,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15491,59,2.46 [1.27-4.79],0.0078847607689827
Chapter II Neoplasms,Melanoma in situ,CPPED1,Serine/threonine-protein phosphatase CPPED1,18561,75,1.16 [0.86-1.57],0.3360502674438329
Chapter II Neoplasms,Melanoma in situ,CPQ,Carboxypeptidase Q,15956,64,0.74 [0.39-1.44],0.3784071704234297
Chapter II Neoplasms,Melanoma in situ,CPTP,Ceramide-1-phosphate transfer protein,15452,62,0.67 [0.33-1.38],0.2748542295384167
Chapter II Neoplasms,Melanoma in situ,CPVL,Probable serine carboxypeptidase CPVL,18533,73,0.68 [0.43-1.07],0.0968260163875389
Chapter II Neoplasms,Melanoma in situ,CPXM1,Probable carboxypeptidase X1,18439,74,1.48 [1.11-1.97],0.0075557916730812
Chapter II Neoplasms,Melanoma in situ,CPXM2,Inactive carboxypeptidase-like protein X2,15975,64,0.67 [0.26-1.74],0.4090394519786329
Chapter II Neoplasms,Melanoma in situ,CR1,Complement receptor type 1,15938,64,0.49 [0.24-0.99],0.0455136588312993
Chapter II Neoplasms,Melanoma in situ,CR2,Complement receptor type 2,18485,74,0.70 [0.45-1.09],0.1114745629708141
Chapter II Neoplasms,Melanoma in situ,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,17977,71,1.11 [0.88-1.42],0.3740013659468665
Chapter II Neoplasms,Melanoma in situ,CRADD,Death domain-containing protein CRADD,18214,69,1.21 [0.91-1.61],0.1998327772652404
Chapter II Neoplasms,Melanoma in situ,CREB3,Cyclic AMP-responsive element-binding protein 3,15421,61,0.65 [0.38-1.11],0.1141338868738826
Chapter II Neoplasms,Melanoma in situ,CREBZF,CREB/ATF bZIP transcription factor,15421,61,1.36 [0.58-3.17],0.4820677558052353
Chapter II Neoplasms,Melanoma in situ,CREG1,Protein CREG1,18153,73,0.73 [0.43-1.26],0.2584358254384941
Chapter II Neoplasms,Melanoma in situ,CRELD1,Protein disulfide isomerase CRELD1,15623,63,0.59 [0.30-1.15],0.1207151033842017
Chapter II Neoplasms,Melanoma in situ,CRELD2,Protein disulfide isomerase CRELD2,18434,74,1.33 [0.90-1.95],0.1521123119506514
Chapter II Neoplasms,Melanoma in situ,CRH,Corticoliberin,17951,71,1.05 [0.82-1.34],0.7110904072970492
Chapter II Neoplasms,Melanoma in situ,CRHBP,Corticotropin-releasing factor-binding protein,18365,74,0.71 [0.33-1.53],0.3814687105307587
Chapter II Neoplasms,Melanoma in situ,CRHR1,Corticotropin-releasing factor receptor 1,18071,70,0.83 [0.57-1.23],0.3594373481481956
Chapter II Neoplasms,Melanoma in situ,CRIM1,Cysteine-rich motor neuron 1 protein,18455,74,1.18 [0.42-3.30],0.7595742111039118
Chapter II Neoplasms,Melanoma in situ,CRIP2,Cysteine-rich protein 2,18242,69,0.71 [0.38-1.32],0.2732488564619359
Chapter II Neoplasms,Melanoma in situ,CRISP2,Cysteine-rich secretory protein 2,18569,74,1.32 [0.88-1.97],0.1764191039357007
Chapter II Neoplasms,Melanoma in situ,CRISP3,Cysteine-rich secretory protein 3,15840,64,1.57 [0.64-3.83],0.3210919293270159
Chapter II Neoplasms,Melanoma in situ,CRKL,Crk-like protein,18400,74,1.17 [0.96-1.42],0.129965081716084
Chapter II Neoplasms,Melanoma in situ,CRLF1,Cytokine receptor-like factor 1,18455,74,1.96 [0.85-4.52],0.11235640629578
Chapter II Neoplasms,Melanoma in situ,CRNN,Cornulin,17875,69,0.83 [0.61-1.13],0.2435531873176984
Chapter II Neoplasms,Melanoma in situ,CRTAC1,Cartilage acidic protein 1,18626,75,0.92 [0.48-1.76],0.7915847776578857
Chapter II Neoplasms,Melanoma in situ,CRTAM,Cytotoxic and regulatory T-cell molecule,18242,69,1.11 [0.73-1.70],0.6259771938948423
Chapter II Neoplasms,Melanoma in situ,CRTAP,Cartilage-associated protein,15567,63,0.62 [0.33-1.16],0.1334006239360348
Chapter II Neoplasms,Melanoma in situ,CRX,Cone-rod homeobox protein,18071,70,0.85 [0.66-1.09],0.2023169390036219
Chapter II Neoplasms,Melanoma in situ,CRYBB1,Beta-crystallin B1,15975,64,1.20 [0.83-1.74],0.3275997006855193
Chapter II Neoplasms,Melanoma in situ,CRYBB2,Beta-crystallin B2,15944,63,1.11 [0.85-1.45],0.4612452359101454
Chapter II Neoplasms,Melanoma in situ,CRYGD,Gamma-crystallin D,15944,63,1.19 [0.93-1.52],0.1763989553086011
Chapter II Neoplasms,Melanoma in situ,CRYM,Ketimine reductase mu-crystallin,15489,61,1.18 [0.88-1.58],0.2724752602103882
Chapter II Neoplasms,Melanoma in situ,CRYZL1,Quinone oxidoreductase-like protein 1,15528,62,1.15 [0.88-1.52],0.3093769594633864
Chapter II Neoplasms,Melanoma in situ,CSDE1,Cold shock domain-containing protein E1,15452,62,1.05 [0.87-1.27],0.6007155751714929
Chapter II Neoplasms,Melanoma in situ,CSF1,Macrophage colony-stimulating factor 1,18455,74,1.35 [0.62-2.92],0.4503812518664862
Chapter II Neoplasms,Melanoma in situ,CSF1R,Macrophage colony-stimulating factor 1 receptor,15994,64,0.68 [0.37-1.27],0.2236033524625195
Chapter II Neoplasms,Melanoma in situ,CSF2,Granulocyte-macrophage colony-stimulating factor,15452,62,0.73 [0.36-1.49],0.3849205992841247
Chapter II Neoplasms,Melanoma in situ,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18242,69,1.26 [0.91-1.73],0.1603264893151371
Chapter II Neoplasms,Melanoma in situ,CSF2RB,Cytokine receptor common subunit beta,15491,59,0.65 [0.37-1.16],0.1489916541529692
Chapter II Neoplasms,Melanoma in situ,CSF3,Granulocyte colony-stimulating factor,18088,71,1.00 [0.65-1.55],0.9934164673619608
Chapter II Neoplasms,Melanoma in situ,CSF3R,Granulocyte colony-stimulating factor receptor,15491,59,1.43 [0.62-3.31],0.4029302110416516
Chapter II Neoplasms,Melanoma in situ,CSH1,Chorionic somatomammotropin hormone 1,15994,64,0.73 [0.32-1.69],0.4674707548768512
Chapter II Neoplasms,Melanoma in situ,CSNK1D,Casein kinase I isoform delta,15491,59,0.97 [0.65-1.45],0.8948886771718715
Chapter II Neoplasms,Melanoma in situ,CSNK2A1,Casein kinase II subunit alpha,15952,63,0.73 [0.42-1.27],0.2681950923975067
Chapter II Neoplasms,Melanoma in situ,CSPG4,Chondroitin sulfate proteoglycan 4,15983,64,0.71 [0.34-1.48],0.3616487522751483
Chapter II Neoplasms,Melanoma in situ,CSPG5,Chondroitin sulfate proteoglycan 5,15489,61,1.19 [0.77-1.85],0.4347273745816659
Chapter II Neoplasms,Melanoma in situ,CSRP3,Cysteine and glycine-rich protein 3,15452,62,0.89 [0.68-1.17],0.3985604441384193
Chapter II Neoplasms,Melanoma in situ,CST1,Cystatin-SN,13875,56,0.99 [0.76-1.28],0.922206691701372
Chapter II Neoplasms,Melanoma in situ,CST3,Cystatin-C,18450,74,0.77 [0.37-1.64],0.5063791617772908
Chapter II Neoplasms,Melanoma in situ,CST5,Cystatin-D,18012,69,0.60 [0.40-0.90],0.0142950638431644
Chapter II Neoplasms,Melanoma in situ,CST6,Cystatin-M,17923,73,1.03 [0.67-1.57],0.9016931572071604
Chapter II Neoplasms,Melanoma in situ,CST7,Cystatin-F,18397,74,1.07 [0.87-1.31],0.5226184448368987
Chapter II Neoplasms,Melanoma in situ,CSTB,Cystatin-B,18146,71,0.98 [0.60-1.62],0.9497317711228942
Chapter II Neoplasms,Melanoma in situ,CTAG1A_CTAG1B,Cancer/testis antigen 1,15669,62,0.65 [0.39-1.08],0.095552521370889
Chapter II Neoplasms,Melanoma in situ,CTBS,Di-N-acetylchitobiase,15773,63,0.70 [0.29-1.70],0.4278423695821864
Chapter II Neoplasms,Melanoma in situ,CTF1,Cardiotrophin-1,18071,70,1.04 [0.81-1.33],0.7675847419704632
Chapter II Neoplasms,Melanoma in situ,CTHRC1,Collagen triple helix repeat-containing protein 1,15983,64,1.21 [0.52-2.81],0.6635600748718216
Chapter II Neoplasms,Melanoma in situ,CTLA4,Cytotoxic T-lymphocyte protein 4,15983,64,0.43 [0.19-0.95],0.036649333501596
Chapter II Neoplasms,Melanoma in situ,CTNNA1,Catenin alpha-1,15489,61,1.51 [0.91-2.49],0.1097737808858667
Chapter II Neoplasms,Melanoma in situ,CTRB1,Chymotrypsinogen B,18396,74,0.70 [0.49-1.00],0.0531130838095455
Chapter II Neoplasms,Melanoma in situ,CTRC,Chymotrypsin-C,18365,74,0.90 [0.66-1.24],0.5295751298466673
Chapter II Neoplasms,Melanoma in situ,CTRL,Chymotrypsin-like protease CTRL-1,15944,63,0.75 [0.54-1.05],0.0941259439708441
Chapter II Neoplasms,Melanoma in situ,CTSB,Cathepsin B,18401,73,0.80 [0.53-1.20],0.2880928108215549
Chapter II Neoplasms,Melanoma in situ,CTSC,Dipeptidyl peptidase 1,18331,74,0.82 [0.51-1.31],0.3958872075861025
Chapter II Neoplasms,Melanoma in situ,CTSD,Cathepsin D,17216,70,0.75 [0.42-1.34],0.3322787704844913
Chapter II Neoplasms,Melanoma in situ,CTSE,Cathepsin E,15623,63,1.41 [0.89-2.24],0.1381471064317296
Chapter II Neoplasms,Melanoma in situ,CTSF,Cathepsin F,18439,74,0.85 [0.50-1.44],0.5478811565980912
Chapter II Neoplasms,Melanoma in situ,CTSH,Pro-cathepsin H,18008,69,0.76 [0.57-1.01],0.0565316890309689
Chapter II Neoplasms,Melanoma in situ,CTSL,Cathepsin L1,18395,74,2.22 [1.00-4.95],0.0507630962951224
Chapter II Neoplasms,Melanoma in situ,CTSO,Cathepsin O,18615,74,0.78 [0.39-1.55],0.4765787381167735
Chapter II Neoplasms,Melanoma in situ,CTSS,Cathepsin S,14522,64,2.13 [0.78-5.81],0.1389778284670317
Chapter II Neoplasms,Melanoma in situ,CTSV,Cathepsin L2,18499,73,0.64 [0.37-1.12],0.1193849346693482
Chapter II Neoplasms,Melanoma in situ,CTSZ,Cathepsin Z,18426,73,0.64 [0.33-1.22],0.1753393976330003
Chapter II Neoplasms,Melanoma in situ,CUZD1,CUB and zona pellucida-like domain-containing protein 1,15567,63,0.67 [0.43-1.04],0.0759528925170248
Chapter II Neoplasms,Melanoma in situ,CWC15,Spliceosome-associated protein CWC15 homolog,15829,63,0.76 [0.46-1.23],0.2598917978115546
Chapter II Neoplasms,Melanoma in situ,CX3CL1,Fractalkine,18242,69,0.45 [0.23-0.89],0.0210390732543978
Chapter II Neoplasms,Melanoma in situ,CXADR,Coxsackievirus and adenovirus receptor,18389,73,1.17 [0.77-1.79],0.4646498390432342
Chapter II Neoplasms,Melanoma in situ,CXCL1,Growth-regulated alpha protein,18345,74,1.14 [0.93-1.39],0.2151929354717198
Chapter II Neoplasms,Melanoma in situ,CXCL10,C-X-C motif chemokine 10,18455,74,1.00 [0.72-1.38],0.9866339406186008
Chapter II Neoplasms,Melanoma in situ,CXCL11,C-X-C motif chemokine 11,18561,75,1.35 [1.11-1.66],0.0032144578283475
Chapter II Neoplasms,Melanoma in situ,CXCL12,Stromal cell-derived factor 1,18088,71,0.98 [0.57-1.69],0.9526966829465604
Chapter II Neoplasms,Melanoma in situ,CXCL13,C-X-C motif chemokine 13,18561,75,1.09 [0.78-1.52],0.6193996615556979
Chapter II Neoplasms,Melanoma in situ,CXCL14,C-X-C motif chemokine 14,18088,71,1.09 [0.77-1.56],0.6130926587736922
Chapter II Neoplasms,Melanoma in situ,CXCL16,C-X-C motif chemokine 16,18595,75,0.56 [0.23-1.38],0.2072301178968866
Chapter II Neoplasms,Melanoma in situ,CXCL17,C-X-C motif chemokine 17,18615,74,1.01 [0.61-1.68],0.9610357665516966
Chapter II Neoplasms,Melanoma in situ,CXCL3,C-X-C motif chemokine 3,18376,74,1.03 [0.83-1.27],0.8150022315405039
Chapter II Neoplasms,Melanoma in situ,CXCL5,C-X-C motif chemokine 5,18333,74,1.03 [0.86-1.24],0.7427640593446871
Chapter II Neoplasms,Melanoma in situ,CXCL6,C-X-C motif chemokine 6,18615,74,1.42 [1.10-1.85],0.0081994357236144
Chapter II Neoplasms,Melanoma in situ,CXCL8,Interleukin-8,18287,71,0.95 [0.69-1.30],0.7395119553422183
Chapter II Neoplasms,Melanoma in situ,CXCL9,C-X-C motif chemokine 9,18455,74,1.19 [0.88-1.60],0.2643074257056788
Chapter II Neoplasms,Melanoma in situ,CYB5A,Cytochrome b5,15421,61,1.18 [0.90-1.55],0.2398361734758434
Chapter II Neoplasms,Melanoma in situ,CYB5R2,NADH-cytochrome b5 reductase 2,15754,61,1.28 [0.83-1.99],0.2681516628629503
Chapter II Neoplasms,Melanoma in situ,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15452,62,0.88 [0.64-1.22],0.4377437349557004
Chapter II Neoplasms,Melanoma in situ,CYTH3,Cytohesin-3,15421,61,0.84 [0.58-1.24],0.3839154101251391
Chapter II Neoplasms,Melanoma in situ,CYTL1,Cytokine-like protein 1,15983,64,0.52 [0.20-1.36],0.1847753797080235
Chapter II Neoplasms,Melanoma in situ,DAAM1,Disheveled-associated activator of morphogenesis 1,15623,63,1.13 [0.85-1.52],0.3985809298060607
Chapter II Neoplasms,Melanoma in situ,DAB2,Disabled homolog 2,18569,74,1.12 [0.93-1.35],0.2390561190930633
Chapter II Neoplasms,Melanoma in situ,DAG1,Dystroglycan,18455,74,1.43 [0.93-2.21],0.1024241838259776
Chapter II Neoplasms,Melanoma in situ,DAND5,DAN domain family member 5,15491,59,0.75 [0.49-1.15],0.1901996710958813
Chapter II Neoplasms,Melanoma in situ,DAPK2,Death-associated protein kinase 2,15491,59,0.99 [0.63-1.55],0.9632780424570054
Chapter II Neoplasms,Melanoma in situ,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18389,73,1.07 [0.90-1.28],0.4239706360324163
Chapter II Neoplasms,Melanoma in situ,DARS1,"Aspartate--tRNA ligase, cytoplasmic",18214,69,1.24 [0.92-1.67],0.1553429606682546
Chapter II Neoplasms,Melanoma in situ,DBH,Dopamine beta-hydroxylase,15973,64,0.96 [0.78-1.18],0.7037831928882783
Chapter II Neoplasms,Melanoma in situ,DBI,Acyl-CoA-binding protein,18309,74,1.08 [0.82-1.40],0.5919569689224016
Chapter II Neoplasms,Melanoma in situ,DBN1,Drebrin,15491,59,1.40 [0.89-2.21],0.1461131752116092
Chapter II Neoplasms,Melanoma in situ,DBNL,Drebrin-like protein,18455,74,1.12 [0.90-1.40],0.3196062148724684
Chapter II Neoplasms,Melanoma in situ,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18439,74,1.38 [0.78-2.45],0.2661164561223009
Chapter II Neoplasms,Melanoma in situ,DCC,Netrin receptor DCC,15567,63,0.54 [0.15-1.92],0.3449734862083045
Chapter II Neoplasms,Melanoma in situ,DCDC2C,Doublecortin domain-containing protein 2C,15421,61,0.94 [0.62-1.42],0.7609098428476035
Chapter II Neoplasms,Melanoma in situ,DCLRE1C,Protein artemis,15421,61,0.48 [0.21-1.09],0.0807765993545752
Chapter II Neoplasms,Melanoma in situ,DCN,Decorin,18071,70,0.74 [0.29-1.91],0.5384335880235757
Chapter II Neoplasms,Melanoma in situ,DCTD,Deoxycytidylate deaminase,15623,63,1.12 [0.87-1.45],0.3827622666540595
Chapter II Neoplasms,Melanoma in situ,DCTN1,Dynactin subunit 1,18569,74,1.18 [0.85-1.62],0.3228713456044377
Chapter II Neoplasms,Melanoma in situ,DCTN2,Dynactin subunit 2,18305,72,1.08 [0.86-1.35],0.4980839158756408
Chapter II Neoplasms,Melanoma in situ,DCTN6,Dynactin subunit 6,18002,70,1.00 [0.74-1.34],0.9996564665536144
Chapter II Neoplasms,Melanoma in situ,DCTPP1,dCTP pyrophosphatase 1,18395,74,1.67 [0.87-3.18],0.1220554404784845
Chapter II Neoplasms,Melanoma in situ,DCUN1D1,DCN1-like protein 1,15489,61,0.94 [0.67-1.32],0.7037134891929262
Chapter II Neoplasms,Melanoma in situ,DCUN1D2,DCN1-like protein 2,15421,61,1.36 [1.08-1.72],0.0102995267092931
Chapter II Neoplasms,Melanoma in situ,DCXR,L-xylulose reductase,18439,74,0.82 [0.55-1.22],0.3324511041172446
Chapter II Neoplasms,Melanoma in situ,DDA1,DET1- and DDB1-associated protein 1,15452,62,0.57 [0.26-1.22],0.1460702724949608
Chapter II Neoplasms,Melanoma in situ,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18305,72,1.01 [0.63-1.64],0.958839827924448
Chapter II Neoplasms,Melanoma in situ,DDC,Aromatic-L-amino-acid decarboxylase,18375,74,1.22 [0.79-1.88],0.3720939080066255
Chapter II Neoplasms,Melanoma in situ,DDHD2,Phospholipase DDHD2,15952,63,1.13 [0.78-1.63],0.5292070858932652
Chapter II Neoplasms,Melanoma in situ,DDI2,Protein DDI1 homolog 2,15623,63,1.01 [0.73-1.39],0.9590126276864828
Chapter II Neoplasms,Melanoma in situ,DDR1,Epithelial discoidin domain-containing receptor 1,18561,75,0.78 [0.32-1.93],0.5901512909020024
Chapter II Neoplasms,Melanoma in situ,DDT,D-dopachrome decarboxylase,15983,64,1.02 [0.58-1.82],0.9352882112079162
Chapter II Neoplasms,Melanoma in situ,DDX1,ATP-dependent RNA helicase DDX1,15920,63,0.90 [0.53-1.52],0.692596994476113
Chapter II Neoplasms,Melanoma in situ,DDX25,ATP-dependent RNA helicase DDX25,15567,63,0.86 [0.41-1.80],0.6904931613410942
Chapter II Neoplasms,Melanoma in situ,DDX39A,ATP-dependent RNA helicase DDX39A,15491,59,1.58 [0.76-3.27],0.2166292315574939
Chapter II Neoplasms,Melanoma in situ,DDX4,Probable ATP-dependent RNA helicase DDX4,15491,59,0.93 [0.57-1.52],0.7709148326895944
Chapter II Neoplasms,Melanoma in situ,DDX53,Probable ATP-dependent RNA helicase DDX53,15567,63,1.07 [0.57-2.00],0.837478815104177
Chapter II Neoplasms,Melanoma in situ,DDX58,Antiviral innate immune response receptor RIG-I,17977,71,0.95 [0.64-1.39],0.7867871296698594
Chapter II Neoplasms,Melanoma in situ,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18389,73,1.11 [0.90-1.38],0.3320007657046331
Chapter II Neoplasms,Melanoma in situ,DEFA1_DEFA1B,Neutrophil defensin 1,18052,72,0.61 [0.39-0.95],0.0300634222048966
Chapter II Neoplasms,Melanoma in situ,DEFB103A_DEFB103B,Beta-defensin 103,15384,59,1.08 [0.61-1.90],0.7866843360051715
Chapter II Neoplasms,Melanoma in situ,DEFB104A_DEFB104B,Beta-defensin 104,15489,61,0.84 [0.51-1.36],0.4721615832023249
Chapter II Neoplasms,Melanoma in situ,DEFB116,Beta-defensin 116,15489,61,1.40 [1.10-1.79],0.0065247808741718
Chapter II Neoplasms,Melanoma in situ,DEFB118,Beta-defensin 118,15489,61,0.79 [0.46-1.37],0.4040071824148524
Chapter II Neoplasms,Melanoma in situ,DEFB4A_DEFB4B,Beta-defensin 4A,18109,69,1.17 [1.01-1.35],0.0353637208658062
Chapter II Neoplasms,Melanoma in situ,DENND2B,DENN domain-containing protein 2B,15452,62,1.17 [0.79-1.73],0.4259949859227997
Chapter II Neoplasms,Melanoma in situ,DENR,Density-regulated protein,15491,59,1.31 [0.89-1.93],0.1737662583504799
Chapter II Neoplasms,Melanoma in situ,DFFA,DNA fragmentation factor subunit alpha,18615,74,1.34 [1.00-1.80],0.053321028794612
Chapter II Neoplasms,Melanoma in situ,DGCR6,Protein DGCR6,15489,61,0.83 [0.43-1.59],0.5796050193079771
Chapter II Neoplasms,Melanoma in situ,DGKA,Diacylglycerol kinase alpha,15491,59,1.12 [0.71-1.77],0.61866602684942
Chapter II Neoplasms,Melanoma in situ,DGKZ,Diacylglycerol kinase zeta,18088,71,1.04 [0.58-1.87],0.9026171870946428
Chapter II Neoplasms,Melanoma in situ,DHODH,Dihydroorotate dehydrogenase,15452,62,0.68 [0.37-1.26],0.2256729871023473
Chapter II Neoplasms,Melanoma in situ,DHPS,Deoxyhypusine synthase,15917,63,1.25 [0.75-2.08],0.3849508509133171
Chapter II Neoplasms,Melanoma in situ,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,15944,63,1.23 [0.77-1.96],0.3913103930739772
Chapter II Neoplasms,Melanoma in situ,DIABLO,"Diablo homolog, mitochondrial",18335,74,1.06 [0.88-1.28],0.543118918389242
Chapter II Neoplasms,Melanoma in situ,DIPK1C,Divergent protein kinase domain 1C,15567,63,0.41 [0.20-0.84],0.0156340419296671
Chapter II Neoplasms,Melanoma in situ,DIPK2B,Divergent protein kinase domain 2B,15623,63,1.31 [0.61-2.83],0.485138789803604
Chapter II Neoplasms,Melanoma in situ,DKK1,Dickkopf-related protein 1,18561,75,1.38 [0.98-1.95],0.0689898954889726
Chapter II Neoplasms,Melanoma in situ,DKK3,Dickkopf-related protein 3,18626,75,0.82 [0.41-1.66],0.5813803952700574
Chapter II Neoplasms,Melanoma in situ,DKK4,Dickkopf-related protein 4,18209,69,1.26 [0.81-1.95],0.3006175858454926
Chapter II Neoplasms,Melanoma in situ,DKKL1,Dickkopf-like protein 1,18305,72,0.96 [0.75-1.21],0.7073971200638169
Chapter II Neoplasms,Melanoma in situ,DLG4,Disks large homolog 4,15944,63,1.19 [0.86-1.64],0.288193136196044
Chapter II Neoplasms,Melanoma in situ,DLGAP5,Disks large-associated protein 5,15952,63,1.22 [0.84-1.76],0.2907891612392066
Chapter II Neoplasms,Melanoma in situ,DLK1,Protein delta homolog 1,18626,75,0.79 [0.55-1.12],0.1827003719737422
Chapter II Neoplasms,Melanoma in situ,DLL1,Delta-like protein 1,18439,74,1.06 [0.53-2.13],0.8709423829539628
Chapter II Neoplasms,Melanoma in situ,DLL4,Delta-like protein 4,15528,62,0.77 [0.49-1.21],0.2598900383950124
Chapter II Neoplasms,Melanoma in situ,DMD,Dystrophin,15528,62,1.11 [0.68-1.83],0.6743054173887713
Chapter II Neoplasms,Melanoma in situ,DMP1,Dentin matrix acidic phosphoprotein 1,15528,62,0.97 [0.62-1.51],0.8864449455593899
Chapter II Neoplasms,Melanoma in situ,DNAJA1,DnaJ homolog subfamily A member 1,15421,61,0.98 [0.55-1.72],0.9342054772431292
Chapter II Neoplasms,Melanoma in situ,DNAJA2,DnaJ homolog subfamily A member 2,18557,74,1.13 [0.88-1.45],0.3562698608958524
Chapter II Neoplasms,Melanoma in situ,DNAJA4,DnaJ homolog subfamily A member 4,15944,63,1.21 [0.87-1.68],0.255701469219406
Chapter II Neoplasms,Melanoma in situ,DNAJB1,DnaJ homolog subfamily B member 1,18305,72,1.23 [0.96-1.57],0.1007861316066439
Chapter II Neoplasms,Melanoma in situ,DNAJB14,DnaJ homolog subfamily B member 14,15920,63,1.07 [0.74-1.56],0.704354005459801
Chapter II Neoplasms,Melanoma in situ,DNAJB2,DnaJ homolog subfamily B member 2,15623,63,1.30 [0.83-2.02],0.250929166741047
Chapter II Neoplasms,Melanoma in situ,DNAJB6,DnaJ homolog subfamily B member 6,15481,63,1.08 [0.80-1.45],0.6152294453423526
Chapter II Neoplasms,Melanoma in situ,DNAJB8,DnaJ homolog subfamily B member 8,18071,70,1.09 [0.76-1.56],0.6304301938274004
Chapter II Neoplasms,Melanoma in situ,DNAJC21,DnaJ homolog subfamily C member 21,15944,63,1.03 [0.56-1.90],0.920610522741838
Chapter II Neoplasms,Melanoma in situ,DNAJC6,Putative tyrosine-protein phosphatase auxilin,15528,62,1.36 [1.03-1.80],0.0311193150384096
Chapter II Neoplasms,Melanoma in situ,DNAJC9,DnaJ homolog subfamily C member 9,15920,63,1.16 [0.85-1.59],0.3436245132637799
Chapter II Neoplasms,Melanoma in situ,DNER,Delta and Notch-like epidermal growth factor-related receptor,18336,74,0.44 [0.20-0.98],0.0445827960469533
Chapter II Neoplasms,Melanoma in situ,DNLZ,DNL-type zinc finger protein,15489,61,0.82 [0.57-1.18],0.2827443295987605
Chapter II Neoplasms,Melanoma in situ,DNM1,Dynamin-1,15920,63,1.06 [0.86-1.32],0.5699359675091626
Chapter II Neoplasms,Melanoma in situ,DNM3,Dynamin-3,15952,63,0.94 [0.59-1.49],0.7924399186967713
Chapter II Neoplasms,Melanoma in situ,DNMBP,Dynamin-binding protein,18242,69,1.17 [0.83-1.64],0.3753400666985026
Chapter II Neoplasms,Melanoma in situ,DNPEP,Aspartyl aminopeptidase,15944,63,1.42 [0.92-2.21],0.113501311450844
Chapter II Neoplasms,Melanoma in situ,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18421,74,1.39 [0.94-2.06],0.1019087266211591
Chapter II Neoplasms,Melanoma in situ,DOC2B,Double C2-like domain-containing protein beta,15567,63,0.94 [0.47-1.87],0.8623202246591434
Chapter II Neoplasms,Melanoma in situ,DOCK9,Dedicator of cytokinesis protein 9,15489,61,0.87 [0.67-1.12],0.2738383497842227
Chapter II Neoplasms,Melanoma in situ,DOK1,Docking protein 1,15944,63,1.07 [0.89-1.28],0.4667337427422249
Chapter II Neoplasms,Melanoma in situ,DOK2,Docking protein 2,18395,74,1.10 [0.93-1.30],0.2809280366985051
Chapter II Neoplasms,Melanoma in situ,DPEP1,Dipeptidase 1,18214,69,0.70 [0.45-1.08],0.1041509062314971
Chapter II Neoplasms,Melanoma in situ,DPEP2,Dipeptidase 2,18305,72,0.74 [0.37-1.47],0.3911327172193586
Chapter II Neoplasms,Melanoma in situ,DPP10,Inactive dipeptidyl peptidase 10,18389,73,0.97 [0.54-1.76],0.9282740037025368
Chapter II Neoplasms,Melanoma in situ,DPP4,Dipeptidyl peptidase 4,18077,73,0.42 [0.20-0.90],0.025904214650782
Chapter II Neoplasms,Melanoma in situ,DPP6,Dipeptidyl aminopeptidase-like protein 6,18305,72,0.57 [0.31-1.06],0.073824423475712
Chapter II Neoplasms,Melanoma in situ,DPP7,Dipeptidyl peptidase 2,18255,73,0.88 [0.63-1.23],0.4544403427567492
Chapter II Neoplasms,Melanoma in situ,DPT,Dermatopontin,18626,75,0.71 [0.33-1.56],0.3964532640528757
Chapter II Neoplasms,Melanoma in situ,DPY30,Protein dpy-30 homolog,18518,73,1.10 [0.79-1.53],0.5753950220478814
Chapter II Neoplasms,Melanoma in situ,DRAXIN,Draxin,18242,69,1.03 [0.62-1.72],0.8989197487686802
Chapter II Neoplasms,Melanoma in situ,DRG2,Developmentally-regulated GTP-binding protein 2,18305,72,1.31 [0.92-1.87],0.1294037139533846
Chapter II Neoplasms,Melanoma in situ,DSC2,Desmocollin-2,18167,74,1.27 [0.70-2.31],0.4334319264755505
Chapter II Neoplasms,Melanoma in situ,DSCAM,Down syndrome cell adhesion molecule,15952,63,0.82 [0.42-1.63],0.5780272458758251
Chapter II Neoplasms,Melanoma in situ,DSG2,Desmoglein-2,18396,74,0.95 [0.44-2.05],0.887204338912273
Chapter II Neoplasms,Melanoma in situ,DSG3,Desmoglein-3,18510,72,0.73 [0.40-1.35],0.3154748090256238
Chapter II Neoplasms,Melanoma in situ,DSG4,Desmoglein-4,18240,72,0.69 [0.45-1.07],0.0952821548935678
Chapter II Neoplasms,Melanoma in situ,DTD1,D-aminoacyl-tRNA deacylase 1,15623,63,1.04 [0.78-1.38],0.7922382081072844
Chapter II Neoplasms,Melanoma in situ,DTNB,Dystrobrevin beta,15878,62,1.14 [0.66-1.99],0.6334784654925321
Chapter II Neoplasms,Melanoma in situ,DTX2,Probable E3 ubiquitin-protein ligase DTX2,15567,63,0.67 [0.40-1.12],0.1281423988179441
Chapter II Neoplasms,Melanoma in situ,DTX3,Probable E3 ubiquitin-protein ligase DTX3,18305,72,0.32 [0.12-0.84],0.0198581488002743
Chapter II Neoplasms,Melanoma in situ,DTYMK,Thymidylate kinase,15975,64,1.23 [0.86-1.75],0.2552591490733097
Chapter II Neoplasms,Melanoma in situ,DUOX2,Dual oxidase 2,18071,70,0.87 [0.62-1.22],0.4185005427482249
Chapter II Neoplasms,Melanoma in situ,DUSP13,Dual specificity protein phosphatase 13 isoform A,15917,63,0.75 [0.41-1.36],0.3409538596597298
Chapter II Neoplasms,Melanoma in situ,DUSP29,Dual specificity phosphatase 29,15567,63,0.79 [0.52-1.22],0.2938561559678424
Chapter II Neoplasms,Melanoma in situ,DUSP3,Dual specificity protein phosphatase 3,18002,70,1.20 [0.99-1.45],0.0671853448493055
Chapter II Neoplasms,Melanoma in situ,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",15920,63,1.16 [0.92-1.46],0.2069574939591882
Chapter II Neoplasms,Melanoma in situ,DXO,Decapping and exoribonuclease protein,15944,63,1.50 [0.91-2.49],0.1130713840644837
Chapter II Neoplasms,Melanoma in situ,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,15917,63,0.59 [0.31-1.16],0.1254557168809348
Chapter II Neoplasms,Melanoma in situ,DYNLT1,Dynein light chain Tctex-type 1,15567,63,1.13 [0.84-1.51],0.4331246022153495
Chapter II Neoplasms,Melanoma in situ,DYNLT3,Dynein light chain Tctex-type 3,15917,63,1.51 [0.90-2.55],0.1187035548954969
Chapter II Neoplasms,Melanoma in situ,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18242,69,1.18 [0.94-1.47],0.1468383708902589
Chapter II Neoplasms,Melanoma in situ,EBI3_IL27,Interleukin-27,18546,74,0.74 [0.37-1.48],0.3900060503178822
Chapter II Neoplasms,Melanoma in situ,ECE1,Endothelin-converting enzyme 1,18002,70,1.27 [0.71-2.27],0.418555967615081
Chapter II Neoplasms,Melanoma in situ,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",15975,64,0.73 [0.51-1.05],0.0913844738499559
Chapter II Neoplasms,Melanoma in situ,ECHS1,"Enoyl-CoA hydratase, mitochondrial",15528,62,0.96 [0.74-1.25],0.7581923160303029
Chapter II Neoplasms,Melanoma in situ,ECI2,Enoyl-CoA delta isomerase 2,15452,62,0.90 [0.59-1.38],0.6350248642796807
Chapter II Neoplasms,Melanoma in situ,ECM1,Extracellular matrix protein 1,15577,63,0.78 [0.42-1.44],0.4278860685373022
Chapter II Neoplasms,Melanoma in situ,ECSCR,Endothelial cell-specific chemotaxis regulator,15489,61,0.66 [0.35-1.24],0.1996244379199503
Chapter II Neoplasms,Melanoma in situ,EDA2R,Tumor necrosis factor receptor superfamily member 27,18569,74,0.55 [0.38-0.81],0.0026418021736361
Chapter II Neoplasms,Melanoma in situ,EDAR,Tumor necrosis factor receptor superfamily member EDAR,18389,73,1.09 [0.87-1.37],0.473806521269508
Chapter II Neoplasms,Melanoma in situ,EDDM3B,Epididymal secretory protein E3-beta,15917,63,1.06 [0.71-1.59],0.761368954581856
Chapter II Neoplasms,Melanoma in situ,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15452,62,0.75 [0.35-1.59],0.4532436612089008
Chapter II Neoplasms,Melanoma in situ,EDF1,Endothelial differentiation-related factor 1,15952,63,1.13 [0.81-1.56],0.4687532095146277
Chapter II Neoplasms,Melanoma in situ,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18071,70,0.60 [0.31-1.15],0.1236642529199626
Chapter II Neoplasms,Melanoma in situ,EDN1,Endothelin-1,15528,62,0.64 [0.28-1.50],0.3039406458453201
Chapter II Neoplasms,Melanoma in situ,EDNRB,Endothelin receptor type B,15491,59,1.08 [0.63-1.86],0.7704486428305422
Chapter II Neoplasms,Melanoma in situ,EEF1D,Elongation factor 1-delta,15975,64,1.20 [0.93-1.55],0.1505048463939662
Chapter II Neoplasms,Melanoma in situ,EFCAB14,EF-hand calcium-binding domain-containing protein 14,15920,63,1.19 [0.56-2.53],0.6442387140446058
Chapter II Neoplasms,Melanoma in situ,EFCAB2,Dynein regulatory complex protein 8,15697,63,1.43 [0.75-2.73],0.272767042129428
Chapter II Neoplasms,Melanoma in situ,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18455,74,0.72 [0.37-1.40],0.3303926262490312
Chapter II Neoplasms,Melanoma in situ,EFHD1,EF-hand domain-containing protein D1,15952,63,0.35 [0.16-0.75],0.0071936915484826
Chapter II Neoplasms,Melanoma in situ,EFNA1,Ephrin-A1,18365,74,1.05 [0.51-2.19],0.886311447697006
Chapter II Neoplasms,Melanoma in situ,EFNA4,Ephrin-A4,18208,69,0.78 [0.37-1.63],0.5030115672178619
Chapter II Neoplasms,Melanoma in situ,EFNB2,Ephrin-B2,15567,63,0.76 [0.46-1.26],0.2898089034713613
Chapter II Neoplasms,Melanoma in situ,EGF,Pro-epidermal growth factor,18345,72,1.15 [0.94-1.41],0.1658906227624751
Chapter II Neoplasms,Melanoma in situ,EGFL7,Epidermal growth factor-like protein 7,17977,71,0.98 [0.56-1.72],0.9555328830608228
Chapter II Neoplasms,Melanoma in situ,EGFLAM,Pikachurin,15920,63,1.46 [0.70-3.06],0.3171457852304957
Chapter II Neoplasms,Melanoma in situ,EGFR,Epidermal growth factor receptor,18626,75,1.60 [0.44-5.78],0.4736771739345538
Chapter II Neoplasms,Melanoma in situ,EGLN1,Egl nine homolog 1,18389,73,1.03 [0.71-1.49],0.8711227077366874
Chapter II Neoplasms,Melanoma in situ,EHBP1,EH domain-binding protein 1,15975,64,1.09 [0.79-1.50],0.5914027156672064
Chapter II Neoplasms,Melanoma in situ,EHD3,EH domain-containing protein 3,15528,62,1.07 [0.87-1.33],0.5101150684066149
Chapter II Neoplasms,Melanoma in situ,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",15944,63,0.98 [0.64-1.50],0.9193829834007624
Chapter II Neoplasms,Melanoma in situ,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",15864,63,1.14 [0.92-1.41],0.2479025142317961
Chapter II Neoplasms,Melanoma in situ,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15452,62,1.02 [0.70-1.50],0.9046915527785948
Chapter II Neoplasms,Melanoma in situ,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15528,62,0.69 [0.36-1.31],0.2535508097418924
Chapter II Neoplasms,Melanoma in situ,EIF4B,Eukaryotic translation initiation factor 4B,18242,69,1.51 [1.02-2.23],0.0414494561133179
Chapter II Neoplasms,Melanoma in situ,EIF4E,Eukaryotic translation initiation factor 4E,15491,59,1.19 [0.90-1.58],0.2136820086298501
Chapter II Neoplasms,Melanoma in situ,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18395,74,1.22 [0.90-1.66],0.1948286379355456
Chapter II Neoplasms,Melanoma in situ,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18615,74,1.23 [1.00-1.52],0.0538024648113686
Chapter II Neoplasms,Melanoma in situ,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,15952,63,1.02 [0.70-1.48],0.9323969597849588
Chapter II Neoplasms,Melanoma in situ,EIF5,Eukaryotic translation initiation factor 5,15452,62,0.57 [0.29-1.11],0.0958303808966675
Chapter II Neoplasms,Melanoma in situ,EIF5A,Eukaryotic translation initiation factor 5A-1,18088,71,0.55 [0.26-1.17],0.1210688804016019
Chapter II Neoplasms,Melanoma in situ,ELAC1,Zinc phosphodiesterase ELAC protein 1,15952,63,1.15 [0.86-1.53],0.3388146796523419
Chapter II Neoplasms,Melanoma in situ,ELAVL4,ELAV-like protein 4,15489,61,0.80 [0.57-1.12],0.187591775371808
Chapter II Neoplasms,Melanoma in situ,ELN,Elastin,15975,64,1.23 [0.60-2.49],0.5738543465281258
Chapter II Neoplasms,Melanoma in situ,ELOA,Elongin-A,18305,72,0.75 [0.47-1.17],0.2066332801285535
Chapter II Neoplasms,Melanoma in situ,ELOB,Elongin-B,15452,62,0.74 [0.36-1.53],0.4173325528763217
Chapter II Neoplasms,Melanoma in situ,ENAH,Protein enabled homolog,18088,71,1.10 [0.71-1.71],0.6672925721656129
Chapter II Neoplasms,Melanoma in situ,ENDOU,Poly(U)-specific endoribonuclease,14735,57,0.95 [0.60-1.50],0.8213600724627133
Chapter II Neoplasms,Melanoma in situ,ENG,Endoglin,18626,75,0.95 [0.29-3.10],0.9298735442853586
Chapter II Neoplasms,Melanoma in situ,ENO1,Alpha-enolase,18382,74,1.21 [0.93-1.58],0.1544640553052822
Chapter II Neoplasms,Melanoma in situ,ENO2,Gamma-enolase,18561,75,1.18 [0.86-1.61],0.2969001857252471
Chapter II Neoplasms,Melanoma in situ,ENO3,Beta-enolase,15528,62,0.90 [0.59-1.37],0.6233087753197526
Chapter II Neoplasms,Melanoma in situ,ENOPH1,Enolase-phosphatase E1,15917,63,0.78 [0.48-1.26],0.3114508542597541
Chapter II Neoplasms,Melanoma in situ,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15452,62,1.34 [0.59-3.01],0.4842808034636761
Chapter II Neoplasms,Melanoma in situ,ENPEP,Glutamyl aminopeptidase,15452,62,0.88 [0.47-1.64],0.6945637742359316
Chapter II Neoplasms,Melanoma in situ,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18626,75,0.73 [0.31-1.72],0.47399265605169
Chapter II Neoplasms,Melanoma in situ,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18455,74,0.72 [0.50-1.03],0.0741080714954519
Chapter II Neoplasms,Melanoma in situ,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15528,62,0.76 [0.38-1.49],0.4239072618849681
Chapter II Neoplasms,Melanoma in situ,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17815,71,1.15 [0.89-1.49],0.275210686712494
Chapter II Neoplasms,Melanoma in situ,ENSA,Alpha-endosulfine,15917,63,1.04 [0.66-1.65],0.8540297016400608
Chapter II Neoplasms,Melanoma in situ,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,17977,71,0.79 [0.48-1.27],0.3285197213663046
Chapter II Neoplasms,Melanoma in situ,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18071,70,1.73 [0.64-4.68],0.2769302311423548
Chapter II Neoplasms,Melanoma in situ,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18071,70,0.81 [0.40-1.67],0.571718234404399
Chapter II Neoplasms,Melanoma in situ,ENTR1,Endosome-associated-trafficking regulator 1,15528,62,1.09 [0.73-1.63],0.6596388803076028
Chapter II Neoplasms,Melanoma in situ,EP300,Histone acetyltransferase p300,15491,59,0.76 [0.32-1.78],0.5293693029175397
Chapter II Neoplasms,Melanoma in situ,EPB41L5,Band 4.1-like protein 5,15567,63,0.92 [0.61-1.38],0.6926636942580702
Chapter II Neoplasms,Melanoma in situ,EPCAM,Epithelial cell adhesion molecule,18360,74,1.07 [0.86-1.33],0.5384060363786143
Chapter II Neoplasms,Melanoma in situ,EPGN,Epigen,15917,63,1.05 [0.64-1.72],0.8553599481410696
Chapter II Neoplasms,Melanoma in situ,EPHA1,Ephrin type-A receptor 1,18421,74,1.13 [0.58-2.20],0.7185615178252209
Chapter II Neoplasms,Melanoma in situ,EPHA10,Ephrin type-A receptor 10,18002,70,1.10 [0.82-1.47],0.5369049588044419
Chapter II Neoplasms,Melanoma in situ,EPHA2,Ephrin type-A receptor 2,17752,68,0.89 [0.43-1.85],0.7544621418560378
Chapter II Neoplasms,Melanoma in situ,EPHA4,Ephrin type-A receptor 4,15623,63,0.78 [0.34-1.79],0.5530853702023839
Chapter II Neoplasms,Melanoma in situ,EPHB4,Ephrin type-B receptor 4,18626,75,1.49 [0.68-3.30],0.3208392626775959
Chapter II Neoplasms,Melanoma in situ,EPHB6,Ephrin type-B receptor 6,18214,69,0.63 [0.31-1.25],0.1841831402378574
Chapter II Neoplasms,Melanoma in situ,EPHX2,Bifunctional epoxide hydrolase 2,18071,70,0.92 [0.63-1.33],0.658479120711972
Chapter II Neoplasms,Melanoma in situ,EPN1,Epsin-1,15697,63,0.63 [0.31-1.24],0.1812044818674416
Chapter II Neoplasms,Melanoma in situ,EPO,Erythropoietin,18389,73,1.13 [0.86-1.48],0.3832158614860169
Chapter II Neoplasms,Melanoma in situ,EPPK1,Epiplakin,15528,62,0.96 [0.67-1.37],0.8246194059411971
Chapter II Neoplasms,Melanoma in situ,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18541,73,0.99 [0.49-1.99],0.9690545650458868
Chapter II Neoplasms,Melanoma in situ,ERBB2,Receptor tyrosine-protein kinase erbB-2,18439,74,0.56 [0.25-1.28],0.1685935853011138
Chapter II Neoplasms,Melanoma in situ,ERBB3,Receptor tyrosine-protein kinase erbB-3,18303,74,4.55 [1.91-10.87],0.0006451677031636
Chapter II Neoplasms,Melanoma in situ,ERBB4,Receptor tyrosine-protein kinase erbB-4,18439,74,0.44 [0.20-0.98],0.044283360741482
Chapter II Neoplasms,Melanoma in situ,ERBIN,Erbin,18305,72,1.12 [0.92-1.38],0.2623216021359619
Chapter II Neoplasms,Melanoma in situ,ERC2,ERC protein 2,15567,63,1.02 [0.74-1.40],0.8965451548944249
Chapter II Neoplasms,Melanoma in situ,ERCC1,DNA excision repair protein ERCC-1,15421,61,0.87 [0.40-1.88],0.7190895285535528
Chapter II Neoplasms,Melanoma in situ,EREG,Proepiregulin,18214,69,1.20 [0.94-1.54],0.1488051660670668
Chapter II Neoplasms,Melanoma in situ,ERI1,3'-5' exoribonuclease 1,15697,63,1.10 [0.54-2.23],0.7971432652774951
Chapter II Neoplasms,Melanoma in situ,ERMAP,Erythroid membrane-associated protein,15491,59,1.19 [0.68-2.10],0.5433838358014167
Chapter II Neoplasms,Melanoma in situ,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,15917,63,1.15 [0.62-2.16],0.6534663248626706
Chapter II Neoplasms,Melanoma in situ,ERP29,Endoplasmic reticulum resident protein 29,15623,63,1.08 [0.88-1.33],0.4673990461433656
Chapter II Neoplasms,Melanoma in situ,ERP44,Endoplasmic reticulum resident protein 44,18279,72,1.62 [0.73-3.61],0.2348287412297557
Chapter II Neoplasms,Melanoma in situ,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15452,62,1.10 [0.63-1.92],0.7308954235014913
Chapter II Neoplasms,Melanoma in situ,ESAM,Endothelial cell-selective adhesion molecule,18626,75,1.24 [0.66-2.32],0.5065770667207115
Chapter II Neoplasms,Melanoma in situ,ESM1,Endothelial cell-specific molecule 1,18365,74,1.09 [0.60-1.99],0.7799145335898062
Chapter II Neoplasms,Melanoma in situ,ESPL1,Separin,15421,61,0.91 [0.56-1.47],0.6918491169114971
Chapter II Neoplasms,Melanoma in situ,ESR1,Estrogen receptor,15491,59,1.08 [0.72-1.62],0.7051891941235817
Chapter II Neoplasms,Melanoma in situ,ESYT2,Extended synaptotagmin-2,15944,63,1.10 [0.82-1.47],0.527059867766262
Chapter II Neoplasms,Melanoma in situ,EVI2B,Protein EVI2B,15421,61,1.36 [0.86-2.14],0.1848083861835361
Chapter II Neoplasms,Melanoma in situ,EVI5,Ecotropic viral integration site 5 protein homolog,15491,59,1.11 [0.84-1.46],0.4639408149633197
Chapter II Neoplasms,Melanoma in situ,EVPL,Envoplakin,15697,63,0.70 [0.30-1.61],0.4015944324022431
Chapter II Neoplasms,Melanoma in situ,EXOSC10,Exosome component 10,15452,62,1.25 [0.88-1.77],0.2179731189333061
Chapter II Neoplasms,Melanoma in situ,EXTL1,Exostosin-like 1,15452,62,0.77 [0.43-1.40],0.3946922421852485
Chapter II Neoplasms,Melanoma in situ,EZR,Ezrin,18561,75,0.80 [0.33-1.92],0.6160167765799085
Chapter II Neoplasms,Melanoma in situ,F10,Coagulation factor X,15994,64,1.61 [0.93-2.80],0.0915125372852377
Chapter II Neoplasms,Melanoma in situ,F11,Coagulation factor XI,15771,62,0.95 [0.43-2.12],0.905597636211564
Chapter II Neoplasms,Melanoma in situ,F11R,Junctional adhesion molecule A,18396,74,1.25 [0.87-1.78],0.2298741679881736
Chapter II Neoplasms,Melanoma in situ,F12,Coagulation factor XII,15998,64,1.04 [0.58-1.89],0.8903997538161232
Chapter II Neoplasms,Melanoma in situ,F13B,Coagulation factor XIII B chain,15930,64,0.83 [0.32-2.13],0.6920982324129954
Chapter II Neoplasms,Melanoma in situ,F2,Prothrombin,15998,64,2.70 [0.57-12.72],0.2103056987820028
Chapter II Neoplasms,Melanoma in situ,F2R,Proteinase-activated receptor 1,18434,74,1.35 [0.94-1.92],0.1041214765079542
Chapter II Neoplasms,Melanoma in situ,F3,Tissue factor,18449,74,0.49 [0.21-1.12],0.0891809392648145
Chapter II Neoplasms,Melanoma in situ,F7,Coagulation factor VII,18456,74,1.08 [0.56-2.11],0.8182209871221733
Chapter II Neoplasms,Melanoma in situ,F9,Coagulation factor IX,18463,74,1.49 [0.48-4.60],0.4921552824020921
Chapter II Neoplasms,Melanoma in situ,FABP1,"Fatty acid-binding protein, liver",18365,74,1.03 [0.83-1.28],0.7785725592198725
Chapter II Neoplasms,Melanoma in situ,FABP2,"Fatty acid-binding protein, intestinal",18395,74,1.06 [0.82-1.36],0.6770714715801041
Chapter II Neoplasms,Melanoma in situ,FABP3,"Fatty acid-binding protein, heart",15975,64,0.76 [0.47-1.23],0.2581339612637059
Chapter II Neoplasms,Melanoma in situ,FABP4,"Fatty acid-binding protein, adipocyte",18626,75,0.74 [0.48-1.14],0.1683964943995952
Chapter II Neoplasms,Melanoma in situ,FABP5,Fatty acid-binding protein 5,18500,74,1.08 [0.79-1.47],0.6234075904610484
Chapter II Neoplasms,Melanoma in situ,FABP6,Gastrotropin,18041,70,1.23 [0.87-1.73],0.2388349245962495
Chapter II Neoplasms,Melanoma in situ,FABP9,Fatty acid-binding protein 9,18389,73,0.70 [0.48-1.04],0.0746413282659852
Chapter II Neoplasms,Melanoma in situ,FADD,FAS-associated death domain protein,18395,74,1.14 [0.87-1.49],0.3385520686859958
Chapter II Neoplasms,Melanoma in situ,FAM13A,Protein FAM13A,15920,63,1.25 [0.88-1.76],0.2078577818030788
Chapter II Neoplasms,Melanoma in situ,FAM171A2,Protein FAM171A2,15952,63,0.99 [0.84-1.16],0.8910997749472928
Chapter II Neoplasms,Melanoma in situ,FAM171B,Protein FAM171B,15917,63,1.05 [0.44-2.50],0.9114854919038788
Chapter II Neoplasms,Melanoma in situ,FAM172A,Cotranscriptional regulator FAM172A,15528,62,1.32 [0.89-1.97],0.1666536376999328
Chapter II Neoplasms,Melanoma in situ,FAM20A,Pseudokinase FAM20A,15975,64,0.80 [0.34-1.90],0.6098964685087647
Chapter II Neoplasms,Melanoma in situ,FAM3B,Protein FAM3B,18305,72,0.57 [0.32-1.03],0.0607166514699923
Chapter II Neoplasms,Melanoma in situ,FAM3C,Protein FAM3C,18375,74,1.23 [0.61-2.47],0.5645520324138977
Chapter II Neoplasms,Melanoma in situ,FAM3D,Protein FAM3D,15920,63,1.26 [0.96-1.66],0.0954411259130212
Chapter II Neoplasms,Melanoma in situ,FAP,Prolyl endopeptidase FAP,18626,75,0.52 [0.25-1.11],0.0905203305601385
Chapter II Neoplasms,Melanoma in situ,FARSA,Phenylalanine--tRNA ligase alpha subunit,15567,63,1.03 [0.73-1.45],0.870724480641861
Chapter II Neoplasms,Melanoma in situ,FAS,Tumor necrosis factor receptor superfamily member 6,18566,75,0.87 [0.45-1.69],0.684382697314454
Chapter II Neoplasms,Melanoma in situ,FASLG,Tumor necrosis factor ligand superfamily member 6,18615,74,0.98 [0.56-1.72],0.9334089480604568
Chapter II Neoplasms,Melanoma in situ,FBLN2,Fibulin-2,15983,64,1.01 [0.46-2.21],0.9844807799156584
Chapter II Neoplasms,Melanoma in situ,FBN2,Fibrillin-2,15567,63,1.06 [0.70-1.60],0.7800838823298859
Chapter II Neoplasms,Melanoma in situ,FBP1,"Fructose-1,6-bisphosphatase 1",18395,74,1.03 [0.78-1.37],0.8354515325023378
Chapter II Neoplasms,Melanoma in situ,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,15975,64,1.05 [0.75-1.47],0.7866927844854569
Chapter II Neoplasms,Melanoma in situ,FCAR,Immunoglobulin alpha Fc receptor,18389,73,0.89 [0.58-1.37],0.5936377690717783
Chapter II Neoplasms,Melanoma in situ,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,15952,63,0.40 [0.15-1.08],0.0720807829819256
Chapter II Neoplasms,Melanoma in situ,FCER2,Low affinity immunoglobulin epsilon Fc receptor,18396,74,1.10 [0.73-1.67],0.6478578835368874
Chapter II Neoplasms,Melanoma in situ,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18339,73,0.80 [0.60-1.07],0.1318681303408549
Chapter II Neoplasms,Melanoma in situ,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,17977,71,0.82 [0.56-1.20],0.312073523205038
Chapter II Neoplasms,Melanoma in situ,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18429,74,0.96 [0.63-1.45],0.8349973834653884
Chapter II Neoplasms,Melanoma in situ,FCN1,Ficolin-1,15973,64,1.36 [0.85-2.19],0.2007712980335609
Chapter II Neoplasms,Melanoma in situ,FCN2,Ficolin-2,18337,74,1.31 [0.76-2.25],0.3256096687865252
Chapter II Neoplasms,Melanoma in situ,FCRL1,Fc receptor-like protein 1,18395,74,0.73 [0.45-1.18],0.1970031971932677
Chapter II Neoplasms,Melanoma in situ,FCRL2,Fc receptor-like protein 2,18531,74,0.94 [0.61-1.46],0.7988183589120333
Chapter II Neoplasms,Melanoma in situ,FCRL3,Fc receptor-like protein 3,18088,71,0.77 [0.51-1.14],0.1921115770611423
Chapter II Neoplasms,Melanoma in situ,FCRL5,Fc receptor-like protein 5,18396,74,0.83 [0.58-1.18],0.2979948044499217
Chapter II Neoplasms,Melanoma in situ,FCRL6,Fc receptor-like protein 6,18389,73,1.34 [0.98-1.82],0.0647836814957837
Chapter II Neoplasms,Melanoma in situ,FCRLB,Fc receptor-like B,17977,71,0.81 [0.55-1.19],0.2773209666089579
Chapter II Neoplasms,Melanoma in situ,FDX1,"Adrenodoxin, mitochondrial",15452,62,0.65 [0.40-1.07],0.0881817937197748
Chapter II Neoplasms,Melanoma in situ,FDX2,"Ferredoxin-2, mitochondrial",15452,62,0.69 [0.42-1.13],0.1361620647385104
Chapter II Neoplasms,Melanoma in situ,FEN1,Flap endonuclease 1,17977,71,0.89 [0.62-1.27],0.5268460684530151
Chapter II Neoplasms,Melanoma in situ,FES,Tyrosine-protein kinase Fes/Fps,17977,71,0.76 [0.47-1.23],0.2623886747511228
Chapter II Neoplasms,Melanoma in situ,FETUB,Fetuin-B,18463,74,1.31 [0.67-2.56],0.4275279467407216
Chapter II Neoplasms,Melanoma in situ,FGA,Fibrinogen alpha chain,15632,62,1.29 [0.58-2.85],0.5328732340911353
Chapter II Neoplasms,Melanoma in situ,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",15952,63,0.96 [0.71-1.30],0.7761563544364211
Chapter II Neoplasms,Melanoma in situ,FGF12,Fibroblast growth factor 12,15491,59,1.31 [0.95-1.82],0.1038564421050529
Chapter II Neoplasms,Melanoma in situ,FGF16,Fibroblast growth factor 16,15491,59,1.32 [0.83-2.10],0.2418820838706696
Chapter II Neoplasms,Melanoma in situ,FGF19,Fibroblast growth factor 19,18455,74,0.97 [0.75-1.26],0.8238601803707444
Chapter II Neoplasms,Melanoma in situ,FGF2,Fibroblast growth factor 2,18389,73,1.09 [0.81-1.47],0.5669268472934501
Chapter II Neoplasms,Melanoma in situ,FGF20,Fibroblast growth factor 20,15491,59,1.12 [0.66-1.91],0.678678102159696
Chapter II Neoplasms,Melanoma in situ,FGF21,Fibroblast growth factor 21,18546,74,0.96 [0.80-1.15],0.6390493726157874
Chapter II Neoplasms,Melanoma in situ,FGF23,Fibroblast growth factor 23,18539,74,1.05 [0.70-1.57],0.807085854257235
Chapter II Neoplasms,Melanoma in situ,FGF3,Fibroblast growth factor 3,15491,59,0.90 [0.37-2.14],0.8029601191168214
Chapter II Neoplasms,Melanoma in situ,FGF5,Fibroblast growth factor 5,18088,71,0.61 [0.32-1.16],0.1327924215461579
Chapter II Neoplasms,Melanoma in situ,FGF6,Fibroblast growth factor 6,15491,59,1.14 [0.63-2.06],0.6757020774116949
Chapter II Neoplasms,Melanoma in situ,FGF7,Fibroblast growth factor 7,15421,61,0.87 [0.59-1.26],0.4511535757796934
Chapter II Neoplasms,Melanoma in situ,FGF9,Fibroblast growth factor 9,15393,60,0.55 [0.31-0.97],0.0402511835994194
Chapter II Neoplasms,Melanoma in situ,FGFBP1,Fibroblast growth factor-binding protein 1,18439,74,1.06 [0.56-1.98],0.8641339556749374
Chapter II Neoplasms,Melanoma in situ,FGFBP2,Fibroblast growth factor-binding protein 2,15983,64,0.83 [0.51-1.33],0.4362099322667958
Chapter II Neoplasms,Melanoma in situ,FGFBP3,Fibroblast growth factor-binding protein 3,15944,63,1.33 [0.70-2.54],0.3855539357729473
Chapter II Neoplasms,Melanoma in situ,FGFR2,Fibroblast growth factor receptor 2,18439,74,0.68 [0.26-1.78],0.429461453966158
Chapter II Neoplasms,Melanoma in situ,FGFR4,Fibroblast growth factor receptor 4,15623,63,1.19 [0.74-1.91],0.4622448960246722
Chapter II Neoplasms,Melanoma in situ,FGL1,Fibrinogen-like protein 1,15994,64,1.01 [0.69-1.46],0.9754392564359718
Chapter II Neoplasms,Melanoma in situ,FGR,Tyrosine-protein kinase Fgr,18002,70,0.91 [0.62-1.33],0.6327577187323659
Chapter II Neoplasms,Melanoma in situ,FH,"Fumarate hydratase, mitochondrial",15489,61,1.05 [0.80-1.39],0.7127790156322016
Chapter II Neoplasms,Melanoma in situ,FHIP2A,FHF complex subunit HOOK interacting protein 2A,15452,62,0.92 [0.54-1.57],0.7613060994337243
Chapter II Neoplasms,Melanoma in situ,FHIT,Bis(5'-adenosyl)-triphosphatase,18002,70,1.08 [0.80-1.46],0.597667145482744
Chapter II Neoplasms,Melanoma in situ,FIS1,Mitochondrial fission 1 protein,18363,74,1.17 [0.89-1.52],0.255241617359097
Chapter II Neoplasms,Melanoma in situ,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,15952,63,1.15 [0.90-1.46],0.2709898184614049
Chapter II Neoplasms,Melanoma in situ,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18463,72,1.13 [0.94-1.35],0.1965197927578306
Chapter II Neoplasms,Melanoma in situ,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18242,69,1.29 [0.78-2.13],0.3223687344779423
Chapter II Neoplasms,Melanoma in situ,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18242,69,1.23 [0.97-1.54],0.0846110714716005
Chapter II Neoplasms,Melanoma in situ,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,17974,70,0.84 [0.51-1.40],0.5063864352278993
Chapter II Neoplasms,Melanoma in situ,FKBPL,FK506-binding protein-like,15920,63,1.32 [0.89-1.96],0.1741662437792637
Chapter II Neoplasms,Melanoma in situ,FLI1,Friend leukemia integration 1 transcription factor,17977,71,1.09 [0.90-1.32],0.3751842532378239
Chapter II Neoplasms,Melanoma in situ,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18242,69,0.65 [0.30-1.39],0.263755361822416
Chapter II Neoplasms,Melanoma in situ,FLT1,Vascular endothelial growth factor receptor 1,18268,72,0.43 [0.15-1.22],0.1124560689185462
Chapter II Neoplasms,Melanoma in situ,FLT3,Receptor-type tyrosine-protein kinase FLT3,17977,71,1.09 [0.55-2.15],0.8112578537159907
Chapter II Neoplasms,Melanoma in situ,FLT3LG,Fms-related tyrosine kinase 3 ligand,18615,74,0.55 [0.31-0.97],0.0402000932399866
Chapter II Neoplasms,Melanoma in situ,FLT4,Vascular endothelial growth factor receptor 3,18439,74,1.63 [0.87-3.06],0.1274976421311009
Chapter II Neoplasms,Melanoma in situ,FMNL1,Formin-like protein 1,18002,70,0.83 [0.57-1.21],0.3345666530977887
Chapter II Neoplasms,Melanoma in situ,FMR1,Synaptic functional regulator FMR1,17977,71,0.87 [0.48-1.60],0.6613017137236785
Chapter II Neoplasms,Melanoma in situ,FN1,Fibronectin,15998,64,0.53 [0.22-1.30],0.1669213594821084
Chapter II Neoplasms,Melanoma in situ,FNDC1,Fibronectin type III domain-containing protein 1,15944,63,0.74 [0.45-1.23],0.2462835591701595
Chapter II Neoplasms,Melanoma in situ,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,15917,63,1.81 [1.12-2.92],0.014999372940206
Chapter II Neoplasms,Melanoma in situ,FOLH1,Glutamate carboxypeptidase 2,15491,59,0.91 [0.69-1.19],0.4832478809029547
Chapter II Neoplasms,Melanoma in situ,FOLR1,Folate receptor alpha,18357,72,0.56 [0.27-1.18],0.1293879033560664
Chapter II Neoplasms,Melanoma in situ,FOLR2,Folate receptor beta,18561,75,1.01 [0.50-2.04],0.9793348542397315
Chapter II Neoplasms,Melanoma in situ,FOLR3,Folate receptor gamma,18383,74,1.01 [0.91-1.12],0.8780146591444999
Chapter II Neoplasms,Melanoma in situ,FOS,Proto-oncogene c-Fos,15393,60,1.45 [0.75-2.82],0.2724397655927577
Chapter II Neoplasms,Melanoma in situ,FOSB,Protein fosB,18002,70,1.39 [0.93-2.09],0.1067390791470558
Chapter II Neoplasms,Melanoma in situ,FOXJ3,Forkhead box protein J3,15491,59,0.84 [0.46-1.54],0.5769787399649347
Chapter II Neoplasms,Melanoma in situ,FOXO1,Forkhead box protein O1,18389,73,1.15 [0.90-1.46],0.2620693302297265
Chapter II Neoplasms,Melanoma in situ,FOXO3,Forkhead box protein O3,17977,71,1.07 [0.87-1.32],0.5281317853877421
Chapter II Neoplasms,Melanoma in situ,FRMD4B,FERM domain-containing protein 4B,15452,62,1.20 [0.85-1.69],0.2921018624176676
Chapter II Neoplasms,Melanoma in situ,FRMD7,FERM domain-containing protein 7,15567,63,0.91 [0.45-1.84],0.7882015935769646
Chapter II Neoplasms,Melanoma in situ,FRZB,Secreted frizzled-related protein 3,18186,69,1.78 [0.70-4.52],0.2233571795545316
Chapter II Neoplasms,Melanoma in situ,FSHB,Follitropin subunit beta,15528,62,1.09 [0.62-1.91],0.7683174827966053
Chapter II Neoplasms,Melanoma in situ,FST,Follistatin,18434,74,1.24 [0.82-1.89],0.3115360365319864
Chapter II Neoplasms,Melanoma in situ,FSTL1,Follistatin-related protein 1,15528,62,3.38 [1.29-8.85],0.0132947860375357
Chapter II Neoplasms,Melanoma in situ,FSTL3,Follistatin-related protein 3,18335,73,1.00 [0.50-1.98],0.9984652016724392
Chapter II Neoplasms,Melanoma in situ,FTCD,Formimidoyltransferase-cyclodeaminase,15905,62,0.84 [0.62-1.14],0.2726790535556861
Chapter II Neoplasms,Melanoma in situ,FUCA1,Tissue alpha-L-fucosidase,18497,74,0.93 [0.74-1.18],0.559494970267576
Chapter II Neoplasms,Melanoma in situ,FUOM,Fucose mutarotase,15623,63,0.87 [0.59-1.30],0.5007745570436637
Chapter II Neoplasms,Melanoma in situ,FURIN,Furin,18439,74,1.42 [0.75-2.69],0.2769519621439192
Chapter II Neoplasms,Melanoma in situ,FUS,RNA-binding protein FUS,17947,71,1.12 [0.66-1.90],0.6801781577744771
Chapter II Neoplasms,Melanoma in situ,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15671,62,0.74 [0.46-1.19],0.2162459346910009
Chapter II Neoplasms,Melanoma in situ,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18561,75,0.70 [0.45-1.09],0.1168712090978384
Chapter II Neoplasms,Melanoma in situ,FUT8,"Alpha-(1,6)-fucosyltransferase",18242,69,1.40 [0.99-2.00],0.0577962246921884
Chapter II Neoplasms,Melanoma in situ,FXN,"Frataxin, mitochondrial",18569,74,1.11 [0.84-1.47],0.4481479751007806
Chapter II Neoplasms,Melanoma in situ,FXYD5,FXYD domain-containing ion transport regulator 5,18088,71,1.07 [0.77-1.48],0.6929528755910956
Chapter II Neoplasms,Melanoma in situ,FYB1,FYN-binding protein 1,18358,74,1.12 [0.89-1.39],0.3369047022080974
Chapter II Neoplasms,Melanoma in situ,FZD10,Frizzled-10,15567,63,0.67 [0.39-1.16],0.1554730885072685
Chapter II Neoplasms,Melanoma in situ,FZD8,Frizzled-8,15489,61,1.01 [0.57-1.79],0.9692049471910532
Chapter II Neoplasms,Melanoma in situ,GABARAP,Gamma-aminobutyric acid receptor-associated protein,15917,63,1.32 [0.86-2.03],0.2099494330780493
Chapter II Neoplasms,Melanoma in situ,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15697,63,0.77 [0.49-1.20],0.2462177298799313
Chapter II Neoplasms,Melanoma in situ,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15489,61,1.04 [0.71-1.53],0.8337611483211976
Chapter II Neoplasms,Melanoma in situ,GAD1,Glutamate decarboxylase 1,15421,61,1.32 [0.52-3.38],0.5620650640244886
Chapter II Neoplasms,Melanoma in situ,GAD2,Glutamate decarboxylase 2,15491,59,0.61 [0.30-1.22],0.1617006718421463
Chapter II Neoplasms,Melanoma in situ,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15697,63,0.61 [0.30-1.25],0.1766548999753316
Chapter II Neoplasms,Melanoma in situ,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15528,62,1.12 [0.72-1.77],0.6109393103514116
Chapter II Neoplasms,Melanoma in situ,GAGE2A,G antigen 2A,15421,61,0.62 [0.37-1.05],0.0737074739939874
Chapter II Neoplasms,Melanoma in situ,GAL,Galanin peptides,18455,74,1.27 [0.93-1.73],0.1290532033534463
Chapter II Neoplasms,Melanoma in situ,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18305,72,0.69 [0.32-1.48],0.3415134380071699
Chapter II Neoplasms,Melanoma in situ,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18569,74,0.74 [0.35-1.60],0.4474810100302179
Chapter II Neoplasms,Melanoma in situ,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18088,71,0.99 [0.61-1.62],0.9647636742768184
Chapter II Neoplasms,Melanoma in situ,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,15975,64,0.88 [0.38-2.07],0.7701741387574927
Chapter II Neoplasms,Melanoma in situ,GALNT7,N-acetylgalactosaminyltransferase 7,18305,72,0.83 [0.30-2.26],0.7155084684712452
Chapter II Neoplasms,Melanoma in situ,GAMT,Guanidinoacetate N-methyltransferase,15452,62,0.53 [0.21-1.33],0.1747664716669142
Chapter II Neoplasms,Melanoma in situ,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15281,63,0.93 [0.43-1.99],0.84365306686263
Chapter II Neoplasms,Melanoma in situ,GART,Trifunctional purine biosynthetic protein adenosine-3,15952,63,0.80 [0.30-2.15],0.6555120181501515
Chapter II Neoplasms,Melanoma in situ,GAS2,Growth arrest-specific protein 2,15697,63,0.65 [0.36-1.17],0.1479110920307103
Chapter II Neoplasms,Melanoma in situ,GAS6,Growth arrest-specific protein 6,18506,74,0.60 [0.26-1.38],0.2304236088497085
Chapter II Neoplasms,Melanoma in situ,GASK1A,Golgi-associated kinase 1A,15452,62,1.07 [0.60-1.91],0.8142861814105721
Chapter II Neoplasms,Melanoma in situ,GAST,Gastrin,15944,63,1.02 [0.86-1.21],0.8033229854744126
Chapter II Neoplasms,Melanoma in situ,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15421,61,0.46 [0.18-1.18],0.10500263285954
Chapter II Neoplasms,Melanoma in situ,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15528,62,0.99 [0.72-1.37],0.9602223949350626
Chapter II Neoplasms,Melanoma in situ,GBA,Lysosomal acid glucosylceramidase,15567,63,1.17 [0.77-1.78],0.4613533904437724
Chapter II Neoplasms,Melanoma in situ,GBP1,Guanylate-binding protein 1,15916,63,1.08 [0.74-1.58],0.693008683925716
Chapter II Neoplasms,Melanoma in situ,GBP2,Guanylate-binding protein 2,18088,71,0.87 [0.61-1.25],0.4492050196875331
Chapter II Neoplasms,Melanoma in situ,GBP4,Guanylate-binding protein 4,18002,70,0.79 [0.49-1.26],0.3180812102259943
Chapter II Neoplasms,Melanoma in situ,GBP6,Guanylate-binding protein 6,15452,62,1.19 [0.73-1.93],0.492286363890248
Chapter II Neoplasms,Melanoma in situ,GC,Vitamin D-binding protein,15998,64,1.46 [0.59-3.63],0.4094368960865232
Chapter II Neoplasms,Melanoma in situ,GCC1,GRIP and coiled-coil domain-containing protein 1,15944,63,1.15 [0.92-1.44],0.2241614653608542
Chapter II Neoplasms,Melanoma in situ,GCG,Pro-glucagon,17977,71,0.97 [0.82-1.15],0.7555515045147623
Chapter II Neoplasms,Melanoma in situ,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15249,63,0.86 [0.50-1.47],0.5720468991142624
Chapter II Neoplasms,Melanoma in situ,GCLM,Glutamate--cysteine ligase regulatory subunit,15452,62,1.07 [0.65-1.79],0.7809168804876113
Chapter II Neoplasms,Melanoma in situ,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18305,72,2.01 [1.12-3.60],0.0188834716965013
Chapter II Neoplasms,Melanoma in situ,GDF15,Growth/differentiation factor 15,18626,75,0.90 [0.54-1.48],0.6670265732091105
Chapter II Neoplasms,Melanoma in situ,GDF2,Growth/differentiation factor 2,18395,74,0.76 [0.42-1.37],0.363135912300105
Chapter II Neoplasms,Melanoma in situ,GDNF,Glial cell line-derived neurotrophic factor,18002,70,0.81 [0.45-1.44],0.4643838146601445
Chapter II Neoplasms,Melanoma in situ,GET3,ATPase GET3,15975,64,1.06 [0.68-1.66],0.7855808484313294
Chapter II Neoplasms,Melanoma in situ,GFAP,Glial fibrillary acidic protein,17947,71,0.80 [0.51-1.26],0.3384235657269152
Chapter II Neoplasms,Melanoma in situ,GFER,FAD-linked sulfhydryl oxidase ALR,17977,71,1.14 [0.82-1.59],0.4325294263124014
Chapter II Neoplasms,Melanoma in situ,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,17977,71,1.04 [0.89-1.22],0.6094938343116483
Chapter II Neoplasms,Melanoma in situ,GFRA1,GDNF family receptor alpha-1,18546,74,0.64 [0.29-1.38],0.253990899441788
Chapter II Neoplasms,Melanoma in situ,GFRA2,GDNF family receptor alpha-2,18305,72,0.63 [0.23-1.71],0.3645756371704708
Chapter II Neoplasms,Melanoma in situ,GFRA3,GDNF family receptor alpha-3,18184,67,0.52 [0.23-1.15],0.1055161023621052
Chapter II Neoplasms,Melanoma in situ,GFRAL,GDNF family receptor alpha-like,15484,63,0.89 [0.59-1.33],0.5717451401662301
Chapter II Neoplasms,Melanoma in situ,GGA1,ADP-ribosylation factor-binding protein GGA1,18002,70,0.62 [0.40-0.96],0.0309008330408798
Chapter II Neoplasms,Melanoma in situ,GGACT,Gamma-glutamylaminecyclotransferase,15975,64,1.14 [0.82-1.60],0.4346612272945119
Chapter II Neoplasms,Melanoma in situ,GGCT,Gamma-glutamylcyclotransferase,15948,64,1.46 [0.93-2.31],0.1031600908664727
Chapter II Neoplasms,Melanoma in situ,GGH,Gamma-glutamyl hydrolase,18103,73,0.58 [0.31-1.08],0.085794506192085
Chapter II Neoplasms,Melanoma in situ,GGT1,Glutathione hydrolase 1 proenzyme,18365,74,0.77 [0.49-1.20],0.2434856137803571
Chapter II Neoplasms,Melanoma in situ,GGT5,Glutathione hydrolase 5 proenzyme,18242,69,0.58 [0.23-1.51],0.268218596896169
Chapter II Neoplasms,Melanoma in situ,GH1,Somatotropin,18375,74,0.98 [0.87-1.10],0.7049688055440348
Chapter II Neoplasms,Melanoma in situ,GH2,Growth hormone variant,17977,71,1.00 [0.88-1.14],0.9661481722721378
Chapter II Neoplasms,Melanoma in situ,GHR,Growth hormone receptor,15623,63,0.74 [0.31-1.77],0.5012887064035071
Chapter II Neoplasms,Melanoma in situ,GHRHR,Growth hormone-releasing hormone receptor,18002,70,0.69 [0.42-1.14],0.1483852087731326
Chapter II Neoplasms,Melanoma in situ,GHRL,Appetite-regulating hormone,18395,74,0.93 [0.73-1.19],0.5855249364345584
Chapter II Neoplasms,Melanoma in situ,GID8,Glucose-induced degradation protein 8 homolog,15952,63,0.67 [0.27-1.65],0.3849667219206087
Chapter II Neoplasms,Melanoma in situ,GIGYF2,GRB10-interacting GYF protein 2,15952,63,1.07 [0.78-1.48],0.6636613513711717
Chapter II Neoplasms,Melanoma in situ,GIMAP7,GTPase IMAP family member 7,15623,63,0.45 [0.18-1.07],0.0718728581784788
Chapter II Neoplasms,Melanoma in situ,GIMAP8,GTPase IMAP family member 8,15421,61,1.38 [0.93-2.07],0.1131394640757719
Chapter II Neoplasms,Melanoma in situ,GIP,Gastric inhibitory polypeptide,15528,62,1.09 [0.71-1.68],0.6968243848771041
Chapter II Neoplasms,Melanoma in situ,GIPC2,PDZ domain-containing protein GIPC2,15944,63,0.65 [0.28-1.50],0.30904762551444
Chapter II Neoplasms,Melanoma in situ,GIPC3,PDZ domain-containing protein GIPC3,15920,63,1.08 [0.84-1.39],0.5309431234543868
Chapter II Neoplasms,Melanoma in situ,GIPR,Gastric inhibitory polypeptide receptor,15491,59,1.18 [0.72-1.94],0.5116587459479445
Chapter II Neoplasms,Melanoma in situ,GIT1,ARF GTPase-activating protein GIT1,15491,59,1.22 [0.94-1.59],0.1307315631408505
Chapter II Neoplasms,Melanoma in situ,GJA8,Gap junction alpha-8 protein,15421,61,0.69 [0.42-1.13],0.1399639531779142
Chapter II Neoplasms,Melanoma in situ,GKN1,Gastrokine-1,17662,69,0.98 [0.44-2.15],0.955799687952898
Chapter II Neoplasms,Melanoma in situ,GLA,Alpha-galactosidase A,15596,63,0.60 [0.33-1.08],0.0897579455962059
Chapter II Neoplasms,Melanoma in situ,GLB1,Beta-galactosidase,18242,69,0.88 [0.53-1.47],0.620445188790259
Chapter II Neoplasms,Melanoma in situ,GLI2,Zinc finger protein GLI2,15491,59,1.09 [0.53-2.26],0.806474763871191
Chapter II Neoplasms,Melanoma in situ,GLO1,Lactoylglutathione lyase,18071,70,1.06 [0.73-1.54],0.7502562543317003
Chapter II Neoplasms,Melanoma in situ,GLOD4,Glyoxalase domain-containing protein 4,18342,74,1.73 [0.95-3.16],0.0718497037184602
Chapter II Neoplasms,Melanoma in situ,GLP1R,Glucagon-like peptide 1 receptor,15489,61,1.08 [0.58-2.02],0.8118751230347634
Chapter II Neoplasms,Melanoma in situ,GLRX,Glutaredoxin-1,18275,74,1.15 [0.80-1.64],0.4437191788151294
Chapter II Neoplasms,Melanoma in situ,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15623,63,1.08 [0.82-1.41],0.6008111953712292
Chapter II Neoplasms,Melanoma in situ,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18002,70,1.14 [0.74-1.74],0.5553869033459891
Chapter II Neoplasms,Melanoma in situ,GLYR1,Putative oxidoreductase GLYR1,15917,63,0.88 [0.55-1.40],0.5870265602224599
Chapter II Neoplasms,Melanoma in situ,GM2A,Ganglioside GM2 activator,15597,64,0.99 [0.52-1.89],0.965551106580966
Chapter II Neoplasms,Melanoma in situ,GMFG,Glia maturation factor gamma,15975,64,1.10 [0.78-1.54],0.5915733553617789
Chapter II Neoplasms,Melanoma in situ,GMPR,GMP reductase 1,18615,74,1.31 [0.85-2.04],0.2233585282193851
Chapter II Neoplasms,Melanoma in situ,GMPR2,GMP reductase 2,15623,63,1.22 [0.84-1.75],0.2916813135206082
Chapter II Neoplasms,Melanoma in situ,GNAS,Neuroendocrine secretory protein 55,15952,63,0.79 [0.56-1.11],0.1680022326177612
Chapter II Neoplasms,Melanoma in situ,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,17977,71,1.07 [0.77-1.47],0.694513653564172
Chapter II Neoplasms,Melanoma in situ,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15567,63,0.75 [0.42-1.36],0.3458016990710125
Chapter II Neoplasms,Melanoma in situ,GNLY,Granulysin,18396,74,1.02 [0.70-1.48],0.9319754612820588
Chapter II Neoplasms,Melanoma in situ,GNPDA1,Glucosamine-6-phosphate isomerase 1,15528,62,0.70 [0.29-1.68],0.4224995175913745
Chapter II Neoplasms,Melanoma in situ,GNPDA2,Glucosamine-6-phosphate isomerase 2,15623,63,1.44 [0.75-2.77],0.2678677153720879
Chapter II Neoplasms,Melanoma in situ,GOLGA3,Golgin subfamily A member 3,15952,63,1.30 [0.97-1.74],0.0831015670136256
Chapter II Neoplasms,Melanoma in situ,GOLM2,Protein GOLM2,18561,75,1.58 [0.65-3.84],0.3097766884044532
Chapter II Neoplasms,Melanoma in situ,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18389,73,1.19 [0.96-1.46],0.1064628277036367
Chapter II Neoplasms,Melanoma in situ,GORASP2,Golgi reassembly-stacking protein 2,15920,63,1.08 [0.65-1.79],0.7651816149747257
Chapter II Neoplasms,Melanoma in situ,GOT1,"Aspartate aminotransferase, cytoplasmic",15983,64,0.74 [0.41-1.36],0.3359169763716915
Chapter II Neoplasms,Melanoma in situ,GP1BA,Platelet glycoprotein Ib alpha chain,18345,74,1.20 [0.65-2.21],0.5575367250593091
Chapter II Neoplasms,Melanoma in situ,GP1BB,Platelet glycoprotein Ib beta chain,15452,62,1.05 [0.73-1.50],0.7915936691802297
Chapter II Neoplasms,Melanoma in situ,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17840,70,0.91 [0.70-1.19],0.5037299244919229
Chapter II Neoplasms,Melanoma in situ,GP5,Platelet glycoprotein V,15623,63,1.34 [0.67-2.69],0.4099298764943673
Chapter II Neoplasms,Melanoma in situ,GP6,Platelet glycoprotein VI,18358,74,1.21 [0.95-1.53],0.1180267049363506
Chapter II Neoplasms,Melanoma in situ,GPA33,Cell surface A33 antigen,18305,72,1.06 [0.91-1.23],0.4770800535904635
Chapter II Neoplasms,Melanoma in situ,GPC1,Glypican-1,18569,74,0.43 [0.22-0.87],0.0193254464044989
Chapter II Neoplasms,Melanoma in situ,GPC5,Glypican-5,18242,69,1.09 [0.74-1.60],0.6667996015966593
Chapter II Neoplasms,Melanoma in situ,GPD1,Glycerol-3-phosphate dehydrogenase,15917,63,1.26 [0.81-1.97],0.3044722419525995
Chapter II Neoplasms,Melanoma in situ,GPHA2,Glycoprotein hormone alpha-2,15920,63,1.38 [0.89-2.13],0.1557341678932847
Chapter II Neoplasms,Melanoma in situ,GPI,Glucose-6-phosphate isomerase,15994,64,1.01 [0.61-1.69],0.9561799541851114
Chapter II Neoplasms,Melanoma in situ,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,15920,63,1.00 [0.72-1.39],0.9825719774822896
Chapter II Neoplasms,Melanoma in situ,GPKOW,G-patch domain and KOW motifs-containing protein,18002,70,0.77 [0.34-1.73],0.5240221816430856
Chapter II Neoplasms,Melanoma in situ,GPNMB,Transmembrane glycoprotein NMB,17906,72,0.66 [0.32-1.35],0.2535436385648634
Chapter II Neoplasms,Melanoma in situ,GPR101,Probable G-protein coupled receptor 101,15489,61,1.06 [0.70-1.62],0.7810602153106998
Chapter II Neoplasms,Melanoma in situ,GPR158,Probable G-protein coupled receptor 158,15952,63,1.24 [0.65-2.36],0.5235129684190701
Chapter II Neoplasms,Melanoma in situ,GPR15L,Protein GPR15L,15920,63,1.09 [0.74-1.61],0.6574953600347251
Chapter II Neoplasms,Melanoma in situ,GPR37,Prosaposin receptor GPR37,18071,70,0.82 [0.59-1.15],0.2549040855879095
Chapter II Neoplasms,Melanoma in situ,GPRC5C,G-protein coupled receptor family C group 5 member C,15917,63,0.97 [0.62-1.52],0.888163008363917
Chapter II Neoplasms,Melanoma in situ,GRAP2,GRB2-related adapter protein 2,18395,74,1.10 [0.94-1.30],0.2395089230088418
Chapter II Neoplasms,Melanoma in situ,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,15975,64,1.22 [0.83-1.78],0.3171147236318141
Chapter II Neoplasms,Melanoma in situ,GRIK2,"Glutamate receptor ionotropic, kainate 2",15952,63,0.33 [0.15-0.69],0.003671454691741
Chapter II Neoplasms,Melanoma in situ,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15489,61,1.20 [0.85-1.68],0.3049335359469793
Chapter II Neoplasms,Melanoma in situ,GRK5,G protein-coupled receptor kinase 5,18071,70,1.22 [0.86-1.75],0.2685805237629255
Chapter II Neoplasms,Melanoma in situ,GRN,Progranulin,18297,74,1.56 [0.67-3.68],0.3040650969091278
Chapter II Neoplasms,Melanoma in situ,GRP,Gastrin-releasing peptide,15528,62,0.87 [0.55-1.37],0.5456009702957807
Chapter II Neoplasms,Melanoma in situ,GRPEL1,"GrpE protein homolog 1, mitochondrial",18305,72,1.07 [0.75-1.52],0.7252082788113267
Chapter II Neoplasms,Melanoma in situ,GRSF1,G-rich sequence factor 1,15333,60,1.00 [0.74-1.34],0.974541997180278
Chapter II Neoplasms,Melanoma in situ,GSAP,Gamma-secretase-activating protein,17977,71,1.01 [0.79-1.30],0.92546039675117
Chapter II Neoplasms,Melanoma in situ,GSN,Gelsolin,15926,64,0.67 [0.19-2.38],0.534599263121417
Chapter II Neoplasms,Melanoma in situ,GSR,"Glutathione reductase, mitochondrial",15910,64,1.43 [0.48-4.24],0.5227652323388088
Chapter II Neoplasms,Melanoma in situ,GSTA1,Glutathione S-transferase A1,18366,74,1.00 [0.78-1.29],0.985187925781374
Chapter II Neoplasms,Melanoma in situ,GSTA3,Glutathione S-transferase A3,17977,71,0.90 [0.67-1.20],0.4701509733610347
Chapter II Neoplasms,Melanoma in situ,GSTM4,Glutathione S-transferase Mu 4,15452,62,0.93 [0.65-1.33],0.6944151142377613
Chapter II Neoplasms,Melanoma in situ,GSTP1,Glutathione S-transferase P,17889,70,1.14 [0.85-1.52],0.3933134735209866
Chapter II Neoplasms,Melanoma in situ,GSTT2B,Glutathione S-transferase theta-2B,15944,63,1.02 [0.92-1.13],0.6540782110204011
Chapter II Neoplasms,Melanoma in situ,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15697,63,0.61 [0.35-1.07],0.0838072938065086
Chapter II Neoplasms,Melanoma in situ,GTPBP2,GTP-binding protein 2,15567,63,1.16 [0.86-1.56],0.3297057244114453
Chapter II Neoplasms,Melanoma in situ,GUCA2A,Guanylin,18295,74,0.86 [0.46-1.59],0.6220607954804447
Chapter II Neoplasms,Melanoma in situ,GUCY2C,Heat-stable enterotoxin receptor,15697,63,0.91 [0.65-1.27],0.5707288228971843
Chapter II Neoplasms,Melanoma in situ,GUK1,Guanylate kinase,15452,62,0.47 [0.21-1.05],0.0653836339327407
Chapter II Neoplasms,Melanoma in situ,GUSB,Beta-glucuronidase,18474,74,0.92 [0.66-1.29],0.6184376309132377
Chapter II Neoplasms,Melanoma in situ,GYS1,"Glycogen [starch] synthase, muscle",18071,70,1.05 [0.83-1.32],0.6721924900480779
Chapter II Neoplasms,Melanoma in situ,GZMA,Granzyme A,18615,74,1.21 [0.67-2.20],0.5317034295645319
Chapter II Neoplasms,Melanoma in situ,GZMB,Granzyme B,18389,73,0.96 [0.69-1.33],0.8093109048349116
Chapter II Neoplasms,Melanoma in situ,GZMH,Granzyme H,18071,70,1.03 [0.78-1.35],0.8474066383934988
Chapter II Neoplasms,Melanoma in situ,H2AP,Huntingtin-interacting protein M,15421,61,0.80 [0.43-1.46],0.4624557585038014
Chapter II Neoplasms,Melanoma in situ,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15452,62,0.54 [0.29-1.01],0.051996456569417
Chapter II Neoplasms,Melanoma in situ,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18520,74,1.05 [0.79-1.41],0.7215169645017734
Chapter II Neoplasms,Melanoma in situ,HAO1,Hydroxyacid oxidase 1,18569,74,0.96 [0.81-1.14],0.638358050117644
Chapter II Neoplasms,Melanoma in situ,HARS1,"Histidine--tRNA ligase, cytoplasmic",18396,74,1.19 [0.91-1.56],0.2015727263255562
Chapter II Neoplasms,Melanoma in situ,HAVCR1,Hepatitis A virus cellular receptor 1,18543,74,1.20 [0.86-1.65],0.2796657548454625
Chapter II Neoplasms,Melanoma in situ,HAVCR2,Hepatitis A virus cellular receptor 2,18396,74,0.99 [0.54-1.79],0.9613354936858024
Chapter II Neoplasms,Melanoma in situ,HBEGF,Proheparin-binding EGF-like growth factor,18520,74,1.34 [1.01-1.78],0.0444001551858117
Chapter II Neoplasms,Melanoma in situ,HBQ1,Hemoglobin subunit theta-1,18569,74,1.08 [0.78-1.49],0.6354483378847229
Chapter II Neoplasms,Melanoma in situ,HBZ,Hemoglobin subunit zeta,15975,64,1.10 [0.88-1.36],0.4153090914497778
Chapter II Neoplasms,Melanoma in situ,HCG22,Protein PBMUCL2,15452,62,0.64 [0.33-1.26],0.1967181749614157
Chapter II Neoplasms,Melanoma in situ,HCLS1,Hematopoietic lineage cell-specific protein,18615,74,1.23 [0.85-1.80],0.2709291877769456
Chapter II Neoplasms,Melanoma in situ,HDAC8,Histone deacetylase 8,15491,59,0.78 [0.47-1.30],0.3458938771333325
Chapter II Neoplasms,Melanoma in situ,HDAC9,Histone deacetylase 9,15489,61,1.00 [0.70-1.43],0.9917951661086608
Chapter II Neoplasms,Melanoma in situ,HDDC2,5'-deoxynucleotidase HDDC2,15920,63,1.69 [1.02-2.81],0.0422064195994131
Chapter II Neoplasms,Melanoma in situ,HDGF,Hepatoma-derived growth factor,18534,74,1.22 [0.98-1.52],0.0815957338263616
Chapter II Neoplasms,Melanoma in situ,HDGFL2,Hepatoma-derived growth factor-related protein 2,15944,63,1.05 [0.73-1.53],0.7814110460816981
Chapter II Neoplasms,Melanoma in situ,HEBP1,Heme-binding protein 1,18071,70,1.12 [0.77-1.63],0.5579546751161832
Chapter II Neoplasms,Melanoma in situ,HEG1,Protein HEG homolog 1,15623,63,0.56 [0.31-1.00],0.0485664940836932
Chapter II Neoplasms,Melanoma in situ,HEPACAM2,HEPACAM family member 2,15944,63,0.60 [0.34-1.05],0.0752180689167876
Chapter II Neoplasms,Melanoma in situ,HEPH,Hephaestin,15975,64,1.14 [0.48-2.70],0.7724788329126334
Chapter II Neoplasms,Melanoma in situ,HEXIM1,Protein HEXIM1,18389,73,1.20 [0.93-1.55],0.1650460388269158
Chapter II Neoplasms,Melanoma in situ,HGF,Hepatocyte growth factor,18615,74,1.30 [0.73-2.34],0.3724457865022674
Chapter II Neoplasms,Melanoma in situ,HGFAC,Hepatocyte growth factor activator,15852,62,0.81 [0.33-2.02],0.6566452797063242
Chapter II Neoplasms,Melanoma in situ,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,17977,71,1.10 [0.84-1.44],0.4882697696580861
Chapter II Neoplasms,Melanoma in situ,HHEX,Hematopoietically-expressed homeobox protein HHEX,15944,63,1.25 [0.91-1.70],0.1629091620417558
Chapter II Neoplasms,Melanoma in situ,HIF1A,Hypoxia-inducible factor 1-alpha,15491,59,0.89 [0.57-1.41],0.6295185061556685
Chapter II Neoplasms,Melanoma in situ,HIP1,Huntingtin-interacting protein 1,15452,62,0.56 [0.23-1.34],0.193007595549579
Chapter II Neoplasms,Melanoma in situ,HIP1R,Huntingtin-interacting protein 1-related protein,15909,63,0.82 [0.45-1.51],0.5308193730288758
Chapter II Neoplasms,Melanoma in situ,HJV,Hemojuvelin,15952,63,0.85 [0.46-1.55],0.5962117283241948
Chapter II Neoplasms,Melanoma in situ,HK2,Hexokinase-2,18071,70,0.76 [0.35-1.65],0.4876794329330026
Chapter II Neoplasms,Melanoma in situ,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",15952,63,0.81 [0.39-1.68],0.5751077593179943
Chapter II Neoplasms,Melanoma in situ,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18327,73,1.03 [0.58-1.81],0.9297610989619082
Chapter II Neoplasms,Melanoma in situ,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18389,73,1.79 [0.94-3.39],0.0763084609217541
Chapter II Neoplasms,Melanoma in situ,HMBS,Porphobilinogen deaminase,18569,74,0.89 [0.54-1.47],0.6608046309522481
Chapter II Neoplasms,Melanoma in situ,HMCN2,Hemicentin-2,15592,62,0.81 [0.53-1.23],0.3165273034888567
Chapter II Neoplasms,Melanoma in situ,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15528,62,1.55 [1.00-2.41],0.0510008689671909
Chapter II Neoplasms,Melanoma in situ,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15452,62,0.71 [0.38-1.32],0.2802328631494353
Chapter II Neoplasms,Melanoma in situ,HMMR,Hyaluronan mediated motility receptor,15382,60,1.41 [0.99-1.99],0.0538354319450782
Chapter II Neoplasms,Melanoma in situ,HMOX1,Heme oxygenase 1,18197,73,1.09 [0.71-1.66],0.6948855449581074
Chapter II Neoplasms,Melanoma in situ,HMOX2,Heme oxygenase 2,18002,70,0.93 [0.58-1.51],0.7753191966789805
Chapter II Neoplasms,Melanoma in situ,HNF1A,Hepatocyte nuclear factor 1-alpha,15567,63,1.21 [0.93-1.57],0.1495586120948002
Chapter II Neoplasms,Melanoma in situ,HNMT,Histamine N-methyltransferase,18158,69,0.99 [0.62-1.56],0.9573287142518628
Chapter II Neoplasms,Melanoma in situ,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18006,70,0.98 [0.74-1.29],0.8600861382121683
Chapter II Neoplasms,Melanoma in situ,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15952,63,1.11 [0.70-1.75],0.6641775606311136
Chapter II Neoplasms,Melanoma in situ,HPCAL1,Hippocalcin-like protein 1,18615,74,1.17 [0.88-1.55],0.2796852245138383
Chapter II Neoplasms,Melanoma in situ,HPGDS,Hematopoietic prostaglandin D synthase,17977,71,0.82 [0.46-1.45],0.497351632678378
Chapter II Neoplasms,Melanoma in situ,HPSE,Heparanase,15790,64,1.21 [0.93-1.56],0.1566012606031111
Chapter II Neoplasms,Melanoma in situ,HRAS,GTPase Hras,15668,63,1.02 [0.80-1.30],0.8800304994584776
Chapter II Neoplasms,Melanoma in situ,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15528,62,0.66 [0.28-1.54],0.3319648218532882
Chapter II Neoplasms,Melanoma in situ,HRG,Histidine-rich glycoprotein,15930,64,0.73 [0.34-1.56],0.4174537686517062
Chapter II Neoplasms,Melanoma in situ,HS1BP3,HCLS1-binding protein 3,15528,62,1.25 [0.95-1.64],0.109257507933404
Chapter II Neoplasms,Melanoma in situ,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18305,72,0.81 [0.46-1.42],0.4662087860280274
Chapter II Neoplasms,Melanoma in situ,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18569,74,0.87 [0.47-1.59],0.645516492497969
Chapter II Neoplasms,Melanoma in situ,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15491,59,0.67 [0.33-1.35],0.2631832985438507
Chapter II Neoplasms,Melanoma in situ,HSBP1,Heat shock factor-binding protein 1,15528,62,1.15 [0.89-1.48],0.2817227666507499
Chapter II Neoplasms,Melanoma in situ,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18389,73,1.03 [0.61-1.74],0.909802987613172
Chapter II Neoplasms,Melanoma in situ,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,15944,63,1.02 [0.69-1.51],0.9200964379893076
Chapter II Neoplasms,Melanoma in situ,HSD17B3,Testosterone 17-beta-dehydrogenase 3,15452,62,1.11 [0.70-1.77],0.656896384648074
Chapter II Neoplasms,Melanoma in situ,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15528,62,0.71 [0.41-1.20],0.2005053501826388
Chapter II Neoplasms,Melanoma in situ,HSP90B1,Endoplasmin,17919,68,0.58 [0.35-0.95],0.030846206263088
Chapter II Neoplasms,Melanoma in situ,HSPA1A,Heat shock 70 kDa protein 1A,18421,74,1.07 [0.80-1.44],0.6273319162814716
Chapter II Neoplasms,Melanoma in situ,HSPA2,Heat shock-related 70 kDa protein 2,15917,63,1.50 [0.88-2.54],0.1341699395590904
Chapter II Neoplasms,Melanoma in situ,HSPB1,Heat shock protein beta-1,18106,74,1.05 [0.78-1.41],0.7462085889639662
Chapter II Neoplasms,Melanoma in situ,HSPB6,Heat shock protein beta-6,18569,74,0.50 [0.28-0.89],0.0185251913112688
Chapter II Neoplasms,Melanoma in situ,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18284,73,0.61 [0.26-1.39],0.2386052566247102
Chapter II Neoplasms,Melanoma in situ,HTR1A,5-hydroxytryptamine receptor 1A,15489,61,0.76 [0.49-1.19],0.2290034527354795
Chapter II Neoplasms,Melanoma in situ,HTR1B,5-hydroxytryptamine receptor 1B,15489,61,0.83 [0.46-1.50],0.5355584722737577
Chapter II Neoplasms,Melanoma in situ,HTRA2,"Serine protease HTRA2, mitochondrial",18439,74,1.19 [0.85-1.67],0.2996323885209062
Chapter II Neoplasms,Melanoma in situ,HYAL1,Hyaluronidase-1,18322,73,0.53 [0.21-1.34],0.180031929177438
Chapter II Neoplasms,Melanoma in situ,HYOU1,Hypoxia up-regulated protein 1,18626,75,2.13 [0.88-5.13],0.0931961249102197
Chapter II Neoplasms,Melanoma in situ,ICA1,Islet cell autoantigen 1,18088,71,1.24 [0.95-1.61],0.1093917123316201
Chapter II Neoplasms,Melanoma in situ,ICAM1,Intercellular adhesion molecule 1,18340,74,0.83 [0.39-1.75],0.6232343349846152
Chapter II Neoplasms,Melanoma in situ,ICAM2,Intercellular adhesion molecule 2,18626,75,1.30 [0.69-2.42],0.4150485628762895
Chapter II Neoplasms,Melanoma in situ,ICAM3,Intercellular adhesion molecule 3,18626,75,0.95 [0.43-2.11],0.9001236477661065
Chapter II Neoplasms,Melanoma in situ,ICAM4,Intercellular adhesion molecule 4,18389,73,1.22 [0.82-1.81],0.3368918587795463
Chapter II Neoplasms,Melanoma in situ,ICAM5,Intercellular adhesion molecule 5,18395,74,0.82 [0.53-1.28],0.3798154948209521
Chapter II Neoplasms,Melanoma in situ,ICOSLG,ICOS ligand,18305,72,1.16 [0.38-3.52],0.7920979439342302
Chapter II Neoplasms,Melanoma in situ,ID4,DNA-binding protein inhibitor ID-4,15697,63,1.11 [0.67-1.86],0.6820256242568177
Chapter II Neoplasms,Melanoma in situ,IDI2,Isopentenyl-diphosphate delta-isomerase 2,18002,70,0.45 [0.27-0.74],0.0015367339962539
Chapter II Neoplasms,Melanoma in situ,IDO1,"Indoleamine 2,3-dioxygenase 1",15528,62,1.03 [0.69-1.53],0.8966208813928891
Chapter II Neoplasms,Melanoma in situ,IDS,Iduronate 2-sulfatase,18615,74,3.63 [0.42-31.15],0.2390114952045423
Chapter II Neoplasms,Melanoma in situ,IDUA,Alpha-L-iduronidase,18569,74,0.78 [0.51-1.20],0.2627156080306522
Chapter II Neoplasms,Melanoma in situ,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15557,61,0.61 [0.33-1.16],0.130794399022951
Chapter II Neoplasms,Melanoma in situ,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15697,63,0.74 [0.44-1.23],0.2453098628362503
Chapter II Neoplasms,Melanoma in situ,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15697,63,1.02 [0.54-1.92],0.9587977459071528
Chapter II Neoplasms,Melanoma in situ,IFNAR1,Interferon alpha/beta receptor 1,15920,63,0.75 [0.28-1.98],0.5642523867562496
Chapter II Neoplasms,Melanoma in situ,IFNG,Interferon gamma,18088,71,1.05 [0.87-1.27],0.6315031050761412
Chapter II Neoplasms,Melanoma in situ,IFNGR1,Interferon gamma receptor 1,18455,74,0.76 [0.28-2.07],0.5870899407925492
Chapter II Neoplasms,Melanoma in situ,IFNGR2,Interferon gamma receptor 2,18242,69,1.24 [0.83-1.83],0.2914063379667795
Chapter II Neoplasms,Melanoma in situ,IFNL1,Interferon lambda-1,18002,70,1.07 [0.66-1.72],0.7912156798994436
Chapter II Neoplasms,Melanoma in situ,IFNL2,Interferon lambda-2,15489,61,1.14 [0.80-1.63],0.4585889660382657
Chapter II Neoplasms,Melanoma in situ,IFNLR1,Interferon lambda receptor 1,18389,73,1.55 [0.97-2.48],0.0649699654328342
Chapter II Neoplasms,Melanoma in situ,IFNW1,Interferon omega-1,15452,62,0.43 [0.17-1.11],0.0819598008974267
Chapter II Neoplasms,Melanoma in situ,IFT20,Intraflagellar transport protein 20 homolog,15567,63,0.82 [0.46-1.47],0.5068911474588659
Chapter II Neoplasms,Melanoma in situ,IGBP1,Immunoglobulin-binding protein 1,15952,63,1.18 [0.79-1.75],0.4201085330941246
Chapter II Neoplasms,Melanoma in situ,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15489,61,0.77 [0.41-1.44],0.4067223844324892
Chapter II Neoplasms,Melanoma in situ,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,15983,64,0.65 [0.29-1.46],0.2959371269802273
Chapter II Neoplasms,Melanoma in situ,IGF1R,Insulin-like growth factor 1 receptor,18305,72,0.42 [0.15-1.17],0.0975680742317277
Chapter II Neoplasms,Melanoma in situ,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15452,62,0.84 [0.47-1.52],0.5736550258763842
Chapter II Neoplasms,Melanoma in situ,IGF2R,Cation-independent mannose-6-phosphate receptor,18396,74,0.73 [0.31-1.73],0.479506623006079
Chapter II Neoplasms,Melanoma in situ,IGFBP1,Insulin-like growth factor-binding protein 1,18601,75,0.92 [0.78-1.09],0.3436406362891984
Chapter II Neoplasms,Melanoma in situ,IGFBP2,Insulin-like growth factor-binding protein 2,18595,74,1.04 [0.73-1.48],0.83115269943259
Chapter II Neoplasms,Melanoma in situ,IGFBP3,Insulin-like growth factor-binding protein 3,18485,74,1.37 [0.71-2.67],0.3480107803035479
Chapter II Neoplasms,Melanoma in situ,IGFBP4,Insulin-like growth factor-binding protein 4,18173,74,0.97 [0.59-1.59],0.9076073070376676
Chapter II Neoplasms,Melanoma in situ,IGFBP6,Insulin-like growth factor-binding protein 6,18337,74,0.72 [0.35-1.47],0.3663086395770746
Chapter II Neoplasms,Melanoma in situ,IGFBP7,Insulin-like growth factor-binding protein 7,18626,75,1.41 [0.79-2.53],0.242434493233364
Chapter II Neoplasms,Melanoma in situ,IGFBPL1,Insulin-like growth factor-binding protein-like 1,18395,74,1.54 [0.85-2.77],0.1549268569791846
Chapter II Neoplasms,Melanoma in situ,IGFL4,Insulin growth factor-like family member 4,15491,59,1.08 [0.79-1.48],0.6110773324075867
Chapter II Neoplasms,Melanoma in situ,IGHMBP2,DNA-binding protein SMUBP-2,15452,62,0.79 [0.49-1.28],0.3475146925177559
Chapter II Neoplasms,Melanoma in situ,IGLC2,Immunoglobulin lambda constant 2,15976,64,0.98 [0.37-2.59],0.9738903540726428
Chapter II Neoplasms,Melanoma in situ,IGLON5,IgLON family member 5,15421,61,1.05 [0.82-1.34],0.7159315574313928
Chapter II Neoplasms,Melanoma in situ,IGSF21,Immunoglobulin superfamily member 21,15528,62,0.69 [0.34-1.37],0.2866587289805667
Chapter II Neoplasms,Melanoma in situ,IGSF3,Immunoglobulin superfamily member 3,18305,72,0.79 [0.40-1.54],0.4886851205080378
Chapter II Neoplasms,Melanoma in situ,IGSF8,Immunoglobulin superfamily member 8,18395,74,1.75 [1.01-3.04],0.0469496216641642
Chapter II Neoplasms,Melanoma in situ,IGSF9,Protein turtle homolog A,15975,64,0.88 [0.66-1.18],0.4089806541520993
Chapter II Neoplasms,Melanoma in situ,IKBKG,NF-kappa-B essential modulator,18389,73,1.24 [0.99-1.56],0.0649798509842389
Chapter II Neoplasms,Melanoma in situ,IKZF2,Zinc finger protein Helios,17977,71,0.88 [0.67-1.16],0.3647523538454948
Chapter II Neoplasms,Melanoma in situ,IL10,Interleukin-10,18088,71,1.16 [0.91-1.47],0.2407230744109846
Chapter II Neoplasms,Melanoma in situ,IL10RA,Interleukin-10 receptor subunit alpha,18088,71,1.08 [0.76-1.52],0.6766739996269037
Chapter II Neoplasms,Melanoma in situ,IL10RB,Interleukin-10 receptor subunit beta,18455,74,0.52 [0.25-1.11],0.0909740747683805
Chapter II Neoplasms,Melanoma in situ,IL11,Interleukin-11,18088,71,0.99 [0.70-1.39],0.9431321951756948
Chapter II Neoplasms,Melanoma in situ,IL12A_IL12B,Interleukin-12,18305,72,1.02 [0.78-1.35],0.865238555858485
Chapter II Neoplasms,Melanoma in situ,IL12B,Interleukin-12 subunit beta,18615,74,0.99 [0.67-1.45],0.9436447439323178
Chapter II Neoplasms,Melanoma in situ,IL12RB1,Interleukin-12 receptor subunit beta-1,18088,71,1.50 [0.87-2.60],0.1468649876961563
Chapter II Neoplasms,Melanoma in situ,IL12RB2,Interleukin-12 receptor subunit beta-2,15491,59,0.76 [0.40-1.47],0.4187553451074709
Chapter II Neoplasms,Melanoma in situ,IL13,Interleukin-13,18088,71,0.97 [0.62-1.51],0.8885442520176836
Chapter II Neoplasms,Melanoma in situ,IL13RA1,Interleukin-13 receptor subunit alpha-1,18155,72,0.68 [0.29-1.58],0.3668597679895004
Chapter II Neoplasms,Melanoma in situ,IL13RA2,Interleukin-13 receptor subunit alpha-2,15489,61,0.57 [0.33-0.99],0.0460733080393296
Chapter II Neoplasms,Melanoma in situ,IL15,Interleukin-15,18389,73,1.47 [0.80-2.69],0.209661312856994
Chapter II Neoplasms,Melanoma in situ,IL15RA,Interleukin-15 receptor subunit alpha,18088,71,1.17 [0.63-2.16],0.6183566686588267
Chapter II Neoplasms,Melanoma in situ,IL16,Pro-interleukin-16,18615,74,0.98 [0.60-1.59],0.9215880270672064
Chapter II Neoplasms,Melanoma in situ,IL17A,Interleukin-17A,18048,71,0.92 [0.55-1.54],0.7486148960353127
Chapter II Neoplasms,Melanoma in situ,IL17C,Interleukin-17C,18088,71,1.38 [1.09-1.74],0.0079808934623478
Chapter II Neoplasms,Melanoma in situ,IL17D,Interleukin-17D,18088,71,1.04 [0.58-1.89],0.8853007410047165
Chapter II Neoplasms,Melanoma in situ,IL17F,Interleukin-17F,18088,71,1.21 [0.96-1.54],0.1043969509328994
Chapter II Neoplasms,Melanoma in situ,IL17RA,Interleukin-17 receptor A,18396,74,1.12 [0.70-1.79],0.6310326028620468
Chapter II Neoplasms,Melanoma in situ,IL17RB,Interleukin-17 receptor B,18166,73,0.96 [0.65-1.42],0.8458502692363052
Chapter II Neoplasms,Melanoma in situ,IL18,Interleukin-18,18302,74,1.38 [0.88-2.18],0.1602977652413352
Chapter II Neoplasms,Melanoma in situ,IL18BP,Interleukin-18-binding protein,18485,74,1.03 [0.52-2.04],0.9357007714709924
Chapter II Neoplasms,Melanoma in situ,IL18R1,Interleukin-18 receptor 1,18615,74,1.52 [0.82-2.84],0.1862537725770957
Chapter II Neoplasms,Melanoma in situ,IL18RAP,Interleukin-18 receptor accessory protein,18129,69,0.95 [0.83-1.08],0.4167012651994287
Chapter II Neoplasms,Melanoma in situ,IL19,Interleukin-19,17932,70,0.95 [0.71-1.29],0.7541677630040661
Chapter II Neoplasms,Melanoma in situ,IL1A,Interleukin-1 alpha,18088,71,0.92 [0.64-1.33],0.6688621408874825
Chapter II Neoplasms,Melanoma in situ,IL1B,Interleukin-1 beta,18002,70,1.30 [0.93-1.80],0.1191533019290016
Chapter II Neoplasms,Melanoma in situ,IL1R1,Interleukin-1 receptor type 1,18365,74,0.77 [0.31-1.90],0.5672520472183237
Chapter II Neoplasms,Melanoma in situ,IL1R2,Interleukin-1 receptor type 2,18336,74,0.52 [0.19-1.43],0.2029366235139321
Chapter II Neoplasms,Melanoma in situ,IL1RAP,Interleukin-1 receptor accessory protein,18396,74,1.23 [0.80-1.90],0.344310476976994
Chapter II Neoplasms,Melanoma in situ,IL1RL1,Interleukin-1 receptor-like 1,18566,75,0.80 [0.52-1.23],0.3025035834203435
Chapter II Neoplasms,Melanoma in situ,IL1RL2,Interleukin-1 receptor-like 2,18088,71,1.75 [0.98-3.13],0.0565711228812565
Chapter II Neoplasms,Melanoma in situ,IL1RN,Interleukin-1 receptor antagonist protein,18334,74,0.79 [0.51-1.21],0.2774188484619102
Chapter II Neoplasms,Melanoma in situ,IL2,Interleukin-2,18088,71,1.28 [0.66-2.48],0.4634596332547611
Chapter II Neoplasms,Melanoma in situ,IL20,Interleukin-20,18088,71,0.72 [0.42-1.22],0.2172637822469685
Chapter II Neoplasms,Melanoma in situ,IL20RA,Interleukin-20 receptor subunit alpha,18088,71,0.80 [0.46-1.40],0.4427707545637939
Chapter II Neoplasms,Melanoma in situ,IL20RB,Interleukin-20 receptor subunit beta,15491,59,0.81 [0.44-1.50],0.5030456878171756
Chapter II Neoplasms,Melanoma in situ,IL21R,Interleukin-21 receptor,15491,59,1.01 [0.64-1.57],0.9748159990190198
Chapter II Neoplasms,Melanoma in situ,IL22,Interleukin-22,15917,63,0.93 [0.65-1.33],0.68748843961174
Chapter II Neoplasms,Melanoma in situ,IL22RA1,Interleukin-22 receptor subunit alpha-1,18088,71,1.04 [0.66-1.64],0.8764652509292447
Chapter II Neoplasms,Melanoma in situ,IL24,Interleukin-24,18088,71,1.02 [0.67-1.56],0.917529747022106
Chapter II Neoplasms,Melanoma in situ,IL25,Interleukin-25,15362,60,1.44 [0.69-2.98],0.3312241418099337
Chapter II Neoplasms,Melanoma in situ,IL2RA,Interleukin-2 receptor subunit alpha,18280,74,1.14 [0.68-1.91],0.6067942009082747
Chapter II Neoplasms,Melanoma in situ,IL2RB,Interleukin-2 receptor subunit beta,18088,71,1.15 [0.68-1.95],0.6017722184440915
Chapter II Neoplasms,Melanoma in situ,IL2RG,Cytokine receptor common subunit gamma,15917,63,1.00 [0.50-1.99],0.995348270827124
Chapter II Neoplasms,Melanoma in situ,IL3,Interleukin-3,15421,61,0.82 [0.60-1.14],0.2447574420513129
Chapter II Neoplasms,Melanoma in situ,IL31,Interleukin-31,15491,59,1.17 [0.80-1.72],0.4249913142558117
Chapter II Neoplasms,Melanoma in situ,IL31RA,Interleukin-31 receptor subunit alpha,15434,58,0.50 [0.26-0.99],0.0461587803245308
Chapter II Neoplasms,Melanoma in situ,IL32,Interleukin-32,18389,73,0.52 [0.31-0.88],0.0137993555084281
Chapter II Neoplasms,Melanoma in situ,IL33,Interleukin-33,18088,71,0.75 [0.44-1.27],0.2830654223752562
Chapter II Neoplasms,Melanoma in situ,IL34,Interleukin-34,17972,70,0.79 [0.44-1.39],0.4101247982875815
Chapter II Neoplasms,Melanoma in situ,IL36A,Interleukin-36 alpha,15491,59,1.09 [0.72-1.64],0.6851464412597916
Chapter II Neoplasms,Melanoma in situ,IL36G,Interleukin-36 gamma,15446,59,0.93 [0.62-1.38],0.7099388163747219
Chapter II Neoplasms,Melanoma in situ,IL3RA,Interleukin-3 receptor subunit alpha,18088,71,0.99 [0.50-1.95],0.972897353239698
Chapter II Neoplasms,Melanoma in situ,IL4,Interleukin-4,18088,71,1.02 [0.81-1.29],0.8656136625988067
Chapter II Neoplasms,Melanoma in situ,IL4R,Interleukin-4 receptor subunit alpha,18389,73,0.94 [0.52-1.70],0.8406569288546801
Chapter II Neoplasms,Melanoma in situ,IL5,Interleukin-5,18088,71,1.02 [0.88-1.18],0.7864681883519106
Chapter II Neoplasms,Melanoma in situ,IL5RA,Interleukin-5 receptor subunit alpha,18389,73,1.05 [0.73-1.52],0.7895198089695753
Chapter II Neoplasms,Melanoma in situ,IL6,Interleukin-6,18305,72,0.92 [0.68-1.25],0.5902291602460261
Chapter II Neoplasms,Melanoma in situ,IL6R,Interleukin-6 receptor subunit alpha,18315,74,1.21 [0.67-2.20],0.5275355242325387
Chapter II Neoplasms,Melanoma in situ,IL6ST,Interleukin-6 receptor subunit beta,18395,74,0.48 [0.14-1.63],0.2423212156406316
Chapter II Neoplasms,Melanoma in situ,IL7,Interleukin-7,18389,73,1.20 [0.87-1.65],0.2574926728241377
Chapter II Neoplasms,Melanoma in situ,IL7R,Interleukin-7 receptor subunit alpha,18396,74,0.90 [0.61-1.32],0.5809660775093652
Chapter II Neoplasms,Melanoma in situ,IL9,Interleukin-9,15697,63,0.75 [0.43-1.30],0.3011120545415804
Chapter II Neoplasms,Melanoma in situ,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,17970,69,1.14 [0.80-1.62],0.4617642139636185
Chapter II Neoplasms,Melanoma in situ,IMMT,MICOS complex subunit MIC60,15917,63,0.76 [0.42-1.40],0.3797504532404163
Chapter II Neoplasms,Melanoma in situ,IMPA1,Inositol monophosphatase 1,18242,69,1.20 [0.85-1.70],0.2927234926740798
Chapter II Neoplasms,Melanoma in situ,IMPACT,Protein IMPACT,15944,63,1.30 [0.84-2.02],0.2447324021925346
Chapter II Neoplasms,Melanoma in situ,IMPG1,Interphotoreceptor matrix proteoglycan 1,15489,61,0.41 [0.16-1.09],0.0738357999302864
Chapter II Neoplasms,Melanoma in situ,ING1,Inhibitor of growth protein 1,17974,70,1.04 [0.67-1.60],0.86701429448369
Chapter II Neoplasms,Melanoma in situ,INHBB,Inhibin beta B chain,15623,63,0.97 [0.61-1.55],0.8996010405192029
Chapter II Neoplasms,Melanoma in situ,INHBC,Inhibin beta C chain,18396,74,1.41 [0.83-2.42],0.2067239889858589
Chapter II Neoplasms,Melanoma in situ,INPP1,Inositol polyphosphate 1-phosphatase,18305,72,1.43 [0.99-2.06],0.0540324372453205
Chapter II Neoplasms,Melanoma in situ,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15528,62,1.52 [1.01-2.30],0.046167060501718
Chapter II Neoplasms,Melanoma in situ,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",15952,63,1.13 [0.66-1.92],0.6545470278644917
Chapter II Neoplasms,Melanoma in situ,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18305,72,1.14 [0.92-1.41],0.2331937051182599
Chapter II Neoplasms,Melanoma in situ,INSL3,Insulin-like 3,15944,63,1.02 [0.79-1.33],0.8655978137306705
Chapter II Neoplasms,Melanoma in situ,INSL4,Early placenta insulin-like peptide,15917,63,1.39 [0.97-1.99],0.0753357140554364
Chapter II Neoplasms,Melanoma in situ,INSL5,Insulin-like peptide INSL5,15920,63,0.90 [0.70-1.17],0.4320308823199283
Chapter II Neoplasms,Melanoma in situ,INSR,Insulin receptor,15491,59,1.53 [0.35-6.76],0.5747461360950391
Chapter II Neoplasms,Melanoma in situ,IPCEF1,Interactor protein for cytohesin exchange factors 1,18208,69,1.20 [0.94-1.52],0.1356438691293816
Chapter II Neoplasms,Melanoma in situ,IQGAP2,Ras GTPase-activating-like protein IQGAP2,18305,72,0.88 [0.59-1.32],0.5450926493319661
Chapter II Neoplasms,Melanoma in situ,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18071,70,1.09 [0.86-1.37],0.4819203977746137
Chapter II Neoplasms,Melanoma in situ,IRAK1,Interleukin-1 receptor-associated kinase 1,18088,71,1.21 [0.89-1.63],0.2174312597875389
Chapter II Neoplasms,Melanoma in situ,IRAK4,Interleukin-1 receptor-associated kinase 4,18389,73,1.17 [0.95-1.44],0.1336418244075469
Chapter II Neoplasms,Melanoma in situ,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17728,70,0.73 [0.42-1.29],0.2821613348335406
Chapter II Neoplasms,Melanoma in situ,ISM1,Isthmin-1,18389,73,1.02 [0.59-1.75],0.9503755243547074
Chapter II Neoplasms,Melanoma in situ,ISM2,Isthmin-2,15983,64,0.83 [0.46-1.49],0.5264355404595891
Chapter II Neoplasms,Melanoma in situ,IST1,IST1 homolog,15793,62,1.12 [0.87-1.45],0.3656029930290921
Chapter II Neoplasms,Melanoma in situ,ITGA11,Integrin alpha-11,18389,73,0.61 [0.33-1.14],0.1198311915232408
Chapter II Neoplasms,Melanoma in situ,ITGA2,Integrin alpha-2,15623,63,0.51 [0.25-1.03],0.0591995139359163
Chapter II Neoplasms,Melanoma in situ,ITGA5,Integrin alpha-5,18396,74,0.91 [0.39-2.13],0.8230915459719254
Chapter II Neoplasms,Melanoma in situ,ITGA6,Integrin alpha-6,18389,73,1.06 [0.72-1.58],0.7628192541691716
Chapter II Neoplasms,Melanoma in situ,ITGAL,Integrin alpha-L,15491,59,0.96 [0.54-1.70],0.8925694645896578
Chapter II Neoplasms,Melanoma in situ,ITGAM,Integrin alpha-M,18396,74,0.60 [0.31-1.18],0.1415106390415143
Chapter II Neoplasms,Melanoma in situ,ITGAV,Integrin alpha-V,18569,74,0.54 [0.16-1.84],0.3243172466803791
Chapter II Neoplasms,Melanoma in situ,ITGAX,Integrin alpha-X,15697,63,0.93 [0.58-1.51],0.7764221796443285
Chapter II Neoplasms,Melanoma in situ,ITGB1,Integrin beta-1,18400,74,0.49 [0.17-1.36],0.1714993143853876
Chapter II Neoplasms,Melanoma in situ,ITGB1BP1,Integrin beta-1-binding protein 1,17977,71,0.58 [0.34-0.97],0.0394026141902673
Chapter II Neoplasms,Melanoma in situ,ITGB1BP2,Integrin beta-1-binding protein 2,18071,70,1.06 [0.87-1.28],0.5642779139433498
Chapter II Neoplasms,Melanoma in situ,ITGB2,Integrin beta-2,18307,73,0.61 [0.28-1.33],0.2143996185094787
Chapter II Neoplasms,Melanoma in situ,ITGB5,Integrin beta-5,18439,74,1.19 [0.70-2.04],0.5162078828210745
Chapter II Neoplasms,Melanoma in situ,ITGB6,Integrin beta-6,18088,71,0.65 [0.33-1.30],0.2266793186229264
Chapter II Neoplasms,Melanoma in situ,ITGB7,Integrin beta-7,18569,74,0.69 [0.43-1.11],0.1285398707631125
Chapter II Neoplasms,Melanoma in situ,ITGBL1,Integrin beta-like protein 1,15983,64,1.27 [0.69-2.34],0.4456122451152576
Chapter II Neoplasms,Melanoma in situ,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,15998,64,0.68 [0.19-2.43],0.5509505404990847
Chapter II Neoplasms,Melanoma in situ,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18485,74,1.21 [0.70-2.09],0.4865351530561203
Chapter II Neoplasms,Melanoma in situ,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,15998,64,1.03 [0.38-2.78],0.9604176123848136
Chapter II Neoplasms,Melanoma in situ,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,15917,63,1.39 [0.91-2.12],0.1224457896929808
Chapter II Neoplasms,Melanoma in situ,ITM2A,Integral membrane protein 2A,18389,73,0.81 [0.58-1.14],0.2256855614223704
Chapter II Neoplasms,Melanoma in situ,ITPA,Inosine triphosphate pyrophosphatase,15452,62,1.03 [0.71-1.49],0.8795165305319285
Chapter II Neoplasms,Melanoma in situ,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15528,62,1.35 [1.02-1.78],0.0342442176743384
Chapter II Neoplasms,Melanoma in situ,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15489,61,0.77 [0.41-1.45],0.426757628565878
Chapter II Neoplasms,Melanoma in situ,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18002,70,1.00 [0.66-1.53],0.9901144255040322
Chapter II Neoplasms,Melanoma in situ,IZUMO1,Izumo sperm-egg fusion protein 1,15421,61,0.83 [0.46-1.49],0.5245847673147916
Chapter II Neoplasms,Melanoma in situ,JAM2,Junctional adhesion molecule B,18561,75,0.68 [0.30-1.52],0.3435371994977021
Chapter II Neoplasms,Melanoma in situ,JAM3,Junctional adhesion molecule C,15623,63,1.07 [0.66-1.73],0.7744729299739016
Chapter II Neoplasms,Melanoma in situ,JCHAIN,Immunoglobulin J chain,18088,71,1.24 [0.89-1.74],0.2061106876637679
Chapter II Neoplasms,Melanoma in situ,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15421,61,0.79 [0.49-1.28],0.3357221378125079
Chapter II Neoplasms,Melanoma in situ,JPT2,Jupiter microtubule associated homolog 2,15920,63,1.20 [0.90-1.59],0.2148367223415134
Chapter II Neoplasms,Melanoma in situ,JUN,Transcription factor AP-1,18088,71,0.64 [0.37-1.13],0.1249158693015111
Chapter II Neoplasms,Melanoma in situ,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18305,72,1.52 [0.93-2.48],0.0956454207310196
Chapter II Neoplasms,Melanoma in situ,KAZN,Kazrin,15920,63,1.25 [0.99-1.58],0.0628872783656348
Chapter II Neoplasms,Melanoma in situ,KCNC4,Potassium voltage-gated channel subfamily C member 4,15489,61,0.68 [0.37-1.23],0.1979851341807537
Chapter II Neoplasms,Melanoma in situ,KCNH2,Potassium voltage-gated channel subfamily H member 2,15567,63,1.04 [0.77-1.41],0.7895296519210515
Chapter II Neoplasms,Melanoma in situ,KCNIP4,Kv channel-interacting protein 4,18002,70,1.49 [1.16-1.92],0.0016827404844655
Chapter II Neoplasms,Melanoma in situ,KCTD5,BTB/POZ domain-containing protein KCTD5,15629,62,0.97 [0.56-1.68],0.9110752236624224
Chapter II Neoplasms,Melanoma in situ,KDM3A,Lysine-specific demethylase 3A,15491,59,0.99 [0.75-1.31],0.949296818754725
Chapter II Neoplasms,Melanoma in situ,KDR,Vascular endothelial growth factor receptor 2,18439,74,1.57 [0.69-3.57],0.2802594181154895
Chapter II Neoplasms,Melanoma in situ,KEL,Kell blood group glycoprotein,18002,70,0.43 [0.24-0.76],0.0037881436249463
Chapter II Neoplasms,Melanoma in situ,KHDC3L,KH domain-containing protein 3,15421,61,0.90 [0.60-1.36],0.6312635588558382
Chapter II Neoplasms,Melanoma in situ,KHK,Ketohexokinase,15528,62,1.22 [0.82-1.81],0.3305886822232668
Chapter II Neoplasms,Melanoma in situ,KIAA0319,Dyslexia-associated protein KIAA0319,15944,63,0.58 [0.25-1.35],0.2032107336349871
Chapter II Neoplasms,Melanoma in situ,KIAA1549,UPF0606 protein KIAA1549,15697,63,1.19 [0.86-1.66],0.2871057209869293
Chapter II Neoplasms,Melanoma in situ,KIAA1549L,UPF0606 protein KIAA1549L,15697,63,0.52 [0.20-1.32],0.167566173592638
Chapter II Neoplasms,Melanoma in situ,KIAA2013,Uncharacterized protein KIAA2013,15917,63,0.92 [0.57-1.49],0.7370261435662696
Chapter II Neoplasms,Melanoma in situ,KIF1C,Kinesin-like protein KIF1C,15452,62,1.04 [0.49-2.17],0.9234823638681686
Chapter II Neoplasms,Melanoma in situ,KIF20B,Kinesin-like protein KIF20B,15489,61,0.92 [0.65-1.31],0.654247183049047
Chapter II Neoplasms,Melanoma in situ,KIF22,Kinesin-like protein KIF22,15452,62,1.08 [0.88-1.32],0.4566237534306401
Chapter II Neoplasms,Melanoma in situ,KIFBP,KIF-binding protein,18305,72,1.06 [0.82-1.37],0.6453860148143654
Chapter II Neoplasms,Melanoma in situ,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,15917,63,1.06 [0.81-1.38],0.6838438309899124
Chapter II Neoplasms,Melanoma in situ,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,17977,71,1.07 [0.82-1.40],0.6117948924056769
Chapter II Neoplasms,Melanoma in situ,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,15920,63,0.90 [0.78-1.05],0.1698990631194653
Chapter II Neoplasms,Melanoma in situ,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,17977,71,0.78 [0.66-0.93],0.0055569931762592
Chapter II Neoplasms,Melanoma in situ,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15421,61,1.08 [0.84-1.40],0.5404266266982689
Chapter II Neoplasms,Melanoma in situ,KIRREL1,Kin of IRRE-like protein 1,15489,61,0.90 [0.55-1.47],0.6743947637015868
Chapter II Neoplasms,Melanoma in situ,KIRREL2,Kin of IRRE-like protein 2,18002,70,0.85 [0.49-1.46],0.5458783652503216
Chapter II Neoplasms,Melanoma in situ,KIT,Mast/stem cell growth factor receptor Kit,18463,74,0.92 [0.46-1.86],0.8190731584417298
Chapter II Neoplasms,Melanoma in situ,KITLG,Kit ligand,18395,74,0.68 [0.39-1.18],0.1676425962643927
Chapter II Neoplasms,Melanoma in situ,KLB,Beta-klotho,18002,70,1.12 [0.84-1.49],0.4374129240034838
Chapter II Neoplasms,Melanoma in situ,KLF4,Krueppel-like factor 4,15489,61,0.87 [0.46-1.61],0.6490913335338091
Chapter II Neoplasms,Melanoma in situ,KLHL41,Kelch-like protein 41,15952,63,0.73 [0.42-1.27],0.2669563198487287
Chapter II Neoplasms,Melanoma in situ,KLK1,Kallikrein-1,18222,72,0.77 [0.64-0.93],0.0066103421192387
Chapter II Neoplasms,Melanoma in situ,KLK10,Kallikrein-10,18386,74,0.99 [0.60-1.65],0.9703180454539776
Chapter II Neoplasms,Melanoma in situ,KLK11,Kallikrein-11,18255,74,0.88 [0.45-1.73],0.7046727523142642
Chapter II Neoplasms,Melanoma in situ,KLK12,Kallikrein-12,17977,71,0.99 [0.84-1.16],0.8843678152271843
Chapter II Neoplasms,Melanoma in situ,KLK13,Kallikrein-13,17967,69,1.14 [0.70-1.83],0.5984658015421993
Chapter II Neoplasms,Melanoma in situ,KLK14,Kallikrein-14,18569,74,0.77 [0.49-1.21],0.2526790689828655
Chapter II Neoplasms,Melanoma in situ,KLK15,Kallikrein-15,15886,63,0.85 [0.54-1.34],0.4905442773735075
Chapter II Neoplasms,Melanoma in situ,KLK3,Prostate-specific antigen,15983,64,1.01 [0.82-1.25],0.94050772682838
Chapter II Neoplasms,Melanoma in situ,KLK4,Kallikrein-4,18569,74,1.08 [0.78-1.49],0.6562613372837947
Chapter II Neoplasms,Melanoma in situ,KLK6,Kallikrein-6,18402,74,1.21 [0.62-2.37],0.5725686560637433
Chapter II Neoplasms,Melanoma in situ,KLK7,Kallikrein-7,15243,63,0.69 [0.36-1.33],0.2654614443576104
Chapter II Neoplasms,Melanoma in situ,KLK8,Kallikrein-8,17773,73,1.05 [0.59-1.87],0.8807641794299116
Chapter II Neoplasms,Melanoma in situ,KLKB1,Plasma kallikrein,15683,63,1.43 [0.52-3.93],0.4896568127206936
Chapter II Neoplasms,Melanoma in situ,KLRB1,Killer cell lectin-like receptor subfamily B member 1,18615,74,1.44 [0.85-2.43],0.176682376333094
Chapter II Neoplasms,Melanoma in situ,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15489,61,0.64 [0.37-1.11],0.112573458966706
Chapter II Neoplasms,Melanoma in situ,KLRD1,Natural killer cells antigen CD94,18615,74,1.64 [1.07-2.52],0.0237166363032641
Chapter II Neoplasms,Melanoma in situ,KLRF1,Killer cell lectin-like receptor subfamily F member 1,15491,59,0.71 [0.36-1.42],0.332198589262986
Chapter II Neoplasms,Melanoma in situ,KLRK1,NKG2-D type II integral membrane protein,15944,63,0.98 [0.59-1.63],0.9329806899053116
Chapter II Neoplasms,Melanoma in situ,KRT14,"Keratin, type I cytoskeletal 14",17449,67,1.22 [0.64-2.35],0.5407387665513084
Chapter II Neoplasms,Melanoma in situ,KRT17,"Keratin, type I cytoskeletal 17",15452,62,0.73 [0.37-1.43],0.3540737975333795
Chapter II Neoplasms,Melanoma in situ,KRT18,"Keratin, type I cytoskeletal 18",18305,72,0.91 [0.70-1.19],0.5026203830918652
Chapter II Neoplasms,Melanoma in situ,KRT19,"Keratin, type I cytoskeletal 19",18358,73,0.74 [0.52-1.04],0.0793499756411703
Chapter II Neoplasms,Melanoma in situ,KRT5,"Keratin, type II cytoskeletal 5",18002,70,1.26 [0.86-1.85],0.2391870801989031
Chapter II Neoplasms,Melanoma in situ,KRT6C,"Keratin, type II cytoskeletal 6C",15452,62,0.85 [0.41-1.77],0.6737229905771063
Chapter II Neoplasms,Melanoma in situ,KRT8,"Keratin, type II cytoskeletal 8",15489,61,0.54 [0.32-0.90],0.0172335883628593
Chapter II Neoplasms,Melanoma in situ,KYAT1,Kynurenine--oxoglutarate transaminase 1,18364,74,1.14 [0.80-1.64],0.4695114639864125
Chapter II Neoplasms,Melanoma in situ,KYNU,Kynureninase,18615,74,1.28 [0.81-2.03],0.2826908767544912
Chapter II Neoplasms,Melanoma in situ,L1CAM,Neural cell adhesion molecule L1,18439,74,0.48 [0.24-0.96],0.0373352846330044
Chapter II Neoplasms,Melanoma in situ,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,15975,64,0.97 [0.74-1.28],0.8495298173896711
Chapter II Neoplasms,Melanoma in situ,LACRT,Extracellular glycoprotein lacritin,15883,63,1.41 [0.97-2.05],0.0737807324254442
Chapter II Neoplasms,Melanoma in situ,LACTB2,Endoribonuclease LACTB2,18395,74,1.15 [0.84-1.57],0.3820359758625183
Chapter II Neoplasms,Melanoma in situ,LAG3,Lymphocyte activation gene 3 protein,18305,72,1.38 [0.86-2.23],0.1828506680691057
Chapter II Neoplasms,Melanoma in situ,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18365,74,1.02 [0.58-1.81],0.9381508357243052
Chapter II Neoplasms,Melanoma in situ,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18242,69,1.06 [0.86-1.31],0.5553473981089658
Chapter II Neoplasms,Melanoma in situ,LAMA1,Laminin subunit alpha-1,15452,62,1.05 [0.66-1.66],0.8492233631383282
Chapter II Neoplasms,Melanoma in situ,LAMA4,Laminin subunit alpha-4,18455,74,1.54 [0.86-2.77],0.144796083277018
Chapter II Neoplasms,Melanoma in situ,LAMB1,Laminin subunit beta-1,15528,62,0.58 [0.26-1.26],0.1693292331097562
Chapter II Neoplasms,Melanoma in situ,LAMP1,Lysosome-associated membrane glycoprotein 1,15552,63,0.63 [0.21-1.87],0.4068162922938722
Chapter II Neoplasms,Melanoma in situ,LAMP2,Lysosome-associated membrane glycoprotein 2,17840,73,1.53 [0.55-4.27],0.4207718147782925
Chapter II Neoplasms,Melanoma in situ,LAMP3,Lysosome-associated membrane glycoprotein 3,18582,74,1.01 [0.68-1.50],0.95459668594896
Chapter II Neoplasms,Melanoma in situ,LAMTOR5,Ragulator complex protein LAMTOR5,15917,63,1.01 [0.55-1.86],0.9690165774005054
Chapter II Neoplasms,Melanoma in situ,LAP3,Cytosol aminopeptidase,18088,71,1.13 [0.73-1.75],0.5804665088142582
Chapter II Neoplasms,Melanoma in situ,LARP1,La-related protein 1,15917,63,1.18 [0.83-1.67],0.3596347195968359
Chapter II Neoplasms,Melanoma in situ,LAT,Linker for activation of T-cells family member 1,18615,74,1.29 [0.97-1.71],0.0785168716237648
Chapter II Neoplasms,Melanoma in situ,LAT2,Linker for activation of T-cells family member 2,18305,72,1.07 [0.91-1.26],0.4116484649677746
Chapter II Neoplasms,Melanoma in situ,LATS1,Serine/threonine-protein kinase LATS1,15491,59,1.12 [0.84-1.50],0.4369495228668033
Chapter II Neoplasms,Melanoma in situ,LAYN,Layilin,18214,69,0.75 [0.39-1.45],0.3930384256166879
Chapter II Neoplasms,Melanoma in situ,LBP,Lipopolysaccharide-binding protein,18485,74,0.79 [0.57-1.12],0.1838347080998681
Chapter II Neoplasms,Melanoma in situ,LBR,Delta(14)-sterol reductase LBR,18561,75,1.02 [0.76-1.36],0.9009443412671604
Chapter II Neoplasms,Melanoma in situ,LCAT,Phosphatidylcholine-sterol acyltransferase,15994,64,1.27 [0.42-3.83],0.6705542261648454
Chapter II Neoplasms,Melanoma in situ,LCN15,Lipocalin-15,15952,63,0.54 [0.32-0.90],0.0178316561108891
Chapter II Neoplasms,Melanoma in situ,LCN2,Neutrophil gelatinase-associated lipocalin,17869,70,0.92 [0.52-1.62],0.7745756883200944
Chapter II Neoplasms,Melanoma in situ,LCP1,Plastin-2,15983,64,0.70 [0.41-1.20],0.1925123191980434
Chapter II Neoplasms,Melanoma in situ,LDLR,Low-density lipoprotein receptor,18444,75,0.95 [0.63-1.43],0.7956236120222244
Chapter II Neoplasms,Melanoma in situ,LDLRAP1,Low density lipoprotein receptor adapter protein 1,15952,63,1.23 [0.97-1.58],0.0937259622143244
Chapter II Neoplasms,Melanoma in situ,LECT2,Leukocyte cell-derived chemotaxin-2,15975,64,1.05 [0.73-1.51],0.8058472639384054
Chapter II Neoplasms,Melanoma in situ,LEFTY2,Left-right determination factor 2,18546,74,0.64 [0.43-0.95],0.0257143194037379
Chapter II Neoplasms,Melanoma in situ,LEG1,Protein LEG1 homolog,15084,62,0.90 [0.62-1.30],0.5588195422946902
Chapter II Neoplasms,Melanoma in situ,LELP1,Late cornified envelope-like proline-rich protein 1,15489,61,1.03 [0.73-1.44],0.8841269295340507
Chapter II Neoplasms,Melanoma in situ,LEO1,RNA polymerase-associated protein LEO1,15952,63,0.68 [0.26-1.75],0.4252823841696859
Chapter II Neoplasms,Melanoma in situ,LEP,Leptin,18395,74,1.06 [0.79-1.43],0.697058929976614
Chapter II Neoplasms,Melanoma in situ,LEPR,Leptin receptor,18395,74,0.97 [0.50-1.87],0.9284429882662916
Chapter II Neoplasms,Melanoma in situ,LETM1,Mitochondrial proton/calcium exchanger protein,15952,63,0.88 [0.55-1.40],0.5892009083212677
Chapter II Neoplasms,Melanoma in situ,LGALS1,Galectin-1,18395,74,0.78 [0.42-1.44],0.424182008709556
Chapter II Neoplasms,Melanoma in situ,LGALS3,Galectin-3,18451,74,1.15 [0.57-2.30],0.6991431676689923
Chapter II Neoplasms,Melanoma in situ,LGALS3BP,Galectin-3-binding protein,15998,64,0.43 [0.18-1.04],0.0621943977125471
Chapter II Neoplasms,Melanoma in situ,LGALS4,Galectin-4,18365,74,0.97 [0.67-1.41],0.8707809003647279
Chapter II Neoplasms,Melanoma in situ,LGALS7_LGALS7B,Galectin-7,18365,72,0.97 [0.59-1.59],0.9133548554878096
Chapter II Neoplasms,Melanoma in situ,LGALS8,Galectin-8,18561,75,1.18 [0.85-1.65],0.3127560009635968
Chapter II Neoplasms,Melanoma in situ,LGALS9,Galectin-9,18376,74,1.00 [0.50-2.02],0.9890042753389042
Chapter II Neoplasms,Melanoma in situ,LGMN,Legumain,18455,74,1.74 [1.00-3.02],0.0489803711817529
Chapter II Neoplasms,Melanoma in situ,LHB,Lutropin subunit beta,17977,71,0.80 [0.60-1.07],0.1308597609663487
Chapter II Neoplasms,Melanoma in situ,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18392,74,1.04 [0.73-1.46],0.8442835710219037
Chapter II Neoplasms,Melanoma in situ,LIF,Leukemia inhibitory factor,18002,70,0.83 [0.53-1.32],0.4383846718196351
Chapter II Neoplasms,Melanoma in situ,LIFR,Leukemia inhibitory factor receptor,18389,73,1.03 [0.43-2.50],0.9459439017641316
Chapter II Neoplasms,Melanoma in situ,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18396,74,0.67 [0.39-1.15],0.150390809312517
Chapter II Neoplasms,Melanoma in situ,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,15983,64,1.02 [0.86-1.21],0.8157782914884172
Chapter II Neoplasms,Melanoma in situ,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15452,62,0.74 [0.42-1.31],0.3024822062687909
Chapter II Neoplasms,Melanoma in situ,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18375,74,0.69 [0.37-1.31],0.262078264180566
Chapter II Neoplasms,Melanoma in situ,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,15975,64,0.91 [0.66-1.26],0.5806112581044083
Chapter II Neoplasms,Melanoma in situ,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18626,75,0.64 [0.30-1.36],0.2447356090516257
Chapter II Neoplasms,Melanoma in situ,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18535,74,0.90 [0.50-1.62],0.7340756308541359
Chapter II Neoplasms,Melanoma in situ,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18088,71,0.89 [0.55-1.47],0.6560815789241262
Chapter II Neoplasms,Melanoma in situ,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18626,75,0.85 [0.65-1.12],0.2579169568350191
Chapter II Neoplasms,Melanoma in situ,LIPF,Gastric triacylglycerol lipase,15528,62,0.69 [0.47-1.02],0.0612658212143836
Chapter II Neoplasms,Melanoma in situ,LMNB1,Lamin-B1,15892,62,0.83 [0.55-1.26],0.3801864828320246
Chapter II Neoplasms,Melanoma in situ,LMNB2,Lamin-B2,15944,63,0.60 [0.24-1.51],0.2803093001611517
Chapter II Neoplasms,Melanoma in situ,LMOD1,Leiomodin-1,15952,63,0.78 [0.36-1.66],0.5146852501208784
Chapter II Neoplasms,Melanoma in situ,LMOD2,Leiomodin-2,15489,61,0.53 [0.32-0.88],0.0134633022720463
Chapter II Neoplasms,Melanoma in situ,LONP1,"Lon protease homolog, mitochondrial",15528,62,1.15 [0.87-1.52],0.3119373000797013
Chapter II Neoplasms,Melanoma in situ,LPA,Apolipoprotein(a),15645,63,0.97 [0.85-1.10],0.6247467690836823
Chapter II Neoplasms,Melanoma in situ,LPCAT2,Lysophosphatidylcholine acyltransferase 2,18305,72,1.01 [0.63-1.62],0.9710679904613392
Chapter II Neoplasms,Melanoma in situ,LPL,Lipoprotein lipase,18395,74,1.01 [0.66-1.56],0.9480239001602604
Chapter II Neoplasms,Melanoma in situ,LPO,Lactoperoxidase,17751,67,0.93 [0.64-1.34],0.6949388993738075
Chapter II Neoplasms,Melanoma in situ,LPP,Lipoma-preferred partner,15452,62,1.13 [0.77-1.64],0.5371841339765303
Chapter II Neoplasms,Melanoma in situ,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15452,62,1.00 [0.69-1.44],0.9978861785304024
Chapter II Neoplasms,Melanoma in situ,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15567,63,0.67 [0.34-1.32],0.2460245685904286
Chapter II Neoplasms,Melanoma in situ,LRG1,Leucine-rich alpha-2-glycoprotein,15998,64,1.14 [0.46-2.84],0.7753774185105355
Chapter II Neoplasms,Melanoma in situ,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18520,74,1.47 [0.83-2.62],0.1875379240168574
Chapter II Neoplasms,Melanoma in situ,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15443,59,0.77 [0.29-2.05],0.603027450508747
Chapter II Neoplasms,Melanoma in situ,LRP1,Prolow-density lipoprotein receptor-related protein 1,18305,72,0.68 [0.30-1.53],0.3475590216072106
Chapter II Neoplasms,Melanoma in situ,LRP11,Low-density lipoprotein receptor-related protein 11,18395,74,1.12 [0.64-1.98],0.6938450507293992
Chapter II Neoplasms,Melanoma in situ,LRP2,Low-density lipoprotein receptor-related protein 2,15567,63,0.87 [0.43-1.77],0.703737583809258
Chapter II Neoplasms,Melanoma in situ,LRP2BP,LRP2-binding protein,15567,63,0.87 [0.61-1.23],0.4219397505277095
Chapter II Neoplasms,Melanoma in situ,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18561,75,1.12 [0.80-1.56],0.5089237712832573
Chapter II Neoplasms,Melanoma in situ,LRRC25,Leucine-rich repeat-containing protein 25,18305,72,0.89 [0.51-1.55],0.6886084260645877
Chapter II Neoplasms,Melanoma in situ,LRRC37A2,Leucine-rich repeat-containing protein 37A2,15920,63,1.11 [0.64-1.91],0.7189717290630013
Chapter II Neoplasms,Melanoma in situ,LRRC38,Leucine-rich repeat-containing protein 38,15567,63,0.88 [0.52-1.49],0.6377905617795459
Chapter II Neoplasms,Melanoma in situ,LRRC59,Leucine-rich repeat-containing protein 59,15975,64,1.10 [0.67-1.78],0.7123901934712848
Chapter II Neoplasms,Melanoma in situ,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,15917,63,1.37 [0.86-2.18],0.1813591511524228
Chapter II Neoplasms,Melanoma in situ,LRRN1,Leucine-rich repeat neuronal protein 1,18088,71,0.57 [0.34-0.96],0.0351095814732465
Chapter II Neoplasms,Melanoma in situ,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15567,63,0.82 [0.43-1.56],0.546103091034744
Chapter II Neoplasms,Melanoma in situ,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,15952,63,0.58 [0.31-1.07],0.0806257757765936
Chapter II Neoplasms,Melanoma in situ,LSM1,U6 snRNA-associated Sm-like protein LSm1,17977,71,1.15 [0.81-1.63],0.4441557937653541
Chapter II Neoplasms,Melanoma in situ,LSM8,U6 snRNA-associated Sm-like protein LSm8,15697,63,1.03 [0.77-1.38],0.8296258768346804
Chapter II Neoplasms,Melanoma in situ,LSP1,Lymphocyte-specific protein 1,18389,73,0.91 [0.54-1.53],0.7185734722278119
Chapter II Neoplasms,Melanoma in situ,LTA,Lymphotoxin-alpha,18389,73,1.03 [0.60-1.76],0.9158624574845315
Chapter II Neoplasms,Melanoma in situ,LTA4H,Leukotriene A-4 hydrolase,18569,74,1.03 [0.73-1.46],0.8682156910589451
Chapter II Neoplasms,Melanoma in situ,LTB,Lymphotoxin-beta,15917,63,1.63 [1.07-2.46],0.0214757273317706
Chapter II Neoplasms,Melanoma in situ,LTBP2,Latent-transforming growth factor beta-binding protein 2,18626,75,0.91 [0.46-1.80],0.7802021544243584
Chapter II Neoplasms,Melanoma in situ,LTBP3,Latent-transforming growth factor beta-binding protein 3,17977,71,0.69 [0.44-1.09],0.1132452191584433
Chapter II Neoplasms,Melanoma in situ,LTBR,Tumor necrosis factor receptor superfamily member 3,18273,74,0.87 [0.42-1.81],0.7040431472252463
Chapter II Neoplasms,Melanoma in situ,LTO1,Protein LTO1 homolog,18088,71,0.96 [0.56-1.66],0.8844813632734759
Chapter II Neoplasms,Melanoma in situ,LUZP2,Leucine zipper protein 2,15917,63,0.85 [0.48-1.52],0.5872916500237708
Chapter II Neoplasms,Melanoma in situ,LXN,Latexin,18159,69,1.03 [0.76-1.40],0.8383331012884243
Chapter II Neoplasms,Melanoma in situ,LY6D,Lymphocyte antigen 6D,18279,73,1.06 [0.61-1.83],0.8329511011996882
Chapter II Neoplasms,Melanoma in situ,LY75,Lymphocyte antigen 75,18389,73,1.32 [0.76-2.29],0.3270611705190959
Chapter II Neoplasms,Melanoma in situ,LY9,T-lymphocyte surface antigen Ly-9,18166,72,1.85 [0.91-3.76],0.0893286218200812
Chapter II Neoplasms,Melanoma in situ,LY96,Lymphocyte antigen 96,18242,69,0.52 [0.28-0.97],0.0409610532234263
Chapter II Neoplasms,Melanoma in situ,LYAR,Cell growth-regulating nucleolar protein,17977,71,0.86 [0.55-1.34],0.5120889335062757
Chapter II Neoplasms,Melanoma in situ,LYN,Tyrosine-protein kinase Lyn,18305,72,1.12 [0.88-1.43],0.3542532586828357
Chapter II Neoplasms,Melanoma in situ,LYPD1,Ly6/PLAUR domain-containing protein 1,18002,70,0.76 [0.48-1.19],0.2226684954314574
Chapter II Neoplasms,Melanoma in situ,LYPD3,Ly6/PLAUR domain-containing protein 3,18299,74,0.79 [0.42-1.48],0.4677171806895743
Chapter II Neoplasms,Melanoma in situ,LYPD8,Ly6/PLAUR domain-containing protein 8,17977,71,1.08 [0.70-1.67],0.7290401955760137
Chapter II Neoplasms,Melanoma in situ,LYPLA2,Acyl-protein thioesterase 2,15489,61,0.81 [0.61-1.09],0.1643722247843478
Chapter II Neoplasms,Melanoma in situ,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15567,63,1.17 [0.97-1.41],0.0921922241528868
Chapter II Neoplasms,Melanoma in situ,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,15998,64,0.66 [0.19-2.28],0.5119263851937645
Chapter II Neoplasms,Melanoma in situ,LYZL2,Lysozyme-like protein 2,15421,61,1.07 [0.56-2.06],0.8341883149334968
Chapter II Neoplasms,Melanoma in situ,LZTFL1,Leucine zipper transcription factor-like protein 1,15623,63,1.19 [0.85-1.67],0.301427164717772
Chapter II Neoplasms,Melanoma in situ,M6PR,Cation-dependent mannose-6-phosphate receptor,15528,62,1.95 [1.37-2.78],0.0001940220398908
Chapter II Neoplasms,Melanoma in situ,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18185,69,0.93 [0.59-1.47],0.7656143712878538
Chapter II Neoplasms,Melanoma in situ,MAEA,E3 ubiquitin-protein transferase MAEA,17977,71,0.86 [0.48-1.54],0.6137049486996813
Chapter II Neoplasms,Melanoma in situ,MAG,Myelin-associated glycoprotein,15567,63,0.85 [0.52-1.40],0.5175515256787491
Chapter II Neoplasms,Melanoma in situ,MAGEA3,Melanoma-associated antigen 3,15697,63,0.95 [0.72-1.26],0.7213256372597674
Chapter II Neoplasms,Melanoma in situ,MAGED1,Melanoma-associated antigen D1,17977,71,1.17 [0.76-1.80],0.4722530746872058
Chapter II Neoplasms,Melanoma in situ,MAMDC2,MAM domain-containing protein 2,15975,64,1.25 [0.64-2.44],0.5088470584976497
Chapter II Neoplasms,Melanoma in situ,MAMDC4,Apical endosomal glycoprotein,15917,63,0.77 [0.49-1.21],0.2575324061806928
Chapter II Neoplasms,Melanoma in situ,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15528,62,1.02 [0.38-2.72],0.9632261804965224
Chapter II Neoplasms,Melanoma in situ,MAN2B2,Epididymis-specific alpha-mannosidase,15975,64,0.81 [0.55-1.20],0.3018493018098771
Chapter II Neoplasms,Melanoma in situ,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15421,61,1.11 [0.69-1.77],0.6657758813697436
Chapter II Neoplasms,Melanoma in situ,MANF,Mesencephalic astrocyte-derived neurotrophic factor,18455,74,1.13 [0.94-1.35],0.192721915742403
Chapter II Neoplasms,Melanoma in situ,MANSC1,MANSC domain-containing protein 1,18439,74,0.86 [0.40-1.84],0.6998390175665681
Chapter II Neoplasms,Melanoma in situ,MANSC4,MANSC domain-containing protein 4,15452,62,0.76 [0.53-1.11],0.1530240886694347
Chapter II Neoplasms,Melanoma in situ,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15489,61,0.85 [0.39-1.85],0.6866974019912124
Chapter II Neoplasms,Melanoma in situ,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15452,62,0.48 [0.24-0.97],0.0396213994637231
Chapter II Neoplasms,Melanoma in situ,MAP2,Microtubule-associated protein 2,15944,63,1.15 [0.69-1.91],0.592665841514654
Chapter II Neoplasms,Melanoma in situ,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,15920,63,1.12 [0.77-1.64],0.5562201174329262
Chapter II Neoplasms,Melanoma in situ,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18389,73,1.08 [0.88-1.34],0.4561031948462883
Chapter II Neoplasms,Melanoma in situ,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,17977,71,1.13 [0.92-1.40],0.2511657041210892
Chapter II Neoplasms,Melanoma in situ,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18214,69,1.15 [0.95-1.39],0.1561143628652248
Chapter II Neoplasms,Melanoma in situ,MAPK13,Mitogen-activated protein kinase 13,15421,61,0.43 [0.23-0.80],0.0080617836033586
Chapter II Neoplasms,Melanoma in situ,MAPK9,Mitogen-activated protein kinase 9,18389,73,1.71 [1.07-2.75],0.025242236120764
Chapter II Neoplasms,Melanoma in situ,MAPKAPK2,MAP kinase-activated protein kinase 2,15697,63,0.98 [0.71-1.37],0.9236234202508264
Chapter II Neoplasms,Melanoma in situ,MAPRE3,Microtubule-associated protein RP/EB family member 3,15421,61,0.95 [0.80-1.14],0.5958678956306598
Chapter II Neoplasms,Melanoma in situ,MAPT,Microtubule-associated protein tau,18002,70,0.87 [0.59-1.28],0.4776526740349375
Chapter II Neoplasms,Melanoma in situ,MARCO,Macrophage receptor MARCO,18395,74,0.70 [0.31-1.59],0.398709642248618
Chapter II Neoplasms,Melanoma in situ,MARS1,"Methionine--tRNA ligase, cytoplasmic",15596,63,1.09 [0.82-1.46],0.5472851056223635
Chapter II Neoplasms,Melanoma in situ,MASP1,Mannan-binding lectin serine protease 1,18214,69,1.10 [0.43-2.80],0.8352352912132455
Chapter II Neoplasms,Melanoma in situ,MATN2,Matrilin-2,18395,74,0.96 [0.47-1.97],0.9085626838544278
Chapter II Neoplasms,Melanoma in situ,MATN3,Matrilin-3,18208,69,0.78 [0.40-1.50],0.454482548975052
Chapter II Neoplasms,Melanoma in situ,MAVS,Mitochondrial antiviral-signaling protein,17977,71,1.12 [0.89-1.42],0.3206046454140315
Chapter II Neoplasms,Melanoma in situ,MAX,Protein max,18002,70,1.21 [0.99-1.47],0.0637145163110628
Chapter II Neoplasms,Melanoma in situ,MB,Myoglobin,18626,75,0.69 [0.46-1.04],0.0730390470614262
Chapter II Neoplasms,Melanoma in situ,MBL2,Mannose-binding protein C,15783,63,0.88 [0.71-1.09],0.2505881159018124
Chapter II Neoplasms,Melanoma in situ,MCAM,Cell surface glycoprotein MUC18,18485,74,0.70 [0.36-1.35],0.2884013472376291
Chapter II Neoplasms,Melanoma in situ,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",15952,63,1.37 [0.87-2.17],0.1780843092994313
Chapter II Neoplasms,Melanoma in situ,MCEMP1,Mast cell-expressed membrane protein 1,15491,59,1.15 [0.88-1.51],0.3109026129675755
Chapter II Neoplasms,Melanoma in situ,MCFD2,Multiple coagulation factor deficiency protein 2,18298,72,1.61 [1.02-2.54],0.0422165776792914
Chapter II Neoplasms,Melanoma in situ,MCTS1,Malignant T-cell-amplified sequence 1,15920,63,1.01 [0.40-2.50],0.9909147065444864
Chapter II Neoplasms,Melanoma in situ,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18242,69,0.96 [0.71-1.31],0.8199112252959572
Chapter II Neoplasms,Melanoma in situ,MDH1,"Malate dehydrogenase, cytoplasmic",15912,64,1.34 [0.76-2.38],0.3106826986962715
Chapter II Neoplasms,Melanoma in situ,MDK,Midkine,18376,73,1.46 [1.04-2.04],0.0279880270400985
Chapter II Neoplasms,Melanoma in situ,MDM1,Nuclear protein MDM1,15567,63,0.54 [0.24-1.24],0.1476686366706579
Chapter II Neoplasms,Melanoma in situ,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15528,62,1.13 [0.87-1.47],0.3674808905695131
Chapter II Neoplasms,Melanoma in situ,MED18,Mediator of RNA polymerase II transcription subunit 18,17977,71,1.17 [0.88-1.54],0.2723926311931833
Chapter II Neoplasms,Melanoma in situ,MED21,Mediator of RNA polymerase II transcription subunit 21,15452,62,0.97 [0.58-1.61],0.9004081538532008
Chapter II Neoplasms,Melanoma in situ,MEGF10,Multiple epidermal growth factor-like domains protein 10,18365,74,0.75 [0.44-1.27],0.2834486588844734
Chapter II Neoplasms,Melanoma in situ,MEGF11,Multiple epidermal growth factor-like domains protein 11,15452,62,0.67 [0.27-1.64],0.3773408183908808
Chapter II Neoplasms,Melanoma in situ,MEGF9,Multiple epidermal growth factor-like domains protein 9,18566,75,1.47 [0.52-4.21],0.4680001912546712
Chapter II Neoplasms,Melanoma in situ,MELTF,Melanotransferrin,15975,64,1.07 [0.48-2.35],0.8727751615493837
Chapter II Neoplasms,Melanoma in situ,MENT,Protein MENT,15623,63,0.74 [0.26-2.07],0.5643922218755839
Chapter II Neoplasms,Melanoma in situ,MEP1A,Meprin A subunit alpha,15920,63,1.07 [0.77-1.49],0.6735007477016894
Chapter II Neoplasms,Melanoma in situ,MEP1B,Meprin A subunit beta,18395,74,0.99 [0.83-1.19],0.9524125905209332
Chapter II Neoplasms,Melanoma in situ,MEPE,Matrix extracellular phosphoglycoprotein,18365,74,1.31 [0.53-3.23],0.5622768936882856
Chapter II Neoplasms,Melanoma in situ,MERTK,Tyrosine-protein kinase Mer,18615,74,0.64 [0.28-1.48],0.2982592477144976
Chapter II Neoplasms,Melanoma in situ,MESD,LRP chaperone MESD,18396,74,1.11 [0.94-1.31],0.2209401647213866
Chapter II Neoplasms,Melanoma in situ,MET,Hepatocyte growth factor receptor,18443,75,1.40 [0.49-4.02],0.5324131555289928
Chapter II Neoplasms,Melanoma in situ,METAP1,Methionine aminopeptidase 1,18002,70,0.65 [0.30-1.40],0.2741240332383035
Chapter II Neoplasms,Melanoma in situ,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18389,73,1.13 [0.88-1.44],0.3483102940470202
Chapter II Neoplasms,Melanoma in situ,METAP2,Methionine aminopeptidase 2,18546,74,1.24 [0.85-1.80],0.2667111760456672
Chapter II Neoplasms,Melanoma in situ,MFAP3,Microfibril-associated glycoprotein 3,18071,70,0.95 [0.60-1.51],0.8441607469510771
Chapter II Neoplasms,Melanoma in situ,MFAP3L,Microfibrillar-associated protein 3-like,15567,63,0.97 [0.67-1.43],0.8948151508625967
Chapter II Neoplasms,Melanoma in situ,MFAP4,Microfibril-associated glycoprotein 4,15623,63,0.98 [0.46-2.10],0.9624302214281188
Chapter II Neoplasms,Melanoma in situ,MFAP5,Microfibrillar-associated protein 5,18626,75,1.03 [0.62-1.72],0.90255960492077
Chapter II Neoplasms,Melanoma in situ,MFGE8,Lactadherin,18396,74,0.86 [0.54-1.38],0.5389747042849262
Chapter II Neoplasms,Melanoma in situ,MGLL,Monoglyceride lipase,18434,74,1.15 [0.91-1.47],0.2420303637848579
Chapter II Neoplasms,Melanoma in situ,MGMT,Methylated-DNA--protein-cysteine methyltransferase,18389,73,1.11 [0.93-1.32],0.2548849708185344
Chapter II Neoplasms,Melanoma in situ,MIA,Melanoma-derived growth regulatory protein,18439,74,0.76 [0.42-1.36],0.358439505525746
Chapter II Neoplasms,Melanoma in situ,MICALL2,MICAL-like protein 2,15567,63,1.21 [0.88-1.67],0.2405418607990991
Chapter II Neoplasms,Melanoma in situ,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18389,73,1.19 [0.99-1.44],0.067730297453608
Chapter II Neoplasms,Melanoma in situ,MIF,Macrophage migration inhibitory factor,18361,74,1.24 [0.91-1.69],0.177783760888535
Chapter II Neoplasms,Melanoma in situ,MILR1,Allergin-1,18088,71,0.74 [0.48-1.13],0.1649489353657692
Chapter II Neoplasms,Melanoma in situ,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,15917,63,1.07 [0.85-1.34],0.5772435861393146
Chapter II Neoplasms,Melanoma in situ,MINK1,Misshapen-like kinase 1,15944,63,1.12 [0.86-1.45],0.4171429338493779
Chapter II Neoplasms,Melanoma in situ,MITD1,MIT domain-containing protein 1,18242,69,1.19 [0.95-1.49],0.1270290040280068
Chapter II Neoplasms,Melanoma in situ,MKI67,Proliferation marker protein Ki-67,15491,59,0.82 [0.40-1.66],0.5837502257819016
Chapter II Neoplasms,Melanoma in situ,MLLT1,Protein ENL,15421,61,1.26 [0.93-1.72],0.1361574587372988
Chapter II Neoplasms,Melanoma in situ,MLN,Promotilin,18389,73,0.75 [0.59-0.94],0.0133717106407909
Chapter II Neoplasms,Melanoma in situ,MME,Neprilysin,18305,72,0.86 [0.65-1.15],0.3141117031640954
Chapter II Neoplasms,Melanoma in situ,MMP1,Interstitial collagenase,17782,70,1.36 [1.06-1.75],0.0145309222918126
Chapter II Neoplasms,Melanoma in situ,MMP10,Stromelysin-2,18342,74,0.95 [0.67-1.37],0.8017213159306722
Chapter II Neoplasms,Melanoma in situ,MMP12,Macrophage metalloelastase,18439,72,0.97 [0.66-1.44],0.8935559255848559
Chapter II Neoplasms,Melanoma in situ,MMP13,Collagenase 3,18002,70,0.75 [0.38-1.46],0.3907363178637411
Chapter II Neoplasms,Melanoma in situ,MMP15,Matrix metalloproteinase-15,15975,64,0.36 [0.15-0.87],0.0236670819178917
Chapter II Neoplasms,Melanoma in situ,MMP3,Stromelysin-1,18396,74,0.90 [0.59-1.37],0.6232661179341215
Chapter II Neoplasms,Melanoma in situ,MMP7,Matrilysin,18047,70,0.96 [0.62-1.47],0.8390678736868152
Chapter II Neoplasms,Melanoma in situ,MMP8,Neutrophil collagenase,18531,75,1.05 [0.79-1.39],0.7571739112738886
Chapter II Neoplasms,Melanoma in situ,MMP9,Matrix metalloproteinase-9,18376,74,0.97 [0.69-1.37],0.8570636572963853
Chapter II Neoplasms,Melanoma in situ,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15452,62,0.50 [0.29-0.89],0.0171987860659652
Chapter II Neoplasms,Melanoma in situ,MN1,Transcriptional activator MN1,15567,63,0.66 [0.39-1.10],0.1117322271491754
Chapter II Neoplasms,Melanoma in situ,MNAT1,CDK-activating kinase assembly factor MAT1,15697,63,0.58 [0.30-1.12],0.1066008921159958
Chapter II Neoplasms,Melanoma in situ,MNDA,Myeloid cell nuclear differentiation antigen,18366,74,0.87 [0.70-1.09],0.2283507171351092
Chapter II Neoplasms,Melanoma in situ,MOCS2,Molybdopterin synthase catalytic subunit,15623,63,1.23 [0.85-1.77],0.2672815756871566
Chapter II Neoplasms,Melanoma in situ,MOG,Myelin-oligodendrocyte glycoprotein,18569,74,0.60 [0.32-1.11],0.1052706544623627
Chapter II Neoplasms,Melanoma in situ,MORC3,MORC family CW-type zinc finger protein 3,15944,63,0.72 [0.27-1.91],0.5109678790756994
Chapter II Neoplasms,Melanoma in situ,MORF4L1,Mortality factor 4-like protein 1,15697,63,0.44 [0.20-0.97],0.0421316730706766
Chapter II Neoplasms,Melanoma in situ,MORF4L2,Mortality factor 4-like protein 2,15421,61,1.06 [0.57-1.95],0.8613056696212074
Chapter II Neoplasms,Melanoma in situ,MORN4,MORN repeat-containing protein 4,15421,61,0.83 [0.57-1.22],0.3421097606621464
Chapter II Neoplasms,Melanoma in situ,MPHOSPH8,M-phase phosphoprotein 8,18071,70,1.08 [0.81-1.42],0.6110855059997775
Chapter II Neoplasms,Melanoma in situ,MPI,Mannose-6-phosphate isomerase,18305,72,1.15 [0.90-1.46],0.2527157599535808
Chapter II Neoplasms,Melanoma in situ,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18434,74,1.24 [0.93-1.65],0.1512166960240368
Chapter II Neoplasms,Melanoma in situ,MPO,Myeloperoxidase,18396,74,0.77 [0.48-1.23],0.2689573950009558
Chapter II Neoplasms,Melanoma in situ,MPRIP,Myosin phosphatase Rho-interacting protein,15891,62,1.35 [0.84-2.17],0.2210582015877114
Chapter II Neoplasms,Melanoma in situ,MRC1,Macrophage mannose receptor 1,15994,64,0.58 [0.24-1.38],0.2151455859031289
Chapter II Neoplasms,Melanoma in situ,MRI1,Methylthioribose-1-phosphate isomerase,15567,63,0.90 [0.63-1.29],0.5629774868755846
Chapter II Neoplasms,Melanoma in situ,MRPL24,"39S ribosomal protein L24, mitochondrial",15452,62,0.70 [0.33-1.47],0.3435647453856694
Chapter II Neoplasms,Melanoma in situ,MRPL28,"39S ribosomal protein L28, mitochondrial",15952,63,0.88 [0.42-1.82],0.7253423162808501
Chapter II Neoplasms,Melanoma in situ,MRPL46,"39S ribosomal protein L46, mitochondrial",18002,70,0.91 [0.41-2.03],0.8119178138900078
Chapter II Neoplasms,Melanoma in situ,MRPL52,"39S ribosomal protein L52, mitochondrial",15382,60,0.47 [0.17-1.31],0.1506286868038863
Chapter II Neoplasms,Melanoma in situ,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",15952,63,1.01 [0.72-1.42],0.9414307634863204
Chapter II Neoplasms,Melanoma in situ,MRPS16,"28S ribosomal protein S16, mitochondrial",15491,59,0.45 [0.14-1.41],0.1698379781281687
Chapter II Neoplasms,Melanoma in situ,MSLN,Mesothelin,18275,72,1.21 [0.86-1.71],0.265367102841969
Chapter II Neoplasms,Melanoma in situ,MSLNL,Mesothelin-like protein,15567,63,1.53 [0.93-2.53],0.0976992234776396
Chapter II Neoplasms,Melanoma in situ,MSMB,Beta-microseminoprotein,18377,73,0.95 [0.71-1.28],0.7344466899346414
Chapter II Neoplasms,Melanoma in situ,MSR1,Macrophage scavenger receptor types I and II,18561,75,0.96 [0.62-1.47],0.8356292603720754
Chapter II Neoplasms,Melanoma in situ,MSRA,Mitochondrial peptide methionine sulfoxide reductase,18439,74,1.12 [0.84-1.49],0.4388068444650301
Chapter II Neoplasms,Melanoma in situ,MST1,Hepatocyte growth factor-like protein,15765,61,0.87 [0.66-1.15],0.320558960649287
Chapter II Neoplasms,Melanoma in situ,MSTN,Growth/differentiation factor 8,18071,70,0.68 [0.46-1.02],0.0606389970585702
Chapter II Neoplasms,Melanoma in situ,MTDH,Protein LYRIC,15491,59,1.14 [0.88-1.49],0.3278953481160556
Chapter II Neoplasms,Melanoma in situ,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",15944,63,0.44 [0.15-1.31],0.1427196539816627
Chapter II Neoplasms,Melanoma in situ,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15697,63,1.04 [0.84-1.29],0.6963298918609351
Chapter II Neoplasms,Melanoma in situ,MTIF3,"Translation initiation factor IF-3, mitochondrial",15920,63,1.06 [0.81-1.39],0.678282570764628
Chapter II Neoplasms,Melanoma in situ,MTPN,Myotrophin,18071,70,1.34 [0.77-2.32],0.3030208092205785
Chapter II Neoplasms,Melanoma in situ,MTR,Methionine synthase,15452,62,0.92 [0.62-1.35],0.6648461487038291
Chapter II Neoplasms,Melanoma in situ,MTSS1,Protein MTSS 1,15920,63,1.20 [0.97-1.49],0.0969879492144821
Chapter II Neoplasms,Melanoma in situ,MTSS2,Protein MTSS 2,15917,63,1.17 [0.92-1.49],0.2030701834565307
Chapter II Neoplasms,Melanoma in situ,MTUS1,Microtubule-associated tumor suppressor 1,15697,63,0.82 [0.51-1.29],0.3860680177907867
Chapter II Neoplasms,Melanoma in situ,MUC13,Mucin-13,18002,70,1.04 [0.68-1.58],0.8618520904531359
Chapter II Neoplasms,Melanoma in situ,MUC16,Mucin-16,18305,72,0.98 [0.88-1.10],0.7815482472203201
Chapter II Neoplasms,Melanoma in situ,MUC2,Mucin-2,15983,64,0.71 [0.54-0.93],0.013459041714613
Chapter II Neoplasms,Melanoma in situ,MUCL3,Mucin-like protein 3,15421,61,0.78 [0.39-1.54],0.4730752903966242
Chapter II Neoplasms,Melanoma in situ,MVK,Mevalonate kinase,18088,71,1.10 [0.85-1.43],0.4628331623896466
Chapter II Neoplasms,Melanoma in situ,MXRA8,Matrix remodeling-associated protein 8,15623,63,0.79 [0.36-1.75],0.5569288273662273
Chapter II Neoplasms,Melanoma in situ,MYBPC1,"Myosin-binding protein C, slow-type",15975,64,0.96 [0.70-1.33],0.8271783545326653
Chapter II Neoplasms,Melanoma in situ,MYBPC2,"Myosin-binding protein C, fast-type",15528,62,0.92 [0.68-1.25],0.5915619117452177
Chapter II Neoplasms,Melanoma in situ,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,15952,63,0.88 [0.59-1.30],0.5144226121258804
Chapter II Neoplasms,Melanoma in situ,MYDGF,Myeloid-derived growth factor,15975,64,1.10 [0.87-1.41],0.4222964097622838
Chapter II Neoplasms,Melanoma in situ,MYH4,Myosin-4,15452,62,0.68 [0.35-1.32],0.2555996593888482
Chapter II Neoplasms,Melanoma in situ,MYH7B,Myosin-7B,15421,61,1.17 [0.72-1.92],0.5234919597619336
Chapter II Neoplasms,Melanoma in situ,MYH9,Myosin-9,15983,64,1.28 [1.04-1.58],0.0188959569207239
Chapter II Neoplasms,Melanoma in situ,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15452,62,0.87 [0.45-1.71],0.6957062766621431
Chapter II Neoplasms,Melanoma in situ,MYL3,Myosin light chain 3,15528,62,0.83 [0.59-1.16],0.2722313179989665
Chapter II Neoplasms,Melanoma in situ,MYL4,Myosin light chain 4,15528,62,0.91 [0.56-1.47],0.6955521078247464
Chapter II Neoplasms,Melanoma in situ,MYL6B,Myosin light chain 6B,15567,63,0.94 [0.72-1.24],0.6784578194696688
Chapter II Neoplasms,Melanoma in situ,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15567,63,1.36 [0.94-1.95],0.0999341300685527
Chapter II Neoplasms,Melanoma in situ,MYO6,Unconventional myosin-VI,15952,63,0.65 [0.30-1.39],0.2636050386964089
Chapter II Neoplasms,Melanoma in situ,MYO9B,Unconventional myosin-IXb,18088,71,1.06 [0.77-1.45],0.7169749620861301
Chapter II Neoplasms,Melanoma in situ,MYOC,Myocilin,18396,74,0.78 [0.49-1.23],0.2869911332024582
Chapter II Neoplasms,Melanoma in situ,MYOM1,Myomesin-1,15489,61,0.66 [0.34-1.29],0.2227098125894126
Chapter II Neoplasms,Melanoma in situ,MYOM2,Myomesin-2,15452,62,1.02 [0.65-1.61],0.9234012478997554
Chapter II Neoplasms,Melanoma in situ,MYOM3,Myomesin-3,15623,63,0.83 [0.64-1.08],0.1663334137907477
Chapter II Neoplasms,Melanoma in situ,MZB1,Marginal zone B- and B1-cell-specific protein,18416,74,0.85 [0.56-1.28],0.4309438079909733
Chapter II Neoplasms,Melanoma in situ,MZT1,Mitotic-spindle organizing protein 1,17977,71,1.17 [0.79-1.75],0.4340294307113789
Chapter II Neoplasms,Melanoma in situ,NAA10,N-alpha-acetyltransferase 10,15452,62,1.19 [0.74-1.94],0.4724980935100549
Chapter II Neoplasms,Melanoma in situ,NAA80,N-alpha-acetyltransferase 80,15567,63,1.14 [0.94-1.39],0.1921348218024883
Chapter II Neoplasms,Melanoma in situ,NAAA,N-acylethanolamine-hydrolyzing acid amidase,18162,69,0.77 [0.53-1.12],0.1662540465787089
Chapter II Neoplasms,Melanoma in situ,NACC1,Nucleus accumbens-associated protein 1,15917,63,1.04 [0.68-1.59],0.8695836912992181
Chapter II Neoplasms,Melanoma in situ,NADK,NAD kinase,18395,74,0.74 [0.49-1.11],0.1454721540703213
Chapter II Neoplasms,Melanoma in situ,NAGA,Alpha-N-acetylgalactosaminidase,15464,59,1.05 [0.69-1.58],0.8280927136744618
Chapter II Neoplasms,Melanoma in situ,NAGK,N-acetyl-D-glucosamine kinase,15500,62,1.33 [0.87-2.03],0.1911398515486644
Chapter II Neoplasms,Melanoma in situ,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15623,63,1.57 [0.51-4.84],0.4351134242274778
Chapter II Neoplasms,Melanoma in situ,NAMPT,Nicotinamide phosphoribosyltransferase,17977,71,0.86 [0.55-1.33],0.4937194026496305
Chapter II Neoplasms,Melanoma in situ,NAP1L4,Nucleosome assembly protein 1-like 4,15881,62,1.56 [0.84-2.90],0.1629566492020618
Chapter II Neoplasms,Melanoma in situ,NAPRT,Nicotinate phosphoribosyltransferase,15944,63,0.80 [0.38-1.68],0.5504471909887988
Chapter II Neoplasms,Melanoma in situ,NARS1,"Asparagine--tRNA ligase, cytoplasmic",15952,63,1.10 [0.65-1.84],0.7309676895080781
Chapter II Neoplasms,Melanoma in situ,NBL1,Neuroblastoma suppressor of tumorigenicity 1,18439,74,0.68 [0.31-1.48],0.3279100691594947
Chapter II Neoplasms,Melanoma in situ,NBN,Nibrin,18088,71,0.77 [0.48-1.25],0.2943263359146808
Chapter II Neoplasms,Melanoma in situ,NCAM1,Neural cell adhesion molecule 1,18485,74,0.55 [0.29-1.05],0.067840768768235
Chapter II Neoplasms,Melanoma in situ,NCAM2,Neural cell adhesion molecule 2,18396,74,0.74 [0.34-1.60],0.4467959990898935
Chapter II Neoplasms,Melanoma in situ,NCAN,Neurocan core protein,18561,75,0.71 [0.41-1.21],0.2076118019840644
Chapter II Neoplasms,Melanoma in situ,NCF2,Neutrophil cytosol factor 2,18350,73,0.89 [0.69-1.15],0.3781139120814246
Chapter II Neoplasms,Melanoma in situ,NCK2,Cytoplasmic protein NCK2,18455,74,1.10 [0.90-1.33],0.3480384550067865
Chapter II Neoplasms,Melanoma in situ,NCLN,Nicalin,18088,71,0.93 [0.60-1.44],0.754358615550877
Chapter II Neoplasms,Melanoma in situ,NCR1,Natural cytotoxicity triggering receptor 1,18364,73,1.33 [0.77-2.30],0.3100158508155347
Chapter II Neoplasms,Melanoma in situ,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,15920,63,1.53 [0.79-2.99],0.208609999969985
Chapter II Neoplasms,Melanoma in situ,NCS1,Neuronal calcium sensor 1,18569,74,0.62 [0.30-1.30],0.204434925270727
Chapter II Neoplasms,Melanoma in situ,NDRG1,Protein NDRG1,18002,70,0.62 [0.39-1.00],0.0501124443462475
Chapter II Neoplasms,Melanoma in situ,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,15917,63,1.07 [0.73-1.56],0.7273773790477522
Chapter II Neoplasms,Melanoma in situ,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15462,59,1.39 [0.71-2.73],0.3337522662499927
Chapter II Neoplasms,Melanoma in situ,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,15920,63,1.10 [0.84-1.44],0.4812503470100597
Chapter II Neoplasms,Melanoma in situ,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",17977,71,1.07 [0.83-1.38],0.6073531260569544
Chapter II Neoplasms,Melanoma in situ,NEB,Nebulin,15452,62,0.82 [0.41-1.66],0.5805191922618576
Chapter II Neoplasms,Melanoma in situ,NECAP2,Adaptin ear-binding coat-associated protein 2,15452,62,1.18 [0.84-1.65],0.3332239568411379
Chapter II Neoplasms,Melanoma in situ,NECTIN1,Nectin-1,15491,59,0.74 [0.33-1.68],0.4704048955220464
Chapter II Neoplasms,Melanoma in situ,NECTIN2,Nectin-2,18375,74,1.40 [0.72-2.72],0.3266291289589194
Chapter II Neoplasms,Melanoma in situ,NECTIN4,Nectin-4,18439,74,0.66 [0.33-1.31],0.2324280284549535
Chapter II Neoplasms,Melanoma in situ,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15491,59,1.05 [0.62-1.78],0.845239285427748
Chapter II Neoplasms,Melanoma in situ,NEDD9,Enhancer of filamentation 1,15491,59,1.02 [0.50-2.08],0.9561718087605078
Chapter II Neoplasms,Melanoma in situ,NEFL,Neurofilament light polypeptide,17950,70,1.00 [0.62-1.61],0.9981167358103812
Chapter II Neoplasms,Melanoma in situ,NEK7,Serine/threonine-protein kinase Nek7,15697,63,1.00 [0.71-1.40],0.9943776359420604
Chapter II Neoplasms,Melanoma in situ,NELL1,Protein kinase C-binding protein NELL1,18439,74,0.88 [0.54-1.45],0.6176751528896984
Chapter II Neoplasms,Melanoma in situ,NELL2,Protein kinase C-binding protein NELL2,18455,74,0.87 [0.42-1.78],0.6942580296455021
Chapter II Neoplasms,Melanoma in situ,NENF,Neudesin,15917,63,0.96 [0.77-1.20],0.7240286297679186
Chapter II Neoplasms,Melanoma in situ,NEO1,Neogenin,15952,63,0.52 [0.16-1.64],0.2611860283917868
Chapter II Neoplasms,Melanoma in situ,NEXN,Nexilin,15994,64,1.25 [0.90-1.74],0.1853319290252092
Chapter II Neoplasms,Melanoma in situ,NFASC,Neurofascin,18615,74,0.68 [0.32-1.43],0.3059939266301362
Chapter II Neoplasms,Melanoma in situ,NFAT5,Nuclear factor of activated T-cells 5,15491,59,1.16 [0.87-1.53],0.3166881446493449
Chapter II Neoplasms,Melanoma in situ,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18389,73,1.21 [0.98-1.49],0.0701790306130022
Chapter II Neoplasms,Melanoma in situ,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18088,71,0.92 [0.65-1.32],0.6667954395862856
Chapter II Neoplasms,Melanoma in situ,NFE2,Transcription factor NF-E2 45 kDa subunit,15528,62,1.37 [0.99-1.90],0.0560451818651252
Chapter II Neoplasms,Melanoma in situ,NFIC,Nuclear factor 1 C-type,15952,63,0.64 [0.29-1.41],0.2648192627495734
Chapter II Neoplasms,Melanoma in situ,NFKB1,Nuclear factor NF-kappa-B p105 subunit,15452,62,1.15 [0.82-1.61],0.4134751209069736
Chapter II Neoplasms,Melanoma in situ,NFKB2,Nuclear factor NF-kappa-B p100 subunit,15697,63,0.77 [0.43-1.38],0.3838554212942547
Chapter II Neoplasms,Melanoma in situ,NFKBIE,NF-kappa-B inhibitor epsilon,17977,71,1.06 [0.68-1.65],0.7881824282480547
Chapter II Neoplasms,Melanoma in situ,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",15920,63,1.06 [0.84-1.34],0.6159019710497662
Chapter II Neoplasms,Melanoma in situ,NFX1,Transcriptional repressor NF-X1,15452,62,1.23 [0.89-1.71],0.2168433618120609
Chapter II Neoplasms,Melanoma in situ,NFYA,Nuclear transcription factor Y subunit alpha,15452,62,0.83 [0.41-1.68],0.6135302853249496
Chapter II Neoplasms,Melanoma in situ,NGF,Beta-nerve growth factor,18242,69,1.67 [0.36-7.74],0.5125894033068336
Chapter II Neoplasms,Melanoma in situ,NGFR,Tumor necrosis factor receptor superfamily member 16,15975,64,0.90 [0.38-2.12],0.8161797094667524
Chapter II Neoplasms,Melanoma in situ,NGRN,Neugrin,15944,63,1.02 [0.35-3.03],0.9646370326503934
Chapter II Neoplasms,Melanoma in situ,NHLRC3,NHL repeat-containing protein 3,15257,62,0.72 [0.33-1.59],0.4202134267542289
Chapter II Neoplasms,Melanoma in situ,NID1,Nidogen-1,18431,74,0.83 [0.46-1.48],0.5234747755487814
Chapter II Neoplasms,Melanoma in situ,NID2,Nidogen-2,18396,74,1.23 [0.94-1.61],0.1328795395977102
Chapter II Neoplasms,Melanoma in situ,NINJ1,Ninjurin-1,17977,71,0.52 [0.29-0.93],0.0274034115759602
Chapter II Neoplasms,Melanoma in situ,NIT1,Deaminated glutathione amidase,15528,62,1.45 [0.81-2.59],0.2082396915189312
Chapter II Neoplasms,Melanoma in situ,NIT2,Omega-amidase NIT2,15915,64,1.15 [0.83-1.61],0.3988623124971282
Chapter II Neoplasms,Melanoma in situ,NLGN1,Neuroligin-1,15567,63,1.16 [0.86-1.57],0.3361147381346557
Chapter II Neoplasms,Melanoma in situ,NLGN2,Neuroligin-2,15489,61,0.88 [0.49-1.58],0.6662439154818208
Chapter II Neoplasms,Melanoma in situ,NME1,Nucleoside diphosphate kinase A,15491,59,0.87 [0.26-2.89],0.8209881091608597
Chapter II Neoplasms,Melanoma in situ,NME3,Nucleoside diphosphate kinase 3,18395,74,0.64 [0.25-1.65],0.3537306643484443
Chapter II Neoplasms,Melanoma in situ,NMI,N-myc-interactor,15850,62,1.02 [0.73-1.44],0.9068485083940364
Chapter II Neoplasms,Melanoma in situ,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18242,69,0.73 [0.53-1.02],0.0679341343715926
Chapter II Neoplasms,Melanoma in situ,NMRK2,Nicotinamide riboside kinase 2,15421,61,0.71 [0.33-1.54],0.3880461286984051
Chapter II Neoplasms,Melanoma in situ,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,15952,63,1.01 [0.70-1.46],0.9706273916344964
Chapter II Neoplasms,Melanoma in situ,NOMO1,Nodal modulator 1,18396,74,1.22 [0.50-2.98],0.6611920412561791
Chapter II Neoplasms,Melanoma in situ,NOP56,Nucleolar protein 56,15452,62,1.01 [0.82-1.26],0.9134996527904196
Chapter II Neoplasms,Melanoma in situ,NOS1,"Nitric oxide synthase, brain",18002,70,0.72 [0.48-1.08],0.1112409173571066
Chapter II Neoplasms,Melanoma in situ,NOS2,"Nitric oxide synthase, inducible",15452,62,0.36 [0.18-0.74],0.0054728060845175
Chapter II Neoplasms,Melanoma in situ,NOS3,"Nitric oxide synthase, endothelial",18002,70,0.82 [0.52-1.30],0.4032524767108553
Chapter II Neoplasms,Melanoma in situ,NOTCH1,Neurogenic locus notch homolog protein 1,18626,75,1.05 [0.29-3.87],0.941689947253255
Chapter II Neoplasms,Melanoma in situ,NOTCH2,Neurogenic locus notch homolog protein 2,15983,64,0.72 [0.23-2.27],0.5711338959525498
Chapter II Neoplasms,Melanoma in situ,NOTCH3,Neurogenic locus notch homolog protein 3,18626,75,1.05 [0.56-1.96],0.8859251724475774
Chapter II Neoplasms,Melanoma in situ,NPC2,NPC intracellular cholesterol transporter 2,15722,64,1.09 [0.51-2.33],0.821820003961107
Chapter II Neoplasms,Melanoma in situ,NPDC1,Neural proliferation differentiation and control protein 1,18395,74,0.54 [0.26-1.11],0.0934093844287755
Chapter II Neoplasms,Melanoma in situ,NPHS1,Nephrin,15491,59,0.65 [0.30-1.43],0.2864578713761826
Chapter II Neoplasms,Melanoma in situ,NPHS2,Podocin,15491,59,0.76 [0.55-1.03],0.0803632666041781
Chapter II Neoplasms,Melanoma in situ,NPL,N-acetylneuraminate lyase,15975,64,1.08 [0.64-1.83],0.7736550175686094
Chapter II Neoplasms,Melanoma in situ,NPPB,Natriuretic peptides B,18071,70,1.12 [0.96-1.30],0.1474084374194601
Chapter II Neoplasms,Melanoma in situ,NPPC,C-type natriuretic peptide,18389,73,0.49 [0.31-0.77],0.0018504392788861
Chapter II Neoplasms,Melanoma in situ,NPR1,Atrial natriuretic peptide receptor 1,15452,62,0.66 [0.43-1.01],0.0533335850692757
Chapter II Neoplasms,Melanoma in situ,NPTN,Neuroplastin,17977,71,1.02 [0.78-1.34],0.8575339244782457
Chapter II Neoplasms,Melanoma in situ,NPTX1,Neuronal pentraxin-1,18396,74,0.76 [0.45-1.28],0.3047879547733004
Chapter II Neoplasms,Melanoma in situ,NPTX2,Neuronal pentraxin-2,15983,64,0.84 [0.41-1.71],0.6241921979584546
Chapter II Neoplasms,Melanoma in situ,NPTXR,Neuronal pentraxin receptor,18395,74,1.10 [0.60-2.02],0.7555344860931389
Chapter II Neoplasms,Melanoma in situ,NPY,Pro-neuropeptide Y,18569,74,1.07 [0.77-1.49],0.6686213306937747
Chapter II Neoplasms,Melanoma in situ,NRCAM,Neuronal cell adhesion molecule,18395,74,0.56 [0.27-1.20],0.1362905658255946
Chapter II Neoplasms,Melanoma in situ,NRGN,Neurogranin,15994,64,1.12 [0.86-1.46],0.3870948350139374
Chapter II Neoplasms,Melanoma in situ,NRN1,Neuritin,15952,63,0.84 [0.40-1.77],0.6556454161814177
Chapter II Neoplasms,Melanoma in situ,NRP1,Neuropilin-1,18518,74,0.68 [0.32-1.47],0.3302693871619286
Chapter II Neoplasms,Melanoma in situ,NRP2,Neuropilin-2,18396,74,1.18 [0.57-2.43],0.6526386160815885
Chapter II Neoplasms,Melanoma in situ,NRTN,Neurturin,18088,71,1.01 [0.66-1.54],0.9766601438299364
Chapter II Neoplasms,Melanoma in situ,NRXN3,Neurexin-3,15567,63,0.90 [0.44-1.84],0.7724162104993988
Chapter II Neoplasms,Melanoma in situ,NSFL1C,NSFL1 cofactor p47,18561,75,1.16 [0.85-1.59],0.3586123450775668
Chapter II Neoplasms,Melanoma in situ,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",15975,64,1.05 [0.75-1.46],0.7862080180407903
Chapter II Neoplasms,Melanoma in situ,NT5C1A,Cytosolic 5'-nucleotidase 1A,15944,63,0.79 [0.34-1.86],0.5953480850247703
Chapter II Neoplasms,Melanoma in situ,NT5C3A,Cytosolic 5'-nucleotidase 3A,18352,73,1.21 [0.95-1.55],0.1284575496069834
Chapter II Neoplasms,Melanoma in situ,NT5E,5'-nucleotidase,18439,74,0.80 [0.53-1.21],0.2863176015669982
Chapter II Neoplasms,Melanoma in situ,NTF3,Neurotrophin-3,18389,73,0.81 [0.44-1.50],0.5071902254905608
Chapter II Neoplasms,Melanoma in situ,NTF4,Neurotrophin-4,17977,71,0.95 [0.52-1.74],0.873893103096857
Chapter II Neoplasms,Melanoma in situ,NTRK2,BDNF/NT-3 growth factors receptor,18395,74,0.58 [0.25-1.32],0.1932339228522602
Chapter II Neoplasms,Melanoma in situ,NTRK3,NT-3 growth factor receptor,18561,75,0.46 [0.18-1.21],0.11449381651479
Chapter II Neoplasms,Melanoma in situ,NTproBNP,N-terminal prohormone of brain natriuretic peptide,18395,74,1.13 [0.95-1.34],0.1713162182346909
Chapter II Neoplasms,Melanoma in situ,NUB1,NEDD8 ultimate buster 1,18389,73,1.16 [0.91-1.47],0.2377162690152728
Chapter II Neoplasms,Melanoma in situ,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,15917,63,0.99 [0.78-1.26],0.9181465892033052
Chapter II Neoplasms,Melanoma in situ,NUCB2,Nucleobindin-2,18541,74,1.22 [0.70-2.13],0.4729437974394885
Chapter II Neoplasms,Melanoma in situ,NUDC,Nuclear migration protein nudC,18615,74,1.34 [0.96-1.87],0.0810855676374245
Chapter II Neoplasms,Melanoma in situ,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15528,62,1.58 [0.78-3.19],0.2000047385494603
Chapter II Neoplasms,Melanoma in situ,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15452,62,1.40 [1.03-1.91],0.032949995943411
Chapter II Neoplasms,Melanoma in situ,NUDT16,U8 snoRNA-decapping enzyme,15895,63,1.22 [0.93-1.60],0.1544151380889516
Chapter II Neoplasms,Melanoma in situ,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18305,72,1.23 [0.88-1.71],0.2261356424957632
Chapter II Neoplasms,Melanoma in situ,NUDT5,ADP-sugar pyrophosphatase,18396,74,1.22 [0.81-1.83],0.3460220922769075
Chapter II Neoplasms,Melanoma in situ,NUMB,Protein numb homolog,15491,59,1.25 [0.92-1.69],0.1534901173740027
Chapter II Neoplasms,Melanoma in situ,NUP50,Nuclear pore complex protein Nup50,15452,62,0.63 [0.36-1.10],0.1060857362447733
Chapter II Neoplasms,Melanoma in situ,NXPE4,NXPE family member 4,15452,62,0.70 [0.29-1.66],0.4158414687108109
Chapter II Neoplasms,Melanoma in situ,NXPH1,Neurexophilin-1,18002,70,1.02 [0.59-1.75],0.9543376835854714
Chapter II Neoplasms,Melanoma in situ,NXPH3,Neurexophilin-3,15491,59,1.30 [0.56-3.02],0.5444093739386385
Chapter II Neoplasms,Melanoma in situ,OBP2B,Odorant-binding protein 2b,18183,68,0.87 [0.60-1.27],0.4768236534915719
Chapter II Neoplasms,Melanoma in situ,OCLN,Occludin,15952,63,0.57 [0.31-1.06],0.0758569427157203
Chapter II Neoplasms,Melanoma in situ,ODAM,Odontogenic ameloblast-associated protein,17972,70,0.78 [0.50-1.21],0.2708866814698009
Chapter II Neoplasms,Melanoma in situ,OFD1,Oral-facial-digital syndrome 1 protein,15697,63,0.83 [0.53-1.29],0.4063990657638533
Chapter II Neoplasms,Melanoma in situ,OGA,Protein O-GlcNAcase,15920,63,1.17 [0.83-1.65],0.3617979466396736
Chapter II Neoplasms,Melanoma in situ,OGFR,Opioid growth factor receptor,18305,72,1.65 [0.88-3.11],0.1186464209389714
Chapter II Neoplasms,Melanoma in situ,OGN,Mimecan,18396,74,0.80 [0.48-1.32],0.3852539255929377
Chapter II Neoplasms,Melanoma in situ,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15697,63,1.07 [0.76-1.53],0.6895054782368217
Chapter II Neoplasms,Melanoma in situ,OLFM4,Olfactomedin-4,15036,61,0.94 [0.77-1.15],0.5384788956635095
Chapter II Neoplasms,Melanoma in situ,OLR1,Oxidized low-density lipoprotein receptor 1,18213,74,1.11 [0.79-1.54],0.5490238872165507
Chapter II Neoplasms,Melanoma in situ,OMD,Osteomodulin,18455,74,1.13 [0.67-1.90],0.638210924946798
Chapter II Neoplasms,Melanoma in situ,OMG,Oligodendrocyte-myelin glycoprotein,18305,72,1.09 [0.81-1.48],0.559886789717482
Chapter II Neoplasms,Melanoma in situ,OMP,Olfactory marker protein,15489,61,0.90 [0.53-1.53],0.6982525241689781
Chapter II Neoplasms,Melanoma in situ,OPHN1,Oligophrenin-1,15944,63,1.22 [0.98-1.53],0.081010577269914
Chapter II Neoplasms,Melanoma in situ,OPLAH,5-oxoprolinase,15528,62,1.10 [0.77-1.57],0.594056560519334
Chapter II Neoplasms,Melanoma in situ,OPTC,Opticin,18305,72,0.79 [0.48-1.30],0.3448230270845471
Chapter II Neoplasms,Melanoma in situ,ORM1,Alpha-1-acid glycoprotein 1,15937,64,1.79 [0.55-5.77],0.3313577175458125
Chapter II Neoplasms,Melanoma in situ,OSBPL2,Oxysterol-binding protein-related protein 2,15944,63,1.17 [0.68-2.00],0.5735408458565643
Chapter II Neoplasms,Melanoma in situ,OSCAR,Osteoclast-associated immunoglobulin-like receptor,18395,74,1.40 [0.77-2.55],0.2741253944554168
Chapter II Neoplasms,Melanoma in situ,OSM,Oncostatin-M,18296,73,1.10 [0.81-1.49],0.5464829905746549
Chapter II Neoplasms,Melanoma in situ,OSMR,Oncostatin-M-specific receptor subunit beta,18518,74,0.49 [0.17-1.44],0.1947187202065113
Chapter II Neoplasms,Melanoma in situ,OSTN,Osteocrin,15567,63,0.46 [0.21-1.01],0.0526371830770176
Chapter II Neoplasms,Melanoma in situ,OTOA,Otoancorin,15489,61,0.65 [0.35-1.20],0.168552013090707
Chapter II Neoplasms,Melanoma in situ,OTUD6B,Deubiquitinase OTUD6B,15920,63,1.16 [0.76-1.75],0.4917664477537194
Chapter II Neoplasms,Melanoma in situ,OTUD7B,OTU domain-containing protein 7B,15952,63,1.08 [0.73-1.59],0.6917410390638072
Chapter II Neoplasms,Melanoma in situ,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15528,62,1.19 [0.85-1.67],0.3222320844853754
Chapter II Neoplasms,Melanoma in situ,OXT,Oxytocin-neurophysin 1,18561,75,1.05 [0.91-1.20],0.5302300537723722
Chapter II Neoplasms,Melanoma in situ,P4HB,Protein disulfide-isomerase,18297,73,1.30 [0.77-2.22],0.3248571121056142
Chapter II Neoplasms,Melanoma in situ,PACS2,Phosphofurin acidic cluster sorting protein 2,15452,62,1.31 [0.90-1.91],0.157317731836727
Chapter II Neoplasms,Melanoma in situ,PADI2,Protein-arginine deiminase type-2,18088,71,0.79 [0.50-1.23],0.2899205243328654
Chapter II Neoplasms,Melanoma in situ,PADI4,Protein-arginine deiminase type-4,17972,70,0.82 [0.59-1.14],0.2326787383600305
Chapter II Neoplasms,Melanoma in situ,PAEP,Glycodelin,18242,69,0.99 [0.81-1.21],0.9337099954636842
Chapter II Neoplasms,Melanoma in situ,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,15952,63,0.94 [0.76-1.17],0.6025786428586604
Chapter II Neoplasms,Melanoma in situ,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15697,63,1.01 [0.63-1.63],0.9556164940437526
Chapter II Neoplasms,Melanoma in situ,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18071,70,0.89 [0.60-1.32],0.5581604015588844
Chapter II Neoplasms,Melanoma in situ,PAGR1,PAXIP1-associated glutamate-rich protein 1,15528,62,1.70 [1.07-2.69],0.0243299736452584
Chapter II Neoplasms,Melanoma in situ,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15393,60,0.50 [0.29-0.87],0.0141660237164686
Chapter II Neoplasms,Melanoma in situ,PAK4,Serine/threonine-protein kinase PAK 4,18002,70,1.23 [0.89-1.69],0.2137819205441314
Chapter II Neoplasms,Melanoma in situ,PALLD,Palladin,15491,59,1.07 [0.58-1.98],0.8344118002549236
Chapter II Neoplasms,Melanoma in situ,PALM,Paralemmin-1,15821,61,0.70 [0.36-1.36],0.290470744880556
Chapter II Neoplasms,Melanoma in situ,PALM2,Paralemmin-2,15944,63,0.53 [0.27-1.06],0.0720603371765069
Chapter II Neoplasms,Melanoma in situ,PALM3,Paralemmin-3,15452,62,0.90 [0.62-1.29],0.5621674017594886
Chapter II Neoplasms,Melanoma in situ,PAM,Peptidyl-glycine alpha-amidating monooxygenase,18544,74,0.75 [0.37-1.51],0.4191891631803199
Chapter II Neoplasms,Melanoma in situ,PAMR1,Inactive serine protease PAMR1,18396,74,1.77 [0.80-3.88],0.1570004807384731
Chapter II Neoplasms,Melanoma in situ,PAPPA,Pappalysin-1,18088,71,1.03 [0.66-1.61],0.9061840876756408
Chapter II Neoplasms,Melanoma in situ,PARD3,Partitioning defective 3 homolog,15697,63,0.94 [0.68-1.32],0.7264140347533196
Chapter II Neoplasms,Melanoma in situ,PARK7,Parkinson disease protein 7,18396,74,1.18 [0.79-1.76],0.4135931456935768
Chapter II Neoplasms,Melanoma in situ,PARP1,Poly [ADP-ribose] polymerase 1,18389,73,1.00 [0.68-1.45],0.9843065384363936
Chapter II Neoplasms,Melanoma in situ,PAXX,Protein PAXX,15623,63,1.25 [0.74-2.10],0.4095742301673614
Chapter II Neoplasms,Melanoma in situ,PBK,Lymphokine-activated killer T-cell-originated protein kinase,15421,61,1.06 [0.48-2.34],0.8761981065722202
Chapter II Neoplasms,Melanoma in situ,PBLD,Phenazine biosynthesis-like domain-containing protein,18002,70,1.08 [0.71-1.64],0.7092094494516453
Chapter II Neoplasms,Melanoma in situ,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,15920,63,0.57 [0.24-1.37],0.2104979840798705
Chapter II Neoplasms,Melanoma in situ,PCARE,Photoreceptor cilium actin regulator,15489,61,1.06 [0.80-1.39],0.6939681140921106
Chapter II Neoplasms,Melanoma in situ,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15588,63,0.95 [0.56-1.63],0.8647982754460881
Chapter II Neoplasms,Melanoma in situ,PCBP2,Poly(rC)-binding protein 2,15952,63,1.10 [0.79-1.54],0.5586868892814436
Chapter II Neoplasms,Melanoma in situ,PCDH1,Protocadherin-1,18550,74,2.35 [1.10-5.04],0.0282779278246512
Chapter II Neoplasms,Melanoma in situ,PCDH12,Protocadherin-12,15952,63,0.31 [0.12-0.78],0.0132501768240102
Chapter II Neoplasms,Melanoma in situ,PCDH17,Protocadherin-17,18395,74,0.86 [0.49-1.52],0.6013673087375493
Chapter II Neoplasms,Melanoma in situ,PCDH7,Protocadherin-7,15920,63,0.75 [0.35-1.63],0.4689797731394906
Chapter II Neoplasms,Melanoma in situ,PCDH9,Protocadherin-9,15920,63,0.73 [0.39-1.38],0.3314458298140562
Chapter II Neoplasms,Melanoma in situ,PCDHB15,Protocadherin beta-15,15917,63,1.14 [0.63-2.04],0.6690176242483126
Chapter II Neoplasms,Melanoma in situ,PCNA,Proliferating cell nuclear antigen,15421,61,1.00 [0.69-1.46],0.995979431574665
Chapter II Neoplasms,Melanoma in situ,PCSK7,Proprotein convertase subtilisin/kexin type 7,15917,63,0.74 [0.41-1.35],0.3271429839264645
Chapter II Neoplasms,Melanoma in situ,PCSK9,Proprotein convertase subtilisin/kexin type 9,18626,75,1.42 [0.85-2.36],0.1753339100700916
Chapter II Neoplasms,Melanoma in situ,PCYT2,Ethanolamine-phosphate cytidylyltransferase,15920,63,1.24 [0.90-1.72],0.1924424925830306
Chapter II Neoplasms,Melanoma in situ,PDAP1,28 kDa heat- and acid-stable phosphoprotein,15975,64,1.15 [0.90-1.47],0.2748738181590183
Chapter II Neoplasms,Melanoma in situ,PDCD1,Programmed cell death protein 1,18536,73,0.79 [0.46-1.36],0.3962024519400401
Chapter II Neoplasms,Melanoma in situ,PDCD1LG2,Programmed cell death 1 ligand 2,18305,72,1.12 [0.58-2.18],0.731001190710059
Chapter II Neoplasms,Melanoma in situ,PDCD5,Programmed cell death protein 5,18561,75,1.30 [0.92-1.83],0.1380425975385536
Chapter II Neoplasms,Melanoma in situ,PDCD6,Programmed cell death protein 6,18395,74,1.57 [1.05-2.34],0.0268745633595821
Chapter II Neoplasms,Melanoma in situ,PDCL2,Phosducin-like protein 2,15421,61,0.83 [0.48-1.43],0.4942579147669006
Chapter II Neoplasms,Melanoma in situ,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15421,61,0.90 [0.54-1.50],0.6863556495285142
Chapter II Neoplasms,Melanoma in situ,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15452,62,1.10 [0.76-1.60],0.6037255879187291
Chapter II Neoplasms,Melanoma in situ,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15623,63,1.15 [0.91-1.47],0.2443244281675367
Chapter II Neoplasms,Melanoma in situ,PDGFA,Platelet-derived growth factor subunit A,18626,75,1.45 [1.09-1.92],0.0116015093809777
Chapter II Neoplasms,Melanoma in situ,PDGFB,Platelet-derived growth factor subunit B,18455,74,1.27 [0.99-1.62],0.0550502446907034
Chapter II Neoplasms,Melanoma in situ,PDGFC,Platelet-derived growth factor C,17977,71,1.66 [0.80-3.44],0.1763448583669579
Chapter II Neoplasms,Melanoma in situ,PDGFRA,Platelet-derived growth factor receptor alpha,18395,74,0.86 [0.41-1.81],0.6844006953238725
Chapter II Neoplasms,Melanoma in situ,PDGFRB,Platelet-derived growth factor receptor beta,18626,75,1.36 [0.74-2.47],0.3181475721831792
Chapter II Neoplasms,Melanoma in situ,PDIA2,Protein disulfide-isomerase A2,15421,61,0.97 [0.53-1.79],0.9328764319823446
Chapter II Neoplasms,Melanoma in situ,PDIA3,Protein disulfide-isomerase A3,15623,63,0.66 [0.23-1.85],0.4241537159042441
Chapter II Neoplasms,Melanoma in situ,PDIA4,Protein disulfide-isomerase A4,15983,64,1.20 [0.82-1.76],0.3478369679219051
Chapter II Neoplasms,Melanoma in situ,PDIA5,Protein disulfide-isomerase A5,15421,61,1.38 [1.01-1.87],0.0409791221906749
Chapter II Neoplasms,Melanoma in situ,PDLIM5,PDZ and LIM domain protein 5,15952,63,1.04 [0.84-1.28],0.7230915703181033
Chapter II Neoplasms,Melanoma in situ,PDLIM7,PDZ and LIM domain protein 7,18455,74,1.11 [0.94-1.31],0.2135908374660384
Chapter II Neoplasms,Melanoma in situ,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",17977,71,0.80 [0.50-1.30],0.3708075234658864
Chapter II Neoplasms,Melanoma in situ,PDRG1,p53 and DNA damage-regulated protein 1,15567,63,0.71 [0.41-1.24],0.2281096539099877
Chapter II Neoplasms,Melanoma in situ,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15421,61,0.65 [0.31-1.35],0.2462319282250619
Chapter II Neoplasms,Melanoma in situ,PDZD2,PDZ domain-containing protein 2,15452,62,1.11 [0.73-1.67],0.6331632066110633
Chapter II Neoplasms,Melanoma in situ,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15491,59,0.78 [0.42-1.45],0.4373676717995167
Chapter II Neoplasms,Melanoma in situ,PEAR1,Platelet endothelial aggregation receptor 1,18626,75,1.34 [0.55-3.28],0.5180390105291531
Chapter II Neoplasms,Melanoma in situ,PEBP1,Phosphatidylethanolamine-binding protein 1,18396,74,1.20 [0.85-1.71],0.3045746641899715
Chapter II Neoplasms,Melanoma in situ,PECAM1,Platelet endothelial cell adhesion molecule,18396,74,1.00 [0.50-2.00],0.993992017818668
Chapter II Neoplasms,Melanoma in situ,PECR,Peroxisomal trans-2-enoyl-CoA reductase,15528,62,0.69 [0.26-1.85],0.465162437181819
Chapter II Neoplasms,Melanoma in situ,PENK,Proenkephalin-A,15623,63,0.81 [0.36-1.83],0.6057525097727277
Chapter II Neoplasms,Melanoma in situ,PEPD,Xaa-Pro dipeptidase,15994,64,0.58 [0.23-1.44],0.2391057366784833
Chapter II Neoplasms,Melanoma in situ,PER3,Period circadian protein homolog 3,15491,59,1.14 [0.94-1.39],0.1942716444550107
Chapter II Neoplasms,Melanoma in situ,PF4,Platelet factor 4,15875,64,1.13 [0.88-1.44],0.3392417949408995
Chapter II Neoplasms,Melanoma in situ,PFDN2,Prefoldin subunit 2,18002,70,0.96 [0.65-1.41],0.8262784214749245
Chapter II Neoplasms,Melanoma in situ,PFDN4,Prefoldin subunit 4,15421,61,1.03 [0.64-1.64],0.908308369030192
Chapter II Neoplasms,Melanoma in situ,PFDN6,Prefoldin subunit 6,15567,63,0.75 [0.47-1.22],0.2459220137593291
Chapter II Neoplasms,Melanoma in situ,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18279,72,1.00 [0.76-1.31],0.9941830849367388
Chapter II Neoplasms,Melanoma in situ,PGA4,Pepsin A-4,15994,64,0.82 [0.63-1.07],0.1510905727160552
Chapter II Neoplasms,Melanoma in situ,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",15975,64,1.67 [1.11-2.53],0.0148448228354929
Chapter II Neoplasms,Melanoma in situ,PGF,Placenta growth factor,18615,74,0.79 [0.34-1.86],0.591347320517007
Chapter II Neoplasms,Melanoma in situ,PGLYRP1,Peptidoglycan recognition protein 1,18535,74,0.99 [0.61-1.62],0.9760149205574732
Chapter II Neoplasms,Melanoma in situ,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15801,63,0.65 [0.29-1.46],0.2964927414955561
Chapter II Neoplasms,Melanoma in situ,PGLYRP4,Peptidoglycan recognition protein 4,15452,62,0.65 [0.37-1.12],0.1210257242192133
Chapter II Neoplasms,Melanoma in situ,PGM2,Phosphoglucomutase-2,15567,63,1.28 [0.96-1.69],0.0873979056173662
Chapter II Neoplasms,Melanoma in situ,PGR,Progesterone receptor,15491,59,1.03 [0.82-1.30],0.7781507380630306
Chapter II Neoplasms,Melanoma in situ,PHACTR2,Phosphatase and actin regulator 2,15952,63,1.18 [0.95-1.45],0.1351112987805991
Chapter II Neoplasms,Melanoma in situ,PHLDB1,Pleckstrin homology-like domain family B member 1,15920,63,1.28 [0.80-2.04],0.3003626307549278
Chapter II Neoplasms,Melanoma in situ,PHLDB2,Pleckstrin homology-like domain family B member 2,15421,61,0.98 [0.75-1.29],0.9095310522678458
Chapter II Neoplasms,Melanoma in situ,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18242,69,0.63 [0.32-1.24],0.1841270087277955
Chapter II Neoplasms,Melanoma in situ,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15623,63,0.97 [0.54-1.75],0.914756613425053
Chapter II Neoplasms,Melanoma in situ,PI16,Peptidase inhibitor 16,15994,64,1.01 [0.38-2.73],0.9769222678269418
Chapter II Neoplasms,Melanoma in situ,PI3,Elafin,18158,73,1.45 [1.05-2.01],0.0241688508515394
Chapter II Neoplasms,Melanoma in situ,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",15952,63,1.15 [0.85-1.56],0.3620921261388587
Chapter II Neoplasms,Melanoma in situ,PIGR,Polymeric immunoglobulin receptor,18169,73,0.77 [0.43-1.41],0.4021134489286656
Chapter II Neoplasms,Melanoma in situ,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18389,73,1.10 [0.79-1.54],0.565185024617552
Chapter II Neoplasms,Melanoma in situ,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18396,74,0.70 [0.32-1.53],0.3708318683130142
Chapter II Neoplasms,Melanoma in situ,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15491,59,1.15 [0.74-1.77],0.536370341851425
Chapter II Neoplasms,Melanoma in situ,PILRA,Paired immunoglobulin-like type 2 receptor alpha,18396,74,0.80 [0.49-1.31],0.3803465090485085
Chapter II Neoplasms,Melanoma in situ,PILRB,Paired immunoglobulin-like type 2 receptor beta,18395,74,0.85 [0.60-1.21],0.3689006769543208
Chapter II Neoplasms,Melanoma in situ,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15623,63,0.62 [0.45-0.84],0.0020247337776977
Chapter II Neoplasms,Melanoma in situ,PITHD1,PITH domain-containing protein 1,15393,60,1.34 [1.06-1.69],0.0149716260365946
Chapter II Neoplasms,Melanoma in situ,PKD1,Polycystin-1,15975,64,0.68 [0.28-1.66],0.393071515862967
Chapter II Neoplasms,Melanoma in situ,PKD2,Polycystin-2,15452,62,1.32 [0.94-1.87],0.1091594161066317
Chapter II Neoplasms,Melanoma in situ,PKLR,Pyruvate kinase PKLR,18400,74,1.08 [0.79-1.47],0.6471768775442865
Chapter II Neoplasms,Melanoma in situ,PKN3,Serine/threonine-protein kinase N3,15697,63,0.82 [0.58-1.17],0.2791672483379814
Chapter II Neoplasms,Melanoma in situ,PLA2G10,Group 10 secretory phospholipase A2,18242,69,1.13 [0.78-1.64],0.5189772824323076
Chapter II Neoplasms,Melanoma in situ,PLA2G15,Phospholipase A2 group XV,18439,74,0.80 [0.37-1.72],0.5605420612109471
Chapter II Neoplasms,Melanoma in situ,PLA2G1B,Phospholipase A2,18601,75,0.57 [0.37-0.89],0.0130827790115001
Chapter II Neoplasms,Melanoma in situ,PLA2G2A,"Phospholipase A2, membrane associated",18382,75,1.42 [1.05-1.91],0.0209107952617036
Chapter II Neoplasms,Melanoma in situ,PLA2G4A,Cytosolic phospholipase A2,18455,74,1.18 [0.94-1.49],0.160862483336861
Chapter II Neoplasms,Melanoma in situ,PLA2G7,Platelet-activating factor acetylhydrolase,18396,74,1.30 [0.68-2.48],0.4205561412291495
Chapter II Neoplasms,Melanoma in situ,PLAT,Tissue-type plasminogen activator,18566,75,0.90 [0.60-1.35],0.6118330426228524
Chapter II Neoplasms,Melanoma in situ,PLAU,Urokinase-type plasminogen activator,18396,74,0.37 [0.17-0.80],0.0117343240000617
Chapter II Neoplasms,Melanoma in situ,PLAUR,Urokinase plasminogen activator surface receptor,18252,73,1.30 [0.61-2.76],0.4925205340802628
Chapter II Neoplasms,Melanoma in situ,PLB1,"Phospholipase B1, membrane-associated",15944,63,0.98 [0.65-1.47],0.9133473846747144
Chapter II Neoplasms,Melanoma in situ,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15491,59,1.15 [0.67-1.97],0.6069983658284359
Chapter II Neoplasms,Melanoma in situ,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",15944,63,1.06 [0.83-1.36],0.639907787848544
Chapter II Neoplasms,Melanoma in situ,PLEKHO1,Pleckstrin homology domain-containing family O member 1,15944,63,1.25 [0.89-1.75],0.203450588466171
Chapter II Neoplasms,Melanoma in situ,PLG,Plasminogen,15604,63,0.89 [0.29-2.75],0.8350896777291814
Chapter II Neoplasms,Melanoma in situ,PLIN1,Perilipin-1,18002,70,0.76 [0.39-1.49],0.4277010361931938
Chapter II Neoplasms,Melanoma in situ,PLIN3,Perilipin-3,18395,74,1.10 [0.68-1.78],0.708998675210182
Chapter II Neoplasms,Melanoma in situ,PLPBP,Pyridoxal phosphate homeostasis protein,18395,74,1.15 [0.85-1.57],0.3558343772904888
Chapter II Neoplasms,Melanoma in situ,PLSCR3,Phospholipid scramblase 3,15916,63,1.14 [0.75-1.75],0.5359795653688776
Chapter II Neoplasms,Melanoma in situ,PLTP,Phospholipid transfer protein,18567,74,0.65 [0.38-1.11],0.1124455170168354
Chapter II Neoplasms,Melanoma in situ,PLXDC1,Plexin domain-containing protein 1,17977,71,1.15 [0.66-2.00],0.6305916376690031
Chapter II Neoplasms,Melanoma in situ,PLXDC2,Plexin domain-containing protein 2,15944,63,0.58 [0.23-1.50],0.2639223196833962
Chapter II Neoplasms,Melanoma in situ,PLXNA4,Plexin-A4,18389,73,1.12 [0.87-1.45],0.3718665312044822
Chapter II Neoplasms,Melanoma in situ,PLXNB2,Plexin-B2,18543,75,1.19 [0.51-2.79],0.6887383864024539
Chapter II Neoplasms,Melanoma in situ,PLXNB3,Plexin-B3,18333,73,1.44 [0.94-2.19],0.0915327823360718
Chapter II Neoplasms,Melanoma in situ,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18319,74,0.96 [0.87-1.07],0.4456686101382728
Chapter II Neoplasms,Melanoma in situ,PMCH,Pro-MCH,15452,62,0.86 [0.59-1.26],0.4443844727966958
Chapter II Neoplasms,Melanoma in situ,PMM2,Phosphomannomutase 2,15452,62,1.00 [0.66-1.52],0.9878801088528444
Chapter II Neoplasms,Melanoma in situ,PMS1,PMS1 protein homolog 1,15567,63,0.70 [0.41-1.22],0.2065810538312442
Chapter II Neoplasms,Melanoma in situ,PMVK,Phosphomevalonate kinase,17974,70,1.16 [0.93-1.44],0.1833955319901298
Chapter II Neoplasms,Melanoma in situ,PNLIP,Pancreatic triacylglycerol lipase,15994,64,0.76 [0.52-1.10],0.1492714043694788
Chapter II Neoplasms,Melanoma in situ,PNLIPRP1,Inactive pancreatic lipase-related protein 1,15944,63,1.01 [0.75-1.36],0.9366015009569753
Chapter II Neoplasms,Melanoma in situ,PNLIPRP2,Pancreatic lipase-related protein 2,18365,74,0.97 [0.91-1.04],0.3838687466074064
Chapter II Neoplasms,Melanoma in situ,PNMA1,Paraneoplastic antigen Ma1,15528,62,1.05 [0.69-1.61],0.8158263085680957
Chapter II Neoplasms,Melanoma in situ,PNMA2,Paraneoplastic antigen Ma2,15489,61,1.03 [0.60-1.76],0.9125869652591342
Chapter II Neoplasms,Melanoma in situ,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18088,71,0.79 [0.62-1.00],0.0480405654516979
Chapter II Neoplasms,Melanoma in situ,PODXL,Podocalyxin,18305,72,0.37 [0.10-1.44],0.152565817343599
Chapter II Neoplasms,Melanoma in situ,PODXL2,Podocalyxin-like protein 2,18439,74,0.98 [0.47-2.04],0.9473410402509926
Chapter II Neoplasms,Melanoma in situ,POF1B,Protein POF1B,15491,59,0.41 [0.20-0.83],0.0127568314229102
Chapter II Neoplasms,Melanoma in situ,POLR2A,DNA-directed RNA polymerase II subunit RPB1,15491,59,1.11 [0.48-2.56],0.8093325630184259
Chapter II Neoplasms,Melanoma in situ,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18305,72,0.85 [0.44-1.64],0.6250547141751529
Chapter II Neoplasms,Melanoma in situ,POMC,Pro-opiomelanocortin,15528,62,1.01 [0.71-1.43],0.9429385927722448
Chapter II Neoplasms,Melanoma in situ,PON1,Serum paraoxonase/arylesterase 1,15994,64,1.65 [0.66-4.13],0.2878695570277884
Chapter II Neoplasms,Melanoma in situ,PON2,Serum paraoxonase/arylesterase 2,18071,70,1.13 [0.62-2.05],0.6965482535204404
Chapter II Neoplasms,Melanoma in situ,PON3,Serum paraoxonase/lactonase 3,18455,74,0.91 [0.45-1.85],0.8035726057912215
Chapter II Neoplasms,Melanoma in situ,POSTN,Periostin,15983,64,0.78 [0.41-1.49],0.45844917834653
Chapter II Neoplasms,Melanoma in situ,PPBP,Platelet basic protein,15874,64,1.24 [0.93-1.63],0.1381244275767885
Chapter II Neoplasms,Melanoma in situ,PPCDC,Phosphopantothenoylcysteine decarboxylase,18561,75,1.18 [0.76-1.82],0.4605278689211906
Chapter II Neoplasms,Melanoma in situ,PPIB,Peptidyl-prolyl cis-trans isomerase B,18408,74,1.19 [0.95-1.48],0.1234766558391249
Chapter II Neoplasms,Melanoma in situ,PPIE,Peptidyl-prolyl cis-trans isomerase E,15697,63,1.11 [0.79-1.57],0.5404219974468982
Chapter II Neoplasms,Melanoma in situ,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",15983,64,1.08 [0.75-1.54],0.680909844835665
Chapter II Neoplasms,Melanoma in situ,PPL,Periplakin,15491,59,0.68 [0.29-1.57],0.3642607613130323
Chapter II Neoplasms,Melanoma in situ,PPM1A,Protein phosphatase 1A,17977,71,0.76 [0.37-1.58],0.4598207909277689
Chapter II Neoplasms,Melanoma in situ,PPM1B,Protein phosphatase 1B,15491,59,0.92 [0.60-1.43],0.724334300109849
Chapter II Neoplasms,Melanoma in situ,PPM1F,Protein phosphatase 1F,15975,64,1.20 [0.76-1.88],0.4391907940050532
Chapter II Neoplasms,Melanoma in situ,PPME1,Protein phosphatase methylesterase 1,18305,72,1.30 [0.92-1.85],0.1401707726647568
Chapter II Neoplasms,Melanoma in situ,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,15917,63,1.13 [0.85-1.50],0.3921340982121098
Chapter II Neoplasms,Melanoma in situ,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18439,74,1.08 [0.87-1.33],0.4966272331749644
Chapter II Neoplasms,Melanoma in situ,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15697,63,1.01 [0.72-1.42],0.963596153622976
Chapter II Neoplasms,Melanoma in situ,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,15952,63,1.06 [0.78-1.44],0.7011990744185552
Chapter II Neoplasms,Melanoma in situ,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,15952,63,0.70 [0.35-1.40],0.3097709804905142
Chapter II Neoplasms,Melanoma in situ,PPP1R2,Protein phosphatase inhibitor 2,18395,74,1.17 [0.91-1.51],0.222013292578198
Chapter II Neoplasms,Melanoma in situ,PPP1R9B,Neurabin-2,18615,74,1.17 [0.94-1.45],0.1544613239522332
Chapter II Neoplasms,Melanoma in situ,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,15920,63,1.02 [0.84-1.25],0.8240543707212985
Chapter II Neoplasms,Melanoma in situ,PPP3R1,Calcineurin subunit B type 1,18242,69,0.94 [0.55-1.60],0.8134841345682686
Chapter II Neoplasms,Melanoma in situ,PPT1,Palmitoyl-protein thioesterase 1,15567,63,0.72 [0.46-1.12],0.1407504341989168
Chapter II Neoplasms,Melanoma in situ,PPY,Pancreatic prohormone,18330,74,1.09 [0.90-1.33],0.387861951928661
Chapter II Neoplasms,Melanoma in situ,PQBP1,Polyglutamine-binding protein 1,17977,71,0.95 [0.65-1.40],0.7935171335394904
Chapter II Neoplasms,Melanoma in situ,PRAME,Melanoma antigen preferentially expressed in tumors,15421,61,0.86 [0.32-2.32],0.7645472470490733
Chapter II Neoplasms,Melanoma in situ,PRAP1,Proline-rich acidic protein 1,15983,64,1.73 [0.91-3.29],0.0959599473559591
Chapter II Neoplasms,Melanoma in situ,PRC1,Protein regulator of cytokinesis 1,15917,63,0.74 [0.36-1.51],0.4007337524751744
Chapter II Neoplasms,Melanoma in situ,PRCP,Lysosomal Pro-X carboxypeptidase,18509,74,0.74 [0.38-1.44],0.3822668737838364
Chapter II Neoplasms,Melanoma in situ,PRDX1,Peroxiredoxin-1,17868,68,1.11 [0.88-1.40],0.3920048186657719
Chapter II Neoplasms,Melanoma in situ,PRDX2,Peroxiredoxin-2,15733,62,0.95 [0.64-1.42],0.8084114770344402
Chapter II Neoplasms,Melanoma in situ,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18088,71,0.97 [0.72-1.30],0.8169132829427186
Chapter II Neoplasms,Melanoma in situ,PRDX5,"Peroxiredoxin-5, mitochondrial",18615,74,1.11 [0.81-1.52],0.5200465800208174
Chapter II Neoplasms,Melanoma in situ,PRDX6,Peroxiredoxin-6,18569,74,1.08 [0.78-1.51],0.6392277113359703
Chapter II Neoplasms,Melanoma in situ,PREB,Prolactin regulatory element-binding protein,18088,71,0.79 [0.37-1.72],0.5577348560016768
Chapter II Neoplasms,Melanoma in situ,PRELP,Prolargin,18365,74,0.95 [0.39-2.34],0.9143585169184832
Chapter II Neoplasms,Melanoma in situ,PRG2,Bone marrow proteoglycan,15983,64,1.48 [0.93-2.33],0.0958226031652986
Chapter II Neoplasms,Melanoma in situ,PRG3,Proteoglycan 3,15983,64,1.24 [0.76-2.04],0.3851040447209992
Chapter II Neoplasms,Melanoma in situ,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18088,71,1.24 [0.86-1.80],0.2520978222600994
Chapter II Neoplasms,Melanoma in situ,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15567,63,0.53 [0.22-1.27],0.15339248190865
Chapter II Neoplasms,Melanoma in situ,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18395,74,1.02 [0.80-1.31],0.8657927887527496
Chapter II Neoplasms,Melanoma in situ,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,15910,63,1.13 [0.83-1.53],0.4465006983080993
Chapter II Neoplasms,Melanoma in situ,PRKCQ,Protein kinase C theta type,18088,71,0.87 [0.52-1.47],0.6043857625097181
Chapter II Neoplasms,Melanoma in situ,PRKD2,Serine/threonine-protein kinase D2,15452,62,0.68 [0.34-1.38],0.2895281687093548
Chapter II Neoplasms,Melanoma in situ,PRKG1,cGMP-dependent protein kinase 1,15623,63,1.10 [0.91-1.34],0.3274933182569042
Chapter II Neoplasms,Melanoma in situ,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,17977,71,1.02 [0.75-1.39],0.8942792833443707
Chapter II Neoplasms,Melanoma in situ,PRL,Prolactin,18561,75,0.92 [0.70-1.20],0.5287903999676703
Chapter II Neoplasms,Melanoma in situ,PRND,Prion-like protein doppel,15944,63,1.16 [0.70-1.92],0.5599722214185457
Chapter II Neoplasms,Melanoma in situ,PROC,Vitamin K-dependent protein C,18463,74,1.98 [0.88-4.47],0.0988432976759032
Chapter II Neoplasms,Melanoma in situ,PROCR,Endothelial protein C receptor,15452,62,0.92 [0.42-2.00],0.8246914687307384
Chapter II Neoplasms,Melanoma in situ,PROK1,Prokineticin-1,18389,73,0.82 [0.54-1.26],0.3724207627039343
Chapter II Neoplasms,Melanoma in situ,PROS1,Vitamin K-dependent protein S,15998,64,1.33 [0.53-3.34],0.5436123116004774
Chapter II Neoplasms,Melanoma in situ,PRR4,Proline-rich protein 4,15513,62,1.30 [0.94-1.79],0.1126616031666669
Chapter II Neoplasms,Melanoma in situ,PRR5,Proline-rich protein 5,15491,59,1.16 [0.70-1.92],0.5704062572990576
Chapter II Neoplasms,Melanoma in situ,PRRT3,Proline-rich transmembrane protein 3,15528,62,0.75 [0.38-1.48],0.4087934968038814
Chapter II Neoplasms,Melanoma in situ,PRSS2,Trypsin-2,18485,74,0.81 [0.55-1.19],0.2849233887284404
Chapter II Neoplasms,Melanoma in situ,PRSS22,Brain-specific serine protease 4,15491,59,0.67 [0.30-1.52],0.339220109523949
Chapter II Neoplasms,Melanoma in situ,PRSS27,Serine protease 27,18335,74,0.90 [0.53-1.53],0.7073316383577659
Chapter II Neoplasms,Melanoma in situ,PRSS53,Serine protease 53,15944,63,0.98 [0.52-1.86],0.9599915639244496
Chapter II Neoplasms,Melanoma in situ,PRSS8,Prostasin,18313,74,1.08 [0.65-1.79],0.7715181597181857
Chapter II Neoplasms,Melanoma in situ,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18002,70,1.20 [0.98-1.46],0.0797033834894882
Chapter II Neoplasms,Melanoma in situ,PRTG,Protogenin,18569,74,0.46 [0.24-0.87],0.0166129657853066
Chapter II Neoplasms,Melanoma in situ,PRTN3,Myeloblastin,17942,73,0.90 [0.57-1.40],0.6364555212556193
Chapter II Neoplasms,Melanoma in situ,PRUNE2,Protein prune homolog 2,15697,63,0.42 [0.16-1.13],0.0849736969999366
Chapter II Neoplasms,Melanoma in situ,PSAP,Prosaposin,15845,64,0.97 [0.40-2.36],0.9459306773530112
Chapter II Neoplasms,Melanoma in situ,PSAPL1,Proactivator polypeptide-like 1,15920,63,1.04 [0.64-1.69],0.8729077294154589
Chapter II Neoplasms,Melanoma in situ,PSCA,Prostate stem cell antigen,15920,63,1.01 [0.92-1.11],0.8708423902809146
Chapter II Neoplasms,Melanoma in situ,PSG1,Pregnancy-specific beta-1-glycoprotein 1,18242,69,1.00 [0.83-1.21],0.9712939340675536
Chapter II Neoplasms,Melanoma in situ,PSIP1,PC4 and SFRS1-interacting protein,18389,73,1.05 [0.77-1.43],0.742854039111163
Chapter II Neoplasms,Melanoma in situ,PSMA1,Proteasome subunit alpha type-1,17977,71,0.92 [0.57-1.48],0.7206145617850854
Chapter II Neoplasms,Melanoma in situ,PSMC3,26S proteasome regulatory subunit 6A,15421,61,0.79 [0.35-1.78],0.5625025809157571
Chapter II Neoplasms,Melanoma in situ,PSMD1,26S proteasome non-ATPase regulatory subunit 1,15952,63,1.09 [0.68-1.75],0.7300207874874032
Chapter II Neoplasms,Melanoma in situ,PSMD5,26S proteasome non-ATPase regulatory subunit 5,15567,63,1.14 [0.76-1.69],0.5323287308720593
Chapter II Neoplasms,Melanoma in situ,PSMD9,26S proteasome non-ATPase regulatory subunit 9,18305,72,1.16 [0.81-1.67],0.4158195342227883
Chapter II Neoplasms,Melanoma in situ,PSME1,Proteasome activator complex subunit 1,18211,68,1.44 [0.82-2.54],0.206745349350713
Chapter II Neoplasms,Melanoma in situ,PSME2,Proteasome activator complex subunit 2,18167,69,1.20 [0.67-2.15],0.5450235194942914
Chapter II Neoplasms,Melanoma in situ,PSMG3,Proteasome assembly chaperone 3,18389,73,1.08 [0.72-1.62],0.7060307473099083
Chapter II Neoplasms,Melanoma in situ,PSMG4,Proteasome assembly chaperone 4,15491,59,0.90 [0.57-1.42],0.6546351998454814
Chapter II Neoplasms,Melanoma in situ,PSPN,Persephin,18389,73,0.91 [0.72-1.15],0.4119169253802863
Chapter II Neoplasms,Melanoma in situ,PSRC1,Proline/serine-rich coiled-coil protein 1,17977,71,1.22 [0.88-1.69],0.2346841262857836
Chapter II Neoplasms,Melanoma in situ,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15066,60,1.20 [0.94-1.54],0.142619880302364
Chapter II Neoplasms,Melanoma in situ,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18002,70,1.52 [0.76-3.04],0.2347479130686824
Chapter II Neoplasms,Melanoma in situ,PTGDS,Prostaglandin-H2 D-isomerase,18289,74,0.66 [0.32-1.36],0.2645611402322858
Chapter II Neoplasms,Melanoma in situ,PTGES2,Prostaglandin E synthase 2,15377,58,1.24 [0.79-1.95],0.3394148097791239
Chapter II Neoplasms,Melanoma in situ,PTGR1,Prostaglandin reductase 1,15975,64,1.14 [0.86-1.51],0.3603554948026959
Chapter II Neoplasms,Melanoma in situ,PTH,Parathyroid hormone,15567,63,1.14 [0.85-1.53],0.3933412319787033
Chapter II Neoplasms,Melanoma in situ,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18389,73,0.87 [0.48-1.59],0.6513703423698077
Chapter II Neoplasms,Melanoma in situ,PTK7,Inactive tyrosine-protein kinase 7,18002,70,0.87 [0.50-1.53],0.6338292731509303
Chapter II Neoplasms,Melanoma in situ,PTN,Pleiotrophin,18071,70,0.96 [0.62-1.48],0.8439541232414555
Chapter II Neoplasms,Melanoma in situ,PTP4A3,Protein tyrosine phosphatase type IVA 3,15491,59,1.03 [0.64-1.66],0.9011559108442756
Chapter II Neoplasms,Melanoma in situ,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18242,69,1.17 [0.90-1.52],0.2537689430623984
Chapter II Neoplasms,Melanoma in situ,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18434,74,1.13 [0.89-1.44],0.3003045650772131
Chapter II Neoplasms,Melanoma in situ,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15465,59,0.82 [0.41-1.65],0.5825273759943572
Chapter II Neoplasms,Melanoma in situ,PTPRB,Receptor-type tyrosine-protein phosphatase beta,15975,64,0.51 [0.22-1.15],0.103622484700046
Chapter II Neoplasms,Melanoma in situ,PTPRC,Receptor-type tyrosine-protein phosphatase C,15983,64,0.52 [0.18-1.56],0.2440248099079015
Chapter II Neoplasms,Melanoma in situ,PTPRF,Receptor-type tyrosine-protein phosphatase F,18626,75,1.27 [0.62-2.59],0.5164069932964519
Chapter II Neoplasms,Melanoma in situ,PTPRH,Receptor-type tyrosine-protein phosphatase H,15920,63,0.91 [0.55-1.50],0.7071896876759654
Chapter II Neoplasms,Melanoma in situ,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,15920,63,0.67 [0.20-2.26],0.5216703067856906
Chapter II Neoplasms,Melanoma in situ,PTPRM,Receptor-type tyrosine-protein phosphatase mu,18357,73,1.77 [0.75-4.16],0.1905509973587226
Chapter II Neoplasms,Melanoma in situ,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18181,69,0.79 [0.41-1.54],0.495661622098935
Chapter II Neoplasms,Melanoma in situ,PTPRR,Receptor-type tyrosine-protein phosphatase R,15944,63,0.75 [0.39-1.45],0.3956696829287315
Chapter II Neoplasms,Melanoma in situ,PTPRS,Receptor-type tyrosine-protein phosphatase S,18626,75,1.13 [0.50-2.54],0.7712991827889699
Chapter II Neoplasms,Melanoma in situ,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,15975,64,1.06 [0.49-2.29],0.8898615740363797
Chapter II Neoplasms,Melanoma in situ,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15623,63,1.29 [0.85-1.94],0.2344700188838093
Chapter II Neoplasms,Melanoma in situ,PTS,6-pyruvoyl tetrahydrobiopterin synthase,17908,69,0.85 [0.56-1.29],0.4420732171058437
Chapter II Neoplasms,Melanoma in situ,PTTG1,Securin,15697,63,1.24 [0.75-2.04],0.4027769794419552
Chapter II Neoplasms,Melanoma in situ,PTX3,Pentraxin-related protein PTX3,18389,73,1.36 [0.85-2.17],0.198634103691681
Chapter II Neoplasms,Melanoma in situ,PVALB,Parvalbumin alpha,18494,74,1.13 [0.93-1.36],0.218408956726085
Chapter II Neoplasms,Melanoma in situ,PVR,Poliovirus receptor,18561,75,0.65 [0.36-1.17],0.1502478817603242
Chapter II Neoplasms,Melanoma in situ,PXDNL,Peroxidasin-like protein,15917,63,0.91 [0.57-1.46],0.6995443747637368
Chapter II Neoplasms,Melanoma in situ,PXN,Paxillin,18002,70,0.85 [0.55-1.30],0.4501629418733183
Chapter II Neoplasms,Melanoma in situ,PYDC1,Pyrin domain-containing protein 1,15528,62,0.63 [0.32-1.24],0.1802210368846152
Chapter II Neoplasms,Melanoma in situ,PYY,Peptide YY,15452,62,0.92 [0.72-1.18],0.5286291295651304
Chapter II Neoplasms,Melanoma in situ,PZP,Pregnancy zone protein,15998,64,1.27 [0.65-2.48],0.4788866129981856
Chapter II Neoplasms,Melanoma in situ,QDPR,Dihydropteridine reductase,18303,74,1.17 [0.72-1.91],0.5210783153509904
Chapter II Neoplasms,Melanoma in situ,QPCT,Glutaminyl-peptide cyclotransferase,18411,74,1.65 [0.75-3.64],0.2137941489589563
Chapter II Neoplasms,Melanoma in situ,QSOX1,Sulfhydryl oxidase 1,15679,63,1.35 [0.90-2.02],0.1460411763363587
Chapter II Neoplasms,Melanoma in situ,RAB10,Ras-related protein Rab-10,15975,64,1.13 [0.73-1.75],0.5814826077499085
Chapter II Neoplasms,Melanoma in situ,RAB11FIP3,Rab11 family-interacting protein 3,15975,64,1.15 [0.92-1.44],0.2262002617894644
Chapter II Neoplasms,Melanoma in situ,RAB27B,Ras-related protein Rab-27B,15975,64,1.15 [0.85-1.55],0.3601942126577654
Chapter II Neoplasms,Melanoma in situ,RAB2B,Ras-related protein Rab-2B,15917,63,1.07 [0.72-1.58],0.7539464184641732
Chapter II Neoplasms,Melanoma in situ,RAB33A,Ras-related protein Rab-33A,15452,62,1.04 [0.72-1.52],0.8272706218277179
Chapter II Neoplasms,Melanoma in situ,RAB37,Ras-related protein Rab-37,18088,71,0.92 [0.70-1.22],0.5793105616585392
Chapter II Neoplasms,Melanoma in situ,RAB39B,Ras-related protein Rab-39B,15452,62,1.03 [0.80-1.32],0.83216587307182
Chapter II Neoplasms,Melanoma in situ,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15489,61,0.84 [0.51-1.37],0.479403642932143
Chapter II Neoplasms,Melanoma in situ,RAB44,Ras-related protein Rab-44,15917,63,0.60 [0.29-1.24],0.1648492640440022
Chapter II Neoplasms,Melanoma in situ,RAB6A,Ras-related protein Rab-6A,18389,73,0.89 [0.55-1.44],0.6362456975646431
Chapter II Neoplasms,Melanoma in situ,RAB6B,Ras-related protein Rab-6B,18002,70,0.83 [0.51-1.34],0.4381569174529954
Chapter II Neoplasms,Melanoma in situ,RABEP1,Rab GTPase-binding effector protein 1,15623,63,1.27 [0.93-1.74],0.1300448918750525
Chapter II Neoplasms,Melanoma in situ,RABEPK,Rab9 effector protein with kelch motifs,17977,71,0.60 [0.38-0.95],0.0277888379284717
Chapter II Neoplasms,Melanoma in situ,RABGAP1L,Rab GTPase-activating protein 1-like,18088,71,1.25 [0.89-1.75],0.2048146428240145
Chapter II Neoplasms,Melanoma in situ,RAC3,Ras-related C3 botulinum toxin substrate 3,15567,63,0.95 [0.64-1.39],0.7753353375870919
Chapter II Neoplasms,Melanoma in situ,RAD23B,UV excision repair protein RAD23 homolog B,17977,71,0.99 [0.63-1.55],0.9597388012723802
Chapter II Neoplasms,Melanoma in situ,RAD51,DNA repair protein RAD51 homolog 1,15697,63,0.73 [0.41-1.28],0.2672244722318299
Chapter II Neoplasms,Melanoma in situ,RALB,Ras-related protein Ral-B,15491,59,1.12 [0.49-2.56],0.7904897792199677
Chapter II Neoplasms,Melanoma in situ,RALY,RNA-binding protein Raly,15917,63,1.36 [0.93-1.99],0.1160044698187033
Chapter II Neoplasms,Melanoma in situ,RANBP1,Ran-specific GTPase-activating protein,15528,62,1.09 [0.68-1.74],0.7195520711517067
Chapter II Neoplasms,Melanoma in situ,RANBP2,E3 SUMO-protein ligase RanBP2,15489,61,0.51 [0.23-1.12],0.0927268094294296
Chapter II Neoplasms,Melanoma in situ,RANGAP1,Ran GTPase-activating protein 1,17977,71,0.84 [0.52-1.35],0.4705962198563918
Chapter II Neoplasms,Melanoma in situ,RAP1A,Ras-related protein Rap-1A,15491,59,0.87 [0.57-1.34],0.5377445241891385
Chapter II Neoplasms,Melanoma in situ,RAPGEF2,Rap guanine nucleotide exchange factor 2,15697,63,1.53 [1.03-2.26],0.0346267931020065
Chapter II Neoplasms,Melanoma in situ,RARRES1,Retinoic acid receptor responder protein 1,17977,71,1.31 [0.76-2.23],0.3281909305283685
Chapter II Neoplasms,Melanoma in situ,RARRES2,Retinoic acid receptor responder protein 2,18518,74,1.16 [0.77-1.74],0.4842285570891004
Chapter II Neoplasms,Melanoma in situ,RASA1,Ras GTPase-activating protein 1,18002,70,1.09 [0.58-2.06],0.7896037651717086
Chapter II Neoplasms,Melanoma in situ,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15421,61,1.04 [0.59-1.82],0.9010439850524248
Chapter II Neoplasms,Melanoma in situ,RASSF2,Ras association domain-containing protein 2,17977,71,0.63 [0.40-1.01],0.0535321225252104
Chapter II Neoplasms,Melanoma in situ,RBFOX3,RNA binding protein fox-1 homolog 3,15952,63,0.63 [0.31-1.27],0.1993989292443782
Chapter II Neoplasms,Melanoma in situ,RBKS,Ribokinase,17971,68,1.10 [0.71-1.70],0.6755987078876561
Chapter II Neoplasms,Melanoma in situ,RBM17,Splicing factor 45,15952,63,1.26 [0.93-1.70],0.1349447072417358
Chapter II Neoplasms,Melanoma in situ,RBM19,Probable RNA-binding protein 19,15452,62,0.63 [0.32-1.24],0.1803682194609079
Chapter II Neoplasms,Melanoma in situ,RBM25,RNA-binding protein 25,15421,61,1.13 [0.67-1.90],0.6409800301005569
Chapter II Neoplasms,Melanoma in situ,RBP1,Retinol-binding protein 1,15567,63,0.90 [0.61-1.32],0.5810777237347444
Chapter II Neoplasms,Melanoma in situ,RBP2,Retinol-binding protein 2,18305,72,1.06 [0.81-1.39],0.6625069429859324
Chapter II Neoplasms,Melanoma in situ,RBP5,Retinol-binding protein 5,18305,72,0.91 [0.61-1.35],0.6298546686049231
Chapter II Neoplasms,Melanoma in situ,RBP7,Retinoid-binding protein 7,15920,63,1.06 [0.73-1.56],0.748686129541206
Chapter II Neoplasms,Melanoma in situ,RBPMS,RNA-binding protein with multiple splicing,15491,59,0.87 [0.56-1.35],0.5447715963292004
Chapter II Neoplasms,Melanoma in situ,RBPMS2,RNA-binding protein with multiple splicing 2,15528,62,1.20 [0.94-1.52],0.1374235676439338
Chapter II Neoplasms,Melanoma in situ,RCC1,Regulator of chromosome condensation,15917,63,1.14 [0.74-1.77],0.5559627883368856
Chapter II Neoplasms,Melanoma in situ,RCOR1,REST corepressor 1,18071,70,0.95 [0.56-1.61],0.8598933113041565
Chapter II Neoplasms,Melanoma in situ,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15528,62,0.32 [0.11-0.94],0.0383739784490976
Chapter II Neoplasms,Melanoma in situ,REEP4,Receptor expression-enhancing protein 4,15952,63,1.23 [0.86-1.77],0.2554260816573582
Chapter II Neoplasms,Melanoma in situ,REG1A,Lithostathine-1-alpha,18310,74,1.14 [0.75-1.71],0.5449851939040278
Chapter II Neoplasms,Melanoma in situ,REG1B,Lithostathine-1-beta,18626,75,1.25 [0.89-1.74],0.2001146766178554
Chapter II Neoplasms,Melanoma in situ,REG3A,Regenerating islet-derived protein 3-alpha,18626,75,0.96 [0.69-1.34],0.8077239427843667
Chapter II Neoplasms,Melanoma in situ,REG3G,Regenerating islet-derived protein 3-gamma,15917,63,0.90 [0.48-1.67],0.7332483475101959
Chapter II Neoplasms,Melanoma in situ,REG4,Regenerating islet-derived protein 4,18395,74,0.89 [0.59-1.35],0.5936282145268703
Chapter II Neoplasms,Melanoma in situ,RELB,Transcription factor RelB,15491,59,1.00 [0.58-1.72],0.994818365611464
Chapter II Neoplasms,Melanoma in situ,RELT,Tumor necrosis factor receptor superfamily member 19L,18396,74,1.14 [0.56-2.32],0.7096150008010285
Chapter II Neoplasms,Melanoma in situ,REN,Renin,18395,74,0.94 [0.73-1.22],0.6542727371482366
Chapter II Neoplasms,Melanoma in situ,REPS1,RalBP1-associated Eps domain-containing protein 1,15491,59,1.43 [0.84-2.45],0.1903922562303708
Chapter II Neoplasms,Melanoma in situ,REST,RE1-silencing transcription factor,15421,61,0.97 [0.48-1.97],0.9382418852561236
Chapter II Neoplasms,Melanoma in situ,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18305,72,0.50 [0.29-0.87],0.0141857431599808
Chapter II Neoplasms,Melanoma in situ,RETN,Resistin,18362,73,0.75 [0.45-1.24],0.2600522977224067
Chapter II Neoplasms,Melanoma in situ,REXO2,"Oligoribonuclease, mitochondrial",15452,62,0.52 [0.25-1.07],0.0742109827352704
Chapter II Neoplasms,Melanoma in situ,RFC4,Replication factor C subunit 4,15917,63,1.26 [0.42-3.78],0.6799505414099118
Chapter II Neoplasms,Melanoma in situ,RGCC,Regulator of cell cycle RGCC,15952,63,1.03 [0.76-1.42],0.8341790453380511
Chapter II Neoplasms,Melanoma in situ,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15697,63,1.11 [0.79-1.56],0.5402529294268537
Chapter II Neoplasms,Melanoma in situ,RGMA,Repulsive guidance molecule A,18561,75,0.63 [0.33-1.21],0.1652241002634774
Chapter II Neoplasms,Melanoma in situ,RGMB,RGM domain family member B,18561,75,0.45 [0.21-0.98],0.0443538303552143
Chapter II Neoplasms,Melanoma in situ,RGS10,Regulator of G-protein signaling 10,15952,63,1.11 [0.74-1.67],0.6007027792135625
Chapter II Neoplasms,Melanoma in situ,RGS8,Regulator of G-protein signaling 8,18088,71,0.95 [0.68-1.33],0.7789291603237554
Chapter II Neoplasms,Melanoma in situ,RHOC,Rho-related GTP-binding protein RhoC,18147,69,1.15 [0.95-1.38],0.1530946818731939
Chapter II Neoplasms,Melanoma in situ,RICTOR,Rapamycin-insensitive companion of mTOR,15491,59,1.22 [0.80-1.88],0.3552925367093695
Chapter II Neoplasms,Melanoma in situ,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15623,63,0.88 [0.53-1.46],0.614926686188116
Chapter II Neoplasms,Melanoma in situ,RILP,Rab-interacting lysosomal protein,18520,74,1.27 [0.90-1.79],0.1701269861557808
Chapter II Neoplasms,Melanoma in situ,RILPL2,RILP-like protein 2,15975,64,1.15 [0.90-1.48],0.2610512472519554
Chapter II Neoplasms,Melanoma in situ,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15452,62,0.77 [0.49-1.21],0.2576929458615369
Chapter II Neoplasms,Melanoma in situ,RLN1,Prorelaxin H1,15952,63,1.29 [0.89-1.85],0.1776970566036295
Chapter II Neoplasms,Melanoma in situ,RLN2,Prorelaxin H2,15599,63,0.90 [0.55-1.46],0.6600762436941341
Chapter II Neoplasms,Melanoma in situ,RNASE1,Ribonuclease pancreatic,15994,64,0.57 [0.21-1.57],0.2772494756231521
Chapter II Neoplasms,Melanoma in situ,RNASE10,Inactive ribonuclease-like protein 10,15528,62,0.97 [0.58-1.64],0.9226363982283836
Chapter II Neoplasms,Melanoma in situ,RNASE3,Eosinophil cationic protein,18306,74,0.91 [0.75-1.10],0.3326775136081613
Chapter II Neoplasms,Melanoma in situ,RNASE4,Ribonuclease 4,15485,58,0.47 [0.17-1.25],0.1310997733520853
Chapter II Neoplasms,Melanoma in situ,RNASE6,Ribonuclease K6,15887,64,0.57 [0.23-1.43],0.232887124249021
Chapter II Neoplasms,Melanoma in situ,RNASEH2A,Ribonuclease H2 subunit A,15952,63,0.85 [0.50-1.43],0.531780124405179
Chapter II Neoplasms,Melanoma in situ,RNASET2,Ribonuclease T2,18541,74,1.39 [0.65-2.99],0.3984839553772117
Chapter II Neoplasms,Melanoma in situ,RNF149,E3 ubiquitin-protein ligase RNF149,15528,62,0.92 [0.41-2.06],0.8462560293470377
Chapter II Neoplasms,Melanoma in situ,RNF168,E3 ubiquitin-protein ligase RNF168,15491,59,0.74 [0.37-1.48],0.4022085841296182
Chapter II Neoplasms,Melanoma in situ,RNF31,E3 ubiquitin-protein ligase RNF31,15491,59,1.16 [0.62-2.16],0.6409717195595991
Chapter II Neoplasms,Melanoma in situ,RNF4,E3 ubiquitin-protein ligase RNF4,15697,63,1.05 [0.75-1.46],0.7947022157360288
Chapter II Neoplasms,Melanoma in situ,RNF41,E3 ubiquitin-protein ligase NRDP1,17977,71,1.33 [0.98-1.79],0.0648122689533763
Chapter II Neoplasms,Melanoma in situ,RNF43,E3 ubiquitin-protein ligase RNF43,15697,63,0.62 [0.34-1.15],0.129825056443698
Chapter II Neoplasms,Melanoma in situ,RNF5,E3 ubiquitin-protein ligase RNF5,15528,62,1.16 [0.82-1.64],0.4024050361271051
Chapter II Neoplasms,Melanoma in situ,ROBO1,Roundabout homolog 1,18395,74,0.74 [0.30-1.79],0.5031285515554014
Chapter II Neoplasms,Melanoma in situ,ROBO2,Roundabout homolog 2,18561,75,0.70 [0.28-1.77],0.4508135349955209
Chapter II Neoplasms,Melanoma in situ,ROBO4,Roundabout homolog 4,15528,62,0.59 [0.15-2.31],0.452165081108947
Chapter II Neoplasms,Melanoma in situ,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18395,74,0.87 [0.45-1.69],0.6906420408029058
Chapter II Neoplasms,Melanoma in situ,RP2,Protein XRP2,18305,72,0.98 [0.60-1.60],0.9251524226872654
Chapter II Neoplasms,Melanoma in situ,RPA2,Replication protein A 32 kDa subunit,15491,59,1.13 [0.51-2.50],0.7554829539761445
Chapter II Neoplasms,Melanoma in situ,RPE,Ribulose-phosphate 3-epimerase,15697,63,1.03 [0.74-1.43],0.8827753939473272
Chapter II Neoplasms,Melanoma in situ,RPGR,X-linked retinitis pigmentosa GTPase regulator,15567,63,0.65 [0.33-1.28],0.214379666090413
Chapter II Neoplasms,Melanoma in situ,RPL14,60S ribosomal protein L14,15528,62,1.21 [0.67-2.17],0.5327913610527619
Chapter II Neoplasms,Melanoma in situ,RPS10,40S ribosomal protein S10,15452,62,0.61 [0.29-1.26],0.1791085859724008
Chapter II Neoplasms,Melanoma in situ,RRAS,Ras-related protein R-Ras,15567,63,1.07 [0.89-1.29],0.4710049312493629
Chapter II Neoplasms,Melanoma in situ,RRM2,Ribonucleoside-diphosphate reductase subunit M2,17977,71,1.29 [0.89-1.88],0.1802701627230818
Chapter II Neoplasms,Melanoma in situ,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,17977,71,1.12 [0.82-1.53],0.4758413812666534
Chapter II Neoplasms,Melanoma in situ,RRP15,RRP15-like protein,15489,61,1.05 [0.80-1.37],0.7401895213664587
Chapter II Neoplasms,Melanoma in situ,RSPO1,R-spondin-1,18242,69,1.45 [0.79-2.68],0.2323819801106826
Chapter II Neoplasms,Melanoma in situ,RSPO3,R-spondin-3,18569,74,0.42 [0.19-0.93],0.0317339522320486
Chapter II Neoplasms,Melanoma in situ,RTBDN,Retbindin,18305,72,1.05 [0.50-2.18],0.9003008200329583
Chapter II Neoplasms,Melanoma in situ,RTKN2,Rhotekin-2,15452,62,0.86 [0.49-1.49],0.5824639508496854
Chapter II Neoplasms,Melanoma in situ,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",15952,63,1.09 [0.84-1.41],0.5024037186213888
Chapter II Neoplasms,Melanoma in situ,RTN4R,Reticulon-4 receptor,18569,74,0.82 [0.43-1.54],0.5317910345493265
Chapter II Neoplasms,Melanoma in situ,RUVBL1,RuvB-like 1,17977,71,1.11 [0.92-1.34],0.2630619884070517
Chapter II Neoplasms,Melanoma in situ,RWDD1,RWD domain-containing protein 1,18561,75,1.28 [0.93-1.78],0.1300142386242809
Chapter II Neoplasms,Melanoma in situ,RYR1,Ryanodine receptor 1,15452,62,0.57 [0.24-1.35],0.2032210470687776
Chapter II Neoplasms,Melanoma in situ,S100A11,Protein S100-A11,18259,73,0.87 [0.54-1.40],0.5541003685830124
Chapter II Neoplasms,Melanoma in situ,S100A12,Protein S100-A12,18127,69,0.91 [0.68-1.22],0.5229209466434636
Chapter II Neoplasms,Melanoma in situ,S100A13,Protein S100-A13,15491,59,0.84 [0.40-1.78],0.654689773858522
Chapter II Neoplasms,Melanoma in situ,S100A14,Protein S100-A14,15952,63,0.86 [0.53-1.41],0.5509564421549231
Chapter II Neoplasms,Melanoma in situ,S100A16,Protein S100-A16,17972,70,1.09 [0.78-1.52],0.6030759467858421
Chapter II Neoplasms,Melanoma in situ,S100A3,Protein S100-A3,15917,63,0.75 [0.37-1.53],0.4272582433614638
Chapter II Neoplasms,Melanoma in situ,S100A4,Protein S100-A4,18439,74,1.15 [0.80-1.67],0.4519272600425648
Chapter II Neoplasms,Melanoma in situ,S100G,Protein S100-G,15952,63,0.82 [0.49-1.37],0.4401336971422491
Chapter II Neoplasms,Melanoma in situ,S100P,Protein S100-P,18071,70,1.08 [0.75-1.56],0.6679999304904835
Chapter II Neoplasms,Melanoma in situ,SAA4,Serum amyloid A-4 protein,15998,64,1.35 [0.80-2.29],0.2650787404562577
Chapter II Neoplasms,Melanoma in situ,SAFB2,Scaffold attachment factor B2,15952,63,0.87 [0.35-2.19],0.7707159057037907
Chapter II Neoplasms,Melanoma in situ,SAG,S-arrestin,15489,61,0.93 [0.57-1.52],0.763061994714225
Chapter II Neoplasms,Melanoma in situ,SAMD9L,Sterile alpha motif domain-containing protein 9-like,18389,73,1.16 [0.88-1.54],0.2904904620468445
Chapter II Neoplasms,Melanoma in situ,SAP18,Histone deacetylase complex subunit SAP18,15697,63,1.13 [0.85-1.50],0.3974005497652615
Chapter II Neoplasms,Melanoma in situ,SARG,Specifically androgen-regulated gene protein,15926,63,1.13 [0.90-1.41],0.2861801266691183
Chapter II Neoplasms,Melanoma in situ,SART1,U4/U6.U5 tri-snRNP-associated protein 1,15452,62,0.77 [0.35-1.70],0.516946684294436
Chapter II Neoplasms,Melanoma in situ,SAT1,Diamine acetyltransferase 1,15452,62,0.94 [0.56-1.58],0.8140457892002245
Chapter II Neoplasms,Melanoma in situ,SAT2,Thialysine N-epsilon-acetyltransferase,15697,63,0.67 [0.43-1.05],0.078946915576504
Chapter II Neoplasms,Melanoma in situ,SATB1,DNA-binding protein SATB1,15952,63,0.85 [0.36-2.02],0.7114487771219169
Chapter II Neoplasms,Melanoma in situ,SBSN,Suprabasin,15953,64,0.86 [0.44-1.70],0.6674900360751347
Chapter II Neoplasms,Melanoma in situ,SCAMP3,Secretory carrier-associated membrane protein 3,18305,72,1.17 [0.92-1.49],0.2066285291520485
Chapter II Neoplasms,Melanoma in situ,SCARA5,Scavenger receptor class A member 5,18561,75,0.48 [0.25-0.93],0.0297892359196534
Chapter II Neoplasms,Melanoma in situ,SCARB1,Scavenger receptor class B member 1,18002,70,1.18 [0.86-1.62],0.2967995834783988
Chapter II Neoplasms,Melanoma in situ,SCARB2,Lysosome membrane protein 2,17891,68,1.05 [0.51-2.16],0.8926932552922773
Chapter II Neoplasms,Melanoma in situ,SCARF1,Scavenger receptor class F member 1,18626,75,1.33 [0.83-2.14],0.2397517844035253
Chapter II Neoplasms,Melanoma in situ,SCARF2,Scavenger receptor class F member 2,18561,75,0.76 [0.36-1.59],0.4699652984587698
Chapter II Neoplasms,Melanoma in situ,SCG2,Secretogranin-2,18492,74,0.94 [0.50-1.79],0.861412452098595
Chapter II Neoplasms,Melanoma in situ,SCG3,Secretogranin-3,18395,74,0.81 [0.44-1.51],0.5081124824900569
Chapter II Neoplasms,Melanoma in situ,SCGB1A1,Uteroglobin,18402,74,0.87 [0.59-1.28],0.4745304383108696
Chapter II Neoplasms,Melanoma in situ,SCGB2A2,Mammaglobin-A,15452,62,0.72 [0.29-1.79],0.4787219083113695
Chapter II Neoplasms,Melanoma in situ,SCGB3A1,Secretoglobin family 3A member 1,15623,63,1.29 [0.51-3.25],0.5910226840101984
Chapter II Neoplasms,Melanoma in situ,SCGB3A2,Secretoglobin family 3A member 2,18434,74,0.92 [0.70-1.21],0.5413300897209411
Chapter II Neoplasms,Melanoma in situ,SCGN,Secretagogin,18088,71,1.03 [0.64-1.67],0.8915764800021517
Chapter II Neoplasms,Melanoma in situ,SCIN,Adseverin,15489,61,0.95 [0.68-1.33],0.7603689128213637
Chapter II Neoplasms,Melanoma in situ,SCLY,Selenocysteine lyase,18520,74,1.06 [0.68-1.66],0.7904791397679996
Chapter II Neoplasms,Melanoma in situ,SCN2A,Sodium channel protein type 2 subunit alpha,15489,61,1.04 [0.63-1.70],0.8885846039811511
Chapter II Neoplasms,Melanoma in situ,SCN2B,Sodium channel subunit beta-2,15567,63,1.31 [0.57-3.04],0.5288080525766338
Chapter II Neoplasms,Melanoma in situ,SCN3A,Sodium channel protein type 3 subunit alpha,15567,63,0.80 [0.37-1.69],0.5514150523035366
Chapter II Neoplasms,Melanoma in situ,SCN3B,Sodium channel subunit beta-3,15489,61,0.71 [0.38-1.31],0.2749636816055953
Chapter II Neoplasms,Melanoma in situ,SCN4B,Sodium channel subunit beta-4,15528,62,0.88 [0.49-1.57],0.6623481664758429
Chapter II Neoplasms,Melanoma in situ,SCP2,Non-specific lipid-transfer protein,17977,71,0.73 [0.51-1.05],0.0938836546984654
Chapter II Neoplasms,Melanoma in situ,SCPEP1,Retinoid-inducible serine carboxypeptidase,15478,62,1.24 [0.77-2.01],0.3773600872225131
Chapter II Neoplasms,Melanoma in situ,SCRG1,Scrapie-responsive protein 1,15975,64,0.54 [0.21-1.38],0.1956640397944312
Chapter II Neoplasms,Melanoma in situ,SCRIB,Protein scribble homolog,15528,62,1.04 [0.80-1.35],0.7829093538401253
Chapter II Neoplasms,Melanoma in situ,SCRN1,Secernin-1,18389,73,1.35 [0.95-1.92],0.0989379026907705
Chapter II Neoplasms,Melanoma in situ,SCT,Secretin,15567,63,0.88 [0.52-1.47],0.6182155767759214
Chapter II Neoplasms,Melanoma in situ,SDC1,Syndecan-1,18395,74,1.11 [0.66-1.86],0.7068590393653142
Chapter II Neoplasms,Melanoma in situ,SDC4,Syndecan-4,18395,74,1.37 [0.87-2.15],0.1699768753499009
Chapter II Neoplasms,Melanoma in situ,SDCCAG8,Serologically defined colon cancer antigen 8,15917,63,1.14 [0.92-1.41],0.2423723747592099
Chapter II Neoplasms,Melanoma in situ,SDHB,Succinate dehydrogenase,15920,63,0.79 [0.51-1.23],0.3025208441981011
Chapter II Neoplasms,Melanoma in situ,SDK2,Protein sidekick-2,15623,63,0.51 [0.26-0.99],0.0468126642431296
Chapter II Neoplasms,Melanoma in situ,SEC31A,Protein transport protein Sec31A,15528,62,1.17 [0.85-1.62],0.3467580944827041
Chapter II Neoplasms,Melanoma in situ,SEL1L,Protein sel-1 homolog 1,15528,62,1.11 [0.52-2.37],0.7943819103409043
Chapter II Neoplasms,Melanoma in situ,SELE,E-selectin,18626,75,0.91 [0.60-1.36],0.6330557886802677
Chapter II Neoplasms,Melanoma in situ,SELENOP,Selenoprotein P,15998,64,0.85 [0.30-2.42],0.7545229165718708
Chapter II Neoplasms,Melanoma in situ,SELL,L-selectin,15998,64,0.81 [0.28-2.35],0.695729668471456
Chapter II Neoplasms,Melanoma in situ,SELP,P-selectin,18485,74,1.12 [0.78-1.60],0.5552523776890546
Chapter II Neoplasms,Melanoma in situ,SELPLG,P-selectin glycoprotein ligand 1,18389,73,1.00 [0.45-2.24],0.999091648086452
Chapter II Neoplasms,Melanoma in situ,SEMA3F,Semaphorin-3F,18395,74,0.66 [0.30-1.48],0.318490238128736
Chapter II Neoplasms,Melanoma in situ,SEMA3G,Semaphorin-3G,15623,63,0.82 [0.46-1.45],0.4889102439091467
Chapter II Neoplasms,Melanoma in situ,SEMA4C,Semaphorin-4C,18305,72,1.78 [1.13-2.80],0.0124723339957814
Chapter II Neoplasms,Melanoma in situ,SEMA4D,Semaphorin-4D,18561,75,1.65 [0.83-3.27],0.1530183717757526
Chapter II Neoplasms,Melanoma in situ,SEMA6C,Semaphorin-6C,15491,59,0.76 [0.27-2.13],0.6016533218716968
Chapter II Neoplasms,Melanoma in situ,SEMA7A,Semaphorin-7A,18566,75,0.81 [0.37-1.76],0.5966361454983737
Chapter II Neoplasms,Melanoma in situ,SEPTIN3,Neuronal-specific septin-3,15952,63,0.94 [0.68-1.30],0.6978869708248561
Chapter II Neoplasms,Melanoma in situ,SEPTIN7,Septin-7,15697,63,1.11 [0.75-1.65],0.59677399271399
Chapter II Neoplasms,Melanoma in situ,SEPTIN8,Septin-8,15912,63,0.76 [0.34-1.71],0.5026753759903075
Chapter II Neoplasms,Melanoma in situ,SEPTIN9,Septin-9,18305,72,0.84 [0.40-1.78],0.6527185214503353
Chapter II Neoplasms,Melanoma in situ,SERPINA1,Alpha-1-antitrypsin,15705,63,1.03 [0.06-18.74],0.9820513239681226
Chapter II Neoplasms,Melanoma in situ,SERPINA11,Serpin A11,18626,75,0.93 [0.57-1.52],0.7754937681971872
Chapter II Neoplasms,Melanoma in situ,SERPINA12,Serpin A12,17879,71,0.94 [0.75-1.19],0.6242653712544135
Chapter II Neoplasms,Melanoma in situ,SERPINA3,Alpha-1-antichymotrypsin,15955,64,1.91 [0.55-6.61],0.3081415772811896
Chapter II Neoplasms,Melanoma in situ,SERPINA4,Kallistatin,15710,64,1.69 [0.62-4.63],0.3061344165109317
Chapter II Neoplasms,Melanoma in situ,SERPINA5,Plasma serine protease inhibitor,15763,64,0.93 [0.40-2.13],0.8625475514671704
Chapter II Neoplasms,Melanoma in situ,SERPINA6,Corticosteroid-binding globulin,15998,64,0.42 [0.15-1.15],0.0909170188183789
Chapter II Neoplasms,Melanoma in situ,SERPINA7,Thyroxine-binding globulin,15998,64,1.10 [0.31-3.99],0.8793840940026836
Chapter II Neoplasms,Melanoma in situ,SERPINA9,Serpin A9,18227,71,0.92 [0.68-1.26],0.6044320021995508
Chapter II Neoplasms,Melanoma in situ,SERPINB1,Leukocyte elastase inhibitor,18341,74,1.07 [0.86-1.34],0.5450116046248958
Chapter II Neoplasms,Melanoma in situ,SERPINB5,Serpin B5,18071,70,0.87 [0.56-1.36],0.5506810088773341
Chapter II Neoplasms,Melanoma in situ,SERPINB6,Serpin B6,18499,75,1.13 [0.79-1.60],0.5033088451609984
Chapter II Neoplasms,Melanoma in situ,SERPINB8,Serpin B8,18615,74,0.69 [0.45-1.04],0.0769743605080739
Chapter II Neoplasms,Melanoma in situ,SERPINB9,Serpin B9,18242,69,1.71 [0.89-3.30],0.1071469164690077
Chapter II Neoplasms,Melanoma in situ,SERPINC1,Antithrombin-III,15973,64,3.36 [0.71-15.97],0.1268351583137787
Chapter II Neoplasms,Melanoma in situ,SERPIND1,Heparin cofactor 2,15973,64,1.23 [0.53-2.85],0.6283964302676435
Chapter II Neoplasms,Melanoma in situ,SERPINE1,Plasminogen activator inhibitor 1,18626,75,1.33 [0.97-1.82],0.0734335857771306
Chapter II Neoplasms,Melanoma in situ,SERPINE2,Glia-derived nexin,15975,64,1.39 [0.97-2.00],0.0705801279187397
Chapter II Neoplasms,Melanoma in situ,SERPINF1,Pigment epithelium-derived factor,15762,63,0.86 [0.34-2.17],0.7426387867906716
Chapter II Neoplasms,Melanoma in situ,SERPINF2,Alpha-2-antiplasmin,15695,63,4.35 [0.81-23.40],0.0866063779933487
Chapter II Neoplasms,Melanoma in situ,SERPING1,Plasma protease C1 inhibitor,15973,64,0.65 [0.17-2.41],0.5173895440748137
Chapter II Neoplasms,Melanoma in situ,SERPINH1,Serpin H1,15697,63,1.05 [0.87-1.28],0.5814803232508909
Chapter II Neoplasms,Melanoma in situ,SERPINI1,Neuroserpin,15596,63,0.62 [0.26-1.50],0.286559253290217
Chapter II Neoplasms,Melanoma in situ,SERPINI2,Serpin I2,15920,63,0.90 [0.57-1.42],0.6505833988805201
Chapter II Neoplasms,Melanoma in situ,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18002,70,1.06 [0.77-1.48],0.7071583217374402
Chapter II Neoplasms,Melanoma in situ,SETMAR,Histone-lysine N-methyltransferase SETMAR,18174,68,0.93 [0.45-1.93],0.8450587819491525
Chapter II Neoplasms,Melanoma in situ,SEZ6,Seizure protein 6 homolog,15567,63,0.69 [0.30-1.59],0.3859905982212784
Chapter II Neoplasms,Melanoma in situ,SEZ6L,Seizure 6-like protein,18439,74,0.53 [0.25-1.12],0.0970883445462282
Chapter II Neoplasms,Melanoma in situ,SEZ6L2,Seizure 6-like protein 2,18305,72,0.47 [0.19-1.18],0.1065621353274343
Chapter II Neoplasms,Melanoma in situ,SF3B4,Splicing factor 3B subunit 4,18305,72,1.03 [0.78-1.37],0.8335808445230126
Chapter II Neoplasms,Melanoma in situ,SFRP1,Secreted frizzled-related protein 1,18175,69,0.99 [0.59-1.65],0.9669770295518756
Chapter II Neoplasms,Melanoma in situ,SFRP4,Secreted frizzled-related protein 4,15623,63,1.32 [0.71-2.45],0.3869555076703432
Chapter II Neoplasms,Melanoma in situ,SFTPA1,Pulmonary surfactant-associated protein A1,17977,71,0.79 [0.50-1.23],0.2992262955946484
Chapter II Neoplasms,Melanoma in situ,SFTPA2,Pulmonary surfactant-associated protein A2,17977,71,0.99 [0.65-1.50],0.9583589254558408
Chapter II Neoplasms,Melanoma in situ,SFTPD,Pulmonary surfactant-associated protein D,18395,74,0.79 [0.58-1.08],0.1342250874013723
Chapter II Neoplasms,Melanoma in situ,SGSH,N-sulphoglucosamine sulphohydrolase,15726,63,0.84 [0.53-1.31],0.4354525579827689
Chapter II Neoplasms,Melanoma in situ,SH2B3,SH2B adapter protein 3,17977,71,1.14 [0.92-1.42],0.2412434272560054
Chapter II Neoplasms,Melanoma in situ,SH2D1A,SH2 domain-containing protein 1A,18389,73,0.79 [0.53-1.19],0.2622194805564274
Chapter II Neoplasms,Melanoma in situ,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15489,61,0.87 [0.55-1.38],0.552340485860476
Chapter II Neoplasms,Melanoma in situ,SH3BP1,SH3 domain-binding protein 1,15920,63,0.77 [0.45-1.34],0.3569369761375766
Chapter II Neoplasms,Melanoma in situ,SH3GL3,Endophilin-A3,15601,62,0.87 [0.66-1.14],0.3022492223828345
Chapter II Neoplasms,Melanoma in situ,SH3GLB2,Endophilin-B2,15944,63,1.26 [0.88-1.79],0.2078720589433645
Chapter II Neoplasms,Melanoma in situ,SHBG,Sex hormone-binding globulin,15994,64,0.66 [0.39-1.09],0.1062320393729317
Chapter II Neoplasms,Melanoma in situ,SHC1,SHC-transforming protein 1,15421,61,0.92 [0.73-1.16],0.4705358714297776
Chapter II Neoplasms,Melanoma in situ,SHD,SH2 domain-containing adapter protein D,15424,62,1.00 [0.74-1.34],0.9812162930433096
Chapter II Neoplasms,Melanoma in situ,SHH,Sonic hedgehog protein,15491,59,1.20 [0.71-2.04],0.5022967378066225
Chapter II Neoplasms,Melanoma in situ,SHISA5,Protein shisa-5,15983,64,0.76 [0.28-2.05],0.5821904861094982
Chapter II Neoplasms,Melanoma in situ,SHMT1,"Serine hydroxymethyltransferase, cytosolic",18434,74,1.17 [0.92-1.50],0.2027778403257188
Chapter II Neoplasms,Melanoma in situ,SHPK,Sedoheptulokinase,15697,63,0.48 [0.22-1.05],0.0669454077116529
Chapter II Neoplasms,Melanoma in situ,SIAE,Sialate O-acetylesterase,18410,74,1.13 [0.72-1.77],0.5814108123454322
Chapter II Neoplasms,Melanoma in situ,SIGLEC1,Sialoadhesin,18455,74,1.11 [0.67-1.85],0.6769196163345266
Chapter II Neoplasms,Melanoma in situ,SIGLEC10,Sialic acid-binding Ig-like lectin 10,18389,73,1.30 [0.69-2.44],0.4203344609074353
Chapter II Neoplasms,Melanoma in situ,SIGLEC15,Sialic acid-binding Ig-like lectin 15,18002,70,1.19 [0.94-1.52],0.1446319877360347
Chapter II Neoplasms,Melanoma in situ,SIGLEC5,Sialic acid-binding Ig-like lectin 5,18396,74,1.14 [0.93-1.41],0.2138394563840396
Chapter II Neoplasms,Melanoma in situ,SIGLEC6,Sialic acid-binding Ig-like lectin 6,18569,74,1.16 [0.62-2.19],0.6402484683455041
Chapter II Neoplasms,Melanoma in situ,SIGLEC7,Sialic acid-binding Ig-like lectin 7,18395,74,1.22 [0.58-2.57],0.6023958768526648
Chapter II Neoplasms,Melanoma in situ,SIGLEC8,Sialic acid-binding Ig-like lectin 8,15528,62,1.71 [1.00-2.91],0.0482990343901269
Chapter II Neoplasms,Melanoma in situ,SIGLEC9,Sialic acid-binding Ig-like lectin 9,18543,74,0.98 [0.49-1.95],0.954187455955818
Chapter II Neoplasms,Melanoma in situ,SIL1,Nucleotide exchange factor SIL1,15528,62,1.44 [0.85-2.44],0.1718150200065151
Chapter II Neoplasms,Melanoma in situ,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18444,74,0.98 [0.69-1.41],0.9285136477174192
Chapter II Neoplasms,Melanoma in situ,SIRPB1,Signal-regulatory protein beta-1,18331,74,1.10 [0.71-1.69],0.6816705282375847
Chapter II Neoplasms,Melanoma in situ,SIRT1,NAD-dependent protein deacetylase sirtuin-1,15491,59,0.93 [0.68-1.28],0.6765625589387894
Chapter II Neoplasms,Melanoma in situ,SIRT2,NAD-dependent protein deacetylase sirtuin-2,18305,72,1.17 [0.92-1.49],0.1893933175171098
Chapter II Neoplasms,Melanoma in situ,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18002,70,0.96 [0.64-1.45],0.847170941040515
Chapter II Neoplasms,Melanoma in situ,SIT1,Signaling threshold-regulating transmembrane adapter 1,18088,71,0.89 [0.60-1.32],0.5705812020714777
Chapter II Neoplasms,Melanoma in situ,SKAP1,Src kinase-associated phosphoprotein 1,18214,69,0.93 [0.69-1.25],0.6333814645109546
Chapter II Neoplasms,Melanoma in situ,SKAP2,Src kinase-associated phosphoprotein 2,18455,74,1.05 [0.86-1.28],0.605557004107144
Chapter II Neoplasms,Melanoma in situ,SKIV2L,Helicase SKI2W,15452,62,1.18 [0.67-2.07],0.5635689653532651
Chapter II Neoplasms,Melanoma in situ,SLA2,Src-like-adapter 2,15952,63,1.08 [0.86-1.36],0.5201060075516177
Chapter II Neoplasms,Melanoma in situ,SLAMF1,Signaling lymphocytic activation molecule,18088,71,0.91 [0.64-1.30],0.6149546903507072
Chapter II Neoplasms,Melanoma in situ,SLAMF6,SLAM family member 6,17977,71,1.14 [0.65-2.02],0.642503207229782
Chapter II Neoplasms,Melanoma in situ,SLAMF7,SLAM family member 7,18389,73,0.85 [0.59-1.22],0.3658662304386115
Chapter II Neoplasms,Melanoma in situ,SLAMF8,SLAM family member 8,17977,71,0.68 [0.47-0.98],0.0405833044338719
Chapter II Neoplasms,Melanoma in situ,SLC12A2,Solute carrier family 12 member 2,15452,62,0.39 [0.14-1.08],0.0706762519785794
Chapter II Neoplasms,Melanoma in situ,SLC13A1,Solute carrier family 13 member 1,15917,63,1.19 [0.85-1.65],0.3105828616488964
Chapter II Neoplasms,Melanoma in situ,SLC16A1,Monocarboxylate transporter 1,18002,70,0.64 [0.40-1.03],0.0640710742318455
Chapter II Neoplasms,Melanoma in situ,SLC1A4,Neutral amino acid transporter A,15567,63,0.49 [0.26-0.93],0.0289375150811808
Chapter II Neoplasms,Melanoma in situ,SLC27A4,Long-chain fatty acid transport protein 4,18002,70,1.12 [0.83-1.51],0.473352850174071
Chapter II Neoplasms,Melanoma in situ,SLC28A1,Sodium/nucleoside cotransporter 1,15421,61,0.94 [0.61-1.45],0.7779066156485388
Chapter II Neoplasms,Melanoma in situ,SLC34A3,Sodium-dependent phosphate transport protein 2C,15421,61,1.32 [0.88-2.00],0.1833391360638827
Chapter II Neoplasms,Melanoma in situ,SLC39A14,Zinc transporter ZIP14,18002,70,1.05 [0.56-1.97],0.8845271916981202
Chapter II Neoplasms,Melanoma in situ,SLC39A5,Zinc transporter ZIP5,18389,73,1.03 [0.69-1.55],0.8688032528768779
Chapter II Neoplasms,Melanoma in situ,SLC44A4,Choline transporter-like protein 4,15567,63,1.20 [0.89-1.62],0.2364535898720686
Chapter II Neoplasms,Melanoma in situ,SLC4A1,Band 3 anion transport protein,15983,64,0.69 [0.41-1.16],0.1608625156696691
Chapter II Neoplasms,Melanoma in situ,SLC51B,Organic solute transporter subunit beta,15452,62,1.27 [0.95-1.70],0.1000844733812575
Chapter II Neoplasms,Melanoma in situ,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15623,63,1.04 [0.78-1.38],0.8102178841266259
Chapter II Neoplasms,Melanoma in situ,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,15920,63,0.79 [0.45-1.39],0.4125957874281925
Chapter II Neoplasms,Melanoma in situ,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15421,61,0.90 [0.57-1.43],0.6640239674736346
Chapter II Neoplasms,Melanoma in situ,SLIT2,Slit homolog 2 protein,18002,70,1.18 [0.82-1.69],0.37669481384503
Chapter II Neoplasms,Melanoma in situ,SLITRK1,SLIT and NTRK-like protein 1,15491,59,0.55 [0.25-1.20],0.133948964643454
Chapter II Neoplasms,Melanoma in situ,SLITRK2,SLIT and NTRK-like protein 2,18569,74,1.04 [0.62-1.74],0.8729022926236529
Chapter II Neoplasms,Melanoma in situ,SLITRK6,SLIT and NTRK-like protein 6,18071,70,1.09 [0.59-2.00],0.7870090111018504
Chapter II Neoplasms,Melanoma in situ,SLK,STE20-like serine/threonine-protein kinase,15697,63,0.94 [0.68-1.31],0.7246090742229453
Chapter II Neoplasms,Melanoma in situ,SLMAP,Sarcolemmal membrane-associated protein,15920,63,1.17 [0.88-1.56],0.269883552619611
Chapter II Neoplasms,Melanoma in situ,SLURP1,Secreted Ly-6/uPAR-related protein 1,15870,64,0.93 [0.47-1.86],0.8417379325295355
Chapter II Neoplasms,Melanoma in situ,SMAD1,Mothers against decapentaplegic homolog 1,17977,71,1.16 [0.90-1.49],0.2432837001803112
Chapter II Neoplasms,Melanoma in situ,SMAD2,Mothers against decapentaplegic homolog 2,15917,63,1.18 [0.84-1.65],0.3367038532542762
Chapter II Neoplasms,Melanoma in situ,SMAD3,Mothers against decapentaplegic homolog 3,15917,63,0.95 [0.59-1.52],0.8336332452220788
Chapter II Neoplasms,Melanoma in situ,SMAD5,Mothers against decapentaplegic homolog 5,18305,72,1.43 [0.48-4.24],0.524136398613411
Chapter II Neoplasms,Melanoma in situ,SMARCA2,Probable global transcription activator SNF2L2,18002,70,0.90 [0.66-1.22],0.4959456089793298
Chapter II Neoplasms,Melanoma in situ,SMC3,Structural maintenance of chromosomes protein 3,15421,61,0.44 [0.24-0.79],0.0065725222499349
Chapter II Neoplasms,Melanoma in situ,SMNDC1,Survival of motor neuron-related-splicing factor 30,15920,63,1.10 [0.77-1.59],0.5939965375768543
Chapter II Neoplasms,Melanoma in situ,SMOC1,SPARC-related modular calcium-binding protein 1,18569,74,1.06 [0.56-2.01],0.8549801580450043
Chapter II Neoplasms,Melanoma in situ,SMOC2,SPARC-related modular calcium-binding protein 2,18455,74,0.49 [0.28-0.86],0.0129033684948298
Chapter II Neoplasms,Melanoma in situ,SMPD1,Sphingomyelin phosphodiesterase,18468,75,0.74 [0.49-1.13],0.1634763834364265
Chapter II Neoplasms,Melanoma in situ,SMPD3,Sphingomyelin phosphodiesterase 3,15491,59,0.97 [0.62-1.51],0.8795720730684681
Chapter II Neoplasms,Melanoma in situ,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18421,74,0.83 [0.62-1.13],0.2366818436055401
Chapter II Neoplasms,Melanoma in situ,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,15917,63,1.02 [0.75-1.39],0.8772765332306321
Chapter II Neoplasms,Melanoma in situ,SMS,Spermine synthase,15489,61,1.01 [0.69-1.48],0.9588717628663443
Chapter II Neoplasms,Melanoma in situ,SMTN,Smoothelin,15912,63,1.24 [0.97-1.59],0.08265100195366
Chapter II Neoplasms,Melanoma in situ,SNAP23,Synaptosomal-associated protein 23,18395,74,1.12 [0.88-1.42],0.3786275249773797
Chapter II Neoplasms,Melanoma in situ,SNAP25,Synaptosomal-associated protein 25,15489,61,1.11 [0.66-1.86],0.692897102193318
Chapter II Neoplasms,Melanoma in situ,SNAP29,Synaptosomal-associated protein 29,18439,74,1.18 [0.94-1.48],0.1423458216069313
Chapter II Neoplasms,Melanoma in situ,SNAPIN,SNARE-associated protein Snapin,15952,63,1.10 [0.73-1.67],0.6380543877139777
Chapter II Neoplasms,Melanoma in situ,SNCA,Alpha-synuclein,15623,63,1.13 [0.92-1.40],0.2470888179331045
Chapter II Neoplasms,Melanoma in situ,SNCG,Gamma-synuclein,18242,69,0.68 [0.50-0.92],0.0129694466483606
Chapter II Neoplasms,Melanoma in situ,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15528,62,0.81 [0.36-1.82],0.6138659124090879
Chapter II Neoplasms,Melanoma in situ,SNRPB2,U2 small nuclear ribonucleoprotein B'',15944,63,0.54 [0.24-1.22],0.1382937533124509
Chapter II Neoplasms,Melanoma in situ,SNU13,NHP2-like protein 1,15452,62,0.82 [0.51-1.30],0.3932228182696863
Chapter II Neoplasms,Melanoma in situ,SNX15,Sorting nexin-15,15623,63,1.41 [0.91-2.18],0.1235862706527241
Chapter II Neoplasms,Melanoma in situ,SNX18,Sorting nexin-18,15920,63,1.07 [0.62-1.84],0.8040104655183316
Chapter II Neoplasms,Melanoma in situ,SNX2,Sorting nexin-2,15917,63,1.07 [0.82-1.40],0.5982424316706932
Chapter II Neoplasms,Melanoma in situ,SNX5,Sorting nexin-5,15528,62,1.45 [0.68-3.12],0.3368240463757733
Chapter II Neoplasms,Melanoma in situ,SNX9,Sorting nexin-9,18395,74,1.13 [0.83-1.53],0.4316674404000137
Chapter II Neoplasms,Melanoma in situ,SOD1,Superoxide dismutase [Cu-Zn],18052,70,0.91 [0.57-1.43],0.6706482965202687
Chapter II Neoplasms,Melanoma in situ,SOD2,"Superoxide dismutase [Mn], mitochondrial",18396,74,0.77 [0.43-1.38],0.3889936929197116
Chapter II Neoplasms,Melanoma in situ,SOD3,Extracellular superoxide dismutase,15994,64,0.62 [0.32-1.20],0.1560403126297341
Chapter II Neoplasms,Melanoma in situ,SORBS1,Sorbin and SH3 domain-containing protein 1,15952,63,0.90 [0.46-1.74],0.7468899744596432
Chapter II Neoplasms,Melanoma in situ,SORCS2,VPS10 domain-containing receptor SorCS2,17977,71,0.73 [0.39-1.37],0.3328522102480247
Chapter II Neoplasms,Melanoma in situ,SORD,Sorbitol dehydrogenase,18487,74,0.94 [0.70-1.28],0.702076931008213
Chapter II Neoplasms,Melanoma in situ,SORT1,Sortilin,18375,74,1.70 [1.00-2.87],0.0490033913464405
Chapter II Neoplasms,Melanoma in situ,SOST,Sclerostin,18375,74,0.68 [0.40-1.15],0.1510072186805828
Chapter II Neoplasms,Melanoma in situ,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15567,63,0.96 [0.58-1.58],0.8612133265416511
Chapter II Neoplasms,Melanoma in situ,SOX2,Transcription factor SOX-2,15913,62,1.01 [0.37-2.73],0.9830221776996764
Chapter II Neoplasms,Melanoma in situ,SOX9,Transcription factor SOX-9,15567,63,0.50 [0.27-0.91],0.0227032892070044
Chapter II Neoplasms,Melanoma in situ,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,15952,63,0.67 [0.28-1.63],0.3796177976735783
Chapter II Neoplasms,Melanoma in situ,SPAG1,Sperm-associated antigen 1,15952,63,0.80 [0.50-1.28],0.3447776281977343
Chapter II Neoplasms,Melanoma in situ,SPARC,SPARC,18439,74,1.27 [0.93-1.72],0.1296507409960332
Chapter II Neoplasms,Melanoma in situ,SPARCL1,SPARC-like protein 1,18421,74,0.66 [0.30-1.44],0.2999099467253293
Chapter II Neoplasms,Melanoma in situ,SPART,Spartin,15623,63,1.19 [0.87-1.62],0.2814869257301653
Chapter II Neoplasms,Melanoma in situ,SPESP1,Sperm equatorial segment protein 1,15975,64,1.07 [0.54-2.13],0.8520090371151561
Chapter II Neoplasms,Melanoma in situ,SPINK1,Serine protease inhibitor Kazal-type 1,18396,74,1.00 [0.60-1.67],0.9975322379211604
Chapter II Neoplasms,Melanoma in situ,SPINK2,Serine protease inhibitor Kazal-type 2,15623,63,1.04 [0.51-2.10],0.9228298389466066
Chapter II Neoplasms,Melanoma in situ,SPINK4,Serine protease inhibitor Kazal-type 4,18389,73,0.92 [0.66-1.28],0.6171543491029485
Chapter II Neoplasms,Melanoma in situ,SPINK5,Serine protease inhibitor Kazal-type 5,18396,74,0.46 [0.24-0.85],0.0127844042654563
Chapter II Neoplasms,Melanoma in situ,SPINK6,Serine protease inhibitor Kazal-type 6,18569,74,0.74 [0.50-1.08],0.1201589541083572
Chapter II Neoplasms,Melanoma in situ,SPINK8,Serine protease inhibitor Kazal-type 8,15452,62,0.69 [0.31-1.54],0.364180788538
Chapter II Neoplasms,Melanoma in situ,SPINT1,Kunitz-type protease inhibitor 1,18330,74,0.83 [0.35-1.94],0.6610801337739971
Chapter II Neoplasms,Melanoma in situ,SPINT2,Kunitz-type protease inhibitor 2,18455,74,1.72 [1.02-2.88],0.0402669043614043
Chapter II Neoplasms,Melanoma in situ,SPINT3,Kunitz-type protease inhibitor 3,15920,63,0.93 [0.81-1.08],0.3523582315201905
Chapter II Neoplasms,Melanoma in situ,SPOCK1,Testican-1,18242,69,0.81 [0.36-1.87],0.62686157138654
Chapter II Neoplasms,Melanoma in situ,SPON1,Spondin-1,18395,74,1.09 [0.57-2.08],0.7906789280442998
Chapter II Neoplasms,Melanoma in situ,SPON2,Spondin-2,18314,74,0.53 [0.28-1.01],0.05313818840572
Chapter II Neoplasms,Melanoma in situ,SPP1,Osteopontin,18595,74,0.66 [0.40-1.08],0.095112516602239
Chapter II Neoplasms,Melanoma in situ,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15491,59,1.10 [0.63-1.94],0.7356039622778145
Chapter II Neoplasms,Melanoma in situ,SPRING1,SREBP regulating gene protein,15421,61,0.86 [0.55-1.35],0.5129838186710931
Chapter II Neoplasms,Melanoma in situ,SPRR1B,Cornifin-B,15697,63,0.87 [0.63-1.21],0.4230261516694056
Chapter II Neoplasms,Melanoma in situ,SPRR3,Small proline-rich protein 3,15944,63,0.96 [0.65-1.41],0.8403501583964841
Chapter II Neoplasms,Melanoma in situ,SPRY2,Protein sprouty homolog 2,18088,71,1.01 [0.80-1.28],0.9202337081522972
Chapter II Neoplasms,Melanoma in situ,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15489,61,1.04 [0.49-2.20],0.919838625432024
Chapter II Neoplasms,Melanoma in situ,SPTLC1,Serine palmitoyltransferase 1,15944,63,1.06 [0.60-1.89],0.8315148487692643
Chapter II Neoplasms,Melanoma in situ,SRC,Proto-oncogene tyrosine-protein kinase Src,18410,74,1.12 [0.94-1.34],0.1920656569357697
Chapter II Neoplasms,Melanoma in situ,SRP14,Signal recognition particle 14 kDa protein,18305,72,0.92 [0.65-1.30],0.6247791859263978
Chapter II Neoplasms,Melanoma in situ,SRPK2,SRSF protein kinase 2,18389,73,1.15 [0.91-1.46],0.2361779420490722
Chapter II Neoplasms,Melanoma in situ,SRPX,Sushi repeat-containing protein SRPX,15975,64,0.75 [0.42-1.33],0.3230342688824008
Chapter II Neoplasms,Melanoma in situ,SSB,Lupus La protein,18002,70,1.19 [0.89-1.60],0.2398895942425091
Chapter II Neoplasms,Melanoma in situ,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15491,59,1.23 [0.66-2.31],0.5159237407378139
Chapter II Neoplasms,Melanoma in situ,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18375,74,0.93 [0.78-1.10],0.3787908343863121
Chapter II Neoplasms,Melanoma in situ,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18485,74,0.72 [0.44-1.16],0.1789930218249108
Chapter II Neoplasms,Melanoma in situ,SSH3,Protein phosphatase Slingshot homolog 3,15421,61,0.68 [0.27-1.71],0.4127025505836388
Chapter II Neoplasms,Melanoma in situ,SSNA1,Sjoegren syndrome nuclear autoantigen 1,15920,63,1.23 [0.78-1.94],0.3802406418999298
Chapter II Neoplasms,Melanoma in situ,ST13,Hsc70-interacting protein,15623,63,1.34 [0.86-2.08],0.1933399620123124
Chapter II Neoplasms,Melanoma in situ,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18305,72,1.47 [1.00-2.16],0.0520284268808033
Chapter II Neoplasms,Melanoma in situ,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18626,75,1.62 [0.95-2.76],0.0771393113595501
Chapter II Neoplasms,Melanoma in situ,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15491,59,0.90 [0.53-1.54],0.7042964371326828
Chapter II Neoplasms,Melanoma in situ,STAB2,Stabilin-2,15983,64,1.02 [0.43-2.42],0.9725927643041292
Chapter II Neoplasms,Melanoma in situ,STAM,Signal transducing adapter molecule 1,15917,63,1.13 [0.60-2.15],0.7006673139226949
Chapter II Neoplasms,Melanoma in situ,STAMBP,STAM-binding protein,18214,69,1.24 [0.89-1.73],0.2128816977130407
Chapter II Neoplasms,Melanoma in situ,STAT2,Signal transducer and activator of transcription 2,15491,59,1.33 [0.97-1.82],0.072424618652296
Chapter II Neoplasms,Melanoma in situ,STAT5B,Signal transducer and activator of transcription 5B,18305,72,1.09 [0.94-1.27],0.2595984368523528
Chapter II Neoplasms,Melanoma in situ,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15421,61,1.29 [0.96-1.74],0.0926047108447704
Chapter II Neoplasms,Melanoma in situ,STC1,Stanniocalcin-1,18561,75,0.61 [0.38-1.00],0.050537645524106
Chapter II Neoplasms,Melanoma in situ,STC2,Stanniocalcin-2,18374,74,1.55 [0.64-3.75],0.3297119539505317
Chapter II Neoplasms,Melanoma in situ,STEAP4,Metalloreductase STEAP4,15489,61,1.01 [0.71-1.43],0.9509226831033094
Chapter II Neoplasms,Melanoma in situ,STIP1,Stress-induced-phosphoprotein 1,18361,74,1.15 [0.84-1.57],0.3891944741738208
Chapter II Neoplasms,Melanoma in situ,STK11,Serine/threonine-protein kinase STK11,18071,70,1.07 [0.80-1.44],0.6526789468118557
Chapter II Neoplasms,Melanoma in situ,STK24,Serine/threonine-protein kinase 24,18002,70,1.13 [0.80-1.59],0.4892985538190982
Chapter II Neoplasms,Melanoma in situ,STK4,Serine/threonine-protein kinase 4,18395,74,1.14 [0.90-1.44],0.2905135278961997
Chapter II Neoplasms,Melanoma in situ,STOML2,"Stomatin-like protein 2, mitochondrial",15421,61,1.02 [0.79-1.31],0.8995956457166298
Chapter II Neoplasms,Melanoma in situ,STX16,Syntaxin-16,17977,71,1.10 [0.78-1.55],0.5938202098113184
Chapter II Neoplasms,Melanoma in situ,STX1B,Syntaxin-1B,15567,63,0.73 [0.36-1.50],0.3994755981700011
Chapter II Neoplasms,Melanoma in situ,STX3,Syntaxin-3,15944,63,0.79 [0.39-1.60],0.5043506123130173
Chapter II Neoplasms,Melanoma in situ,STX4,Syntaxin-4,18305,72,1.06 [0.75-1.50],0.7274839691969335
Chapter II Neoplasms,Melanoma in situ,STX5,Syntaxin-5,15491,59,1.27 [0.75-2.16],0.3711783526918532
Chapter II Neoplasms,Melanoma in situ,STX6,Syntaxin-6,17977,71,1.01 [0.73-1.40],0.9518611759196433
Chapter II Neoplasms,Melanoma in situ,STX7,Syntaxin-7,15491,59,1.30 [0.78-2.17],0.3154405750881724
Chapter II Neoplasms,Melanoma in situ,STX8,Syntaxin-8,18389,73,1.19 [0.78-1.81],0.4166335971498234
Chapter II Neoplasms,Melanoma in situ,STXBP1,Syntaxin-binding protein 1,15952,63,1.06 [0.77-1.44],0.7269359431437519
Chapter II Neoplasms,Melanoma in situ,STXBP3,Syntaxin-binding protein 3,17977,71,1.03 [0.63-1.67],0.9148920804166149
Chapter II Neoplasms,Melanoma in situ,SUGP1,SURP and G-patch domain-containing protein 1,15920,63,1.38 [0.79-2.40],0.2543327279673171
Chapter II Neoplasms,Melanoma in situ,SUGT1,Protein SGT1 homolog,17977,71,1.08 [0.82-1.41],0.5868153545454838
Chapter II Neoplasms,Melanoma in situ,SULT1A1,Sulfotransferase 1A1,18561,75,1.05 [0.90-1.23],0.5324664676503703
Chapter II Neoplasms,Melanoma in situ,SULT2A1,Bile salt sulfotransferase,18389,73,0.78 [0.52-1.18],0.2384314941987847
Chapter II Neoplasms,Melanoma in situ,SUMF1,Formylglycine-generating enzyme,15491,59,1.17 [0.84-1.61],0.3521408777335293
Chapter II Neoplasms,Melanoma in situ,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18561,75,1.28 [0.85-1.92],0.2302279348537104
Chapter II Neoplasms,Melanoma in situ,SUOX,"Sulfite oxidase, mitochondrial",15952,63,0.77 [0.50-1.18],0.2316254110431989
Chapter II Neoplasms,Melanoma in situ,SUSD1,Sushi domain-containing protein 1,18071,70,1.09 [0.70-1.70],0.6998093359184936
Chapter II Neoplasms,Melanoma in situ,SUSD2,Sushi domain-containing protein 2,18396,74,0.68 [0.32-1.46],0.3250274941003564
Chapter II Neoplasms,Melanoma in situ,SUSD4,Sushi domain-containing protein 4,15917,63,1.00 [0.54-1.85],0.9908334194973812
Chapter II Neoplasms,Melanoma in situ,SUSD5,Sushi domain-containing protein 5,15551,61,0.78 [0.37-1.63],0.508249067481447
Chapter II Neoplasms,Melanoma in situ,SV2A,Synaptic vesicle glycoprotein 2A,15567,63,1.01 [0.68-1.50],0.9598771496126086
Chapter II Neoplasms,Melanoma in situ,SWAP70,Switch-associated protein 70,15920,63,1.21 [0.65-2.24],0.5458021309941882
Chapter II Neoplasms,Melanoma in situ,SYAP1,Synapse-associated protein 1,15623,63,1.18 [0.79-1.78],0.4200762180660637
Chapter II Neoplasms,Melanoma in situ,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15489,61,0.67 [0.39-1.16],0.1497237258209179
Chapter II Neoplasms,Melanoma in situ,SYT1,Synaptotagmin-1,15944,63,0.84 [0.44-1.62],0.6071738988339426
Chapter II Neoplasms,Melanoma in situ,SYTL4,Synaptotagmin-like protein 4,15975,64,1.24 [0.91-1.69],0.167002832052055
Chapter II Neoplasms,Melanoma in situ,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15697,63,1.14 [0.90-1.44],0.2685890122978217
Chapter II Neoplasms,Melanoma in situ,TACC3,Transforming acidic coiled-coil-containing protein 3,18305,72,1.08 [0.91-1.30],0.3847401961833554
Chapter II Neoplasms,Melanoma in situ,TACSTD2,Tumor-associated calcium signal transducer 2,16304,64,0.65 [0.30-1.42],0.2789472957921295
Chapter II Neoplasms,Melanoma in situ,TADA3,Transcriptional adapter 3,15917,63,1.37 [0.79-2.37],0.2587580240627392
Chapter II Neoplasms,Melanoma in situ,TAFA5,Chemokine-like protein TAFA-5,18305,72,0.70 [0.38-1.28],0.2475717894747657
Chapter II Neoplasms,Melanoma in situ,TAGLN3,Transgelin-3,15421,61,0.98 [0.65-1.48],0.919046117136258
Chapter II Neoplasms,Melanoma in situ,TALDO1,Transaldolase,15935,64,1.30 [0.77-2.21],0.3244605932952968
Chapter II Neoplasms,Melanoma in situ,TANK,TRAF family member-associated NF-kappa-B activator,18088,71,1.16 [0.87-1.56],0.3164844901105437
Chapter II Neoplasms,Melanoma in situ,TAP1,Antigen peptide transporter 1,15697,63,1.01 [0.67-1.54],0.9567965023769388
Chapter II Neoplasms,Melanoma in situ,TARBP2,RISC-loading complex subunit TARBP2,18002,70,1.24 [0.95-1.62],0.1136045867032125
Chapter II Neoplasms,Melanoma in situ,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15567,63,0.94 [0.66-1.32],0.7059890237648895
Chapter II Neoplasms,Melanoma in situ,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",15917,63,0.71 [0.37-1.39],0.320579832072452
Chapter II Neoplasms,Melanoma in situ,TAX1BP1,Tax1-binding protein 1,15944,63,1.52 [1.07-2.14],0.0188488342242087
Chapter II Neoplasms,Melanoma in situ,TBC1D17,TBC1 domain family member 17,18002,70,1.30 [0.83-2.03],0.2593427214178589
Chapter II Neoplasms,Melanoma in situ,TBC1D23,TBC1 domain family member 23,18305,72,1.13 [0.90-1.42],0.3040970117405657
Chapter II Neoplasms,Melanoma in situ,TBC1D5,TBC1 domain family member 5,18389,73,1.11 [0.86-1.43],0.4181997564714889
Chapter II Neoplasms,Melanoma in situ,TBCA,Tubulin-specific chaperone A,15623,63,1.22 [0.91-1.62],0.1836840384265156
Chapter II Neoplasms,Melanoma in situ,TBCB,Tubulin-folding cofactor B,18242,69,1.17 [0.94-1.46],0.158242630784849
Chapter II Neoplasms,Melanoma in situ,TBCC,Tubulin-specific chaperone C,18242,69,1.30 [1.00-1.69],0.0527035813126027
Chapter II Neoplasms,Melanoma in situ,TBL1X,F-box-like/WD repeat-containing protein TBL1X,17977,71,1.06 [0.82-1.36],0.6535129519179508
Chapter II Neoplasms,Melanoma in situ,TBR1,T-box brain protein 1,15567,63,0.51 [0.24-1.07],0.0754815607212629
Chapter II Neoplasms,Melanoma in situ,TCL1A,T-cell leukemia/lymphoma protein 1A,18218,68,0.89 [0.72-1.10],0.2783304479577922
Chapter II Neoplasms,Melanoma in situ,TCL1B,T-cell leukemia/lymphoma protein 1B,18071,70,0.92 [0.68-1.23],0.5634697256203007
Chapter II Neoplasms,Melanoma in situ,TCN1,Transcobalamin-1,15679,63,1.06 [0.55-2.06],0.8599644577879497
Chapter II Neoplasms,Melanoma in situ,TCN2,Transcobalamin-2,18595,74,0.95 [0.48-1.89],0.8940738294482211
Chapter II Neoplasms,Melanoma in situ,TCOF1,Treacle protein,15975,64,0.78 [0.34-1.76],0.545250431922347
Chapter II Neoplasms,Melanoma in situ,TCP11,T-complex protein 11 homolog,15697,63,0.84 [0.51-1.40],0.5126394075327534
Chapter II Neoplasms,Melanoma in situ,TCTN3,Tectonic-3,15975,64,0.77 [0.35-1.70],0.5244246587744308
Chapter II Neoplasms,Melanoma in situ,TDGF1,Teratocarcinoma-derived growth factor 1,18002,70,0.98 [0.85-1.13],0.7825753250230354
Chapter II Neoplasms,Melanoma in situ,TDO2,"Tryptophan 2,3-dioxygenase",15567,63,0.54 [0.24-1.18],0.1220657011114185
Chapter II Neoplasms,Melanoma in situ,TDP1,Tyrosyl-DNA phosphodiesterase 1,15917,63,0.72 [0.47-1.10],0.1314719073838743
Chapter II Neoplasms,Melanoma in situ,TDRKH,Tudor and KH domain-containing protein,18002,70,1.28 [1.02-1.62],0.0367425297830972
Chapter II Neoplasms,Melanoma in situ,TEF,Thyrotroph embryonic factor,15452,62,0.71 [0.38-1.33],0.2836037353657051
Chapter II Neoplasms,Melanoma in situ,TEK,Angiopoietin-1 receptor,18439,74,0.98 [0.39-2.47],0.9607597977928904
Chapter II Neoplasms,Melanoma in situ,TERF1,Telomeric repeat-binding factor 1,15491,59,1.08 [0.45-2.57],0.8604624143889041
Chapter II Neoplasms,Melanoma in situ,TET2,Methylcytosine dioxygenase TET2,15668,63,0.97 [0.75-1.24],0.7961958402035165
Chapter II Neoplasms,Melanoma in situ,TEX101,Testis-expressed protein 101,15567,63,1.34 [0.93-1.94],0.1216524367876588
Chapter II Neoplasms,Melanoma in situ,TEX33,Testis-expressed protein 33,15697,63,0.75 [0.35-1.61],0.4612000607267049
Chapter II Neoplasms,Melanoma in situ,TF,Serotransferrin,15998,64,0.85 [0.28-2.57],0.7793881091658456
Chapter II Neoplasms,Melanoma in situ,TFAP2A,Transcription factor AP-2-alpha,15489,61,0.92 [0.61-1.41],0.7076951494217405
Chapter II Neoplasms,Melanoma in situ,TFF1,Trefoil factor 1,18320,74,0.94 [0.72-1.23],0.6398523271900682
Chapter II Neoplasms,Melanoma in situ,TFF2,Trefoil factor 2,18434,74,0.75 [0.51-1.10],0.1446072033677644
Chapter II Neoplasms,Melanoma in situ,TFF3,Trefoil factor 3,18403,74,0.70 [0.36-1.37],0.2981214173908324
Chapter II Neoplasms,Melanoma in situ,TFPI,Tissue factor pathway inhibitor,18372,74,0.89 [0.44-1.76],0.7280480551069404
Chapter II Neoplasms,Melanoma in situ,TFPI2,Tissue factor pathway inhibitor 2,18385,74,1.20 [0.74-1.94],0.4558511975243079
Chapter II Neoplasms,Melanoma in situ,TFRC,Transferrin receptor protein 1,18485,73,0.71 [0.40-1.26],0.2432221088809429
Chapter II Neoplasms,Melanoma in situ,TG,Thyroglobulin,15917,63,1.12 [0.90-1.39],0.3259425352983297
Chapter II Neoplasms,Melanoma in situ,TGFA,Protransforming growth factor alpha,18389,73,1.41 [0.92-2.16],0.1159370655327773
Chapter II Neoplasms,Melanoma in situ,TGFB1,Transforming growth factor beta-1 proprotein,18582,74,1.39 [0.85-2.29],0.192031204910037
Chapter II Neoplasms,Melanoma in situ,TGFB2,Transforming growth factor beta-2 proprotein,15917,63,1.50 [1.04-2.15],0.029110049543489
Chapter II Neoplasms,Melanoma in situ,TGFBI,Transforming growth factor-beta-induced protein ig-h3,18315,74,1.49 [0.70-3.19],0.2991842976127339
Chapter II Neoplasms,Melanoma in situ,TGFBR1,TGF-beta receptor type-1,15491,59,0.78 [0.24-2.52],0.677015905196233
Chapter II Neoplasms,Melanoma in situ,TGFBR2,TGF-beta receptor type-2,18439,74,0.67 [0.34-1.32],0.2515006497288662
Chapter II Neoplasms,Melanoma in situ,TGFBR3,Transforming growth factor beta receptor type 3,18626,75,0.92 [0.46-1.83],0.8091206539503031
Chapter II Neoplasms,Melanoma in situ,TGM2,Protein-glutamine gamma-glutamyltransferase 2,18363,74,0.98 [0.74-1.29],0.858171217824761
Chapter II Neoplasms,Melanoma in situ,TGOLN2,Trans-Golgi network integral membrane protein 2,15994,64,0.51 [0.20-1.29],0.1578794143854063
Chapter II Neoplasms,Melanoma in situ,THAP12,52 kDa repressor of the inhibitor of the protein kinase,15393,60,1.03 [0.78-1.37],0.8333920644844124
Chapter II Neoplasms,Melanoma in situ,THBD,Thrombomodulin,18395,74,0.76 [0.36-1.58],0.4640265513680194
Chapter II Neoplasms,Melanoma in situ,THBS2,Thrombospondin-2,18396,74,0.95 [0.54-1.68],0.8712003363699239
Chapter II Neoplasms,Melanoma in situ,THBS4,Thrombospondin-4,18431,74,0.60 [0.38-0.94],0.0271342966267003
Chapter II Neoplasms,Melanoma in situ,THOP1,Thimet oligopeptidase,18312,74,1.28 [0.67-2.46],0.449519908816502
Chapter II Neoplasms,Melanoma in situ,THPO,Thrombopoietin,18071,70,1.35 [0.79-2.31],0.2744540023001973
Chapter II Neoplasms,Melanoma in situ,THRAP3,Thyroid hormone receptor-associated protein 3,15452,62,0.94 [0.72-1.21],0.6101775326723079
Chapter II Neoplasms,Melanoma in situ,THSD1,Thrombospondin type-1 domain-containing protein 1,15371,57,0.68 [0.30-1.50],0.3344845468576054
Chapter II Neoplasms,Melanoma in situ,THTPA,Thiamine-triphosphatase,15878,63,1.17 [0.88-1.55],0.2755147000632252
Chapter II Neoplasms,Melanoma in situ,THY1,Thy-1 membrane glycoprotein,18561,75,0.93 [0.45-1.91],0.8456013061354505
Chapter II Neoplasms,Melanoma in situ,TIA1,Nucleolysin TIA-1 isoform p40,17868,70,1.05 [0.88-1.25],0.6063946093393171
Chapter II Neoplasms,Melanoma in situ,TIE1,Tyrosine-protein kinase receptor Tie-1,18626,75,0.91 [0.57-1.45],0.6869129510556544
Chapter II Neoplasms,Melanoma in situ,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",17974,70,0.73 [0.45-1.17],0.1903034189526022
Chapter II Neoplasms,Melanoma in situ,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15697,63,0.51 [0.24-1.07],0.0765082216874539
Chapter II Neoplasms,Melanoma in situ,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18485,74,0.71 [0.43-1.16],0.1699781835445074
Chapter II Neoplasms,Melanoma in situ,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,15975,64,1.20 [0.67-2.13],0.538918308983407
Chapter II Neoplasms,Melanoma in situ,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,15944,63,1.02 [0.77-1.35],0.90934052418838
Chapter II Neoplasms,Melanoma in situ,TIMP1,Metalloproteinase inhibitor 1,18229,74,1.13 [0.54-2.36],0.7463466704421877
Chapter II Neoplasms,Melanoma in situ,TIMP2,Metalloproteinase inhibitor 2,15975,64,0.80 [0.29-2.17],0.6551344502886993
Chapter II Neoplasms,Melanoma in situ,TIMP3,Metalloproteinase inhibitor 3,18455,74,1.05 [0.90-1.23],0.5333775848438116
Chapter II Neoplasms,Melanoma in situ,TIMP4,Metalloproteinase inhibitor 4,18396,74,0.61 [0.35-1.06],0.0815481686103055
Chapter II Neoplasms,Melanoma in situ,TINAGL1,Tubulointerstitial nephritis antigen-like,18346,74,0.60 [0.23-1.58],0.3046089269130496
Chapter II Neoplasms,Melanoma in situ,TJAP1,Tight junction-associated protein 1,18439,74,1.26 [0.99-1.61],0.060528052693961
Chapter II Neoplasms,Melanoma in situ,TJP3,Tight junction protein ZO-3,15489,61,0.41 [0.21-0.83],0.0124634176439343
Chapter II Neoplasms,Melanoma in situ,TK1,"Thymidine kinase, cytosolic",15697,63,1.08 [0.63-1.84],0.7795968618815963
Chapter II Neoplasms,Melanoma in situ,TLR1,Toll-like receptor 1,15491,59,1.14 [0.45-2.94],0.7784358228090957
Chapter II Neoplasms,Melanoma in situ,TLR2,Toll-like receptor 2,15697,63,0.44 [0.15-1.23],0.1158693912769814
Chapter II Neoplasms,Melanoma in situ,TLR3,Toll-like receptor 3,18615,74,0.70 [0.52-0.96],0.0268323013626179
Chapter II Neoplasms,Melanoma in situ,TLR4,Toll-like receptor 4,15491,59,1.83 [0.80-4.18],0.153848833401665
Chapter II Neoplasms,Melanoma in situ,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15567,63,0.91 [0.57-1.45],0.6985768979552234
Chapter II Neoplasms,Melanoma in situ,TMED1,Transmembrane emp24 domain-containing protein 1,15697,63,0.85 [0.53-1.37],0.5074123419655909
Chapter II Neoplasms,Melanoma in situ,TMED10,Transmembrane emp24 domain-containing protein 10,15452,62,1.01 [0.60-1.71],0.9599836118412444
Chapter II Neoplasms,Melanoma in situ,TMED4,Transmembrane emp24 domain-containing protein 4,15452,62,0.32 [0.16-0.62],0.0007358742566505
Chapter II Neoplasms,Melanoma in situ,TMED8,Protein TMED8,15920,63,1.18 [0.93-1.50],0.1846979294227494
Chapter II Neoplasms,Melanoma in situ,TMEM106A,Transmembrane protein 106A,15917,63,1.12 [0.81-1.55],0.491635401012921
Chapter II Neoplasms,Melanoma in situ,TMEM132A,Transmembrane protein 132A,15528,62,1.19 [0.81-1.73],0.3775709319912675
Chapter II Neoplasms,Melanoma in situ,TMEM25,Transmembrane protein 25,15952,63,0.79 [0.44-1.42],0.4369624528894721
Chapter II Neoplasms,Melanoma in situ,TMOD4,Tropomodulin-4,15421,61,0.54 [0.28-1.02],0.0583695189409869
Chapter II Neoplasms,Melanoma in situ,TMPRSS11B,Transmembrane protease serine 11B,15489,61,0.99 [0.72-1.37],0.958148431972972
Chapter II Neoplasms,Melanoma in situ,TMPRSS11D,Transmembrane protease serine 11D,15912,63,0.73 [0.39-1.39],0.3405297651137571
Chapter II Neoplasms,Melanoma in situ,TMPRSS15,Enteropeptidase,18305,72,1.13 [0.89-1.42],0.3141353901867694
Chapter II Neoplasms,Melanoma in situ,TMPRSS5,Transmembrane protease serine 5,18153,67,1.00 [0.57-1.77],0.9971847108831708
Chapter II Neoplasms,Melanoma in situ,TMSB10,Thymosin beta-10,18396,74,1.10 [0.84-1.44],0.503635327753581
Chapter II Neoplasms,Melanoma in situ,TNC,Tenascin,18485,74,0.98 [0.63-1.51],0.9191357390933608
Chapter II Neoplasms,Melanoma in situ,TNF,Tumor necrosis factor,18046,70,0.99 [0.53-1.86],0.9847366283622953
Chapter II Neoplasms,Melanoma in situ,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,15920,63,1.18 [0.74-1.87],0.4828383880844333
Chapter II Neoplasms,Melanoma in situ,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18088,71,0.91 [0.50-1.64],0.7480939541280205
Chapter II Neoplasms,Melanoma in situ,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15623,63,1.13 [0.77-1.65],0.5444365956353314
Chapter II Neoplasms,Melanoma in situ,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18242,69,0.93 [0.47-1.82],0.8304644771355858
Chapter II Neoplasms,Melanoma in situ,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18242,69,0.82 [0.42-1.60],0.5605350691213539
Chapter II Neoplasms,Melanoma in situ,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18438,73,0.89 [0.58-1.34],0.5675054384452849
Chapter II Neoplasms,Melanoma in situ,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18615,74,1.25 [0.74-2.09],0.400344415886721
Chapter II Neoplasms,Melanoma in situ,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18365,74,0.78 [0.38-1.63],0.5132389741855031
Chapter II Neoplasms,Melanoma in situ,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18439,74,0.67 [0.36-1.24],0.1999333968259465
Chapter II Neoplasms,Melanoma in situ,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18395,74,1.03 [0.53-1.97],0.9390197435307184
Chapter II Neoplasms,Melanoma in situ,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18088,71,0.76 [0.45-1.30],0.3222840729889606
Chapter II Neoplasms,Melanoma in situ,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18395,74,1.62 [0.86-3.08],0.1376957668367918
Chapter II Neoplasms,Melanoma in situ,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15623,63,0.68 [0.38-1.21],0.1868438146067969
Chapter II Neoplasms,Melanoma in situ,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18569,74,0.64 [0.33-1.26],0.1989416928924849
Chapter II Neoplasms,Melanoma in situ,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18396,74,0.84 [0.41-1.73],0.6345754283604892
Chapter II Neoplasms,Melanoma in situ,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18396,74,1.00 [0.56-1.81],0.9882999988751044
Chapter II Neoplasms,Melanoma in situ,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18561,75,1.01 [0.48-2.13],0.9865526752793444
Chapter II Neoplasms,Melanoma in situ,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18582,74,0.67 [0.37-1.21],0.1805674376498417
Chapter II Neoplasms,Melanoma in situ,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18242,69,1.22 [0.85-1.75],0.2781701988081445
Chapter II Neoplasms,Melanoma in situ,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18561,75,1.06 [0.66-1.68],0.8156716447540837
Chapter II Neoplasms,Melanoma in situ,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18242,69,0.98 [0.56-1.72],0.954835679069436
Chapter II Neoplasms,Melanoma in situ,TNFSF10,Tumor necrosis factor ligand superfamily member 10,18615,74,2.25 [1.01-5.01],0.0473603649750453
Chapter II Neoplasms,Melanoma in situ,TNFSF11,Tumor necrosis factor ligand superfamily member 11,18389,73,0.94 [0.66-1.32],0.704514884664933
Chapter II Neoplasms,Melanoma in situ,TNFSF12,Tumor necrosis factor ligand superfamily member 12,18615,74,2.12 [1.05-4.27],0.0356382169409165
Chapter II Neoplasms,Melanoma in situ,TNFSF13,Tumor necrosis factor ligand superfamily member 13,18455,74,2.07 [0.97-4.41],0.0584414851824139
Chapter II Neoplasms,Melanoma in situ,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18595,75,1.28 [0.60-2.70],0.5208249538825142
Chapter II Neoplasms,Melanoma in situ,TNFSF14,Tumor necrosis factor ligand superfamily member 14,18242,69,1.28 [0.90-1.83],0.1704400933501307
Chapter II Neoplasms,Melanoma in situ,TNFSF8,Tumor necrosis factor ligand superfamily member 8,15983,64,0.74 [0.37-1.47],0.3930639440151073
Chapter II Neoplasms,Melanoma in situ,TNIP1,TNFAIP3-interacting protein 1,15944,63,1.14 [0.87-1.49],0.3291987258132378
Chapter II Neoplasms,Melanoma in situ,TNN,Tenascin-N,15983,64,1.27 [0.73-2.21],0.3949354924105346
Chapter II Neoplasms,Melanoma in situ,TNNI3,"Troponin I, cardiac muscle",18071,70,1.06 [0.82-1.37],0.6629163331035153
Chapter II Neoplasms,Melanoma in situ,TNPO1,Transportin-1,15697,63,0.51 [0.26-1.03],0.0607673890308935
Chapter II Neoplasms,Melanoma in situ,TNR,Tenascin-R,18242,69,1.22 [0.73-2.02],0.447594721188723
Chapter II Neoplasms,Melanoma in situ,TNXB,Tenascin-X,18396,74,1.07 [0.48-2.40],0.8682248774111907
Chapter II Neoplasms,Melanoma in situ,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,15975,64,1.08 [0.80-1.47],0.6017717789367367
Chapter II Neoplasms,Melanoma in situ,TOP1,DNA topoisomerase 1,15920,63,0.90 [0.73-1.09],0.2806066212187475
Chapter II Neoplasms,Melanoma in situ,TOP1MT,"DNA topoisomerase I, mitochondrial",15421,61,1.04 [0.63-1.71],0.8920293775845644
Chapter II Neoplasms,Melanoma in situ,TOP2B,DNA topoisomerase 2-beta,15491,59,1.15 [0.84-1.57],0.3794471883169408
Chapter II Neoplasms,Melanoma in situ,TOR1AIP1,Torsin-1A-interacting protein 1,15528,62,1.02 [0.64-1.61],0.9477270317464682
Chapter II Neoplasms,Melanoma in situ,TP53,Cellular tumor antigen p53,17977,71,0.72 [0.44-1.17],0.1847731103309499
Chapter II Neoplasms,Melanoma in situ,TP53BP1,TP53-binding protein 1,15491,59,0.85 [0.62-1.15],0.2954852683717157
Chapter II Neoplasms,Melanoma in situ,TP53I3,Quinone oxidoreductase PIG3,15282,62,1.05 [0.65-1.69],0.8322987980587115
Chapter II Neoplasms,Melanoma in situ,TP53INP1,Tumor protein p53-inducible nuclear protein 1,18071,70,0.61 [0.25-1.51],0.2823272149174601
Chapter II Neoplasms,Melanoma in situ,TP73,Tumor protein p73,15567,63,0.61 [0.30-1.24],0.1695030807174803
Chapter II Neoplasms,Melanoma in situ,TPBGL,Trophoblast glycoprotein-like,15567,63,0.76 [0.40-1.47],0.4203906701727816
Chapter II Neoplasms,Melanoma in situ,TPD52L2,Tumor protein D54,15623,63,1.10 [0.88-1.39],0.3993725772403332
Chapter II Neoplasms,Melanoma in situ,TPK1,Thiamin pyrophosphokinase 1,15975,64,1.37 [0.58-3.25],0.4771726301026817
Chapter II Neoplasms,Melanoma in situ,TPM3,Tropomyosin alpha-3 chain,15452,62,0.71 [0.39-1.29],0.2641957929111823
Chapter II Neoplasms,Melanoma in situ,TPMT,Thiopurine S-methyltransferase,17977,71,1.15 [0.87-1.53],0.3157688919575896
Chapter II Neoplasms,Melanoma in situ,TPP1,Tripeptidyl-peptidase 1,18249,73,1.18 [0.76-1.82],0.4532611529880143
Chapter II Neoplasms,Melanoma in situ,TPPP2,Tubulin polymerization-promoting protein family member 2,15697,63,1.23 [0.97-1.57],0.0894703807745718
Chapter II Neoplasms,Melanoma in situ,TPPP3,Tubulin polymerization-promoting protein family member 3,18002,70,0.92 [0.52-1.64],0.7842306012687024
Chapter II Neoplasms,Melanoma in situ,TPR,Nucleoprotein TPR,15452,62,0.94 [0.56-1.59],0.8294318618039714
Chapter II Neoplasms,Melanoma in situ,TPRKB,EKC/KEOPS complex subunit TPRKB,15421,61,0.91 [0.60-1.37],0.6472278506520842
Chapter II Neoplasms,Melanoma in situ,TPSAB1,Tryptase alpha/beta-1,18589,74,0.97 [0.66-1.44],0.895500057778818
Chapter II Neoplasms,Melanoma in situ,TPSD1,Tryptase delta,15952,63,1.36 [0.87-2.12],0.180694920559163
Chapter II Neoplasms,Melanoma in situ,TPSG1,Tryptase gamma,15491,59,1.91 [0.92-3.95],0.0829886232101877
Chapter II Neoplasms,Melanoma in situ,TPT1,Translationally-controlled tumor protein,18088,71,0.86 [0.59-1.25],0.4354694797573547
Chapter II Neoplasms,Melanoma in situ,TRAF2,TNF receptor-associated factor 2,18389,73,1.25 [0.93-1.67],0.1377142040807447
Chapter II Neoplasms,Melanoma in situ,TRAF3,"TNF receptor-associated factor 3, Isoform 2",15491,59,0.75 [0.36-1.56],0.4486451389641975
Chapter II Neoplasms,Melanoma in situ,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15452,62,1.02 [0.62-1.69],0.9301324876468736
Chapter II Neoplasms,Melanoma in situ,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15697,63,1.13 [0.87-1.46],0.3763750237472815
Chapter II Neoplasms,Melanoma in situ,TREH,Trehalase,15983,64,0.91 [0.66-1.24],0.5510638747649227
Chapter II Neoplasms,Melanoma in situ,TREM2,Triggering receptor expressed on myeloid cells 2,18365,74,0.84 [0.57-1.26],0.4023030414416069
Chapter II Neoplasms,Melanoma in situ,TREML1,Trem-like transcript 1 protein,15994,64,1.18 [0.76-1.85],0.4609413335229578
Chapter II Neoplasms,Melanoma in situ,TREML2,Trem-like transcript 2 protein,18396,74,1.27 [0.69-2.31],0.442621204380917
Chapter II Neoplasms,Melanoma in situ,TRIAP1,TP53-regulated inhibitor of apoptosis 1,18569,74,1.08 [0.78-1.51],0.6375954452690685
Chapter II Neoplasms,Melanoma in situ,TRIM21,E3 ubiquitin-protein ligase TRIM21,18389,73,1.28 [0.96-1.71],0.0907645551798846
Chapter II Neoplasms,Melanoma in situ,TRIM24,Transcription intermediary factor 1-alpha,15669,62,1.23 [0.87-1.75],0.2359995219416611
Chapter II Neoplasms,Melanoma in situ,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,15920,63,1.13 [0.90-1.41],0.2965240937002309
Chapter II Neoplasms,Melanoma in situ,TRIM26,Tripartite motif-containing protein 26,15421,61,1.00 [0.65-1.55],0.9913072527352518
Chapter II Neoplasms,Melanoma in situ,TRIM40,E3 ubiquitin ligase TRIM40,15567,63,1.09 [0.78-1.52],0.6030667360399196
Chapter II Neoplasms,Melanoma in situ,TRIM5,Tripartite motif-containing protein 5,18389,73,1.21 [0.95-1.53],0.12694538861263
Chapter II Neoplasms,Melanoma in situ,TRIM58,E3 ubiquitin-protein ligase TRIM58,15917,63,1.22 [0.93-1.61],0.1569357399738504
Chapter II Neoplasms,Melanoma in situ,TRPV3,Transient receptor potential cation channel subfamily V member 3,15452,62,1.07 [0.67-1.71],0.7919337433044431
Chapter II Neoplasms,Melanoma in situ,TSC1,Hamartin,15491,59,1.05 [0.77-1.44],0.7445535056139634
Chapter II Neoplasms,Melanoma in situ,TSC22D1,TSC22 domain family protein 1,15952,63,1.15 [0.80-1.65],0.446733809516692
Chapter II Neoplasms,Melanoma in situ,TSHB,Thyrotropin subunit beta,18395,74,1.03 [0.77-1.37],0.860962148387779
Chapter II Neoplasms,Melanoma in situ,TSLP,Thymic stromal lymphopoietin,18071,70,0.98 [0.67-1.41],0.89604791434604
Chapter II Neoplasms,Melanoma in situ,TSNAX,Translin-associated protein X,15452,62,1.19 [0.64-2.18],0.585153837274172
Chapter II Neoplasms,Melanoma in situ,TSPAN1,Tetraspanin-1,18071,70,0.83 [0.63-1.11],0.2142888285786846
Chapter II Neoplasms,Melanoma in situ,TSPAN15,Tetraspanin-15,15452,62,0.94 [0.57-1.55],0.7970591122206094
Chapter II Neoplasms,Melanoma in situ,TSPAN7,Tetraspanin-7,15489,61,0.70 [0.50-1.00],0.0490125992293081
Chapter II Neoplasms,Melanoma in situ,TSPAN8,Tetraspanin-8,15920,63,0.93 [0.71-1.20],0.5636640080620035
Chapter II Neoplasms,Melanoma in situ,TSPYL1,Testis-specific Y-encoded-like protein 1,15491,59,1.54 [0.88-2.67],0.1285067619159651
Chapter II Neoplasms,Melanoma in situ,TST,Thiosulfate sulfurtransferase,17973,70,1.15 [0.87-1.52],0.3330538206488898
Chapter II Neoplasms,Melanoma in situ,TTF2,Transcription termination factor 2,15567,63,1.11 [0.69-1.81],0.6654207356903594
Chapter II Neoplasms,Melanoma in situ,TTN,Titin,15452,62,0.93 [0.64-1.36],0.7229452279547395
Chapter II Neoplasms,Melanoma in situ,TTR,Transthyretin,15834,63,1.19 [0.44-3.19],0.7296633947731851
Chapter II Neoplasms,Melanoma in situ,TUBB3,Tubulin beta-3 chain,15489,61,0.33 [0.14-0.80],0.0143658944992474
Chapter II Neoplasms,Melanoma in situ,TWF2,Twinfilin-2,15983,64,1.10 [0.83-1.46],0.5057356171492164
Chapter II Neoplasms,Melanoma in situ,TXK,Tyrosine-protein kinase TXK,15697,63,0.98 [0.71-1.36],0.9139799081913448
Chapter II Neoplasms,Melanoma in situ,TXLNA,Alpha-taxilin,18242,69,1.24 [0.97-1.58],0.0885162760870271
Chapter II Neoplasms,Melanoma in situ,TXN,Thioredoxin,15738,63,1.17 [0.69-1.99],0.5572081572045626
Chapter II Neoplasms,Melanoma in situ,TXNDC15,Thioredoxin domain-containing protein 15,18439,74,1.02 [0.48-2.17],0.9515248785393272
Chapter II Neoplasms,Melanoma in situ,TXNDC5,Thioredoxin domain-containing protein 5,18561,75,1.13 [0.84-1.52],0.4146944411754389
Chapter II Neoplasms,Melanoma in situ,TXNDC9,Thioredoxin domain-containing protein 9,15944,63,1.00 [0.63-1.59],0.9951810427807658
Chapter II Neoplasms,Melanoma in situ,TXNL1,Thioredoxin-like protein 1,15462,61,1.00 [0.78-1.26],0.9742008100099754
Chapter II Neoplasms,Melanoma in situ,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18396,74,1.09 [0.70-1.70],0.7012509443662893
Chapter II Neoplasms,Melanoma in situ,TYMP,Thymidine phosphorylase,18280,72,1.17 [0.85-1.61],0.3311076630367729
Chapter II Neoplasms,Melanoma in situ,TYRO3,Tyrosine-protein kinase receptor TYRO3,18395,74,1.06 [0.51-2.18],0.8824971611031334
Chapter II Neoplasms,Melanoma in situ,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15491,59,1.41 [0.93-2.14],0.1015147827486767
Chapter II Neoplasms,Melanoma in situ,UBAC1,Ubiquitin-associated domain-containing protein 1,18305,72,1.28 [0.69-2.37],0.430794473698785
Chapter II Neoplasms,Melanoma in situ,UBE2B,Ubiquitin-conjugating enzyme E2 B,15917,63,0.83 [0.35-1.93],0.6610148935779246
Chapter II Neoplasms,Melanoma in situ,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,15975,64,1.27 [0.86-1.87],0.2256113790262526
Chapter II Neoplasms,Melanoma in situ,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15491,59,1.08 [0.72-1.62],0.7115181333242063
Chapter II Neoplasms,Melanoma in situ,UBQLN3,Ubiquilin-3,15452,62,0.84 [0.51-1.37],0.4820785885860343
Chapter II Neoplasms,Melanoma in situ,UBXN1,UBX domain-containing protein 1,15623,63,1.26 [0.89-1.78],0.1954204975666706
Chapter II Neoplasms,Melanoma in situ,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,15920,63,1.09 [0.92-1.30],0.3112169268428514
Chapter II Neoplasms,Melanoma in situ,UGDH,UDP-glucose 6-dehydrogenase,15452,62,0.79 [0.57-1.10],0.1579402862227288
Chapter II Neoplasms,Melanoma in situ,UHRF2,E3 ubiquitin-protein ligase UHRF2,15452,62,0.37 [0.15-0.93],0.0347478796518232
Chapter II Neoplasms,Melanoma in situ,ULBP2,UL16-binding protein 2,18242,69,0.65 [0.36-1.16],0.1468192919289011
Chapter II Neoplasms,Melanoma in situ,UMOD,Uromodulin,18562,75,0.86 [0.59-1.25],0.4299424921953427
Chapter II Neoplasms,Melanoma in situ,UNC5D,Netrin receptor UNC5D,15491,59,0.77 [0.29-2.06],0.607603128346267
Chapter II Neoplasms,Melanoma in situ,UNC79,Protein unc-79 homolog,15421,61,1.09 [0.70-1.69],0.7051447635599397
Chapter II Neoplasms,Melanoma in situ,UNG,Uracil-DNA glycosylase,15917,63,0.60 [0.29-1.26],0.177009844310567
Chapter II Neoplasms,Melanoma in situ,UPB1,Beta-ureidopropionase,15975,64,1.00 [0.77-1.32],0.971760196298473
Chapter II Neoplasms,Melanoma in situ,UPK3A,Uroplakin-3a,15489,61,1.24 [0.78-1.97],0.3587844919345211
Chapter II Neoplasms,Melanoma in situ,UPK3BL1,Uroplakin-3b-like protein 1,15658,62,0.70 [0.37-1.31],0.2670986316549593
Chapter II Neoplasms,Melanoma in situ,UROD,Uroporphyrinogen decarboxylase,15623,63,1.33 [0.93-1.90],0.1177691377132054
Chapter II Neoplasms,Melanoma in situ,UROS,Uroporphyrinogen-III synthase,15567,63,1.22 [0.88-1.69],0.2437382702335959
Chapter II Neoplasms,Melanoma in situ,USO1,General vesicular transport factor p115,18305,72,1.21 [0.96-1.53],0.1104435866626094
Chapter II Neoplasms,Melanoma in situ,USP25,Ubiquitin carboxyl-terminal hydrolase 25,15917,63,1.36 [0.98-1.90],0.0673356498230324
Chapter II Neoplasms,Melanoma in situ,USP28,Ubiquitin carboxyl-terminal hydrolase 28,15944,63,1.65 [1.06-2.58],0.0266108223770809
Chapter II Neoplasms,Melanoma in situ,USP47,Ubiquitin carboxyl-terminal hydrolase 47,15452,62,0.98 [0.74-1.31],0.8947671661267282
Chapter II Neoplasms,Melanoma in situ,USP8,Ubiquitin carboxyl-terminal hydrolase 8,18071,70,1.12 [0.89-1.40],0.3290907080238913
Chapter II Neoplasms,Melanoma in situ,UXS1,UDP-glucuronic acid decarboxylase 1,17977,71,1.09 [0.73-1.62],0.673807008800331
Chapter II Neoplasms,Melanoma in situ,VAMP5,Vesicle-associated membrane protein 5,18071,70,0.50 [0.28-0.88],0.0163266387118947
Chapter II Neoplasms,Melanoma in situ,VAMP8,Vesicle-associated membrane protein 8,15491,59,1.17 [0.88-1.56],0.2697660038450831
Chapter II Neoplasms,Melanoma in situ,VASH1,Tubulinyl-Tyr carboxypeptidase 1,18389,73,1.09 [0.84-1.40],0.5229410640341352
Chapter II Neoplasms,Melanoma in situ,VASN,Vasorin,18126,72,0.72 [0.33-1.57],0.4076457237565721
Chapter II Neoplasms,Melanoma in situ,VASP,Vasodilator-stimulated phosphoprotein,15994,64,1.18 [0.85-1.64],0.3149560933094474
Chapter II Neoplasms,Melanoma in situ,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18305,72,0.93 [0.31-2.76],0.8992651255751678
Chapter II Neoplasms,Melanoma in situ,VAV3,Guanine nucleotide exchange factor VAV3,15489,61,1.08 [0.84-1.39],0.5435343061725195
Chapter II Neoplasms,Melanoma in situ,VCAM1,Vascular cell adhesion protein 1,18463,74,0.91 [0.42-1.99],0.8147958302849411
Chapter II Neoplasms,Melanoma in situ,VCAN,Versican core protein,18561,75,0.96 [0.48-1.92],0.9119159801463712
Chapter II Neoplasms,Melanoma in situ,VCPKMT,Protein-lysine methyltransferase METTL21D,15421,61,1.25 [1.02-1.53],0.0288611481806745
Chapter II Neoplasms,Melanoma in situ,VEGFA,Vascular endothelial growth factor A,18559,73,1.30 [0.92-1.84],0.1336545982533514
Chapter II Neoplasms,Melanoma in situ,VEGFB,Vascular endothelial growth factor B,15491,59,1.11 [0.47-2.65],0.8134024578983681
Chapter II Neoplasms,Melanoma in situ,VEGFC,Vascular endothelial growth factor C,18439,74,1.50 [1.04-2.17],0.0306869602689292
Chapter II Neoplasms,Melanoma in situ,VEGFD,Vascular endothelial growth factor D,18587,73,1.21 [0.70-2.10],0.4889739858810618
Chapter II Neoplasms,Melanoma in situ,VGF,Neurosecretory protein VGF,15952,63,0.66 [0.29-1.48],0.3119030601923567
Chapter II Neoplasms,Melanoma in situ,VIM,Vimentin,18071,70,0.88 [0.75-1.03],0.1027223218913167
Chapter II Neoplasms,Melanoma in situ,VIPR1,Vasoactive intestinal polypeptide receptor 1,15528,62,0.66 [0.22-2.03],0.4732116158816499
Chapter II Neoplasms,Melanoma in situ,VIT,Vitrin,15975,64,0.79 [0.42-1.49],0.4702620811011596
Chapter II Neoplasms,Melanoma in situ,VMO1,Vitelline membrane outer layer protein 1 homolog,18305,72,1.35 [0.96-1.88],0.0808245657993072
Chapter II Neoplasms,Melanoma in situ,VNN1,Pantetheinase,15994,64,0.85 [0.62-1.16],0.299067146469508
Chapter II Neoplasms,Melanoma in situ,VNN2,Vascular non-inflammatory molecule 2,18305,72,0.81 [0.52-1.25],0.3426948694828016
Chapter II Neoplasms,Melanoma in situ,VPS28,Vacuolar protein sorting-associated protein 28 homolog,15697,63,1.27 [0.89-1.80],0.1887707895842637
Chapter II Neoplasms,Melanoma in situ,VPS37A,Vacuolar protein sorting-associated protein 37A,18305,72,1.27 [0.99-1.63],0.0617687031871167
Chapter II Neoplasms,Melanoma in situ,VPS4B,Vacuolar protein sorting-associated protein 4B,15917,63,1.15 [0.89-1.48],0.2862594309700317
Chapter II Neoplasms,Melanoma in situ,VPS53,Vacuolar protein sorting-associated protein 53 homolog,18305,72,1.17 [0.90-1.52],0.2321581497404008
Chapter II Neoplasms,Melanoma in situ,VSIG10,V-set and immunoglobulin domain-containing protein 10,15917,63,0.54 [0.24-1.25],0.1506905261924449
Chapter II Neoplasms,Melanoma in situ,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15452,62,0.36 [0.16-0.84],0.0172600731862779
Chapter II Neoplasms,Melanoma in situ,VSIG2,V-set and immunoglobulin domain-containing protein 2,15917,63,0.89 [0.60-1.31],0.549112145595503
Chapter II Neoplasms,Melanoma in situ,VSIG4,V-set and immunoglobulin domain-containing protein 4,18374,74,1.34 [0.82-2.19],0.2442803406331682
Chapter II Neoplasms,Melanoma in situ,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18366,74,1.21 [0.88-1.66],0.2402497374480632
Chapter II Neoplasms,Melanoma in situ,VSNL1,Visinin-like protein 1,15944,63,0.71 [0.36-1.39],0.3191714854467609
Chapter II Neoplasms,Melanoma in situ,VSTM1,V-set and transmembrane domain-containing protein 1,18002,70,0.92 [0.60-1.41],0.7013462936390892
Chapter II Neoplasms,Melanoma in situ,VSTM2B,V-set and transmembrane domain-containing protein 2B,15697,63,0.75 [0.38-1.47],0.4035312168934625
Chapter II Neoplasms,Melanoma in situ,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18071,70,1.07 [0.75-1.51],0.719368936376518
Chapter II Neoplasms,Melanoma in situ,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18561,75,1.07 [0.81-1.43],0.6244540621118633
Chapter II Neoplasms,Melanoma in situ,VTCN1,V-set domain-containing T-cell activation inhibitor 1,17977,71,0.56 [0.28-1.13],0.1061833925874895
Chapter II Neoplasms,Melanoma in situ,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15623,63,1.17 [0.78-1.78],0.4489881040475181
Chapter II Neoplasms,Melanoma in situ,VWA1,von Willebrand factor A domain-containing protein 1,18546,74,0.92 [0.56-1.51],0.7510760213888794
Chapter II Neoplasms,Melanoma in situ,VWA5A,von Willebrand factor A domain-containing protein 5A,15421,61,1.10 [0.84-1.46],0.4849232199984566
Chapter II Neoplasms,Melanoma in situ,VWC2,Brorin,18180,69,0.97 [0.56-1.67],0.9097299053792558
Chapter II Neoplasms,Melanoma in situ,VWC2L,von Willebrand factor C domain-containing protein 2-like,15952,63,0.90 [0.51-1.58],0.7212484438847652
Chapter II Neoplasms,Melanoma in situ,VWF,von Willebrand factor,18626,75,0.83 [0.63-1.09],0.1727624773493729
Chapter II Neoplasms,Melanoma in situ,WARS,"Tryptophan--tRNA ligase, cytoplasmic",18396,74,1.13 [0.65-1.95],0.6618996439594094
Chapter II Neoplasms,Melanoma in situ,WAS,Wiskott-Aldrich syndrome protein,18088,71,0.98 [0.70-1.36],0.8858686213309966
Chapter II Neoplasms,Melanoma in situ,WASF1,Wiskott-Aldrich syndrome protein family member 1,18071,70,1.14 [0.91-1.42],0.2471454894256332
Chapter II Neoplasms,Melanoma in situ,WASF3,Wiskott-Aldrich syndrome protein family member 3,18002,70,1.03 [0.80-1.34],0.7976729716035451
Chapter II Neoplasms,Melanoma in situ,WASHC3,WASH complex subunit 3,15944,63,1.12 [0.82-1.52],0.475402814223263
Chapter II Neoplasms,Melanoma in situ,WASL,Neural Wiskott-Aldrich syndrome protein,15491,59,1.14 [0.78-1.68],0.4974978161135984
Chapter II Neoplasms,Melanoma in situ,WDR46,WD repeat-containing protein 46,15917,63,1.12 [0.58-2.15],0.7401407702762232
Chapter II Neoplasms,Melanoma in situ,WFDC1,WAP four-disulfide core domain protein 1,15580,60,0.69 [0.39-1.23],0.2102852689483884
Chapter II Neoplasms,Melanoma in situ,WFDC12,WAP four-disulfide core domain protein 12,18533,73,1.08 [0.78-1.50],0.6426484997172162
Chapter II Neoplasms,Melanoma in situ,WFDC2,WAP four-disulfide core domain protein 2,17468,72,1.16 [0.68-1.98],0.5933271504839337
Chapter II Neoplasms,Melanoma in situ,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18174,68,1.16 [0.69-1.97],0.5729038708123035
Chapter II Neoplasms,Melanoma in situ,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18395,74,0.93 [0.50-1.73],0.8141873456726696
Chapter II Neoplasms,Melanoma in situ,WIF1,Wnt inhibitory factor 1,18569,74,1.11 [0.60-2.05],0.7307993412483844
Chapter II Neoplasms,Melanoma in situ,WNT9A,Protein Wnt-9a,18088,71,0.89 [0.42-1.89],0.764363341024103
Chapter II Neoplasms,Melanoma in situ,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18242,69,1.32 [0.89-1.95],0.163829588937972
Chapter II Neoplasms,Melanoma in situ,XCL1,Lymphotactin,18569,74,0.95 [0.64-1.40],0.7894276305174668
Chapter II Neoplasms,Melanoma in situ,XG,Glycoprotein Xg,18538,75,0.92 [0.52-1.63],0.7674940419079125
Chapter II Neoplasms,Melanoma in situ,XIAP,E3 ubiquitin-protein ligase XIAP,15491,59,1.17 [0.76-1.79],0.4708266752543079
Chapter II Neoplasms,Melanoma in situ,XPNPEP2,Xaa-Pro aminopeptidase 2,18439,74,0.86 [0.72-1.03],0.1021891893907265
Chapter II Neoplasms,Melanoma in situ,XRCC4,DNA repair protein XRCC4,18002,70,0.96 [0.54-1.72],0.9002869434006271
Chapter II Neoplasms,Melanoma in situ,YAP1,Transcriptional coactivator YAP1,15944,63,0.40 [0.15-1.03],0.0571468248289845
Chapter II Neoplasms,Melanoma in situ,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",15920,63,1.09 [0.92-1.30],0.3076146238710499
Chapter II Neoplasms,Melanoma in situ,YES1,Tyrosine-protein kinase Yes,18305,72,1.13 [0.94-1.36],0.1813999948562136
Chapter II Neoplasms,Melanoma in situ,YJU2,Splicing factor YJU2,15917,63,0.71 [0.32-1.58],0.4084622203701231
Chapter II Neoplasms,Melanoma in situ,YOD1,Ubiquitin thioesterase OTU1,15452,62,1.09 [0.74-1.62],0.6533058172962853
Chapter II Neoplasms,Melanoma in situ,YTHDF3,YTH domain-containing family protein 3,18088,71,1.06 [0.83-1.36],0.6341867952302056
Chapter II Neoplasms,Melanoma in situ,YWHAQ,14-3-3 protein theta,15623,63,1.23 [0.89-1.71],0.2117682440992217
Chapter II Neoplasms,Melanoma in situ,YY1,Transcriptional repressor protein YY1,15491,59,0.38 [0.15-0.98],0.0451369092742234
Chapter II Neoplasms,Melanoma in situ,ZBP1,Z-DNA-binding protein 1,15491,59,1.08 [0.59-1.98],0.8054482293575542
Chapter II Neoplasms,Melanoma in situ,ZBTB16,Zinc finger and BTB domain-containing protein 16,17977,71,1.23 [0.93-1.61],0.1474852934674944
Chapter II Neoplasms,Melanoma in situ,ZBTB17,Zinc finger and BTB domain-containing protein 17,18071,70,0.92 [0.53-1.58],0.7534146529772026
Chapter II Neoplasms,Melanoma in situ,ZCCHC8,Zinc finger CCHC domain-containing protein 8,15452,62,0.61 [0.36-1.05],0.0736515825391238
Chapter II Neoplasms,Melanoma in situ,ZFYVE19,Abscission/NoCut checkpoint regulator,15920,63,1.08 [0.82-1.42],0.5860029581274366
Chapter II Neoplasms,Melanoma in situ,ZHX2,Zinc fingers and homeoboxes protein 2,15944,63,0.86 [0.38-1.94],0.7144425186144197
Chapter II Neoplasms,Melanoma in situ,ZNF174,Zinc finger protein 174,15491,59,0.85 [0.40-1.79],0.6704503753221895
Chapter II Neoplasms,Melanoma in situ,ZNF75D,Zinc finger protein 75D,15697,63,0.94 [0.62-1.43],0.7748078232342135
Chapter II Neoplasms,Melanoma in situ,ZNF830,Zinc finger protein 830,15917,63,0.93 [0.67-1.30],0.6643388085775747
Chapter II Neoplasms,Melanoma in situ,ZNRD2,Protein ZNRD2,15920,63,1.10 [0.78-1.56],0.5809780549517347
Chapter II Neoplasms,Melanoma in situ,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,15917,63,0.69 [0.42-1.13],0.1396665524026526
Chapter II Neoplasms,Melanoma in situ,ZP3,Zona pellucida sperm-binding protein 3,15528,62,1.03 [0.94-1.14],0.4820138356398608
Chapter II Neoplasms,Melanoma in situ,ZP4,Zona pellucida sperm-binding protein 4,15421,61,1.29 [0.70-2.37],0.4145461996168255
Chapter II Neoplasms,Melanoma in situ,ZPR1,Zinc finger protein ZPR1,15489,61,1.08 [0.86-1.36],0.5059642763030279
